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Summary
Vanadium haloperoxidases represent a class of non-heme peroxidases with a high stabil-
ity to organic solvents and high temperatures. These enzymes proved also to be very
stable in presence of excess of their product (HOCl) which will readily inactivate the
heme-haloperoxidases. The active group of the enzymatic system consists in a vana-
date moiety, solely covalently bonded to a histidine residue and embedded in the protein
shell via a strong hydrogen bonding network. Structural similarities between the hydro-
gen bonding site of vanadium haloperoxidases and some acid phosphatases are evident.
An important role for the haloperoxidase activity has been attributed to the hydrogen
bonding interactions which besides the fixation of the prosthetic group in the protein
environment are also activating the peroxide-intermediate.
The goal of this work was the synthesis of vanadium(v) complexes which model
the active site and the catalytic function of these enzymes. Vanadium in the highest
oxidation state proved to be a compulsory characteristic of model complexes, since the
reduced form of vanadium haloperoxidase showed no activity. Therefore, vanadium(v)
complexes with versatile N-salicylidene carbonic acid hydrazide were prepared. Both oxo
and dioxovanadium complexes will be described in Chapter 2 and Chapter 3, with both
types of vanadium coordination compounds regarded as model complexes for the natural
system. Besides the crystallographic description of these complexes, reactivity in solution
will be also discussed.
Starting from a non-substituted aliphatic side chain of the N-salicylidene hydrazide
ligand, new functionalities were introduced stepwise. This achievement had the role to
probe the importance of the amino acid residues which are in hydrogen bonding inter-
action with the equatorial oxygen atoms of the prosthetic group in vanadium containing
haloperoxidases. The modification of the aliphatic side chain will be discussed in sepa-
rate chapters, therefore additional groups such as hydroxyl, amine and guanidine afforded
vanadium(v) complexes with relevant functionalized side chain for the vanadium haloper-
oxidases, namely regarding the serine, lysine and arginine residues.
The mechanism of the catalytic reaction performed by vanadium haloperoxidases
was proposed to take place by addition first of the hydrogen peroxide at the vanadate
1
center to form a peroxo-intermediate which is subsequently able to oxidize the halides
in slightly acidic media. In Chapter 2, the characterization and reactivity of an oxo-
monoperoxovanadium(v) complex is presented. Further on, the cyclization on vanadium
coordination of a short amino-functionalized aliphatic side chain of N-salicylidene hy-
drazide ligand as well as the first example of guanilation reaction of a vanadium coordi-
nation compound will be described in Chapter 4 and 5, respectively.
The cis-dioxovanadium(v) complexes obtained with N-salicylidene carbonic acid
hydrazides proved also to catalyze the biomimetic reaction. The bromide oxidation re-
action by hydrogen peroxide was monitored by bromination of 1,3,5-trimetoxybenezene
in acidified DMF solution. Apart from this specific enzymatic reaction, the model com-
plexes were also able to catalyze the peroxide-mediated oxidation of phenyl methyl sulfide
to the corresponding sulfoxide.
The replacement of vanadate from vanadium haloperoxidase with molybdate or
tungstate yielded an inactive enzyme. Therefore, cis-dioxomolybdenum(vi) complexes
based on N-salicylidene amino-functionalized aliphatic acid hydrazide were also obtained
in order to address the question whether a synthetic molybdenum complex can catalyze
the bromoperoxidase reaction. This was also based on the reported high bromoperoxidase
activity of the inorganic MoO3 (aq.) compound. But, however the cis-dioxomolybdenum
complex based on N-salicylidene dihydropyrrole hydrazide showed no bromoperoxidase
activity, but instead the complex was capable of catalyzing efficiently the oxidation of
sulfide to sulfoxide.
In the last chapter, bis-N-salicylidene hydrazide ligands were prepared by the con-
densation of salicylaldehyde with bis-aliphatic hydrazides. The ligand H4Ln may be con-
sidered as two N-salicylidene hydrazide cavities linked via a methylene chain of variable
length. The ligand is able to bind two metal ions in a hexacoordinate fashion yielding bin-
uclear cis-dioxovanadium(v) and cis-dioxomolybdenum(vi) complexes. The complexes
showed a high efficient capacity in catalyzing the oxidation of sulfide when H2O2 was used
as oxidant. Moreover, a chiral binuclear cis-dioxomolybdenum(vi) complex was isolated
and used as catalyst of the sulfoxidation reaction. The complex proved to be an efficient
catalyst of the reaction, but only 4% ee was obtained when the catalytic reaction was
performed in dichlormethane.
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Zusammenfassung
Vanadium-Haloperoxidasen stellen eine Klasse von nicht-Ha¨m-Peroxidasen mit hoher
Besta¨ndigkeitgegenu¨ber organischen Lo¨sungsmitteln und hohen Temperaturen dar. Diese
Enzyme sind außerdem in Gegenwart von U¨berschuss ihres Produktes (HOCl), was ha¨m-
Haloperoxidasen leicht inaktivieren wu¨rde, sehr stabil. Das aktive Zentrum des enzyma-
tischen Systems besteht aus einer Vanadatumgebung, welche kovalent an nur einen Histid-
inrest gebunden und im Proteinrumpf mittels eines starken Wasserstoffbru¨ckennetzwerks
verankert ist. Strukturelle A¨hnlichkeiten zwischen der Wasserstoffbru¨ckenumgebung von
Vanadium-Haloperoxidasen und einigen sauren Phophatasen sind bewiesen. Eine wichtige
Rolle fu¨r die Haloperoxidaseaktivita¨t wird den Wasserstoffbru¨ckenwechselwirkungen ein-
erseits bei der Fixierung der prosthetischen Gruppe in der Proteinumgebung und ander-
erseits bei der Aktivierung des Peroxid-Intermediates zugeordnet.
Das Ziel dieser Arbeit war die Synthese von Vanadium(v)-Komplexen welche das ak-
tive Zentrum und die katalytischen Eigenschaften dieser Enzyme nachbilden. Die ho¨chste
Oxidationsstufe fu¨r das Vanadium wird als zwingende Eigenschaft solcher Modellkom-
plexe angesehen, da die reduzierte Form der Vanadium-Haloperoxidase keine Aktivita¨t
zeigte. Folglich wurden Vanadium(v)-komplexe mit vielseitigen N-Salicylidensa¨urehydra-
ziden hergestellt. Die Oxo- und Dioxo-Vanadium-Komplexe werden in Kapitel 2 und 3
beschrieben. Sie stellen die zwei Arten von Vanadium-Koordinationsverbindungen dar,
welche als Modell-Komplexe fu¨r das natu¨rliche System angesehen werden. Neben der
kristallographischen Beschreibung dieser Komplexe wird auch ihre Reaktivita¨t in Lo¨sung
diskutiert werden.
Ausgehend von den unsubstituierten aliphatischen Seitenketten der N-Salicylidenhy-
drazid-Liganden werden schrittweise neue Funktionalita¨ten eingefu¨hrt. Dies hat zum Ziel
die Bedeutung der Aminosa¨urereste, welche u¨ber Wasserstoffbru¨ckenbindungen mit den
equatorialen Sauerstoffatomen der prosthetischen Gruppe in vanadium haltigen Haloper-
oxidasen wechselwirken, zu erkunden. Die Modifizierung der aliphatischen Seitenkette
wird in eigenen Kapiteln diskutiert werden. Dabei dienen zusa¨tzliche Gruppen, wie
Hydroxyl, Amin und Guanidin und die davon abgeleiteten Vanadium(v)-Komplexe mit
wichtigen funktionalisierten Seitenketten als Vanadium-Haloperoxidase-Modelle, die spe-
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ziell die Serin-, Lysin- und Argininreste betrachten.
Im postulierten Mechanismus der durch Vanadium-Haloperoxidasen katalysierten
Reaktion findet erst die Addition des Wasserstoffperoxids am Vanadat-Zentrum unter
Bildung eines Peroxo-Intermediates statt, welches dann in leicht saurem Medium die
Halogene oxidieren kann. In Kapitel 2 ist die Charakterisierung und Reaktivita¨t eines
Oxomonoperoxo-Vanadium(v)-Komplexes beschrieben. Weiterhin werden, in Kapitel 4
und 5, die Zyklisierung einer an Vanadium-koordinierten kurzen mit Amino-Funktion
versehenen aliphatischen Seitenkette des N-Salicylidenhydrazid-Liganden sowie das erste
Beispiel einer Guanilierungsreaktion einer vanadium-koordinierten Verbindung beschrie-
ben.
Die cis-Dioxovanadium(v)-Komplexe der N-Salicylidencarbonsa¨urehydrazid-Ligan-
den katalysieren die biomimetische Reaktion. Die Oxidation von Bromid mit Wasserstoff-
peroxid wurde durch die Bromierung von 1,3,5-Trimethoxybenzen in saurer DMF-Lo¨sung
beobachtet. Unabha¨ngig von dieser spezifischen enzymatischen Reaktion waren die Mod-
ellkomplexe in der Lage die peroxidvermittelte Oxidation von Phenylmethylsulfid zum
korrespondierenden Sulfoxid zu katalysieren.
Der Austausch von Vanadat in Vanadium-Haloperoxidasen gegen Molybdat oder
Wolframat fu¨hrte zu inaktiven Enzymen. Es wurden cis-Dioxomolybda¨n(vi)-Komplexe
der N-salicyliden-amnino-funktionalisierten aliphatischen Hydrazide dargestellt um die
Frage zu beantworten, ob ein synthetischer Molybda¨nkomplex die Bromoperoxidasereak-
tion katalysieren kann. Fu¨r die anorganische MoO3(aq.)-Verbindung konnte Bromoper-
oxidaseaktivita¨t nachgewiesen werden. Die auf N-Salicylidenhydrazid basierenden cis-
Dioxomolybda¨n(vi)-Komplexe zeigten leider keine Bromoperoxidaseaktivita¨t, statt dessen
war der Komplex in der Lage die Oxidation von Sulfid zu Sulfoxid effizient zu katalysieren.
Im letzten Kapitel wurden bis-N-Salicylidenhydrazid-Liganden durch Kondensation
von Salicylaldehyd mit bis-aliphatischen Dihydraziden dargestellt. Die Verbindung H4Ln
kann als ligand mit zwei N-Salicylidenhydrazid-Taschen, welche u¨ber eine Methylen-
kette variabler La¨nge verbunden sind, angesehen werden. Der Ligand kann zwei Met-
allionen in Sechsfachkoordination binden, was zu binuklearen cis-Dioxovanadium(v)-
und cis-Dioxomolybda¨n(vi)-Komplexen fu¨hrt. Die Komplexe zeigten eine sehr effiziente
Fa¨higkeit die Oxidation von Sulfid mittels H2O2 zu katalysieren. Ferner wurde ein chiraler
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binuklearer cis-Dioxomolybda¨n(vi)-Komplex isoliert und als Katalysator fu¨r die Sulfox-
idation eingesetzt. Der Komplex stellte sich als effizienter Katalysator fu¨r die Reaktion
heraus, es wurden aber nur 4% ee bei Durchfu¨hrung in Dichlormethan gefunden.
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Chapter 1
Theoretical Background
1.1 History and occurrence of vanadium
Vanadium was first discovered in Mexico in 1802 by the mineralogist A. M. del Rio,
who named the new element ”panchromium” due to its various colors when it changes
oxidation state.
V(II)
V(III) V(IV) V(V)
Later he renamed it ”erythronium” due to the the red colored salts of the new
metal obtained when it was treated with acids. However shortly thereafter he withdrew
his discovery, being convinced that he had discovered only a new source of chromium. In
1831, the element was rediscovered in remnants of iron ore from southern Sweden by the
Swedish chemist N. G. Sefstro¨m, who named it ”vanadin” (vanadium) in honor of the
goddess of beauty, love and youth, ”Vanadis”, commonly known as the goddess Freya
by the Northern Germanic tribes. In the same year, ”erythronium” was reanalyzed by
Wo¨hler who establish its identity with vanadium.1
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Vanadium can be found in earth’s crust in 0.014% abundance, as well as in aquas-
phere in concentrations ranging between 20-35 nM. In ores, vanadium is quite rare, but
nevertheless few examples are known, such as patronite (a mixture of VS4 with SiO2 and
Al2O3), vanadinite (Pb5[(VO4)3Cl]) and carnotite (K[VO2·UO2], a mineral which after
preparation affords concomitantly both uranium and vanadium). Vanadium is instead
more often found in iron ores, clays and basalts, as well as in fossilized organic materials
and crude oil. In seawater, vanadium is the second most abundant transition metal, ex-
isting mainly in the ionic form as H2VO
−
4 . It is contained in red and brown algae
2,3 and in
tunicates, which accumulate vanadium in their blood cells.4,5 However the accumulation
of vanadium by living organisms is not restricted to marine organisms and vanadium-
containing enzymes have been also isolated from terrestrial fungi Curvularia Inaequalis,6
as well as from the toadstool Amanita muscaria where a low molecular weight vanadium
compound has been found.7,8
Vanadium compounds have a large variety of applications, ranging from the semi-
conductoring properties of the V2O5-GeO2 system to the industrial use of V2O5 as cat-
alyst in the production of sulfuric acid. Moreover, a few vanadium complexes have been
reported to posses therapeutic effects, ranging from the insulin-like mimetic peroxovana-
dates9 to the antitumor effect shown by vanadocene dichloride.10
The oxidation state of vanadium varies between -1 and +5, with the exception of
+1, but only the higher oxidation states +3, +4 and +5 are of biological importance.
Vanadium forms stable compounds in the +4 and +5 oxidation states under normal
conditions. Vanadium(iv) chemistry is dominated by vanadyl complexes, which contain
a VO2+ unit. Due to the d1 configuration, vanadium(iv) species can be identified by EPR
spectroscopy when an eight-hyperfine line signal is observed as a consequence of electron-
nuclei (I=7/2) interaction. Vanadium(v) compounds are diamagnetic species and 51V
NMR is a useful tool to characterize them, since the resonances are sensitive to the
coordination sphere of the vanadium center.11 Thus, vanadium in complexes that contain
O and N donor atoms resonate between -400 and -600 ppm. Resonances far downfield
have been reported for vanadium complexes that contain a catecholate and hydroxymate
entity,12 while resonances upfield of -600 ppm have been found in bidentate ligands, such
as peroxide ligands.13 Early 51V NMR spectroscopy studies on vanadium(v)-containing
12
enzyme reported a very broad -1200 ppm resonance.14 The association of the quadrupolar
vanadium nuclei (Q=-0.052·10−28m2) with the protein can be responsible for broadening
of the signal width, but no synthetic vanadium models have been reported to give similar
51V resonances.
1.2 Vanadium in biological systems
Vanadium in the oxidation state +3 has been found in the blood cells of ascidians such
as Ascidia gemmata, and the fan worm Pseudopotamilla occelata.4,15 Ascidians (tuni-
cates or sea squirts) constitute a class of invertebrate marine organisms that accumulate
vanadium(iii). Investigations on these organisms have been made and suggest a redox
conversion of V(v) species from seawater to V(iv) and V(iii), respectively. Isolation and
characterization of such organisms showed that considerable amounts of sulfate coexist
with vanadium(iii).16–18 Vanadium in the lower oxidation state has been reported to be
accumulated especially in morula cells, a class of vacuolated cells of ascidians that are
strongly yellow fluorescent due to the tunichrome content. Tunichromes are polyphenolic
tripeptides (see Figure 1) capable of binding V(iii) and maintaining it in its +3 oxidation
state at physiological pH.19,20 Hypothesis of the implications of these tunichromes in the
redox process of vanadium have been proposed, but the mechanism remains unclear.
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Figure 1: Selected examples of tunichrome ligands, R1=R2=OH, R1=H R2=OH, R1=OH
R2=H, R3=H and/or iso-butyl.
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The accumulation of vanadium(iii) in ascidian blood cells was correlated to the
existence of the anionic transporter and a vanadium transporter has been suggested.21
Vanabis is a vanadium-associated protein complex that has been proposed to facilitate
the transport and accumulation of vanadium in the vacuoles of these organisms.21,22 The
fact that vanabis binds V(iv) preferentially suggests that the reduction takes place before
the vanadium ion binds to the protein. Spectroscopic studies showed that vanadium(v)
persists in blood plasma and that it is trapped by the blood cells, thus facilitating the
reduction to vanadium(iv) and vanadium(iii).22 However, the accumulation and storage
of vanadium(iii) ions by ascidians is still a subject left unsolved and the role of vana-
dium(iii) is both a controversial issue and big challenge for inorganic chemists. The aqua
ion [V(H2O)6]
3+ can be obtained from V2O5 by reaction with acids or by electrolytic or
chemical reductions of vanadium(iv) and (v) under stringent anaerobic conditions. Vana-
dium(iii) can be maintained in solution only under acidic conditions or in the presence of
potent chelate systems, otherwise the aqua vanadium(iii) blue-green ion is rapidly oxi-
dized by air to vanadium(iv) (standard reduction potential vs. normal hydrogen electrode
is 0.337 V for vanadium(iii)).
Vanadium in the oxidation state +4 has been found in vanadium nitrogenases iso-
lated from the nitrogen fixing bacteria Azotobacter 23 and as amavadin isolated from the
mushroom Amanita muscaria.24
The bacterial enzyme nitrogenase is able to catalyze the reduction of atmospheric
N2 to NH3 and is responsible for cycling about 10
8 tons of nitrogen per year from the at-
mosphere to the soil.23,25 The industrial fixation of N2 to form NH3 requires temperatures
between 300 and 500◦C, pressure over 300 atmospheres and the presence of Fe-based cata-
lyst, whereas the nature paradoxically solved the process with relatively small number
of microorganisms called diazotrophs and nitrogenase enzyme systems.23 Nitrogenases
are a class of enzymes that contain two metalloprotein components: the Fe-protein and
the MoFe-protein and/or VFe-protein as cofactors.26 Conventional nitrogenase with the
molybdenum cofactor has been well studied and it has been reported to function by sub-
strate reduction, a process that involves three basic types of electron transfer reactions:
1) the Fe-protein component can be reduced in vivo by electron carriers such as dithio-
nite; 2) transfer of single electrons from the Fe-protein to the MoFe-protein component
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in a MgATP-dependent process with a minimum two MgATPs hydrolyzed per electron
transferred; and 3) electron transfer to the substrate which is bound to the active site
within the FeMo-protein. The overall reaction of dinitrogen reduction by nitrogenases
involves 16 molecules of MgATP under optimal conditions.27
N2 + 8e
− + 8H+ + 16MgATP −→ 2NH3 + H2 + 16MgADP + 16Pi
X-ray crystal structure determination of Mo-nitrogenase showed that the Fe-protein com-
ponent is formed by a [Fe4S4] cluster, while the MoFe-protein component consists of a
[Fe8S7] unit known as P-cluster and a FeMo-cofactor (FeMoco) formed by a [Fe7S9Mo-
homocitrate] center. FeMoco contains a cysteine residue coordinated to the terminal
iron atom in a thiol manner, while the molybdenum atom is coordinated next to the
sulfur bridges by a homocitrate moiety and a histidine residue.28,29 The vanadium-
nitrogenase enzyme, with a VFe-cofactor, is widely distributed with homologous genes to
Mo-nitrogenase enzyme. It has been suggested that the vanadium system does not arise
from a simple substitution of molybdenum from the MoFe-cofactor and the two enzymes
present different reactivity at certain pH values and temperatures.23 Investigations on
V-nitrogenase isolated from Azobacter chroococcum showed that the catalyzed reduction
of dinitrogen to ammonia takes place in a similar manner as with the Mo-nitrogenase
enzyme, but instead a greater amount of H2 is generated and more consume of ATP is
required.25
N2 + 12e
− + 12H+ + 40MgATP −→ 2NH3 + 3H2 + 40MgADP + 40Pi
Based on several methods of characterization (EPR, MCD and Mo¨ssbauer studies23) and,
later, according to crystallographic characterization of a [VFe3S4Cl3(dmf)3]
− complex,
the molecular structure of V-nitrogenases have been proposed to contain similar features
to Mo-nitrogenases (see Figure 2). Several vanadium complexes with a [VFe3S4]
2+ core
have been developed, but none of them have been reported to be capable of reducing
nitrogen to ammonia. A structural Fe-V sulfur bridged cluster [VFe3S4Cl3(dmf)3]
− has
been reported as being able to catalyze the conversion of hydrazine to ammonia.30,31
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Figure 2: Proposed vanadium protein in vanadium-nitrogenase (left) and V-Fe model
complex (right).
Amavadine is a vanadium(iv) complex that contain two equivalents of S,S -2,2’-
hydroxy-iminodipropionic acid (H3hidpa) and one equivalent of vanadium
32 (Figure 3).
The natural product contains five chiral centers, four from chiral carbon atoms all in
a S configuration and the fifth from the manner in which the ligand wraps around the
vanadium.33 The structural elucidation of amavadine was initially controversial, because
it contains a rare example of non-oxovanadium(iv) compound.34 The compound has
great hydrolytic stability and can undergo an irreversible one electron redox transfer,
and therefore it has been proposed as an electron-transfer agent in mushrooms.
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Figure 3: Schematic representation of the H3hidpa ligand and its vanadium complex
amavadine.
Further, amavadine has been reported as catalyst for thiol oxidation,35 peroxidative halo-
genation, hydroxylation and oxygenation of alkyl and aromatic substrates.36 Recently, it
has been reported that amavadine can also convert methane to acetic acid in the presence
of a perdisulfate salt and trifluoroacetic acid. Amavadine can be replaced by vanadium(v)
complexes with ethanolamine, while the trifluoroacetic acid and the
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CH4 CH3COOH
amavadine
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disulfate salt are necessary for reaction to proceed.37
Vanadium in its highest oxidation state has been found in vanadium-haloperoxidase
enzymes isolated from marine algae2,3 and terrestrial fungi.38 Vanadate has been recog-
nized as a structural and electronic analogue of phosphate and is most evident in the
tetrahedral trianionic forms (VO3−4 and PO
3−
4 ). Vanadium(v) forms vanadate and vana-
date derivates in aqueous solution and the analogy with phosphorus chemistry is extended
to its electronic properties as a consequence of the similarity between the pKa values of
vanadate and those of phosphate.39
H3VO4 + H2O ⇀↽ H2VO
−
4 + H3O
+ pKa=3.5 (2.1 for H3PO4)
H2VO
−
4 + H2O ⇀↽ HVO
2−
4 + H3O
+ pKa=7.8 (7.2 for H2PO
−
4 )
HVO2−4 + H2O ⇀↽ VO
3−
4 + H3O
+ pKa=12.5 (12.7 for HPO
2−
4 )
A notable difference is the existence at physiological pH of vanadate as a mono-anion
H2VO
−
4 , while phosphate exits primarily as the dianion HPO
2−
4 . In contrast to phosphate
chemistry, where H3PO4 is very stable, the similar H3VO4 is not well documented and
its existence is doubtful. Under strongly acidic conditions (pH=1), VO+2 is the major
species in aqueous vanadate solutions. This species is thermodynamically stable due to
the hydration effect which increases its coordination number.40 At around neutral pH,
H2VO
−
4 and H2VO
2−
4 oligomerize to form dimers (a), tetramers (b) and pentamers (c).
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These vanadium anhydrides are analogous to pyrophosphate and polymeric phosphate
anhydride. The tetrameric and pentameric vanadates are cyclic in solution and fail to
show a linear analogy with biologically linear phosphates.
Both vanadium and phosphorus form esters varying from the tetra-coordinated
phosphorus esters to the common five-coordinated vanadium esters. Four-coordinated
V–P analogy exists in biphenolic diol,41 phenoxide42 and tri-tert-butyl-siloxide43 when a
bulky group introduced in the alkoxide molecules leads to a sterically restricted coordina-
tion number of the vanadium atom. Nevertheless, examples of four-coordinated vanadium
atoms are quite rare and vanadium generally has a higher coordination number.
R'
O O
But ButV
O Cl
R R
O
O
O
V
O
V
Ph3SiO OSiPh3
Ph3SiO
O
Vanadium esters (alkoxides) formed in aqueous solution have been reported to be
substrates for phosphate-involving enzymes, such as dehydrogenase, isomerase and al-
dolase.44–47
ROH +H2VO
−
4
⇀↽ ROVO3H
− + H2O
The formation of such esters take place rapidly at room temperature, while phos-
phate ester bond formation is much slower. Moreover, the vanadate-ester bond is more
labile in aqueous solution than the analogues phosphorus bond.48 A biologically impor-
tant vanadate ester formation results from the reaction of vanadate with D-glucose, an
organic ligand containing several hydroxyl groups capable of forming vanadate esters.
Indeed 1H and 13C NMR investigations have confirmed the coexistence of several species
in solution. However, it has been reported that a small amount of glucose-6-vanadate
complex is also formed. This glucose-6-vanadate has been reported to be recognized
by glucose-6-phosphate dehydrogenase, resulting in a rapid oxidation of D-glucose to
D-gluconate in presence of the vanadate.44,45
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Although there are many parallels between vanadate and phosphate in their chemi-
stry and biological action, there are also notable differences. For instance vanadium(v)
can be easily reduced to V(iv), while phosphate cannot. Vanadium, due to its d-
orbital, can adopt coordination numbers of 5, 6, 7 and 8, while phosphorus in biologi-
cally relevant compounds is four-coordinated. Penta-coordinated phosphate is thermo-
dynamically unstable and has been reported only for high-energy intermediates, whereas
penta-coordinated vanadate is a common feature for vanadium compounds. Penta-
coordinated vanadium compounds are therefore regarded as analogues for phosphate
transition states.49
A large variety of phosphate-metabolizing enzymes including phosphatases,
ATPases and ribonucleases have been reported to be strongly inhibited by vanadium com-
plexes. These enzymes catalyze the hydrolysis of phosphate ester bonds via a mechanism
that involves the formation of penta-coordinated phosphate as high-energy transition
state. The potent inhibition of these enzymes by vanadate is due to the chemical similar-
ities between vanadate and phosphate,50 with vanadate functioning as a transition state
analogue.
Phosphatase enzymes can be divided into three main categories, according to the
amino acid residue involved in the intermediate phosphate ester formation. Therefore,
alkaline phosphatases have a nucleophilic serine residue in the active phosphate ester, acid
phosphatases are based on a histidine residue linked to the ester and protein phosphatases
contain a cysteine residue resulting in a thiophosphate ester (Figure 4).
The inhibition of phosphatases by vanadium compounds indicates that vanadate
mimics the five-coordinate transition state of phosphate ester hydrolysis. Because the
acid and alkaline phosphatases are compatible with vanadium(v) compounds, they have
been particularly well studied.
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Figure 4: Schematic representation of the phosphointermediate esters in alkaline phos-
phatase (Ser residue), in acid phosphatase (His residue) and protein phosphatase (Cys
residue).
The cis-dioxovanadium complex with dipicolinate, which contains a five-coordinated
metal center, is known as the strongest inhibitor of these classes of phosphatases.51 How-
ever, protein phosphatases are also inhibited by vanadium compounds and here it is
worth mentioning the tyrosine-phosphatase, an enzyme involved in signal transduction
mechanisms for controlling and regulating intracellular processes, e.g. in the insulin re-
ceptor system.52 The inhibition of protein-phosphatases is likely to be important for
the insulin enhancing effect of vanadium compounds and their therapeutic antidiabetic
effect has been correlated with the possibility of increasing the autophosphorylation of
the insulin receptor on a tyrosine residue, as well as to the stimulation of the transloca-
tion of the insulin-like growth receptor from an intracellular compartment to the plasma
membrane.53,54 This process is analogous to the insulin-induced movement of the glucose
transporter from an intracellular compartment to the plasma membrane55 and it has been
postulated that, while vanadium complexes can not substitute insulin, they can manifest
insulin enhancing actions.9
1.3 Vanadium-containing haloperoxidase enzymes
Haloperoxidases are enzymes capable of catalyzing the two-electron oxidation of halides
by hydrogen peroxide forming hypohalous acid (HOX).6,56 There are two main categories
of haloperoxidases: those based on the heme group which are called heme-containing
haloperoxidases and the second group is represented by non-heme haloperoxidases. The
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latter class of haloperoxidases are subdivided into two categories: vanadium-containing
haloperoxidases, with vanadate as prosthetic group, and ”metal-free” haloperoxidases,57
respectively. The nomenclature of haloperoxidases is established according to the most
electronegative halide which can be oxidized catalytically. Therefore vanadium-containing
chloroperoxidases (V-CPO) catalyze the oxidation of Cl−, Br− and I−; vanadium-contai-
ning bromoperoxidases can catalyze the oxidation of Br− and I− and vanadium-containing
iodoperoxidases have been reported as catalyst for oxidation of I−. The first report of an
enzyme-based vanadate date from 1984, when Vilter discovered that the bromoperoxidase
enzyme isolated from a brown algae, Ascophyllum nodosum, is inhibited by phosphate
and the enzyme could not be re-activated by iron or other metals.2 Thus, he established
the existence of a new class of ”non-heme” haloperoxidases. Since then, the interest in
studying vanadium haloperoxidases has increased and several sources of isolation have
been reported. Vanadium bromoperoxidases can be also isolated from the red seaweeds
Corralina pilulifera3 and Corralina officinalis58 and from Macrocystis pyrifera.59 Vana-
dium chloroperoxidases have been found in the terrestrial fungi Curvularia inaequalis.6
More recently, vanadium-iodoperoxidases have been isolated from Pelvetia canalicuta60
and the Laminariaceae family.61
Vanadium chloroperoxidase enzymes are the most studied vanadium-containing en-
zymes and crystal structure determination of the azide-substituted form, the apo-form
(metal free) and the tungstate-containing enzyme are available.62 The crystal structure
determination of the native form of the enzyme was first reported in 199638 by Messer-
schmidt et al., for the V-CPO enzyme isolated from Curvularia Inaequalis. This showed
vanadate as the prosthetic group linked to the protein through only a covalently bonded
histidine residue (His496). The protein fold is mainly α-helical, with two four-helix bun-
dles as structural motif. The vanadate moiety is located at the top of one of them, in
a broad channel that is lined on one hydrophilic and one hydrophobic half, respectively.
The proposed geometry of the vanadium atom is trigonal bipyramidal, with three non-
proteinous oxygen atoms in the equatorial plane and the fourth, in the apical position,
postulated as an OH group (V–O 193 pm). An extensive hydrogen bonding interac-
tion has been observed, that is capable of fixing the vanadate in the protein shell. The
equatorial oxygen atoms of the prosthetic group are in hydrogen bonding contact with
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positively charged amino acid residues, such as Lys353, Arg360 and Arg490 (Figure 5).
The lysine and one arginine amino acid are also used to compensate for the negative
charge of the vanadate moiety. Moreover, the Arg490 residue is further stabilized and
kept close to the active binding site by the formation of a salt-bridge with an aspartate
residue, namely Asp292. Other key residues in the active site are Gly403 and Ser402,
also forming hydrogen bonds with the equatorial oxygen atoms. Furthermore the His404
residue is the single amino acid hydrogen bonded to the apical hydroxy group. All these
amino acids play a very important role in the chloroperoxidase activity.
Figure 5: Crystal structure of the Vanadium chloroperoxidase isolated from Curvularia
Inaequalis.
Mutagenesis studies performed by replacement His496 with alanine has been re-
ported and support its vital role63 in stabilizing the vanadate group through covalent
bond of Nε atom of the imidazole ring. The site-direct mutant with alanine yields the
inactive apo-enzyme due to the incapacity of the enzyme to bind vanadate. A mutage-
nesis experiment on His40438 with alanine resulted in the loss of chlorination activity,
but the mutant still functions as a partial bromoperoxidase.64 The vital role of the se-
cond histidine residue in the catalyzed chloride oxidation reaction has been explained
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as a possible acid-base role during catalysis. Steady-state kinetic data suggests the
acid-base role is played by vanadate-coordinated water or a histidine residue, due the
determined pKa value of 5.6-6.5.
65 The single alanine mutant of the positively charged
amino acids (Lys353, Arg490 and Arg360) have been also reported as inactive vanadium
chloroperoxidases, but still with vanadium bromoperoxidase function.63 Replacement of
vanadate with other oxo-metals, such as molybdate and tungstate has also been stu-
died. The crystal structure of vanadium chloroperoxidase with tungstate in the active
site has been reported. By comparison to the vanadate-containing enzyme where the
vanadium-histidine bond is strong (211 pm), the tungstate-containing enzyme contains a
very weak W–N(His) (255 pm) bond.62 When vanadate was replaced by molybdate, the
molybdate-containing chloroperoxidase was incapable of performing the catalytic reac-
tion, although the protein environment is able to bind molybdate.62,66 This observation
demonstrates the affinity of the enzyme for vanadate, while the results from site-direct
mutagenesis studies clearly show the importance of the hydrogen bonding interaction
in the catalytical activity of the enzyme. Apparently, any change in the vicinity of the
prosthetic group converts V-CPO to V-BPO, while substitution of vanadate with similar
oxometalates yields an inactive enzyme.
Spectroscopic and kinetic studies on the oxidative halogenation of V-CPO showed
no change in the redox state of the transition metal during the catalytic cycle. The
vanadate functions as a Lewis acid,67 reacting first with hydrogen peroxide to form a
side-on bound peroxide, which subsequently reacts with the halide.6 Crystal structure
determination of such a peroxo-chloroperoxidase has also been reported6 and is depicted
in Figure 6. The vanadium atom has a distorted tetragonal geometry with an apical
oxygen atom, while the η2 coordinated peroxide, the histidine residue and another non-
proteinous oxygen atom are in the basal plane. The His404 is no longer in hydrogen
bonding contact with the oxygen atoms of the peroxovanadate moiety, but instead the
Lys353 residue is activating one of the peroxo-oxygen atoms through hydrogen bonding
interaction.
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Figure 6: Crystal structure of the peroxo form of vanadium chloroperoxidase.
The catalytic cycle proceeds through hydrogen bonding network. For instance lys
residue activates the intermediate peroxide prior to halide attack by increasing the elec-
trophilicity on the Operoxo oxygen.
68,69 Acid requirement for the catalytic turnover has
been reported with the enzyme functioning optimally at pH 5.0 by forming a strong
oxidizing intermediate with a protonated peroxide group (see Figure 9).
The X-ray structure determination of the vanadium bromoproxidase isolated from
Ascophyllum nodosum has been also reported in 1999 by Vilter et al. at 2.0 A˚.70 There is a
significant overlap of the active site between the two vanadium-containing enzymes, with
a highly conserved vanadate binding site motif (see Figure 7). The vanadium atom has a
distorted trigonal bipyramidal geometry with three non-proteinous oxygen atoms in the
equatorial plane and the hydroxyl group and histidine (His486V −BPO and His496V −CPO)
residue in apical positions. The equatorial oxygen atoms of the vanadate moiety are
also involved in hydrogen bonding interactions with the amino acid residues of the same
chemical structure, i.e His418, Lys341, Arg349, Arg480, Ser416 and Gly417. The diffe-
rence appears first in the further hydrogen bonding interactions of the arginine residues,
respectively Arg480V−BPO and Arg490V−CPO, that are part of vanadate-binding site. In
V-CPO this arginine residue forms a salt-bridge to Asp292, while in V-BPO Arg480
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is hydrogen bonded with an amino acid residue (Thr275) from the second shell of the
protein environment. The main difference between the two enzymes is the presence of an
additional histidine residue (His411) in V-BPO near the vanadate-binding site instead
of Phe397 in V-CPO. In the peroxo-form of V-CPO, the peroxide moiety is directed
towards Phe397 and forms a hydrogen bond with the Lys353 residue, whereas when the
peroxovanadate is modelled into V-BPO, the additional His411 residue will be within
hydrogen bonding distance. Therefore in V-BPO the additional histidine amino acid
might be an additional donor/acceptor site.
Asp292
Thr275
His411
Phe397
V
Lys
His404 (V-CPO)
His418 (V-BPO)
Arg
Figure 7: Overlay of the active site of V-CPO isolated from Curvularia Inaequalis (black
drawings) with active site of V-BPO isolated from Ascophyllum nodosum.
Nevertheless, besides these differences, the two vanadium-containing enzymes have
an α-helical structure, formed by two four helix bundles with a common active vanadate-
binding site feature that highlights the close relationship between them and could be an
evidence of a common genetic origin. The substrate affinity of the enzymes for diffe-
rent halide oxidation reactions has been structurally attributed to the catalytic histidine
residues (His418V −BPO and His404V−CPO). These amino acids are stabilized differently in
the two enzymes via hydrogen bonding interactions with the amino acids in their vicinity,
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being tight in V-BPO and, therefore, leading to a different pH dependence.
The importance of these enzymes lie in their role in the halogenation of various
organic substrates by HOX, formed in the enzyme-catalyzed reaction.59,71,72 This can
have industrial applications, since many halogenated derivatives are of pharmaceutical
use and/or used for synthesizing active compounds. If no organic scavenger is present, the
oxidized halide reacts with an additional hydrogen peroxide to form singlet oxygen.73–75
X− + H2O2 + RH
V−HPO−→ RX + 2H2O
X− + H2O2
V−HPO−→ 2H2O + 1O2
The vanadium-containing bromoperoxidases are enzymes with high thermal stabi-
lity, presenting significant activity at temperature up to 70 ◦C. Moreover, this class of
enzymes shows high tolerance to organic solvents, e.g. methanol, ethanol, iso-propanol
and acetone do not inactivate the enzyme and can be used for enzyme purification.71
Vanadium bromoperoxidases are also unaffected by detergents and their activity is still
detectable after electrophoresis with sodium dodecyl sulfate.76 Since crystallographic de-
termination of the two enzymes shows high similarities in the vanadium-binding active
site, it is most likely that these peroxidases share the same stability. Additionally, V-
HPOs support a high concentration of both their substrate (H2O2) and their product
(HOX), which would readily inactivate the corresponding heme-haloperoxidases. Thus,
the haloperoxidases with vanadate as prosthetic group represent potent biocatalyst can-
didates for industrial applications in organic synthesis.
The Fe-heme moiety from heme-haloperoixdase isolated from the fungus Caldari-
omyces fumago is oxidized by hydrogen peroxide to form a Heme+Feiv=O intermediate
capable of oxidizing the halide ion.77 In this case, the mechanism involves a redox process,
whereas in V-HPOs this mechanism is not operative and the vanadium atom does not
change its oxidation state, rather it functions as Lewis acid.78 Mechanistic investigations
involving kinetic and product analysis suggest initial addition of H2O2, resulting in the
formation of a side-on peroxide, followed by subsequent reaction with halide.68 Spectro-
scopic investigations for VO2-O2 species were monitored by
17O NMR and showed the
formation of the peroxo-intermediate, but no evidence for an intermediate in which the
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halide binds to the vanadium atom.79 The rate-determining step in the catalytic cycle
is the nucleophilic attack of the halide on the active peroxide-intermediate, generating
HOX. This intermediate oxidized halide is able to halogenate a large variety of organic
substrates. The proposed mechanism of the reaction is depicted in Figure 8.
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Figure 8: Schematic representation of the proposed mechanism of vanadium haloperoxi-
dases catalyzed reactions.
A different pH dependence has been reported for the two types of vanadium halopero-
xidases, varying from pH 5 for vanadium chloroperoxidase to pH 6.5 for vanadium bro-
moperoxidase. On these basis the intermediate peroxide was proposed to be different
(see Figure 9). Protonation of the peroxo-intermediate has been proposed in the case of
V-CPO, which requires an acidic medium for catalyzing the reaction. This is explained
as a consequence of the higher electronegativity of the chloride compared to bromide.
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Figure 9: Peroxo-intermediate for V-CPOs (left) and V-BPOs (right).
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The classic organic substrate for evaluating haloperoxidase activity is monochlordi-
medone (2-chloro-5,5-dimethyl-1,3-dimedone; MCD).80 The reaction can be followed spec-
trophotometrically at 290 nm as a consequence of different absorption coefficient between
the enol and ketone forms (Figure 10). In addition, phenol red can be used as organic
substrate for oxidative bromination, resulting in the formation of bromphenol blue.81
OH
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O XCl OO
+ Cl- + H2O2 H++
V- HPO
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ε = 20.000 M-1cm-1
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Figure 10: Halogenation of specific substrate, MCD, by vanadium-dependent chloropero-
xidases (upper reaction) and the catalytic bromination of phenol red to bromophenol
blue and their tautomerization equilibria (lower reaction).
Furthermore, V-HPOs exibit chemo-, regio- and stereoselectivity, which leads to
the conclusion that the oxidized bromide is not diffusible, but is instead linked to the
enzyme.82 Competitive kinetic studies comparing the bromination of indoles and MCD as
substrates in equimolecular amounts, using V-BPO/H2O2/Br
−, showed that the enzyme
catalyzes preferentially the bromination of indole derivatives over MCD. In contrast, the
same reaction performed with aqueous bromine showed the simultaneous bromination of
all substrates present in solution.82–84 The first regiospecific bromoperoxidative oxidation
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was reported using 1,3-di-tert-butylindole as substrate, which, in the presence of H2O2
and Br−, is oxidized quantitatively to 1,3-di-tert-butyl-2-indolinone with no brominated
product (Figure 11). Conversely, the chemical reaction with aqueous bromine solution
produces a mixture of brominated 2-indolinone derivatives.85
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Figure 11: V-BPO catalyzed regiospecific bromoperoxidative oxidation of 1,3-di-tert-
butylindole.
The only reported stereoselective reaction catalyzed by V-HPO is the oxidation
of sulfides in the absence of halides. The oxidation of sulfides has been studied quite
extensively in the recent times, especially when it proceeds in a stereospecific manner.
Enantiopure sulfoxides are useful synthons in asymmetric synthesis and they have wide
application in the pharmaceutical industry.86 Methodologies for catalytic asymmetric
sulfide oxidation are based on transition metal complexes, such as complexes of titanium,
vanadium, chromium, iron and manganese with chiral Schiff base ligands. Vanadium
haloperoxidases also catalyze the oxidation of sulfides to the corresponding sulfoxides,
varying from an enantiolselective behavior in the case of the vanadium bromoperoxi-
dases87,88 to a racemic mixture of sulfoxides when vanadium chloroperoxidase89 is used
as catalyst (Figure 12). The reaction rate of enantioselective oxidation of methyl phenyl
sulfide is rather slow (about 1 min−1), but occurs with 96% ee for the (R)-enantiomer
when the V-BPO is isolated from Ascophyllum nodosum and 55% ee of the (S )-enantiomer
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Figure 12: Enatioselective oxidation of thioanisole by vanadium bromoperoxidases.
when V-BPO is isolated from Coralina pilulifera.87,88,90,91
The ability of these vanadium-dependent bromoperoxidases to produce different
enantiomers suggests that subtle differences present near the vanadium-binding site are
also very important for the catalytic activity. This is also obvious when comparing
the V-BPOs and V-CPOs, where different mechanisms have been suggested in order to
explain the observed results. Nucleophilic attack of the sulfide at the peroxo intermediate
take place when V-BPOs are used as catalyst, whereas a radical mechanism have been
proposed in the case of V-CPOs-catalyzed sulfide oxidations. The later case consists in
the formation of a positively charged sulfur radical R2S
•+ that is chemically oxidized.
The suggested mechanism (see Figure 13) was confirmed by H182 O2-labeled experiments
and might explain the different reactivity of the two enzymes.89
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Figure 13: Schematic representation of the supposed mechanism of sulfur oxidation by
vanadium bromoperoxidase (left) and vanadium chloroperoxidase (right).
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1.4 From vanadium haloperoxidases to acid phos-
phatases
Hydrogen bonding interactions are of great biological relevance and their important role
in the regulation of metal ion reactivity is well documented.92 In the case of vanadium
haloperoxidases, an example has been found in the activation of the peroxo form of the
enzyme, where the coordinated peroxide is activated via hydrogen bonding interaction
with the nearest amino acid residue. Another important role of the hydrogen bonding
interactions in natural systems is related to the recognition and transport of ions. In
this case, of particular interest is the analogy between vanadate and phosphate, the
importance of the hydrogen bonding interaction on the mechanism of the phosphate
transport system being well established.93,94
The prosthetic group vanadate of V-HPO can be removed by incubation of the
enzyme in the presence of phosphate, resulting in the formation of apo-enzyme.2 The
reconstitution of the halo-form is achieved by back-reaction with vanadate at neutral pH,
but the reconstitution is inhibited competitively by phosphate, molybdate and arsenate,
which are structural analogs of vanadate. The inactivation of vanadium haloperoxidases
by phosphate can be prevented by addition of H2O2 in line with the reported affinity of
the active site of V-HPO for peroxovanadate.95 On the other hand, phosphatase enzymes
are also reported to be inhibited by vanadate, indicating a possible common architecture
of the active site within these two different types of enzymes. Indeed the structural simi-
larity between vanadate and phosphate results in a striking connection between vanadium
haloperoxidase and several phosphatases,96 with the amino acid sequence of the active
site of V-HPO conserved within three families of acid phosphatases, including lipid phos-
phatases, mammalian glucose-6-phosphatase and bacterial nonspecific acid phosphatases.
Several phosphatase enzymes have been crystallographically characterized with vanadate
as transition state analog. The structurally characterized V-CPO shows vanadate linked
to the protein only through an axially bound histidine residue and fixed in the protein
shell via strong hydrogen bonding interactions. A similar motif has been found in rat
prostatic acid phosphatase from Escherichia blattae, with vanadate as transition state
analog covalently bound to His12 residue.97
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Figure 14: Crystal structure of the vanadate binding site in rat prostatic acid phosphatase
from Escherichia blattae.
The vanadate forms a strong hydrogen bonding interaction with the nearby amino acid
residues of the same chemical structure to the key amino acid residues that are hydrogen
bonded to the prosthetic group in vanadium haloperoxidase enzymes. This similarity
confirms that these two classes of enzymes are related evolutionarily and share the same
ancestor.98
The most interesting acid phosphatase is mammalian glucose-6- phosphatase, a key
enzyme in glucogenesis and glucose homeostasis, which is potently inhibited by vana-
date.99 Deficiency of this enzyme causes glycogen storage in the liver, leading to von
Gierke disease and subsequent earlier patient death. Due to the problematic isolation and
purification of this enzyme, a real crystal structure determination has not been reported,
but, based on similarities between vanadium haloperoxidase and acid phosphatase, a
prediction of the molecular structure is now possible.96
V-HPOs and phosphatases have different biological functions. The former catalyze
the oxidation of halides, whereas the later catalyze the hydrolysis of phosphoesters and
phosphor anhydride bonds. As previously described, since these two different types of
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enzyme share the same supramolecular environment at their active sites, it is reasonable
to assume that both may exhibit the dual activities. Indeed, the apo-form of V-CPO has
been reported to exhibit phosphatase activity, catalyzing the hydrolysis of p-nitrophenyl
phosphate with a turnover rate of 1.7 min−1 of p-nitrophenol.64 The possibility that per-
oxidase activity could be observed for vanadate-incorporated phosphatases has also been
investigated. The vanadate-substituted acid phosphatases have also been reported to
exhibit haloperoxidase activity, catalyzing the oxidative halogenation of bromide.100 The
turnover values for vanadium-substituted phosphatase enzymes have been reported to be
3.4 to 33 min −1, depending on the vanadate-recombined acid phosphatase. This turnover
rate is much slower than the catalytic activity of the native vanadium bromoperoxidase
from Ascophyllum nodosum. At this time, analogy between these two classes of enzyme
includes both structural and catalytic aspects, although it is obvious from kinetic data
that the active site of vanadium haloperoxidase is not optimized for phosphatase activity
and vice versa.
1.5 Model complexes for vanadium haloperoxidases
The discovery of V-HPOs has increased the interest in vanadium chemistry. A large num-
ber of vanadium complexes have been reported in recent decades as model compounds for
the native enzymes and they contain both vanadium(v) and vanadium(iv) moieties. The
crystallographic characterization and spectroscopic investigation of the native forms of
V-CPO and V-BPO, as well as the peroxo-form, restricted the development of vanadium-
model complexes with vanadium in the highest oxidation state only. It has been shown
that these enzymes lose their activity on reduction101 of the vanadate moiety and that
the activity is fully restored by re-oxidation of vanadium atom,2,81 demonstrating that
vanadium(v) plays a vital role in the catalytic activity. Two general categories of com-
plexes have been described as structural models for haloperoxidase enzymes. The first
class, defined by oxo- and dioxo-vanadium(v) complexes based on ligands with oxygen
and nitrogen donor atoms, contains the largest number of compounds. Within this class
the Schiff base compounds are the largest group. Some examples are shown in Figure 15
(1.1-1.4, 1.8).
33
NO
O
O
Me
C
N
V
O
O
-
O N
O O
N+HN
V
O
O
-
N
N
N
O
V
O O
N
N
N
H
N
N
V
O
PrO OPr
N
O
N
H
O
NH2
V
O O
N
N
O
N
O
R
V
O OCH3
CH2OH
-
N N
O
OO
V
O
N
O NH
OHV
O O
1.1 1.2
1.4
1.5 1.6 1.7 1.8
1.3
Figure 15: Structural model complexes for vanadium-dependent haloperoxidases. (1.1,102
1.2,103 1.3,104 1.4,105 1.5,106 1.6,107 1.7,108 1.8109).
The second class of model compounds includes peroxovanadium(v) complexes.
These complexes are of interest not only because they are able to model the peroxide
intermediate of the catalytic cycle, but also because of their use as catalysts in organic
synthesis. Numerous oxo-peroxo- and oxo-di- and/or tri-peroxovanadium complexes cat-
alyze a variety of net two-electron oxidation reactions, e.g. epoxidation and hydroxylation
of alkenes and allylic alcohols, oxidation of sulfides to sulfoxides, hydroxylation of ben-
zene and other arenes, oxidation of primary and secondary alcohols.110 Moreover, peroxo-
vanadium complexes also perform the oxidation of a thiolato Co(iii) complex to sulfenato
complex, 2,2’-bipyridine to picolinic acid and the oxidation of sulfur dioxide to sulfate.
An intriguing reaction is represented by a C6-substitution of nicotinic acid performed
by peroxovanadium complexes in aqueous ethanol to give 6-(1-hydroxyethyl)nicotinic
acid.110 A wide range of peroxovanadium complexes has been reported with a side-on
bound peroxide containing a V–O bond length of around 185 pm and an O–O bond of
140 pm, respectively, with a vanadium atom usually six or seven-coordinated. Some of
these complexes have also been described as functional models capable of catalyzing the
oxidation of bromide in acetonitrile with a turnover rate of ca. 300 product hour−1.111
In addition, peroxovanadium complexes have been reported as insulin-enhancing com-
pounds. Administration to cell cultures was found to increase protein phosphorylation
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Figure 16: Selected peroxo-vanadium model complexes for vanadium-dependent haloper-
oxidases. (1.9,112,113 1.10,114 1.11, 1.12111).
of the insulin receptor presumably by inhibition of protein phosphatases.
A very important characteristic for structural models of vanadium dependent halo-
peroxidase enzymes is the existence of similar hydrogen bonding patterns. Unfortunately,
at this time, only two reported systems exhibit hydrogen bonding network similar to that
found in the natural system (Figure 17).
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Figure 17: Peroxovanadium complexes modelling the hydrogen bonding interaction found
in the peroxide form of vanadium chloroperoxidases.
The first model complex, 1.13, contains an intramolecular hydrogen bonding inter-
action established by a pendant amine functionality and the oxygen atom of the peroxide
group,115 while in the second case, 1.14, the peroxo-oxygen atom is in hydrogen bonding
contact with a water molecule.116 Both peroxo-vanadium(v) complexes model struc-
turally the peroxo-intermediate of the vanadium chloroperoxidase enzymes.
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Besides structural similarities, an important role is attributed to functional model
complexes and, in this direction insight into the mechanism of haloperoxidase reactions
can be achieved using model compounds. This is due to their ease of isolation and the
availability of many methods of characterization and monitoring, something not easily
accessible with the enzymes. The first reported functional mimic of V-HPOs enzyme was
reported by Butler et al. in 1992 for cis-dioxovanadium(v) species. Here, the peroxidative
bromination of 1,3,5-trimetoxybenezene (TMB) was monitored.117 A detailed mechanism
involving the reactivity of ammonium vanadate with H2O2 under acidic conditions has
been described (see Figure 18) and differences regarding the proposed mechanism of the
enzymatic system have been presented. These comprise firstly the more acidic medium
required for the synthetic model to catalyze the oxidation of bromide by hydrogen per-
oxide, with cis-VO+2 working optimally at pH around 2. The second difference concerns
the active intermediates formed by reaction of vanadate with hydrogen peroxide. In this
system, the reaction with H2O2 leads to formation of monoperoxo- or diperoxo vanadium
species, in a ratio strongly dependent on hydrogen peroxide and acid concentrations. 51V
nuclear magnetic resonance monitoring of the catalytic reaction showed the formation of
a mono-peroxovanadium (VO(O2)
+) complex, independent of the pH conditions, while
the formation of the diperoxo vanadium (VO(O2)
−
2 ) species depends of the amount of
acid used and is less favored at high acid concentrations (Figure 18). Neither VO(O2)
+,
nor VO(O2)
−
2 oxidize bromide, rather they combine to form the dinuclear dioxo-triperoxo
vanadium(v) complex, (VO)2(O2)3, which is the actual oxidant.
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Analogous to the vanadate-catalyzed oxidation of bromide by H2O2, Secco car-
ried out detailed kinetic studies on vanadate-catalyzed iodide oxidation. The reaction of
cis-VO+2 with H2O2 yielded the mono- and diperoxovanadium(v) species, as described
previously, but no dimerization was observed. On the other hand, a different reactivity to-
wards reaction with halide, namely iodide, has been observed. Reduction of VO(O2)
+ and
VO(O2)
−
2 by iodide takes place, resulting in the formation of vanadyl (VO
2+) species.119
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Figure 18; Proposed mechanism of vanadate-catalyzed peroxidative bromination of 1,3,5-
trimethoxy benzene (TMB).
These reports demonstrate that even simple inorganic salts can catalyze the ox-
idation of halide by hydrogen peroxide, although they follow a different mechanism
than the enzymatic system. Therefore vanadium coordination compounds are expected
to enhance or to retard the catalytic reaction and, perhaps, to show closer mechanis-
tic features to the enzymatic catalysis. The same author also investigated the per-
oxidative bromination reaction of TMB using N-(2-carboxyphenyl) salicylideneamine,
[(HPS)VO(OEt)(EtOH)].120 Using DMF as solvent and HClO4 as the source of acidic
conditions, the mechanism of the peroxidation of bromide was shown to take place by
formation of a mono-peroxovanadium(v) complex, [(HPS)VO(O2)]
−, as the active inter-
mediate (Figure 19). The reaction has been proposed to proceed first by protonation of
the oxo-vanadium(v) catalyst to form a [(HPS)VO(OH)] moiety that consequently re-
acts with hydrogen peroxide resulting in the formation of the mono-peroxovanadium(v)
complex. Addition of bromide affords one turnover cycle of oxidized bromide which
brominates one equivalent of TMB. The bromination reaction becomes catalytic when
acid is present at least in equimolecular amounts with respect to H2O2. The reactiv-
ity of the mono-oxovanadium(v) complex in solution has been monitored by 51V NMR
and UV-Vis spectrophotometry, while the monitoring of the reaction was performed by
GC determination of the formed Br-TMB compound. The catalytic activity was higher
than for the previous described ammonium vanadate, but the acidic condition were still
required for the reaction to be catalytic.
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Figure 19: Proposed mechanism of peroxidative bromination reaction of 1,3,5-trimethoxy
benzene (TMB) catalyzed by mono oxovanadium(v) complex.
Moreover, it has been proved that the bromination of an organic substrate in the
above used conditions proceeds exclusively via an electrophilic mechanism and that no
radical intermediates are involved in the reaction. Therefore, the chlorination of a toluene
derivative has been performed and only the electrophilic products were detected, with no
chlorination occurring at the methyl group.
The best catalytic results have been reported by Pecoraro et al. using the vana-
dium(v) complexes 1.11 and 1.12, depicted in Figure 15. Starting from the correspond-
ing cis-dioxovanadium(v) complexes, a detailed mechanism of the oxidation of bromide
has been provided.121 One key point in the catalytic reaction is the use of acetonitrile as
solvent, as no reaction was observed in purely aqueous conditions. The kinetics of perox-
ide binding to cis-dioxovanadium(v) complexes, VO2L, to form the oxo-peroxovanadium
complexes is first order in VO2L. One very important factor for performing the catalytic
oxidation of bromide in acetonitrile was the need for one equivalent of acid. In the absence
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of acid no reaction occurred, suggesting that the peroxo-complexes should be protonated,
presumably at the peroxide group, in order to be activated. Further spectrophotometric
investigations revealed a slight red-shift of the peroxo-to-vanadium charge transfer band
when one equivalent of acid had reacted with the peroxo complex 1.12 (Figure 15). A
mechanism consistent with that of the enzymatic system has been proposed and includes
a partial positive charge on the protonated peroxide oxygen atom that will favor the
nucleophilic attack of the halide121 (Figure 20).
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Figure 20: Proposed mechanism of halide oxidation by cis-dioxovanadium(v) complex.
Although much progress has been achieved in recent years towards oxidation of
bromide by hydrogen peroxide using vanadium complexes as catalysts, the lack of struc-
tural similarities concerning the hydrogen bonding interaction and positively charged
donor sites of the V-HPO active binding site limits their significance for mechanism com-
parison. Therefore, structural models which exhibit hydrogen bonding at the vanadate
center related to the observed supramolecular environment of the native V-HPO proteins
are expected to give further insight into the mechanism of the reaction and to be more
appropriate functional models.
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1.6 Design of vanadium(v) complexes with N-salicyli-
dene hydrazides
Although the first reported crystal structure of a vanadium containing haloperoxidase
dates from 1996 and much progress has been made since then, there remain a number of
open questions. One such persisting question concerns the actual structure of the vana-
date moiety: is it a monoprotonated vanadate [VO3(OH)]
2− as has been suggested or is
it a diprotonated vanadate [VO2(OH)2]
−, in accordance with the observation that, under
physiological conditions, vanadate exists in its diprotonated form? A possible answer to
this question will be given by synthesis of mono- and di-oxovanadium(v) complexes
(VO3+ or VO+2 ) obtained with ligand systems capable of accommodating both species,
as described herein. Such a ligand system is represented by N-salicylidene hydrazides, a
tridentate chelate ligand that can react towards complex formation in its mono- and di-
anionic forms, thus making possible a variation of the protonation state in the obtained
vanadium complexes. In vanadium-chloroperoxidase enzyme, a vital role has been at-
tributed to the His404 residue suggested to play the acid-base role during the catalytic
cycle. The vanadium model complexes with N-salicylidene hydrazide contain an amide
functionality with a NH group which can be regarded as playing a similar role during
vanadium-catalyzed bromide oxidation reaction.
A second question concerns the catalytic activity of the enzyme and is focused on
the forces that enable the enzymatic system to catalyze the oxidation of halide by hydro-
gen peroxide so powerfully, with a turnover number in the range of 105 mol product/h. An
answer to this question came from the importance of the supramolecular hydrogen bond-
ing interaction that fixes the prosthetic group in the protein shell. Single site-directed
mutants of the amino acid residue of the active binding site showed the vital role of the
hydrogen bonding interaction and proved that any small change in the vicinity of the
vanadate moiety can change the affinity of the enzyme for its substrate, thus yielding an
alteration on its reactivity. The functionalization of the N-salicylidene hydrazide ligands
makes possible the isolation of bio-inspired vanadium complexes that mimic the hydrogen
bonding interaction of the key amino acid residues with the vanadate moiety found in
the natural system. A comparison between the active channel of the azide-substituted
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vanadium chloroperoxidase and the substitution patterns of N-salicylidene hydrazide are
depicted in Figure 21.
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Figure 21: Schematic representation of the active channel of the azide form of V-CPO
(left) and N-salicylidenehydrazide ligands with different substitution patterns (right).
Additionally, using the new synthetic vanadium analogues that approach signif-
icant properties of the protein active site, mechanistic investigations of the catalytic
reaction, through isolation of oxo-monoperoxovanadium(v) complexes, will also bring
new insights into the enzymatic catalytic reaction. Moreover, the possible influence of
different aliphatic chain length in their reactivity is also investigated. Afterwards, the
capacity of the isolated vanadium complexes to be functional models for the enzymatic
system will also be discussed, together with solution studies that are relevant for the
enzymatic catalytic reaction.
However, a difference in the vanadium coordination geometry between the vana-
dium haloperoxidase enzymes and the structural model systems that will be described
here is obvious. Vanadium in the +5 oxidation state forms typically complexes with
square-pyramidal geometry in five-coordinated compounds and has an octahedral ge-
ometry in six-coordinated complexes. In cis-dioxovanadium(v) complexes, the used
tridentate chelate ligands prefer a planar arrangement of the donor atoms, yielding a
square pyramidal geometry, whereas in the vanadium-containing enzyme, the protein en-
vironment is responsible for significant steric constraint, enforcing a distorted trigonal
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bipyramidal geometry around the vanadium atom. However, vanadium complexes with
a distorted trigonal bypiramidal geometry are also known, but distortion to both ideal
geometries is present. To quantitatively compare these structures in terms of relative ge-
ometries around the vanadium atom, an angular structural parameter τ was defined.122
The τ value is given by the difference of the largest angle values formed by the donor
atoms which coordinate at the vanadium center. Therefore, τ is 0 when an ideal square
pyramidal geometry is established around the metal center and has a value of 1 when the
coordination sphere is arranged in an ideal trigonal bypiramidal geometry (Figure 22).
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Figure 22: Schematic representation of the geometries around five-coordinated vanadium
atom, with numbering of the donor atoms exemplified for the cis-dioxovanadium(v)
complexes with N-salicylidenehydrazide ligand.
Nevertheless, despite the differences in geometrical arrangement around the vana-
dium center, the vanadium(v) complexes with N-salicylidene hydrazide present relevant
hydrogen bonding interaction and, thus, they can be regarded as structural model com-
plexes of the enzymatic system. On the other hand, N-salicylidene hydrazide ligands
have also attracted interest due to their pharmacological importance. Benzoyl substi-
tuted N-salicylidene hydrazide has been reported to possess mild bacteriostatic activity,
as well as being an inhibitor of DNA synthesis and cell growth.123,124 The compound is
used as drug for genetic disorders like thalassemia.125,126 The potency of the ligand to in-
hibit DNA synthesis and cell growth was found to increase upon complexation of divalent
transition metal ions. The Cu(ii) complex was reported to be the most potent pharma-
cological agent,124,126 whereas recently vanadium(v) complexes based on N-salicylidene
semicarbazone ligand were reported to posses anti-tumor activity.127
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Chapter 2
Vanadium(v) complexes based on
N-salicylidene aliphatic acid
hydrazides
Based on the reported crystal structure of vanadium chloroperoxidase,38 vanadium com-
plexes which exhibit hydrogen bonding interaction have been obtained using N-salicyli-
dene aliphatic acid hydrazides. The ligand system acts as tridentate chelate ligand with
a hydrophobic side-chain. Although various crystal structures of different vanadium
haloperoxidases have been reported,62,70,128 the real structure and the protonation state of
the vanadate center remain uncertain. A monoprotonated vanadate moiety [VO3(OH)]
2−
has been proposed as the active site in the native enzyme by analogy with phosphate
chemistry although, the vanadate exists in the diprotonated form [VO2(OH)2]
− at phys-
iological pH as it has been mentioned. At this point, comparison with synthetic models
is expected to give further insight into the mechanism of the reaction, as well as to
establish the protonation state of the prosthetic group. Various cis-dioxo-114,121 and
monooxo-vanadium(v)120,129 complexes have been reported as structural models for V-
HPO enzymes, but the reports of a ligand system able to accommodate both species
are rather scarce. Therefore, a versatile ligand system should be capable of accom-
modating both the cis-dioxo- and monooxovanadium(v) complexes regarded as struc-
tural models for the enzymatic system. Additionally, it should make possible variation
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of the protonation state in the obtained complexes. The N-salicylidene aliphatic acid
hydrazide ligand system reacts with ammonium metavanadate yielding anionic and/or
neutral cis-dioxovanadium(v). Further, the neutral cis-dioxovanadium(v) complexes re-
act stoichiometrically with 8-hydroxyquinoline to form mono-oxovanadium(v) complexes,
thus proving the versatility of the chosen chelate system.
The synthesis of the N-salicylidene aliphatic acid hydrazides is relatively straight-
forward and involves, in the first step, the hydrazinolysis of aliphatic acid esters with
near quantitative formation of the corresponding carbonic acid hydrazide. In the second
step, the isolated ω-aliphatic acid hydrazide reacts with salicylaldehyde via Schiff base
condensation to form the title ligands. The schematic representation of the synthesis and
substitution patterns described in this chapter are depicted in Figure 23. N-salicylidene
aliphatic acid hydrazides act as a tridentate chelate systems, permitting coordination in
both the mono- and dianionic forms due to the presence of the amide functionality, which
makes possible an amide-iminole equilibrium.
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Figure 23: Schematic representation of the synthesis and tautomeric forms of N-
salicylidene aliphatic acid hydrazides, where n=1 H2salhyb, n=2 H2salhyp and n=3
H2salhyh.
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2.1 cis-Dioxovanadium(v) complexes derived from
N-salicylidene aliphatic acid hydrazides
Stoichiometric reaction of the Schiff base ligands with ammonium metavanadate in reflux-
ing methanol for one day results in the formation of the ammonium salts of the anionic cis-
dioxovanadium(v) complexes NH4[VO2L]. Over prolonged reaction time, the primarily
formed ammonium salts were found to be converted to the neutral cis-dioxovanadium(v)
complexes VO2HL, with release of ammonia. A net difference regarding the solubility of
the two types of complexes is obvious. The anionic species have a very good solubility
in polar solvents and water, while the neutral complexes have a very poor solubility in
polar solvents and are completely insoluble in water. Interconversion between these two
cis-dioxovanadium species takes place, by modification of the protonation state of the
hydrazide nitrogen atom of the amide functionality. The neutral cis-dioxovanadium com-
plexes can be deprotonated by reaction with liquid ammonia, resulting in the reconversion
to the anionic species.
NH4VO3 + H2L NH4[VO2L]
NH3
 H2O+
NH4[VO2L]  H2O+ +
NH3(l)+ NH4[VO2L]
[VO2L]
[VO2L]
2.1.1 Structural characterization
Crystallographic characterization of an anionic cis-dioxovanadium(v) complex, as well
as a neutral cis-dioxovanadium(v) complex, has been achieved using N-salicylidene-5-
pentanoic acid hydrazide as ligand (H2salhyp). Stoichiometric reaction of H2salhyp ligand
with ammonium metavanadate in refluxing methanol yields the anionic cis-dioxovana-
dium(v) complex NH4[(salhyp)] (1), which crystallizes upon slow evaporation of the
mother liquor at room temperature. Molecular structure determination of the anionic
complex 1 shows two crystallographically distinct cis-dioxovanadium moieties, as de-
picted in Figure 24. The vanadium atoms are five-coordinated in a distorted square-
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pyramidal geometry. The tridentate chelate system is fully deprotonated and coordinates
in its dianionic form through the phenolate (O13 and O23) and iminolate (O14 and O24)
oxygen atoms, as well as the imine nitrogen atoms (N11 and N21). The bond lengths
C18–O14 and C28–O24 of 130 pm are consistent with the enolized form of the amide
functionality and are in agreement with the observed V1–O14 and V2–O24 bond lengths
of 195 and 197 pm, respectively. Relative to the mean plane given by the chelate ligand
system, the vanadium atom is displaced toward the apical oxo group O11 by 33 pm and to
O21 by 34 pm, whereas the oxo groups O12 and O22 are slightly distorted to the opposite
side by 27 and 25 pm, respectively. This leads to a τ value of around 0.04 for both vana-
dium centers (τ = 0 for an ideal square pyramid122) consistent with a distorted square
pyramidal geometry at the metal centers. The vanadium to oxo group bond lengths
(V=O) of 161 pm and 163 pm, respectively, are similar to reported bond distances in cis-
dioxovanadium(v) complexes, as well as the V-N and V-O bond lengths.130,131 Selected
bond lengths and angles are listed in Table 1. Complex 1 crystallizes in the triclinic space
group P
−
1 with two methanol molecules as solvent of crystallization and the ammonium
cations placed in the vicinity of one vanadate center.
Figure 24: Molecular structure and numbering scheme of the anionic complex 1 in crystals
of NH4[VO2(salhyp)]·MeOH; displacement ellipsoids are drawn at 50% probability level.
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Figure 25: Representation of the hydrogen bonding interaction of the anionic
complex 1 with the ammonium cations and methanol molecules in crystals of
NH4[VO2(salhyp)]·MeOH (broken lines represent hydrogen bonds); relevant distances
(in pm): N3· · ·N22 291.8, N3· · ·O1M 285.4, N3· · ·O22D 295.1, N3· · ·O13 301.7,
N3· · ·O12 296.7, N3· · ·O21C 287.9, N4· · ·O11 283.5, N4· · ·O2M 278.4, N4· · ·O12A
281.1, N4· · ·N12B 293.2, O21· · ·N3C 287.9, O22· · ·N3D 295.1, O22· · ·O2MD 279.9 and
O1M· · ·O23D 283.1 (symmetry transformations: A : x-1, y, z; B: -x+1, -y+1, -z+1; C:
-x+2, -y+1, -z+2; D: -x+1, -y+1, -z+2).
In the solid state, an extensive hydrogen bonding interaction is observed, which
involves particularly both double bonded oxo groups of the vanadate moiety, mimicking
the environment found in the native enzyme. One ammonium cation connects, via a
hydrogen bonding interaction, the two cis-dioxovanadium moieties by hydrogen bonding
contacts with the hydrazide nitrogen atom N3· · ·N22 (291.8 pm) of one molecule and the
equatorial and phenolate oxygen atoms of the other moiety, N3· · ·O12 (296.7 pm) and
N3· · ·O13 (301.7 pm), respectively. The apical double bonded oxygen atoms are in hydro-
gen bonding interactions with two different ammonium cations, N4· · ·O11 (283.5 pm) and
N3D· · ·O22 (295.1 pm), respectively. A similar situation has been reported for the native
enzyme, where the apical oxygen atom of the vanadate moiety is in hydrogen bonding
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contact with His404, resulting in a V–O· · ·N bridge formation. The hydrogen bond-
ing network is completed by the methanol molecules, which are involved in bifurcated
hydrogen bonding interaction with the ammonium cations and the equatorial oxygen
atoms from neighboring molecules, as depicted in Figure 25. The observed vast hydro-
gen bonding interaction leads to the formation of a three-dimensional hydrogen bonded
polymer with the ammonium cations establishing the layer, while the hydrophobic parts
are oriented to the outside (see Figure 26).
Figure 26: Representation of the hydrogen bonding network in crystals of
NH4[VO2(Hsalhyp)]·MeOH (broken lines represent hydrogen bonds).
A very important role in the native vanadium haloperoxidases is attributed to the
lysine residue that is hydrogen bonded to the equatorial oxygen atoms of the vanadate as
the prosthetic group (V–O· · ·NH+3 ). A similar situation is found in the case of the anionic
complex described here, where the place of the Lys residue is taken by the ammonium
cation, leading to a similar V–O· · ·N bridge. On the other hand, hydrophobic compo-
nents have been reported as parts of the active channel in both V-CPO and V-BPO.
The amino acids constituting part of the channel of the helix bundle are different from
V-CPO and V-BPO and are responsible for the specificity of these enzyme for certain
substrates. The herein described anionic cis-dioxovanadium(v) complex has also a hy-
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drophobic constitution formed by the aliphatic side-chain of the N-salicylidene hydrazide
ligand, which is oriented to the outside part of the resulting polymer.
A neutral complex [VO2(Hsalhyp)] 2 has also been isolated after a prolonged time
of the reaction between N-salicylidene 5-pentanoic acid hydrazide and ammonium meta-
vanadate. The ligand coordinates in its monoanionic form, containing a protonated
hydrazide nitrogen atom. Although the structure is also characterized by the presence
of a cis-dioxovanadium(v) moiety, the protonation of the hydrazide atoms N12 and N22,
respectively, leads to significant changes within the molecular structure of the vanadate
fragment as compared to the NH4[VO2(salhyp)] salt.
Figure 27: Molecular structure and numbering scheme of the neutral complex 2 in crystals
of [VO2(Hsalhyp)]: displacement ellipsoids are drawn at 50% probability level.
The N12–C18 bond length of 133 pm and N22–C28 of 132 pm, respectively, are
elongated, as are the V1–O14 and V2–O24 (195 and 197 pm, respectively) bond lengths
due to the weak coordination effect of the carbonyl oxygen atom. Moreover, the C–O
bond length of the amide functionalities vary from 127 pm for C18–O14 to 128 pm for
C28–O24, corresponding to partially double bond character. They are around 3 pm
shorter than the iminol bond length observed in complex 1. Similar to the previous case,
the neutral cis-dioxovanadium(v) complex also crystallizes in the triclinic space group
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−
1, with two very similar, but crystallographically different, moieties. The molecular
structure and numbering scheme of complex 2 is depicted in Figure 27. The geometry
around the vanadium center is also distorted square-pyramidal, with τ values of 0.25 and
0.26 pm, respectively. The distortion from an ideal square-pyramidal geometry is larger
than that found in the anionic complex 1. It is known that the local geometry at a cis-
dioxovanadium(v) is rather flexible and can be varied by crystal packing effects.130,131
Hydrogen bonding interactions are also observed in solid state, involving the protonated
hydrazide nitrogen atoms N12 and N22, respectively, and the equatorial oxygen atoms of
neighboring molecules.
Figure 28: Representation of the hydrogen bonding interactions in the complex
[VO2(Hsalhyp)] (broken lines represent hydrogen bonds); selected bond lengths (in pm):
O22· · ·N22 300.5, O12· · ·N22A 272.7 (symmetry transformations: A : -x+1, -y, -z).
The two molecules are hydrogen bridged via the protonated hydrazide nitrogen
atom and the equatorial double bonded oxygen atom N12· · ·O22 (300.5 pm). The hydro-
gen bonding network is completed by hydrogen bonding contact between the equatorial
oxygen atom O12 and protonated hydrazide nitrogen atom from the neighboring molecule
O12· · ·N22A (272.7 pm). Conversely to the anionic complex, no hydrogen bonding inter-
action involving the apical oxo groups (O11 and O12) are observed.
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Table 1: Selected bond lengths (pm) and angles (◦) in complexes 1 and 2.
1 2 1 2
V1−O11 161.6(2) 161.1(4) V2−O21 161.1(2) 161.3(3)
V1−O12 164.6(2) 163.1(3) V2−O22 164.9(2) 163.0(3)
V1−O13 190.8(2) 192.1(4) V2−O23 190.2(2) 191.9(4)
V1−O14 195.6(2) 203.0(4) V2−O24 197.0(2) 202.4(4)
V1−N11 213.8(2) 216.8(4) V2−N21 214.3(2) 216.1(4)
O14−C18 129.9(3) 127.3(6) O24−C28 129.9(3) 128.6(6)
N11−N12 140.9(3) 137.6(6) N21−N22 140.9(3) 138.4(6)
N12−C18 130.8(3) 133.1(7) N22−C28 130.3(3) 131.9(7)
O11−V1−O12 109.01(11) 106.80(17) O21−V2−O22 108.71(11) 106.90(18)
O11−V1−O13 102.50(10) 101.33(18) O21−V2−O23 104.67(11) 101.71(18)
O12−V1−O13 94.76(10) 99.61(17) O22−V2−O23 95.83(10) 100.15(17)
O11−V1−O14 109.23(10) 99.78(17) O21−V2−O24 102.55(11) 99.91(16)
O12−V1−O14 93.49(9) 93.15(16) O22−V2−O24 91.83(9) 92.37(16)
O13−V1−O14 151.78(9) 150.91(14) O23−V2−O24 147.55(9) 150.56(15)
O11−V1−N11 110.48(10) 103.59(17) O21−V2−N21 105.47(10) 103.60(17)
O12−V1−N11 140.08(9) 145.45(16) O22−V2−N21 145.03(10) 148.25(16)
O13−V1−N11 82.39(8) 82.39(15) O23−V2−N21 82.43(8) 81.92(15)
O14−V1−N11 74.10(8) 73.34(15) O24−V2−N21 73.53(8) 73.72(15)
2.1.2 Spectroscopic data
The formation of the cis-dioxovanadium complexes is confirmed by strong IR vibrations
corresponding to the ν(VO+2 ) group, which are observed at 894 and 908 cm
−1 in the
anionic complexes and 893 and 919-921 cm−1 in the neutral complexes. The coordina-
tion mode of the Schiff base ligands is obvious by comparison of the IR patterns of the
free ligands with those of the complexes. Selected IR data for the cis-dioxovanadium
complexes obtained with these ligands system are given in the experimental part of this
51
chapter, together with the IR data of the free ligands. The infrared spectra of the lig-
ands exhibit bands around 1669-1673 cm−1 due to the ν (C=O) stretch vibration. This
band is shifted at 1628 cm−1 upon complexation in the neutral cis-dioxovanadium(v)
complexes and disappears in the IR spectra of the corresponding anionic complexes. The
IR spectra of the ammonium salts shows instead a strong band at 1612 cm−1, attributed
to the stretching vibration of the conjugate –HC=N–N=C– group,132,133 a characteristic
IR feature of vanadium complexes with the enolized form of N-salicylidenehydrazide lig-
ands.134,135 A broad band for the free ligand, at approximately 3185 cm−1, is assigned to
intramolecular hydrogen bonds involving phenolic OH group. This band is not present
in the IR spectra of both cis-dioxo complexes, indicating deprotonation of the phenol
group on coordination of the metal center. However, the presence of a broad band at
approximately 3435 cm−1 in the complexes of type NH4[VO2L] indicates the presence of
the ammonium cations. Whereas in the IR spectrum of the neutral cis-dioxovanadium
complexes the vibration assigned to the ν(NH) stretching vibration appears at 3210 cm−1.
Solution characterization of the complexes has been achieved through 1H and 51V NMR
measurements. The 1H data for the novel cis-dioxovanadium(v) complexes are consis-
tent with the proposed structures and exhibit shifted resonances in comparison with the
corresponding proton resonances of the free ligands. In particular, the full deprotonation
of the free N-salicylidene hydrazide ligands in the anionic complexes is confirmed by the
absence of the downfield 1H NMR resonances corresponding to the O−H and N−H pro-
tons. Moreover, the 1H NMR spectra of the Schiff base ligands always show two sets of
resonances at 8.33 and 8.99 ppm, attributable to the azomethine (-CH=N) proton due to
the E-Z isomerism. The azomethine bond is present as one conformer through vanadium
coordination proved by an observed deshielded resonance of its singlet at 8.75 ppm in the
1H NMR of the complexes (see Experimental part). A net difference between the neutral
and the ammonium salts of the cis-dioxovanadium(v) complexes is observed in their 1H
NMR. A broad resonance at 7.11 ppm is observed in the 1H NMR of the ammonium salt
of the cis-dioxovanadium(v) complexes and is attributed to NH+4 protons. This resonance
is absent in the 1H NMR of the corresponding neutral cis-dioxo- complexes which exhibit
instead the specific resonance of the NH proton at around 11 ppm. Furthermore, 51V
NMR is indicative of the cis-VO+2 formation.
51V NMR performed in DMSO-d6 shows
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one resonance for the ammonium salts of cis-dioxovanadium(v) complexes at -534 ppm
(ν1/2 ∼ 615 Hz) and two resonances for the neutral complexes at -535 ppm (ν1/2 ∼
590 Hz) and -572 ppm (ν1/2 ∼ 600 Hz). While the first resonance is certainly specific for
cis-dioxovanadium(v) complexes with this type of ligand, the -572 ppm resonance may
be due to association of the molecules in solution, leading to the formation of a dimeric
cis-dioxovanadate structure.
2.1.3 Oxidative bromination
Vanadium bromoperoxidases, isolated mainly from marine organisms catalyze the oxi-
dation of bromide75 and iodide2 by hydrogen peroxide. The oxidized halide species
can subsequently react with appropriate organic substrates to yield halogen-containing
derivates.56,81 Although several vanadium complexes have been reported as structural
models for vanadium haloperoxidases, little is known about the vanadium-catalyzed per-
oxidative halogenation reactions. The first functional mimic of the V-BPO enzyme
is represented by ammonium vanadate.117 This is able to catalyze the peroxidative
halogenation of 1,3,5-trimetoxybenzene (TMB) in acidified DMF solution with a max-
imum turnover rate of 15 mol Br-TMB×(mol catalyst×h)−1.117 V-BPO enzymes have
been reported to catalyze the same reaction with a turnover rate of 4.7×105 mol Br-
TMB×(mol enzyme×h)−1 at pH 6.5.59,72,75 Contrary to the native enzyme, all the re-
ported functional vanadium complexes catalyze the oxidation of bromide at lower pH,
with turnover rates 104 slower.120 The herein reported cis-dioxovanadium(v) complexes
have been also tested towards their capacity to catalyze the oxidative bromination of
trimethoxybenezene using hydrogen peroxide as oxidant and HClO4 as the source of
acidic medium.
OMe
OMeMeO
Br
OMe
OMeMeO
cis-dioxovanadium as catalyst
     Bu4NBr
H2O2/ HClO4
Figure 29: Oxidative bromination of 1,3,5-trimethoxybenzene catalyzed by cis-
dioxovanadium(v) complexes.
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In a typical experiment, 10 mol% complex was added to a DMF solution containing
5 mM TMB and an excess of tetra-butylammonium bromide (50 mM). The reactions were
initiated by simultaneous addition of perchloric acid and hydrogen peroxide. Aliquots
of the reaction solution were quenched with NaOH and extracted with ethyl acetate for
GC measurements. The results are summarised in Table 2. In contrast to the natural
system, which functions optimally at approximately neutral pH,71,117 both types of cis-
dioxovanadium(v) complexes catalyze the oxidative bromination of TMB only in the
presence of acid at a rate much slower than vanadium bromoperoxidase enzymes. The
turnover rate lay in the range 45-58 mol product×(mol catalyst×h)−1, similar to those
reported for other vanadium complexes based on Schiff base ligands.120,136 At this point,
it should be mention that the blank reaction produced no Br-TMB in the measuring
period.
Table 2. Catalytic oxidative bromination of TMB
Compound % Br-TMB after 5 min.
            (µmol]
TON (mol Br-TMB/ mol
           catalyst h-1
N
O
N
O
V
O O
-
NH4+
37.4 % (56.1 µmol) 45
N
O
N
O
V
O O
-
NH4+
37.9 % (56.8 µmol) 46
N
O
N
O
V
O O
-
NH4+
44.1 % (66.1 µmol) 53
N
O
N
H
O
V
O O
48.1 % (72.1 µmol) 58
A small difference in reactivity was observed between the anionic complex NH4[VO2-
(salhyb)] compared to the neutral one [VO2(Hsalhyb)]. No big influence in the reactivity
was observed by increasing the length of the aliphatic side-chain by one or two methylene
groups, showing that this part of the ligand does not interfere with the reactivity of the
vanadate center. It is known that electronic effects are less effective over more than four
bonds, particularly inductive effects, and most likely an increase in reactivity of the model
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complexes can be achieved by insertion of electron-withdrawing and/or electron-donating
groups on the aromatic ring of the N-salicylidene aliphatic acid hydrazides.
2.2 Mono-oxovanadium(v) complexes based on
N-salicylidene aliphatic acid hydrazides
Reaction between equimolar amounts of neutral cis-dioxovanadium (v) complexes
[VO2(HL)] and 8-hydroxyquinoline in refluxing methanol yields the desired mono-oxova-
nadium(v) complexes [VO2(L(Q)]. These complexes have a very good solubility in oxygen-
and halogen-containing organic solvents and acetonitrile. The mono-oxovanadium(v)
complexes can also be obtained by in situ stoichiometric reaction of N-salicylidene hy-
drazide ligands, ammonium metavanadate and 8-hydroxyquinoline in refluxing methanol.
The in situ reaction can also be performed starting from a vanadium(iv) precursor as a
source of vanadium. Thus, addition of a methanolic solution of the Schiff base ligand to
a suspension of vanadyl acetylacetonate under aerobic conditions yields a brown-colored
solution as a consequence of the fast oxidation of the vanadium(iv) precursor to vana-
dium(v) complex. Stepwise addition of 8-hydroxyquinoline to this solution yields dark
violet solutions from which the dark-colored mono-oxovanadium(v) complexes were sep-
arated. Here should be mentioned that the equimolar reaction of N-salicylidenehydrazide
with VO(acac)2 results in the formation of the neutral cis-dioxovanadium(v) complexes
upon air oxidation of the vanadium(iv) precursor. This method represents an alternative
method to synthesize [VO2(HL)] complexes and has the advantage of shorter reaction
times due to the higher reactivity towards complexation of the vanadyl acetylacetonate
precursor and its better solubility properties compared to the ammonium metavanadate
precursor.
HL + HQ + NH4VO3
HL + HQ + VO(acac)2
HL + VO(acac)2
[VO(Q)(L)] + H2O
[VO(Q)(L)] + Hacac + H2O
[VO2(HL)] + Hacac + H2O
[VO2(HL)] + HQ [VO(Q)(L)] + H2O
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2.2.1 Structural characterization
The molecular structures of all mono-oxovanadium(v) complexes using the three N-
salicylidenehydrazide ligands were determined by X-ray crystallography and are depicted
in Figures 30-32.
Figure 30: Molecular structure and numbering scheme for [VO(salhyb)(Q)] (3); displace-
ment ellipsoids are drawn at 50% probability. Distorted CH3 group in a ratio of 80% C11
and 20 % C11A.
In all cases the vanadium atom is six-coordinated as a VO(ONO)ON moiety in a
distorted octahedral geometry. The fully deprotonated N-salicylidene hydrazide ligands
form a tetragonal plane through the phenolate oxygen atom O2, the imine nitrogen atom
N1 and the iminolate oxygen atom O3 together with the oxygen atom O21 of the biden-
tate 8-hydroxyquinoline ligand. Relative to this plane, the vanadium atom is displaced
toward the terminal oxygen atom O1 by 31.5, 31.7 and 30.9 pm in complexes 3, 4 and
5, respectively. Trans to the oxo group O1 is located the nitrogen atom N21 of the 8-
hydroxyquinoline ligand with the angle O1–V–N21 being 176.6◦, 176.2◦ and 175.6◦ in com-
plexes 3, 4 and 5, respectively. The vanadium to terminal oxo group (O1) bond lengths is
of around 159 pm in complex 3, 4 and 5, respectively. These distances are slightly longer
than those reported for VO3+ complexes with hydrazones and 8-hydroxyquinoline as coli-
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gand (158 pm),137 but are within the range of 157-160 pm reported for monooxovanadium
complexes when catechol,138 hydroxamates139,140 or polyols141 are used as coligands. The
Schiff base ligands form five- and a six-membered chelate rings with bite angles of around
84◦ (O2–V–N1) and 75◦ (O3–V–N1), respectively. Selected bond lengths and angles for
complexes 3, 4 and 5 are given in Tables 3.
Figure 31: Molecular structure and numbering scheme for [VO(salhyp)(Q)] (4); displace-
ment ellipsoids are drawn at 50% probability.
The coordination of N-salicylidenehydrazide ligands containing the enolized amide func-
tionality in the dianionic form is consisting with 130 pm bond length for N2–C8 and 131
pm for C8–O2 bond, respectively. These bond lengths are comparable with the distances
found in the ammonium salts of the cis-dioxovanadium(v) complex NH4[VO2(salhyp)]
(1). The vanadium to oxygen bond lengths in the defined tetragonal plane follow the or-
der V–O21 (quinoline oxygen)<V–O2 (phenol oxygen)<V–O3 (iminolate oxygen). This
can be explained as a consequence of the trans position of the quinoline oxygen O21 to
the weak donor nitrogen atom N1, while the phenol oxygen atom O2 of the Schiff base
ligand is located trans to the iminolate oxygen atom O3 of the same ligand. On the other
hand, the bond length for vanadium to nitrogen atom N21 of the 8-hydroxyquinoline co-
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Figure 32: Molecular structure and numbering scheme for [VO(salhyh)(Q)] (5); displace-
ment ellipsoids are drawn at 50% probability.
ligand is also lengthened due to the trans location to the terminal oxo group O1, which
is strongly covalently bound to the vanadium atom.
Finally, all the mono-oxovanadium(v) complexes shown here crystallized in the
monoclinic space group P21/n with common structural features. Nevertheless, small
differences between them are present, regarding the orientation of the aliphatic side chain.
In complex 3 a distorted methyl group is present, as a consequence of the crystal packing,
in a ratio of 80% for C11 and 20% for C11A, respectively. Further, increase of the side-
chain with one and respectively two methylene groups did not afford the same effect,
but a different torsion angle for N2-C8-C9-C10 was observed. This varied from 123◦ in
complex 3 to 136◦ in complex 4 and 97◦ in complex 5, resulting in a different orientation
of the methylene group close to the enolized amide functionality. The flexibility of the
aliphatic side chain is depicted in Figure 33 by the overlay of the molecular structures of
complex 4 and 5.
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Figure 33: Overlay of the molecular structures of [VO(salhyp)(Q)] 4 (thick lines) and
[VO(salhyh)(Q)] 5 (atoms extension A, broken lines).
2.2.2 Spectroscopic studies
The 1H and 13C NMR data for the novel mono-oxovanadium complexes summarized in
the experimental section are consistent with the determined molecular structures. In
particular, deprotonation of the dianionic form of the N-salicylidene hydrazide ligands
upon coordination to vanadium is confirmed by the absence of the downfield 1H NMR
resonances corresponding to the O−H and N−H protons. The azomethine (-CH=N)
proton resonate at 9.15 ppm, a dieshielding effect of 0.16-0.82 ppm upon coordination
to vanadium being observed. The methylene hydrogen atoms located in the vicinity of
the carbonyl group present upfield resonances in the 1H NMR spectra of the vanadium
complexes and exhibit one resonance corresponding to the existence of only one isomer
when the vanadium atom is coordinated. Moreover, the aromatic region is accompanied
by additional resonances that are indicative of the coordination of 8-hydroxyquinoline.
Further characterization of the complexes is given by the 51V NMR spectra, recorded in
DMSO-d6 and CDCl3. The
51V NMR spectra of all three mono-oxovanadium(v) com-
plexes is somehow solvent dependent, i.e. in DMSO-d6 a shift at -471 ppm with a width
at half height of ν1/2 = 310 Hz is observed, while in CDCl3 the peak appears at -482 ppm
with a width at half height of ν1/2 = 145 Hz. The obtained complexes are stable in solu-
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Table 3. Selected bond lengths (pm) and angles (◦) in complexes 3, 4 and 5.
3 4 5
V−O1 159.41(18) 158.99(17) 159.01(14)
V−O2 185.69(16) 185.98(17) 186.37(13)
V−O3 194.34(16) 195.00(17) 195.29(13)
V−O21 184.55(16) 185.98(17) 184.86(13)
V−N1 208.1(2) 208.35(19) 207.84(15)
V−N21 237.0(2) 235.70(19) 236.04(15)
C8−O3 131.0(3) 131.0(3) 131.0(2)
C8−N2 130.0(3) 129.9(3) 130.3(2)
O1−V−O2 99.11(9) 99.04(9) 99.72(7)
O1−V−O3 97.48(8) 98.12(8) 98.53(7)
O1−V−O21 101.31(8) 101.27(8) 100.84(7)
O1−V−N1 99.46(9) 99.15(8) 97.35(7)
O1−V−N21 176.59(8) 176.22(8) 175.63(7)
O2−V−O21 101.86(7) 103.45(7) 102.14(5)
O2−V−O3 155.23(8) 154.54(7) 153.38(6)
O2−V−N1 84.19(7) 83.91(7) 83.65(6)
O3−V−O21 92.73(7) 91.43(7) 93.24(6)
O3−V−N1 75.01(7) 74.90(7) 74.91(6)
O3−V−N21 80.59(7) 79.11(7) 78.54(5)
O21−V−N1 157.09(8) 156.84(8) 159.61(6)
O21−V−N21 76.05(7) 76.34(7) 76.22(5)
N1−V−N21 82.80(7) 82.68(7) 85.06(6)
N2−V−C9 119.6(2) 119.6(2) 118.71(17)
tion and no decomposition was observed in the presence of water. The oxovanadium(v)
complexes can be converted in cis-dioxovanadium(v) complexes by reaction with NaOH.
51V NMR monitoring of the reaction with 0.5 equivalents of base in a DMSO-d6/D2O
(9:1) mixture showed the coexistence of both species (δ = -472 ppm (ν1/2 = 300 Hz) and
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δ = -535 ppm (ν1/2 = 600 Hz)). One equivalent of NaOH generates only the anionic
cis-dioxovanadium(v) complexes which resonate at -538 ppm (ν1/2 = 600 Hz). Further
addition of base, up to two equivalents, did not produce any further change in the 51V
NMR spectra. The difference of 3 ppm between the resonances of the cis-dioxocomplexes
can be explained by the influence of more than one species existing in solution when 0.5
equivalents of base have been added.
The coordination modes of the N-salicylidene hydrazide ligands were further con-
firmed by comparison of the IR patterns of these ligands with those of the complexes, as
well as with 8-hydroxyquinoline spectra. The characteristic ligand stretching vibrations
at 3185 cm−1 and 1673-1669 cm−1 due to the ν(NH) and ν(C=O) vibrations, respectively,
were not observed in the IR spectra of the complexes, indicating enolization of the amide
functionality to the iminol form and its involvement in coordination to vanadium. Instead
a strong band at 1605 cm−1 is observed in the IR spectra of the complexes. This can be
attributed to the asymmetric vibration of the conjugated ν(-CH=N-N=C-) group132,133
and is 6 cm−1 shifted to a lower frequency compared to the corresponding vibration found
in the ammonium salts of cis-dioxovanadium(v) complexes (see Experimental Part).
Further differences are observed for the IR vibrations of the 8-hydroxyquinoline, used
here as a coligand, namely the disappearance of the ν(OH) characteristic vibration at
3152 cm−1. For all complexes, a strong vibration is observed at 970 cm−1 and is assigned
as stretching vibration of V=O moiety. Further information was gained by electronic
absorption studies carried out on acetonitrile solutions. All the vanadium complexes ex-
hibit strong absorption maxima at 241, 273, 322 and 540 nm (see experimental part).
The N-salicylidenehydrazide ligands exhibit absorption maxima at 278, 288 and 319 nm
(see experimental part for ε value), while 8-hydroxyquinoline absorbs at 241 (ε = 39.2
×103 cm−1M−1) and 328 (ε = 0.9 ×103 cm−1M−1) nm in acetonitrile solution. From
comparison of the UV-Vis spectra of the complexes and the organic ligands, it is obvious
that, except for 540 nm band, all the other absorption maxima are shifted due to coordi-
nation. The visible absorption maxima in the UV-Vis spectra of the complexes appears
most likely due to a ligand-to-metal charge transfer.
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2.2.3 Electrochemical investigations
A characteristic feature of the vanadate moiety in vanadium bromoperoxidases is the
reducible capacity of the prosthetic group to form an EPR-active vanadium center.101,142
The reduced state, [VivO(ONO)(ON)]−, of the [VO(L)(Q)] complexes can be generated
in acetonitrile solutions by electrochemical reduction at 0.355V vs. Ag/AgCl electrode
as reference electrode. All three mono-oxovanadium(v) complexes presented here showed
the same electrochemical behavior. In particular, the potentials of the charge transfer
processes were within ± 2 mV of each other. The square wave voltammograms (SWV),
measured with a drop hanging mercury electrode, were obtained using 2.4 mM acetoni-
trile solutions using square wave frequencies of 25, 50, 100, 200, 400, 800 and 1500 Hz,
respectively. The cyclic voltammograms exhibit in all cases two reversible one-electron
reduction steps at 0.355 V and -1.638V. The SWV for complex 4 will be discussed in
detail and is shown in Figure 34.
The first one-electron reduction step can be expressed as:
ML + e− ⇀↽ ML− (reaction 1)
and occurs at a positive potential E◦ = 0.355 V, being fully reversible for square wave
frequencies up to 1500 Hz.
The second reduction step occurs at a negative potential of E◦ = -1.638 V and is accom-
panied by a pre-wave. This can be expressed as:
ML− + e− ⇀↽ ML2− (reaction 2)
Looking at the frequency dependence of the second reduction peak and of the
accompanying pre-wave shown in Figure 35, it is clear that this second reduction process
remains diffusion-controlled over the entire frequency range. The accompanying pre-wave
tends to become equal to the diffusion-controlled current if the square wave frequency
moves towards zero, while a steady state current appears to be reached for very high
square wave frequencies. This indicates that the pre-wave results from the reduction of
a species produced in a preceding chemical equilibrium.
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Figure 34: Square wave voltammogram of complex 4 using square wave frequencies from
25, 50, 100, 200, 400, 800 and 1500 Hz.
In other words, the height of the plateau current (ik) is at least partly under kinetic
control and satisfies the Bard-Faulkner equation:143
id/ik = 1.02 + Kτ
−1/2
where id is the diffusion control peak current, τ the time scale and K is a parameter
that depends on the thermodynamic and kinetic constants associated with the previous
chemical equilibrium from which the electrochemically active species are produced. Be-
cause the time scale, τ , is inversely proportional to the square wave frequency, f, a linear
dependence could be obtained as depicted in Figure 36.
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Figure 35: Height of the peak current (white circles) and the plateau of the accompanying
pre-wave (black circles) associated with the second reduction step for complex 4. The
peak current associated with the first reduction step exhibits virtually the same frequency
dependence as that indicated by white circles.
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Figure 36: Ratio between the diffusion controlled peak current and the kinetically con-
trolled plateau current as a function of the square wave frequency. If the pre-wave results
from a previous chemical reaction this ratio should satisfy the Bard-Faulkner equation
with τ−1/2 =
√
f .
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This once more confirmed that the pre-wave which accompanies the second reduc-
tion process is really an effect of a preceding chemical reaction. Taking into account that
the 8-hydroxyquinoline anion itself shows a reversible reduction process, which take place
at potential - 1.52 V, this could lead to the conclusion that a split off/addition reaction
is responsible for the appearance of the pre-wave. This can be expressed as:
ML− ⇀↽ M + L− (reaction 3)
where L− is the reduced 8-hydroxyquinoline ligand as a radical anion.
However, since the production of the species L− consumed in the pre-wave goes
at the consuming of ML− which is coupled with L− by the chemical reaction 3, the
above finding is not in agreement with the observation that the reduction of ML− at
about -1.64 V remains fully diffusion-controlled over the entire frequency range. Also in
disagreement with the simple pre-equilibrium expressed in reaction 3 is the shift of the
pre-wave to more positive potentials with the increased period of time of the underlying
electrochemical method (i.e. the lower the square wave frequency), because the opposite
shift would be expected theoretically. Reasonable agreement with the experimental data
was obtained (at least qualitatively) by taking an additional ligand addition/elimination
reaction for the vanadium(v) complex into consideration
ML ⇀↽ M + L (reaction 4)
where L is the deprotonated quinoline anion.
It is important to emphasize that the equilibrium for both reactions, i.e. reaction
3 and 4 is far to the left. Actually, reaction 3 is slightly pushed to the right site, only
because any (infinitesimal) small amount of L− is immediately re-oxidized to L if the
potential is moving between the first reduction step and the pre-wave. Although L then
reacts with M, so that the resulting ML is immediately reduced again, the difference
in the equilibrium/rate constants of reactions 3 and 4 (as well as the differences of the
diffusion coefficients of the underlying species- the latter effect has been neglected in
simulations) results in an accumulation of effects. This means that the second reduction
step is accompanied by a pre-wave exhibiting an unusual frequency dependence of the
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Figure 37: Comparison between measured SWVs (left) and simulated SWVs based on
chemical equations (right) using the conditions quoted in Figure 34.
potential shift and an almost diffusion-controlled growth of the peak current associated
with the charge transfer process (reaction 2).
Moreover, the reduction of the mono-oxovanadium(v) complexes was also achieved
using Zn-Hg amalgam, a reducing agent which does not interfere with the second reduc-
tion process described in the cyclic voltametry experiments. EPR studies on this reduced
form of complexes showed a specific eight-line EPR signal with a g value of 1.992 and A
value of 96 G, as one would expect for a vanadium(iv) complex.
2.2.4 Peroxidative bromination reaction of 1,3,5-trimethoxyben-
zene catalyzed by mono-oxovanadium(v) complexes
Following the procedure described in 2.1.3, the mono-oxovanadium(v) complexes de-
scribed here were also tested regarding their capacity to catalyze the oxidation of bromide,
monitored by GC determination of mono-brominated TMB product. Unfortunately, the
results showed almost no catalytic activity of these mono-oxovanadium complexes. From
the entries listed in Table 4, it is obvious that the complexes present a lower catalytic
activity than vanadyl acetylacetonate. The slow peroxidative bromination of TMB cata-
lyzed by these complexes can be attributed to the high stability of the six-coordinated
vanadium center, which does not permit side-on bonding of the peroxide ligand to form
the active intermediate necessary for the reaction to proceed. This can lead to the con-
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clusion that a five-coordinated metal center is favored for the catalytic reactivity and/or
the six-coordination site of the vanadium center should be occupied by a weak donor
ligand, such as solvent molecules.
Table 4. Catalytic oxidation experiments using mono-oxovanadium(v) complexes- 3, 4
and 5 as catalysts.
Complex % Br-TMB (µmol) (after 5 min.) % Br-TMB (µmol) (after 10 min.)
3 3.2(4.8) 9.0(13.5)
4 3.0(4.5) 7.5(11.2)
5 4.6(6.9) 11.1(16.6)
VO(acac)2 16.0(24.0) 17.2(25.8)
2.3 Conclusions
N-salicylidenehydrazide ligands with aliphatic side chain are capable of accommodat-
ing mono-oxovanadium(v) complexes and cis-dioxovanadium(v) complexes, both types
of compounds being regarded as structural model complexes for vanadium-dependent
haloperoxidases. The reaction of N-salicylidene n-aliphatic acid hydrazides with am-
monium metavanadate results in the formation of anionic cis-dioxovanadate, as well as
neutral cis-dioxovanadium(v) complexes. An extensive hydrogen bonding interaction
has been observed in the solid state in the crystal structure determined for two such cis-
dioxovanadium complexes. The hydrogen bonding network involves hydrogen bonding
contacts between oxo groups of the vanadate center and the donor atoms of the Schiff
base ligand and/or the ammonium cations. Moreover, the neutral cis-dioxovanadium(v)
complexes can be reacted with 8-hydroxyquinoline in refluxing methanol to form the six-
coordinated mono-oxovanadium(v) complexes. Conversion of the mono-oxovanadium(v)
to the corresponding cis-dioxovanadium(v) complexes has been achieved in solution by
reaction with NaOH in different ratios. 51V NMR monitoring of the reaction with base
in deuterated DMSO:D2O solution showed that one equivalent of NaOH is sufficient to
yield the dioxovanadium complexes. Moreover, addition of simple deuterated water to
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a solution of oxovanadium(v) complexes in DMSO-d6 did not yield any decomposition
of the complexes. Electrochemical investigations on acetonitrile solutions of the mono-
oxovanadium(v) complexes showed quasi-reversible cyclic voltammograms with two one-
electron reduction steps. The first consists in the formation of a vanadium(iv) complex
[VivO(ONO)(ON)]− and occurs at positive potential, while the second process seems to
be most likely generated by the reduction of the split off coligand.
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Figure 38: Schematic representation of reactivity pathways described in this chapter.
A different reactivity between the cis-dioxovanadium and monooxovanadium com-
plexes has been observed towards vanadium-catalyzed peroxidative bromination of 1,3,5-
trimetoxybenezene. Cis-dioxovanadium(v) complexes are also functional models of vana-
dium bromoperoxidase enzymes, being capable of catalyzing the peroxidative bromination
of 1,3,5-trimetoxybenzene with a turnover rate ranging from 45-53 mol Br-TMB×(mol
catalyst×h)−1, when the anionic complexes were used as catalysts, to 58 mol Br-TMB×
(mol catalyst×h)−1 when neutral cis-dioxovanadium(v) complex catalyzed the biomimetic
reaction. Attempts to perform the same catalytic reaction with mono-oxovanadium(v)
complexes were not very successful due to the slow turnover rate of the reaction. There-
fore, a five-coordinated vanadium center seems to be more appropriate for the oxidative
bromination reaction, due to the presence of empty sites at the vanadium atom, favoring
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thus, the addition of H2O2 to form a side-on bound peroxo-complex. As the mono-
oxovanadium(v) complexes described here contain a six-coordinated vanadium center,
the formation of the peroxo-vanadium(v) complex requires most likely the splitting off
of the bidentate coligand (8-HQ).
2.4 Experimental Part
2.4.1 Materials
Abbreviations used throughout the text: H2salhyb = butyric acid (2-hydroxy benzyli-
dene) hydrazide, H2salhyp = pentanoic acid (2-hydroxy benzylidene) hydrazide, H2salhyh
= hexanoic acid (2-hydroxy benzylidene) hydrazide; HQ = 8-hydroxyquinoline, TMB =
1,3,5-trimethoxybenzene. ω-Carbonic acid hydrazides were prepared by reaction of the
corresponding n-alkyl esters with 1.2 equivalents of hydrazine hydrate. All other chem-
icals were used as received. Cyclic voltametry measurements and square wave volta-
metric measurements were conducted by a three-electrode technique using a homemade
computer-controlled instrument based on the PCI 6110-E data acquisition board (Na-
tional Instruments). The experiments were performed in acetonitrile solutions containing
0.25 M tetra-butylammonium hexafluorophosphate under a blanket of solvent saturated
with argon. The ohmic resistance to be compensated for was determined by measuring
the impedance of the system at potentials where the Faraday current was negligible.
Background corrections were accomplished, only for cyclic voltammograms, by subtract-
ing the current curves of the blank electrolyte containing the same concentration of
the supporting electrolyte from the experimental cyclic voltammograms. Ag/AgCl was
used as reference electrode in acetonitrile containing 0.25 M tetra-butylammonium chlo-
ride. The potential of this reference system was calibrated by measuring the potential
of the couple ferrocenium/ferrocene at the end of each experiment and was found to be
0.812±0.002 V throughout the measurements. The working electrode was hanging drop
mercury (mHg−drop= 4 mg) produced by a CGME instrument from Bioanalytical Systems
Inc., West Lafayette, USA. Theoretical square wave voltammograms were simulated using
the DigiElch package, available from www.DigiElch.de.
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2.4.2 Synthesis of N-salicylidene ω-carbonic acid hydrazides
H2salhyb
To a solution of butyric acid hydrazide (6.6 g, 64.7 mmol) in 30 mL methanol, salicylalde-
hyde (7.9 g, 14.3 mL, 64.7 mol) was added dropwise under continuous stirring at room
temperature. The resulting slightly yellow solution was stirred at r.t. for additional 12
hours. The formed precipitate was filtered and the solvent removed under reduced pres-
sure. Yield: 12.2 g (59.1 mmol, 91%). Anal. Calc. for C11H14N2O2 (206.24): C 64.06, H
6.84, N 13.58; Found C 63.94, H 7.26, N 13.33. 1H NMR (200 MHz, DMSO-d6): δ = 0.91
(dt, 3H, CH3,
3J=7.31 Hz), 1.53-1.61 (m, 2H, CH2CH3), 2.18 and 2.54 (t, 2H, CH2CO,
3J=7.22 Hz and 3J=7.31 Hz, ratio 1.4:0.8), 6.80-6.95 (m, 2H, arom. CH ), 7.17-7.30 (m,
1H, arom. CH ), 7.44-7.66 (m, 1H, arom. CH ), 8.24 and 8.33 (s, total 1H, CH=N, ratio
0.3:0.7), 10.24, 11.18, 11.57 (NH, OH, total 2H in a ratio of 0.3:1.0:0.6) ppm. Selected IR
data (cm−1): ν= 3185 (s; NH, OHass), 1673 (s, C=O), 1623 (s, CH=N). UV/Vis (CH3CN
solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (18.5), 288 (17.3), 319 (8.7).
H2salhyp
This ligand was prepared as described above from pentanoic acid hydrazide (7.7 g,
66.0 mmol) and salicylaldehyde (8.1 g, 7.0 mL, 66.0 mmol) in methanol. Yield: 13.8 g
(62.6 mmol, 95%). Anal. Calc. for C12H16N2O2 (220.27): C 65.43, H 7.32, N 12.72;
Found C 65.57, H 7.34, N 12.89. 1H NMR (200 MHz, DMSO-d6): δ = 0.87 (t, 3H, CH3,
3J=7.13 Hz), 1.28-1.35 (m, 2H, CH2CH3), 1.51-1.59 (m, 2H, CH2CH2CO), 2.20 and 2.56
(t, 2H, CH2CO,
3J=7.31 Hz, ratio 1.4:0.7), 6.80-6.99 (m, 2H, arom. CH ), 7.17-7.30 (m,
1H, arom. CH ), 7.44-7.60 (m, 1H, arom. CH ), 8.24 and 8.33 (s, total 1H, CH=N, ratio
0.4:0.6), 10.12, 11.18, 11.56 (NH, OH, total 2H in a ratio 0.3:1.0:0.6) ppm. Selected IR
data (cm−1): ν= 3185 (s; NH, OHass), 1669 (s, C=O), 1623 (s, CH=N). UV/Vis (CH3CN
solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (18.4), 288 (17.6), 319 (8.9).
H2salhyh
H2salhyh was obtained analogously to the other ligands from hexanoic acid hydrazide
(7.6 g, 58.0 mmol) and salicylaldehyde (7.1 g, 6.1 mL, 58.0 mmol) using the same solvent.
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Yield: 12.1 g (51 mmol, 89%). Anal. Calc. for C13H18N2O2 (234.29): C 66.64, H 7.74,
N 11.96; Found C 66.66, H 7.76, N 11.97. 1H NMR (200 MHz, DMSO-d6): δ = 0.85 (t,
3H, CH3,
3J=6.68 Hz), 1.22-1.31 (m, 4H, CH2), 1.49-1.64 (m, 2H, CH2CH2CO), 2.19 and
2.60 (t, 2H, CH2CO,
3J=7.40 Hz and 3J=7.50 Hz, ratio 1.2:0.8), 6.80-6.99 (m, 2H, arom.
CH ), 7.21-7.30 (m, 1H, arom. CH ), 7.44-7.60 (m, 1H, arom. CH ), 8.24 and 8.33 (s, total
1H, CH=N, ratio 0.4:0.6), 10.12, 11.18, 11.56 (NH, OH, total 2H in a ratio 0.3:1.0:0.6)
ppm. Selected IR data (cm−1): ν= 3186 (s; NH, OHass), 1669 (s, C=O), 1623 (s, CH=N).
UV/Vis (CH3CN solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (19.0), 288 (17.3), 319
(8.0).
2.4.3 Synthesis of the ammonium salts of cis-dioxovanadium
complexes
Preparation of NH4[VO2(salhyb)]
To a solution of H2salhyb (1.0 g, 4.8 mmol) in 100 mL MeOH was added NH4VO3 (0.6 g,
4.8 mmol). The resulting mixture was refluxed with continuous stirring for 24 hours and
filtered hot for removal of unreacted ammonium metavanadate. The resulting solution
volume was reduced under reduced pressure to about half of its original volume. After
standing overnight at room temperature in an open flask, a yellow precipitate was formed.
Additional material could be obtained by removal of the solvent to dryness and washing
the yellow-brownish solid with chloroform (3x20 ml). Total yield: 0.5 g (1.5 mmol, 30%).
1H NMR (400 MHz, DMSO-d6): δ = 0.89 (t, 3H, CH3), 1.58-1.60 (m, 2H, CH2), 2.22 (t,
2H, CH2CO), 6.73-6.75 (m, 2H, arom. CH ), 7.12 (m, 4H, arom. NH
+
4 ), 7.28-7.47 (m, 2H,
arom. CH ), 8.74 (s, 1H, CH=N) ppm. 51V NMR (105 MHz, DMSO-d6): -533.8 ppm
(ν1/2=585 Hz). Selected IR data (cm
−1): ν= 3434 (br, NH+4 ), 1612 (s, -CH=N-N=CH-),
908 and 894 (s, VO2).
Preparation of NH4[VO2(salhyp)](1)
To a solution of H2salhyp (1.0 g, 4.5 mmol) in 100 mL MeOH was added NH4VO3 (0.5 g,
4.5 mmol). The resulting mixture was refluxed with continuous stirring for one day
and filtered hot for removal of unreacted ammonium metavanadate. The work-up of the
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resulting solution is similar to that described previously for NH4[VO2(Hsalhyb)]. Total
yield: 0.5 g (1.5 mmol, 35%). 1H NMR (400 MHz, DMSO-d6): δ = 0.87 (t, 3H, CH3),
1.29-1.36 (m, 2H, CH2), 1.52-1.59 (m, 2H, CH2), 2.26 (t, 2H, CH2CO), 6.73-6.77 (m,
2H, arom. CH ), 7.08 (m, 4H, arom. NH+4 ), 7.28-7.48 (m, 2H, arom. CH ), 8.75 (s, 1H,
CH=N) ppm. 51V NMR (105 MHz, DMSO-d6): -534.3 (ν1/2=610 Hz) ppm; Selected IR
data (cm−1): ν= 3434 (br, NH+4 ), 1611 (br, -CH=N-N=CH-), 895, 908 (s, VO2).
Preparation of NH4[VO2(salhyh)]
This complex was prepared analogously, using the above described procedure, from
H2salhyh (1.0 g, 4.3 mmol) and NH4VO3 (0.5 g, 4.3 mmol). Total yield: 0.4 g (1.2 mmol,
30%). 1H NMR (400 MHz, DMSO-d6): δ = 0.85 (m, 3H, CH3), 1.28 (m, 4H, CH2), 1.57
(m, 2H, CH2), 2.24 (m, 2H, CH2CO), 6.73-6.76 (m, 2H, arom. CH ), 7.11 (br., 4H, NH
+
4 ),
7.17-7.19 (m, 1H, arom. CH ), 7.47-7.51 (m, 1H, arom. CH ), 8.76 (s, 1H, CH=N) ppm.
51V NMR (105 MHz, DMSO-d6): -534.2 (ν1/2=615 Hz) ppm. Selected IR data (cm
−1):
ν= 3434 (br, NH+4 ), 1612 (s, -CH=N-N=CH-), 895, 908 (s, VO2).
2.4.4 Synthesis of the neutral cis-dioxovanadium complexes
The synthesis of these complexes follows the procedure describe above for each ammonium
salt of cis-dioxovanadium(v) complexes with the reflux period prolonged to about three
days.
Preparation of [VO2(Hsalhyb)]
Yield: 0.6 g (2.1 mmol, 44%). Anal. Calc. for C11H13N2O4V (288.170): C 45.85, H 4.55,
N 9.72. Found: C 45.85, H 4.58, N 9.61. This complex was alternatively prepared by
reaction of H2salhyb (0.42 g, 2 mmol) with VO(acac)2 (0.52 g, 2 mmol) in 50 mL methanol
under continuous stirring and reflux for about four hours. Removal of the solvent to about
third of the initial volume lead overnight a yellow precipitate. Yield: 0.34 g (1.18 mmol,
60%). 1H NMR (400 MHz, DMSO-d6): δ = 0.94 (t, 3H, CH3,
3J=7.2 Hz), 1.60-1.67 (m,
2H, CH2), 2.36 (t, 2H, CH2CO,
3J= 7.2 Hz), 6.82-6.98 (m, 2H, arom. CH ), 7.43-7.71
(m, 2H, arom. CH ), 8.80 (s, 1H, CH=N) ppm and 11.15, 11.58 (br. NH ); 51V NMR
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(105 MHz, DMSO-d6): -533.9 (shoulder), -541 (ν1/2=790 Hz), -570.6 (ν1/2=870 Hz) ppm
in a ratio 0.7:1.0. MS (ESI-negative mode): m/z = 287.3 [M - H+](100%). Selected IR
data (cm−1): ν= 3434 (br, NH), 1628 (s, CO), 1611 (s, -CH=N), 921 and 893 (s, VO2).
Preparation of [VO2(Hsalhyp)] (2)
Yield: 0.5 g (1.8 mmol, 40%). Anal. Calc. for C12H15N2O4V (302.201): C 47.69, H
5.00, N 9.27. Found: C 46.90, H 5.10, N 10.21. 51V NMR (105 MHz, DMSO-d6): -537.3
(ν1/2=570 Hz) and -570.1 ppm in a ratio 1.0:0.2. Selected IR data (cm
−1): ν= 3435 (br,
NH), 1628 (s, CO), 1611 (s, -CH=N), 921 and 892 (s, VO2).
Preparation of [VO2(Hsalhyh)]
Yield: 0.9 g (2.9 mmol, 67%). Anal. Calc. for C13H17N2O4V (316.221): C 49.38, H 5.42,
N 8.86. Found: C 49.36, H 5.27, N 8.84. 1H NMR (400 MHz, DMSO-d6): δ = 0.95
(t, 3H, CH3), 1.28-1.35 (m, 4H, CH2), 1.60-1.66 (m, 2H, CH2), 2.34 (t, 2H, CH2CO),
6.80-6.98 (m, 2H, arom. CH ), 7.24-7.70 (m, 2H, arom. CH ), 8.79 (s, 1H, CH=N) and
10.10, 11.15, 11.60 (br. NH ). 51V NMR (105 MHz, DMSO-d6): -540.6 (ν1/2=665 Hz)
and -570.7 (ν1/2=780 Hz) ppm in a ratio 1.0:0.8. MS (FAB in nba): m/z = 235.3 [L +
H+](20%), 300 (58%), 317 [M + H+](44%), 438 (20%). Selected IR data (cm−1): ν=
3437 (br, NH), 1627 (s, CO), 1610 (s, -CH=N), 919 and 893 (s, VO2).
2.4.5 Synthesis of the mono-oxovanadium(v) complexes
Preparation of [VO(salhyb)(Q)] (3)
Method 1: To a suspension of [VO2(Hsalhyb)] (0.49 g, 1.71 mmol) in 30 mL methanol
was added dropwise (15 minutes), under reflux and continuous stirring, a solution of
8-hydroxyquinoline (0.24 g, 1.70 mmol) in 10 mL methanol. The resulting dark-violet
solution was refluxed for additional two hours and the solution was filtered hot. The
solvent was reduced to dryness under reduced pressure and redissolved in 5 mL methanol.
Upon standing at room temperature overnight, a dark-violet solid was formed. Yield:
0.40 g (0.96 mmol, 56%).
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Method 2: A solution of H2salhyb (0.21 g, 1.00 mmol) in 15 mL methanol was added
under stirring to a suspension of VO(acac)2 (0.26 g, 1.00 mmol) in 15 mL methanol.
The resulting reaction mixture was refluxed for two hours under continued stirring, dur-
ing which time the color changed from green to brown. 8-Hydroxyquinoline (0.14 g,
1.00 mmol), dissolved in 10 mL methanol, was added dropwise over a period of 15 min-
utes and the reaction solution was refluxed and stirred for an additional 30 minutes. The
reaction mixture was reduced to dryness under reduced pressure and redissolved in 5 mL
methanol. Upon standing at room temperature, overnight a dark-violet solid is formed.
Yield: 0.32 g (0.77 mmol, 77%).
Method 3: To a suspension of NH4VO3 (0.24 g, 2.00 mmol) in 10 mL methanol was
added H2salhyb (0.42 g, 2.00 mmol) dissolved in 30 mL methanol, followed by immediate
addition of a solution of 8-hydroxyquinoline (0.29 g, 2.00 mmol) in 10 mL methanol. The
reaction mixture was refluxed with continuous stirring over a period of two hours. The
reaction volume was reduced to around 10 mL and kept at room temperature in an open
flask. Yield: 0.60 g (1.44 mmol, 72%).
Anal. Calc. for C20H18N3O4V (415.321): C 57.84, H 4.36, N 10.11. Found: C
58.08, H 4.18, N 10.15. 1H NMR (400 MHz, DMSO-d6): δ = 0.48 (t, 3H, CH3,
3J=7.31
Hz), 1.09-1.22 (m, 2H, CH2CH3), 1.99-2.11 (m, 2H, CH2CO), 6.73-6.75 (d, 1H, arom.
CH ), 6.99-7.02 (m, 1H, arom. CH ), 7.17-7.19 (m, 1H, arom. CH ), 7.46-7.50 (m, 1H,
arom. CH ), 7.56-7.59 (m, 1H, arom. CH ), 7.69-7.72 (m, 2H, arom. CH ), 7.78-7.81
(m, 1H, arom. CH ), 8.09-8.11 (m, 1H, arom. CH ), 8.50-8.53 (m, 1H, arom. CH ),
9.15 (s, 1H, CH=N) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 12.9 (CH3), 19.1
(CH2CH3), 31.3 (CH2CO), 111.5, 115.5 (arom.CH), 119.5 (arom.C ), 120.4, 122.5, 123.0,
128.3, 129.0, 133.3, 135.3, 138.3, 138.8, 146.3 (arom.CH and C ), 154.2 (arom.CH=N)
ppm), 162.3, 163.3 (arom.CO–V), 175.8 (CO–V). 51V NMR (105 MHz, DMSO-d6): -
471.7 ppm (ν1/2=315 Hz);
51V NMR (105 MHz, CDCl3): - 481.3 ppm (ν1/2=145 Hz).
Selected IR data (cm−1): 1605 (s, -CH=N-N=C-), 1553 (s, -CH=N arom., quinoline),
969 (s, VO). UV/Vis (CH3CN solution, λmax in nm (ε in 10
3 M−1 cm−1)): 241 (41.5),
273 (19.1), 322 (8.5), 540 (6.8).
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Preparation of [VO(salhyp)(Q)] (4)
Complex 4 was prepared as described above from [VO2(Hsalhyp)] (2) (0.51 g, 1.71 mmol)
and 8-hydroxyquinoline (0.24 g, 1.70 mmol) in refluxing methanol. The in situ reactions
were similar to the previously described. Method 1 : H2salhyp (0.22 g, 1.00 mmol),
VO(acac)2 (0.26 g, 1.00 mmol) and 8-hydroxyquinoline (0.14 g, 1.00 mmol) in methanol
or alternatively by Method 3 by reaction of H2salhyp (0.44 g, 2.00 mmol) with stoi-
chiometric amounts of NH4VO3 and 8-hydroxyquinoline in methanol solution. Yield:
0.53 g (1.23 mmol; 72 %) (method 1), 0.41 g (0.95+mmol; 95 %) (method 2) and 0.58 g
(1.35 mmol; 67.5 %) (method 3). Anal. Calc. for C21H20N3O4V (429.347): C 58.75, H
4.70, N 9.79. Found: C 58.73, H 4.60, N 9.92. 1H NMR (400 MHz, DMSO-d6): δ = 0.50
(t, 3H, CH3,
3J=7.33 Hz), 0.71-0.83 (m, 2H, CH2CH3), 1.02-1.08 (m, 2H, CH2CH2CO),
2.02-2.09 (m, 2H, CH2CO), 6.72-6.76 (m, 1H, arom. CH ), 6.99-7.02 (m, 1H, arom.
CH ), 7.17-7.20 (m, 1H, arom. CH ), 7.47-7.59 (m, 2H, arom. CH ), 7.68-7.74 (m, 2H,
arom. CH ), 7.79-7.81 (m, 1H, arom. CH ), 8.09-8.10 (m, 1H, arom. CH ), 8.49-8.53
(m, 1H, arom. CH ), 9.14 (s, 1H, CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ
= 13.4 (CH3), 21.1 (CH2), 27.7 (CH2), 29.2 (CH2CO), 111.0, 115.4 (arom.CH), 119.5
(arom.C ), 120.4, 122.5, 123.0, 128.2, 129.1, 133.3, 135.3, 138.3, 138.6, 146.3 (arom.CH
and C ), 154.2 (CH=N) ppm), 162.3, 163.4 (arom.CO–V), 176.1 (CO–V). 51V NMR
(105 MHz, DMSO-d6): - 471.5 ppm (ν1/2=310 Hz);
51V NMR (105 MHz, CDCl3): -
482.3 ppm (ν1/2=145 Hz). Selected IR data (cm
−1): 1605 (s, -CH=N-N=C-), 1552 (s,
-CH=N arom., quinoline), 972 (s, VO). UV/Vis (CH3CN solution, λmax in nm (ε in 10
3
M−1 cm−1)): 241 (42.9), 273 (19.8), 322 (8.8), 540 (7.0).
Preparation of [VO(salhyh)(Q)] (5)
Complex 5 was prepared by analogous methods. Method 1 : [VO2(Hsalhyh)] (0.54 g,
1.71 mmol) in 30 mL methanol and 8-hydroxyquinoline (0.24 g, 1.70 mmol); Method 2 :
from H2salhyh (0.23 g, 1.00 mmol), VO(acac)2 and 8-hydroxyquinoline in stoichiomet-
ric amounts; and Method 3 : reaction of H2salhyh (0.47 g, 2.00 mmol) with equimolar
amounts of NH4VO3 and 8-hydroxyquinoline in methanol. Yield: 0.61 g (1.37 mmol; 80
%) (method 1), 0.38 g (0.85 mmol; 85 %) (method 2) and 0.68 g (1.53 mmol; 76.5 %)
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(method 3). Anal. Calc. for C22H22N3O4V (443.373): C 59.60, H 5.00, N 9.48. Found: C
59.55, H 5.11, N 9.79. 1H NMR (400 MHz, DMSO-d6): δ = 0.54 (m, 3H, CH3,
3J=7.31
Hz), 0.60-0.91 (m, 4H, CH2), 1.05-1.12 (m, 2H, CH2CH2CO), 2.00-2.14 (m, 2H, CH2CO),
6.73-6.76 (m, 1H, arom. CH ), 6.99-7.03 (m, 1H, arom. CH ), 7.17-7.19 (m, 1H, arom.
CH ), 7.47-7.51 (m, 1H, arom. CH ), 7.56-7.59 (m, 1H, arom. CH ), 7.69-7.74 (m, 2H,
arom. CH ), 7.79-7.81 (m, 1H, arom. CH ), 8.09-8.11 (m, 1H, arom. CH ), 8.51-8.54
(m, 1H, arom. CH ), 9.14 (s, 1H, CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ
= 13.4 (CH3), 21.5 (CH2), 25.3 (CH2), 29.3 (CH2), 30.1 (CH2CO), 111.9, 115.4, 119.5
(arom.CH and C ), 120.4, 122.4, 122.9, 128.2, 129.1, 133.2, 135.2, 138.2, 138.6, 146.2
(arom.CH and C ), 154.1 (CH=N) ppm), 162.3, 163.3 (arom.CO–V), 176.1 (CO–V).
51V NMR (105 MHz, DMSO-d6): - 472.6 ppm (ν1/2=310 Hz);
51V NMR (105 MHz,
CDCl3): - 481.1 ppm (ν1/2=145 Hz). Selected IR data (cm
−1): 1605 (s, -CH=N-N=C-),
1551 (s, -CH=N arom., quinoline), 973 (s, VO). UV/Vis (CH3CN solution, λmax in nm
(ε in 103 M−1 cm−1)): 241 (42.8), 273 (19.5), 322 (8.6), 540 (7.1).
Reduction of [VO(salhyp)(Q)] (4) complex
Complex 4 (0.05 g, 0.12 mmol) was dissolved in 5 mL acetonitrile under argon atmosphere
in presence of an excess of Zn-Hg amalgam. The resulting violet solution was stirred at
r.t. for about 30 minutes when a green precipitate was formed. The precipitate was
filtered off under argon atmosphere and redissolved in dried DMF for EPR measurement.
2.4.6 Catalytic oxidative bromination of TMB
TMB (25 mg, 0.15 mmol) was dissolved in 10 mL DMF. 10 mL of stock solution of
tetrabutylammonium bromide (48.3g/L) (1.5 mmol, 10 equiv.) were added, followed
by addition of 1 mL of vanadium complex, 0.15 mol% in DMF (0.015 mmol), HClO4
(0.15 mmol) and H2O2 (0.15 mmol) in this order. Aliquots of the reaction (250 µL)
were quenched in 2 mL of NaOH 2 mM aqueous solution and extracted with 3 mL ethyl
acetate. The reaction products were identified by gas-chromatography using the following
temperature programm: 80 ◦C to 240 ◦C with a heating rate of 15 ◦C per minute, followed
by 5 minutes holding of 240 ◦C temperature.
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Chapter 3
Vanadium complexes based on
N-salicylidene hydrazides with
hydroxyl substituted aliphatic side
chains
The hydroxy-functionalization of the aliphatic side chain of the N-salicylidene hydrazide
ligands has been achieved in order to design a ligand system capable of mimicking the
hydrogen bonding interaction of the vanadate moiety from the natural system with the
serine residue. The synthesis of this ligand system involves, in the first step, the reaction
between lactone and two equivalents of hydrazine hydrate. The reaction was performed
under reflux and continuous stirring for 12 hours to form the n-hydroxy aliphatic acid
hydrazides. In the second step, Schiff base condensation with salicylaldehyde affords
N-salicylidene hydrazides that contain hydroxyl substituted aliphatic side chains. The
schematic representation of the synthesis pathway is depicted in Figure 39.
The synthesis of vanadium(v) complexes with these type of Schiff base ligands
follows in general the procedure outlined in Chapter 2 with some differences regarding
the synthesis of oxovanadium(v) complexes.
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Figure 39: Schematic representation of the synthesis and tautomeric forms of hydroxyl-
substituted N-salicylidene hydrazides. n=1 H2salhyhb; n=2 H2salhyhp; n=3 H2salhyhh.
Every attempt to perform the in situ reaction using stoichiometric amounts of the new N-
salicylidene hydrazide ligands, ammonium metavanadate and 8-hydroxyquinoline failed.
Instead a mixture of the ammonium salt of cis-dioxovanadium(v) complexes134,135 and
methoxy-bis-(8-quinolinato)-oxovanadium(v)(6) has been obtained. Complex 6 crystal-
lizes overnight from the reaction mixture as violet prisms. Removal of the reaction solvent
to dryness and redissolving of the residue in chloroform, afforded a good separation of the
two complexes due to the insolubility of the anionic cis-dioxovanadium complex in the
chosen solvent. Complex 6 has been reported first time by Blair et al. in 1958144 and later
on by Riechel et al.,145 Giacomelly et al.146 and it has been crystallographically char-
acterized by Scheidt147 as an oxo-isopropoxo-bis-(8-quinolinato) vanadium(v) complex.
The similar complex 6 crystalizes in the monoclinic space group C2/c with two crys-
tallographically distinct oxovanadium moieties. Each molecule contains an octahedrally
six-coordinated vanadium atom with the two nitrogen atoms of the hydroxyquinoline
ligand placed in trans position to the oxo (O3) and methoxy (O4C) ligands (Figure 40).
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Figure 40: Molecular structure and numbering scheme for [VO(Q)2(OCH3)] 6; displace-
ment ellipsoids are drawn at the 50% probability level.
The bond lengths and angles are very similar to those previous reported for isopro-
poxy-vanadium complex except the vanadium to nitrogen atom located trans to the oxo
group. This bond length is slightly shortened to around 230 pm, compared to 231.7 pm
reported by Scheidt. Selected bond lengths and angles for complex 6 are given in Table
5.
Complexes of type 6 represent the first models of vanadium(v) complexes able to be-
have as the corresponding organic ester. This complex can be converted in vanadium(v)
anhydrides, as well as in the corresponding acids of type oxo-hydroxo-vanadium(v) quino-
linate complex-[VO(OH)Q2] when reacted with acid.
146,148
This is a significant difference to the ligand system outlined in Chapter 2, since in the
case of the alcoholic side chain, the reaction of the ammonium salt of cis-dioxovanadium
complexes with 8-hydroxyquinoline did not afford the desired mono-oxovanadium(v)
complexes. However the reaction was successful by performing in situ reaction using
a vanadium(iv) precursor and equimolecular amounts of N-salicylidene hydrazides and
8-hydroxyquinoline in methanol and/or acetonitrile solution.
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Table 5. Selected bond lengths (pm) in complex 6.
V1A−O1A 191.98(18) V1B−O1B 192.82(18)
V1A−O2A 189.93(17) V1B−O2B 190.21(18)
V1A−O3A 159.91(17) V1B−O3B 160.27(18)
V1A−O4A 178.16(17) V1B−O4B 176.80(17)
V1A−N1A 220.1(2) V1B−N1B 220.6(2)
V1A−N2A 230.1(2) V1B−N2B 229.7(2)
O3A−V1A−O4A 101.07(9) O3B−V1B−O4B 101.73(9)
O3A−V1A−O2A 97.15(8) O3B−V1B−O2B 95.84(9)
O4A−V1A−O2A 102.92(8) O4B−V1B−O2B 102.20(8)
O3A−V1A−O1A 101.31(8) O3B−V1B−O1B 101.59(9)
O4A−V1A−O1A 91.46(8) O4B−V1B−O1B 91.83(8)
O2A−V1A−O1A 153.93(8) O2B−V1B−O1B 154.91(8)
O3A−V1A−N1A 93.17(8) O3B−V1B−N1B 92.75(9)
O4A−V1A−N1A 163.39(8) O4B−V1B−N1B 163.13(9)
O2A−V1A−N1A 83.53(8) O2B−V1B−N1B 84.68(8)
O1A−V1A−N1A 77.27(8) O1B−V1B−N1B 76.65(8
O3A−V1A−N2A 172.50(8) O3B−V1B−N2B 171.11(9)
O4A−V1A−N2A 84.23(7) O4B−V1B−N2B 84.47(7)
O2A−V1A−N2A 76.36(7) O2B−V1B−N2B 76.48(7
O1A−V1A−N2A 83.72(7) O1B−V1B−N2B 84.42(7)
N1A−V1A−N2A 82.45(7) N1B−V1B−N2B 82.20(8)
The vanadium(v) complexes synthesized using the title ligand system represent a
side-chain functionalized model system for vanadium dependent haloperoxidases, namely
regarding the serin residue. In the native enzyme structure this serine residue is most
likely used as a hydrogen bonding acceptor, whereas in the apo-protein the serine residue
can be involved in phosphatase activity.98 Moreover, this Ser402 residue became a matter
of considerable interest recently. EXAFS studies on vanadium bromoperoxidase isolated
from Ascophylum nodosum, suggested that serine plays a vital role in the catalysis, being
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the actual site of bromination, forming a carbon-bromide bond during the turnover.149
This proposed essential role could not be verified by site-directed mutagenesis experi-
ment performed on the vanadium chloroperoxidase enzyme from the fungus Curvularia
inaequalis.150 Although, the basic activity of the enzyme is retained by mutation of the
active serine with alanine, a significant decrease of the enzyme activity has been reported
for both the chlorination and the bromination activity. The catalytic activity of the ap-
propriate active site-mutant decreased to about 4% and 20%, respectively. The role of
the serine residue has also been addressed using synthetic model, namely the ammonium
salt of the cis-dioxovanadium(v) complex based on N-salicylidene 5-hydroxy pentanoic
acid hydrazide NH4[VO2(salhyhp)], a catalyst which contains a similar hydroxyl group
which was proposed to be halogenated.135
N
O
N
O
OH
V
O O
-
NH4+
Bu4NBr + HClO4 + H2O2 +
HOBr
Br+?
OMe
OMeMeO
Br
OMe
OMeMeO
+
catalyst-complex NH4[VO2(salhyhp)]
TMB Br-TMB
Figure 41: Schematic representation of the oxidative bromination reaction catalyzed by
NH4[VO2(salhyhp)].
In a typical experiment using 10 mM TMB, 10 equivalents bromide, one aliquot
hydrogen peroxide and 10 mol% catalyst in DMF solution acidified with perchloric acid,
the possible formation of the carbon-bromide bond by a hypothetic bromination of the
aliphatic hydroxyl group was verified. After three hours of reaction, at room temperature,
the formed Br-TMB was extracted with ethyl acetate and the DMF solvent removed
under strong vacuum by partial frozen. 1H NMR performed on the isolated catalyst
using DMSO-d6 as solvent showed a free OH group which resonated at 4.26 ppm. This
is consistent with the results reported by Tanaka et al.150 that such a bromination does
not occur during the catalytic cycle.
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In the following parts of this chapter the discussions will be focused on the vana-
dium(v) complexes derived from N-salicylidene 4-hydroxy-butanoic acid hydrazide due
to the crystallographic characterization of the whole series of vanadium(v) complexes
involved in the mechanism of the oxidative halogenation of an organic substrate; whereas
all the other corresponding complexes with 5-hydroxy and 6-hydroxy-N-salicylidene hy-
drazides have been spectroscopically characterized and there are presented in the exper-
imental part of this chapter.
3.1 cis-Dioxovanadium(v) complexes derived from
N-salicylidene 4-hydroxy-butanoic acid hydrazide
The reaction of N-salicylidene 4-hydroxy-butanoic acid hydrazide with ammonium meta-
vanadate in methanol, under reflux for about 24 hours results in the formation of the
corresponding ammonium salt of the anionic cis-dioxovanadium(v) complex
NH4[VO2(salhyhb)]·H2O (7). Complex 7 is soluble in water and polar organic solvents
such as DMSO and DMF. For prolonged reaction times the primarily formed ammonium
salt was found to be converted to the corresponding neutral complex [VO2(Hsalhyhb)] (8)
by release of ammonia. [VO2(Hsalhyhb)] (8) was isolated as yellow crystalline compound
which is poorly soluble in organic solvents and insoluble in water. The neutral complex
8 can be de-protonated by reaction with neat ammonia resulting in formation back of
the anionic complex,151 as depicted below:
N
O
N
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V
O O
- NH3
+ NH3 (l)
N
O
N
O
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V
O O NH4+
3.1.1 Structural characterization
The molecular structure of the anionic complex NH4[VO2(salhyhb)]·H2O (7) has been
reported by Pohlmann et al.134,151,152 and is shown in Figure 42, while selected bond
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lengths and angles are listed in Table 6. For the vanadium atom a distorted square
pyramidal coordination is found with the equatorial plane formed by the ONO donor
atoms of the Schiff base ligand together with one oxo group O2. The apical position at
the vanadium atom is occupied by the other oxo group O1 with a V=O1 bond distance
of 163 pm. This bond distance is only 2 pm longer than that of the anionic complex 1
described previously and within the reported range of vanadium to axial oxygen atom
distances in cis-dioxovanadium(v) complexes.103,153,154 The distortion to an ideal square
pyramidal geometry is larger than in the similar anionic complex 1, with a τ value of
0.12. This observation demonstrates the flexibility of the geometry at the vanadium
center dictated by hydrogen bonding interactions. The molecular structure of the am-
monium salt NH4[VO2(salhyhb)]·H2O (7) shows high similarity with that observed for
the corresponding NH4[VO2(salhyp)] (1). The Schiff base ligand coordinates as dianionic
tridentate system with deprotonated hydrazide nitrogen atom N2, hence is the partial
double bond character of N2–C8 of around 131 pm. This is further in agreement with
O4–C8 and V–O4 bond lengths of 130 and 196 pm, respectively. These values are con-
sistent with the enolate form of the amide functionality and are in good agreement with
the corresponding bond distances found for the pentanoic analog 1.
Figure 42: Molecular structure and numbering scheme for NH4[VO2(salhyhb)] (7); dis-
placement ellipsoids are drawn at the 50% probability level.
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The complex crystalizes in the monoclinic space group P21/c with a water molecule
as solvent of crystallization. As observed for the ammonium salt of the pentanoic-
derivative complex 1, both oxo groups of the cis-dioxovanadium(v) moiety are parts
of the hydrogen bonding network.
Figure 43: Hydrogen bonding interaction in crystals of complex 7 (broken lines represent
hydrogen bonds); relevant distances (in pm): N3· · ·O1 289.1, N3· · ·O6 274.3, N3· · ·O2A
281.4, N3· · ·N2A 290.2, O5· · ·O6 272.6 and O6· · ·O3A 292.3 (symmetry operators: A:
x-1, y, z; B: -x+1, -0.5+y, -1.5-z; C: x-1, 0.5-y, -0.5+z).
The important difference between the pentyl and the hydroxy butanoic derivative
is, that, the network observed for NH4[VO2(salhyhb)]·H2O contains an additional donor
group, namely hydroxyl functionality which is in hydrogen bonding contact with the
water molecule (O5· · ·O6 272.6 pm). The water of crystallization establishes further an
intramolecular hydrogen bonding interaction with the ammonium cation (O6· · ·N3 274.3
pm) and the phenol oxygen atom (O6· · ·O3C 292.3 pm) of a neighboring molecule. The
ammonium cation completes this hydrogen bonding network by hydrogen bonding inter-
actions with the apical oxo group O1 (N3· · ·O1 289.1 pm), with each of the symmetrical
equivalent oxo group O2 (N3· · ·O2A 281.4 pm) and the hydrazide nitrogen atom N2
(N3· · ·N2B 274.3 pm) of neighboring molecule.
Over prolonged reaction time, the stoichiometric reaction of N-salicylidene 4-hydroxy
butanoic acid hydrazide with ammonium metavanadate to around three days, results in
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the formation of the neutral cis-dioxovanadium(v) complex (8). Slow evaporation at
room temperature of the mother liquor yielded yellow crystals, suitable for X-ray mea-
surement.151 Molecular structure and numbering scheme for [VO2(Hsalhyhb)] is shown
in Figure 44 and presents a cis-dioxovanadium moiety with a five-coordinated vanadium
atom. The two oxo groups are in cis position to each other, one in the apical position and
the other forming the equatorial plane together with the phenolate and carbonyl oxygen
atoms (O3 and O4), respectively, as well as the weakly coordinated imine nitrogen atom
(N1) of the tridentate chelate ligand. The vanadium atom is displaced out from the
plane, formed by the ligand, with 27 pm toward the apical oxygen atom O1, while the
equatorial oxo group O2 is slightly distorted on the opposite side by 25 pm. This leads
to a τ value of 0.14 consistent with a distorted square-pyramidal geometry around the
vanadium atom. The distortion to an ideal-square pyramidal geometry of the vanadium
atom in the neutral complex 8 is very similar with the distortion found in the anionic
complex 7. This indicates, that within similar hydrogen bonding network, the geometry
is conserved. The vanadium to apical oxygen atom O1 bond distance of 161 pm is very
similar with the corresponding bond length in complex 2. Relevant bond distances and
angles in complex 8 are listed in Table 6.
Figure 44: Molecular structure and numbering scheme for [VO2(Hsalhyhb)] (8); displace-
ment ellipsoids are drawn at the 50% probability level.
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The complex crystallizes in the monoclinic space group P21/c with the N-salicylidene
4-hydroxy butanoic acid hydrazide containing the protonated hydrazide nitrogen atom
N2H. This is in agreement with the shortening of the C8–O4 bond length to 126 pm
and elongation of the V–O4 bond length to 203 pm compared to corresponding bond
distances of the anionic complex 7.
At first glance the molecular structure of complex 8 shows high similarity with
the one determined for non-substituted 5-pentanoic chain [VO2(Hsalhyp)] (2). This is
particularly obvious as the hydrogen bonding interactions are concerned, since in both
cases the same functional groups of the vanadium coordination environment are consti-
tuing parts; i.e. the equatorial oxo group O2 and the protonated hydrazide nitrogen
atom N2. However, the additional hydroxyl group of the substituted side-chain present
in [VO2(Hsalhyhb)] also constitutes part of the hydrogen bonding network. This bridges
the equatorial oxygen atom (O5· · ·O2A 281.6 pm) and the protonated hydrazide nitrogen
atom (O5· · ·N2C 273.3 pm) of two neighboring molecules (Figure 45).
Figure 45: Hydrogen bonding interaction in complex [VO(HSahyb)] (8) (broken lines
represent hydrogen bonds); relevant distances (in pm): O2· · ·O5A 281.6 and N2· · ·O5B
273.3 (symmetry aperators: A: -x, -y, -z; B: -x, 0.5+y, -0.5-z; C: -x, -0.5+y, -0.5-z).
Moreover, at first sight, the molecular structure of [VO2(Hsalhyhb)](8) shows also
high similarity with that observed for the corresponding anionic complex 7. The overlay
of the covalent parts of the two structures shown in Figure 46 confirms this but however
it is also obvious, that there are significant differences regarding the orientation of the
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alkylic side chain of the ligand system. The hydroxy-alkyl side chain deviates from the
mean plane by an angle (C9–C10–C11–O5) of 62◦ in complex 8, whereas in complex 7
the hydroxyl substituted side-chain is orientated on the opposite site with an angle value
of 168◦. This, clearly indicates, the importance of the hydrogen bonding interactions
which can have an influence on the actual molecular structure.
Figure 46: Overlay of the covalent backbone of the molecular structures of
[VO2(Hsalhyhb)] 8 (thick lines) and NH4[VO2(salhyhb)] 7 (broken lines).
Table 6. Selected bond lengths (pm) and angles (◦) in complexes 7 and 8.
7 8 7 8
V−O1 163.22(16) 161.41(15) O1−V−O2 109.93(9) 108.85(8)
V−O2 163.58(16) 164.22(14) O1−V−O3 104.14(8) 103.97(7)
V−O3 189.12(15) 189.92(14) O1−V−O4 103.00(8) 98.94(7)
V−O4 196.09(16) 203.01(15) O2−V−O3 94.07(7) 98.00(7)
V−N1 213.25(18) 216.39(17) O2−V−O4 91.67(7) 91.15(7)
C8−O4 130.6(3) 126.4(2) O3−V−O4 148.39(7) 150.27(6)
C8−N2 130.7(3) 132.2(3) O1−V−N1 108.16(7) 107.81(7)
O2−V−N1 141.43(8) 141.97(7) O3−V−N1 82.36(6) 81.60(6)
O4−V−N1 73.99(6) 73.45(6)
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3.1.2 Spectroscopic data
The spectroscopic characterization of the complex is consistent with the proposed struc-
tures. The extension of the aliphatic side-chain to 5-hydroxy- and 6-hydroxy- derivatives
made possible the isolation of anionic and neutral cis-dioxovanadium(v) complexes. The
IR spectra contain strong stretching vibration in the region 885-927 cm−1 for the an-
ionic complexes and 892-910 cm−1 for the neutral complexes. These stretching vibrations
were assigned to the cis-VO2 moiety and the vibrations are similar with reported values
for ν(VO+2 ) group.
104,121,155 Similarly with cis-dioxovanadium(v) complexes described
in Chapter 2, the Schiff base ligands coordination mode is identical. When neutral cis-
dioxovanadium(v) complexes are formed, the ν(NH) vibration is observed at 3217 cm−1
as a broad band, together with the ν(CO) vibration at 1627 cm−1. These stretching
modes are shifted compared to their vibrations at 3185 and 1669-1673 cm−1 in the free
ligands. However, these vibrations are absent in the IR spectra of the ammonium salt of
cis-dioxovanadium(v) complexes due to the enolization of the amide functionality and,
instead the 1613 cm −1 band assigned as ν(–CH=N–N=CH–) vibrates in the same re-
gion as was described in previous chapter. Further evidence of the coordination mode
of the Schiff base ligands was obtained from the 1H and 13C NMR spectra, which are
summarized in the experimental section. The resonances of OH and NH protons of the
free ligands are absent in the 1H NMR of the anionic cis-dioxovanadium(v) complexes,
indicating the enolization of the amide functionality upon complexation. Instead, a new
resonance at 7.11 ppm, corresponding to 4H+, is observed, indicative of the formation
of the ammonium salts of complexes. A significant downfield shift of ca. 0.4 ppm for
the azomethine (–CH=N–) proton in the 1H NMR of anionic complexes, relative to the
corresponding free ligand, supports the coordination of the azomethine nitrogen atom.
A very good indication of the integrity of complexes in solution is represented by 51V
NMR spectra. Both types of cis-dioxovanadium(v) complexes resonate at δ = -533 ppm
region in DMSO-d6 solution, being what one would expect for a dioxovanadium complex
containing a rich O/N environment.11 The 51V NMR data for the ammonium salt of
the anionic cis-dioxovanadium(v) complex is somehow solvent dependent; for example
an up-field shift of around 5 ppm has been observed in D2O solution (δ = -538 ppm)
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compared to the resonance recorded in DMSO-d6 solution. Unfortunately, the neutral
complexes have a very poor solubility in organic solvents and their characterization in
solution was limited.
3.1.3 Oxidative bromination of 1,3,5-trimethoxybenzene
Following the procedure outlined in Chapter 2, the ammonium salts of cis-dioxovana-
dium(v) complexes were tested for their capacity to catalyze the oxidative bromination
of 1,3,5-trimetoxybenzene (TMB).
From the entries presented in Table 7, it is clear that the vanadium complex obtained
with N-salicylidene 4-butanoic acid hydrazide NH4[VO2(salhyhb)], is the most potent cat-
alyst of this serie. The turnover rate of about 55 mol Br-TMB×(mol catalyst×h)−1, is
superior compared to that performed by ammonium salt of cis-dioxovanadium complex
with non-substituted aliphatic side-chain NH4[VO2(salhyb)] (Table 2, Chapter 2). This
observation is in agreement with the observed influence of the hydrogen bonding inter-
actions in the reactivity of the prosthetic group in V-HPO enzymes.
Table 7. Catalytic oxidation experiments using ammonium salts of cis-dioxovanadium(v)
complexes as catalysts.
Complex 2 min. 5 min. 10 min. 15 min. TON
NH4[VO2(salhyhb)] 13.5(20.2) 46.1(69.1) - - 55
NH4[VO2(salhyhp)] 9.5(14.2) 28.0(42.0) 54.3(81.4) 70.3(105.4) 34
NH4[VO2(salhyhh)] 11.5(17.2) 34.7(52.0) 68.1(102.1) 74.1(111.1) 41
Note: The results are given in obtained % Br-TMB and as µmol Br-TMB within parenthe-
sis. The turnover numbers were calculated taking into account the conversions obtained
within 5 minutes.
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3.1.4 Reactivity of the complexes towards HCl
The formation of an oxo-hxdroxy-vanadate moiety [VvO(OH)]2+ became a matter of
considerable interest in the last period. The metal to hydroxy group bond is in general
a common feature in metal-containing enzymes. M–OH units have been proposed as ac-
tive species in iron and cobalt nitrile hydratases,156 iron-containing lipoxygenases,157,158
zinc and nickel hydrolytic enzymes,159,160 acid phosphatases161 and vanadium haloper-
oxidases.6 Synthetic models that contain a Mii/iii-OH bond were often reported, either
as monomeric structure or as hydroxy-bridged complexes of type M–(OH)n–M. The syn-
thesis of such compounds requires either the presence of water or base as a source of
hydroxyl ligand and complexes with Coii/iii–OH,162,163 Feii/iii–OH50,164,165 and Znii–
OH166 moiety have been crystallographically characterized. In vanadium chemistry, only
Viv–OH units are known, both as monomer167,168 as well as dimer complexes.169,170 The
formation of a vanadium to terminal hydroxyl group moiety has been reported in vana-
dium(iv) compounds based on pyrazolyl and bi-pyridine rings after hydrolysis of V–OCl
or V–Cl bonds of the starting inorganic salts. Based on similarities between the vanadium
and molybdenum chemistry, a Mov–(OH)n–Mo
v moiety has also been crystallographi-
cally identified.171 Moreover, the reported crystal structure of V-ClPO contains a metal-
to-terminal hydroxy unit. Various attempts to isolate or to identify the intermediates
[VvO(OH)]2+ species have been reported.104,155 The first reported vanadium(v) complex
of this type was proposed in 1958144,148 for the bis-(8-quinolinato)-oxo-hydroxy vanadium
complex. The complex was generated in situ using first acetic acid as a source of hydroxyl
ligand and, later by stoichiometric reaction of complexes of type 6 with hydrochloride
acid.145,146 Although later reports are known,104,155,172 the molecular structure deter-
mination of such [VvO(OH)]-containing compound has not been reported. Pecoraro et
al. reported the spectrophotometric titration of a cis-dioxovanadium(v) (see also Figure
14, compound 1.1) complex with HCl in acetonitrile solution suggesting the formation
of a [VvO(OH)]2+ unit, based on the stoichiometry of the reaction.102 The protona-
tion reaction takes place preferentially at the cis-dioxovanadate center (Figure 47) and
secondly, at the secondary amine which leads to an unstable compound. Addition of
HCl as acetonitrile diluted solution to the dioxo-complex solution leads to red-shifts of
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the absorption maxima, generating a red-colored material with an absorption maxima at
496 nm, whereas further addition of HCl generated a violet, very unstable compound.
In accordance with the structure of the starting cis-dioxovanadium(v) complex, it is
plausible that the protonation occurs first at the vanadate center, whereas the protonation
of the secondary amine will lead to an unstable complex due to the breakdown of the
weak covalent bound V–N through involvement of the nitrogen pair electron in binding
hydrogen.
VvO2(HSHED)  +  [VvO2[(HSHED)]2
1.1- monomer              dimer
VOSO4  +
N
OH
HN
HO
 H2SHED
NaOH
[VvO(OH)(HSHED)]+
      red solution
+ HCl
[VvO(HSHED-H)]2+
  violet solution
      unstable
+ HCl
Figure 47: Schematic representation of the reactivity of complex (1.1) toward HCl in
acetonitrile solution in accordance with reference 38.
In order to confirm or deny the formation of such [VvO(OH)]2+ moiety in vana-
dium model-complexes based on N-salicylidene hydrazide, investigation regarding the
reactivity towards hydrochloric acid has been performed. The reaction of the anionic
cis-dioxovanadium(v) NH4[VO2(salhyhb)], with HCl in aqueous solution has been spec-
trophotometrically investigated. Spectrophotometric titration of an aqueous solution of
complex 7 has been monitored by stepwise addition of 5 equivalents of HCl, 0.01 M stan-
dardized aqueous solution. The complex itself has a very good solubility in water with
a high stability and exhibits three absorption maxima at: 214 (ε= 22.3×103 M−1cm−1),
281 (ε= 11.0×103 M−1cm−1) and 371 (ε= 3.2×103 M−1cm−1) nm, respectively. Stepwise
addition of 0.25 equivalents HCl generates a constant decrease in absorbance of 371 nm
band, accompanied by a slight split of the 281 nm band. The spectrum presents an isos-
bestic point at 294 nm, which can be interpreted as an equilibrium between the existing
species in solution.
Most likely only one protonation step takes place, which occurs at the hydrazide
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nitrogen atom: This hydrazide site is more basic compared to vanadate moiety and its
protonation takes place preferentially. The reconversion of the initial spectrum can be
achieved by back-titration with NaOH 0.01 M aqueous solution and it has been found
that 6.5 equiv. of base were necessary to recover the initial UV-Vis spectra of the anionic
complex. Theoretical interpretation of data set using a programme based on one devel-
oped by Zuberbu¨hler (SPECFIT-32)173,174 is in agreement with the proposed reaction.
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Figure 48. Spectrophotometric titration of NH4[VO2(Salhyhb)] 7 (33.4µM) with 5 equiv-
alents HCl 0.01 M in water. Successive addition of 0.25 equivalent of acid was performed
at 18 ◦C with an equilibration time of 2 minutes within acid additions.
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O O
-
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+ NaOH
Figure 49. Proposed reactivity of NH4[VO2(salhyhb)] with HCl in aqueous solution at
18 ◦C.
A reasonable fit of the measured data when 5 equivalents of acid have been used,
was obtained by taking into account one protonation step, resulting in a value of 10 000
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of the equilibrium constant which corresponds to a calculated pKb value of 10.0±0.2. The
standard deviation was found to be around 1×10−3 and it increases to around 1.5×10−3
when an additional protonation reaction had been taken into account. Further confir-
mation of the proposed one step protonation reaction has been achieved by 51V NMR
monitoring of the reaction in D2O. The cis-dioxovanadium complex exhibits one reso-
nance at -538 ppm. This resonance remains unchanged when up to one equivalent of HCl
1M is added, whereas further increase of the amount of hydrochloric acid to 1.5 and 3
equivalents, generated an insoluble yellow material. This is indicative of the protonation
of the hydrazide nitrogen atom upon neutral vanadium complex formation (Figure 49).
The neutral complex is known as having a poor solubility in organic solvent and it is
completely insoluble in water. Moreover, it should be mentioned that the resonance of
the 51V nuclei in cis-dioxovanadium(v) complexes based on N-salicylidene hydrazide, are
independent of counter ions. Thus, the two cis-dioxospecies, anionic and neutral com-
plexes, exhibit the same 51V resonance. Therefore, it can be concluded that, in aqueous
solution, the protonation reaction with HCl occurs at the hydrazide nitrogen atom, the
most basic site comparing to the oxo groups of the vanadium center.
3.1.5 Reactivity of the complexes towards H2O2
Vanadium haloperoxidases are enzymes capable of catalyzing halide oxidation by hy-
drogen peroxide to hypohalous acid.6 This oxidized halogen intermediate is able to
halogenate various organic substrate,68 or to react with a second equivalent of hydrogen
peroxide to produce singlet oxygen.73–75 Moreover, these enzymes can also catalyze the
oxidation of organic sulfides to corresponding sulfoxides.89,90,175 The mechanism of these
catalytic reactions involves a peroxo-intermediate formation. Spectroscopic and kinetic
studies on the native enzyme showed no change in the redox state of the prosthetic group
during the catalytic cycle. Thus, the vanadate was proposed to function as a Lewis-acid
catalyst, reacting firstly with hydrogen peroxide to form a side-on bonded peroxo moiety.
This peroxide may be activated through hydrogen-bonding interactions with the first
shell of amino acids and nearby water molecules.78 An rearrangement of the geometry of
the prosthetic group occurs during the turnover, varying from a trigonal bipyramidal
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Figure 50: The active site in V-CPO: native form (left), peroxo form (right).
geometry in the native form to a tetragonal arrangement in its peroxo form.78
A vital role for the peroxide-intermediate activation has been attributed to lysine residue
which is in hydrogen bonding contact with one of the peroxide-oxygen atom. It has
been suggested that this hydrogen bonding interaction is responsible for an increased
electrophilicity on the peroxide moiety, favoring therefore, the subsequent attack of the
halide. Based on this aspect of the biological function of the vanadate in VHPO, the
synthesis of structural models with relevant hydrogen bonding interaction has recently
been reported115,116 (Figure 17). Both vanadium(v) peroxo complexes are designed to
model the corresponding intermediate of vanadium haloperoxidases. Nevertheless the
knowledge about peroxo-vanadium(v) complexes capable to mimic the hydrogen bonding
interaction found in the natural system is limited.
Renirie et al.95 monitored spectrophotometrically the formation of the peroxo-form
of vanadium chloroperoxidase enzyme. The native enzyme presents a near-UV absorption
maxima which is pH dependent, varying from 315 nm at pH value of 8.3 (similar with
UV-Vis spectra of V-BPO) to 305-310 nm at pH around 5. Spectrophotometric titration
with H2O2 cause a decrease in intensity of this band accompanied by a red-shift of the
absorption maxima at 389 nm, indicative of the addition of hydrogen peroxide at the
vanadate moiety.
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The anionic complex NH4[VO2(salhyhb)] was also reacted with hydrogen peroxide in
order to mimic the reactivity of the V-CPO enzyme. The reactivity of NH4[VO2(salhyhb)]
towards H2O2 has been studied using UV-Vis spectroscopy in different solvents medium.
Spectrophotometric titration of complex 7 with H2O2 in aqueous solution was monitored
by stepwise addition of the oxidant. The UV-Vis spectra showed a constant decrease
of the 371 nm maxima of the cis-dioxovanadium complex with the added amount of
hydrogen peroxide. A slight splitting of the 278 nm maxima into two new bands (278
and 287 nm) is also obvious (Figure 51). At this point similarity between the resulting
spectra by titration with hydrogen peroxide and the characteristic UV-Vis absorption
maxima of the free ligand becomes apparent.
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Figure 51: Spectrophotometric titration of NH4[VO2(salhyhb)] with 10 equivalents H2O2
in water solution at 20 ◦C. The titration was performed by successive addition of 0.25
equivalents of H2O2 (25 mM) aqueous solution after every two minutes.
Further addition of hydrogen peroxide up to 20 equivalents yielded an increase of the new
278 (ε= 16.2×103 M−1cm−1), and 287 (ε= 15.6×103 M−1cm−1) nm bands, whereas the
315 nm shoulder also increased in intensity (ε= 8.6×103 M−1cm−1). This excess of hy-
drogen peroxide (20 equivalents) yielded an UV-Vis spectrum which exhibits the features
of the free ligand (Figure 52), recorded as 50 µM aqueous solution. The Schiff base ligand
(H2salhyhb) exhibited three absorption maxima in water solution, detected at 215 (ε=
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14.8×103 M−1cm−1), 278 (ε= 19.7×103 M−1cm−1), 287 (ε= 17.7×103 M−1cm−1) and 318
(ε= 8.8×103 M−1cm−1) nm, respectively. Therefore, the result of the spectrophotometric
titration of complex 7 with 20 equivalents of hydrogen peroxide in water solution can be
interpreted as a decomposition of the anionic cis-dioxovanadium(v) complex. This might
be due to the presence of excess water which makes the azomethine bond very sensitive
to hydrolysis.
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Figure 52: Spectrophotometric titration of NH4[VO2(salhyhb)] with 20 equivalents H2O2
in water solution at 20 ◦C (left panel) and the UV-Vis spectrum of the free ligand
(H2salhyhb as 50 µM aqueous solution) (right panel).
Moreover, such an interpretation is sustained by 51V NMR monitoring of the reac-
tion using D2O as solvent. The anionic complex resonate at -538 ppm. Addition of 2.5
equivalents of H2O2 generates a decrease in intensity of this resonance accompanied by
the appearance of a new resonance at -691 ppm. The later resonance becomes predom-
inant by increasing the amount of H2O2 to 5 equivalents. The further increase of the
added amount of hydrogen peroxide cause a single resonance, the one at -691 ppm (ν1/2=
136 Hz), assigned to the inorganic oxo-di-peroxovanadium(v) [VO(O2)2(H2O)]
−
2 (Figure
18).118 This value of the 51V resonance coincide with the resonance reported by Conte et
al. for inorganic [VO(O2)2(H2O)]
−
2 in water solution.
176 These results are in agreement
with the UV-Vis interpretation of the reaction and they showed the decomposition of the
cis-dioxovanadium(v) complex in presence of excess of water.
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Figure 53: Titration of NH4[VO2(salhyhb)] with H2O2 in D2O solution monitored by
51V
NMR; complex (blue spectra), complex + 2.5 equiv. H2O2 (red spectra), complex + 5.0
equiv. H2O2 (green spectra), complex + 10.0 equiv. H2O2 (violet spectra).
The spectrophotometric titration of complex 7 with H2O2 has also been performed
in methanol solution. Stepwise addition of H2O2 causes a red-shift of the 384 nm band
to 392 nm which increases in intensity with the increasing amount of added H2O2. The
278 nm broad band is increasing also in intensity accompanied by sharpening and split-
ting into two new bands. The 310 nm shoulder observed in the initial spectrum of the
anionic cis-dioxovanadium(v) complex is also increasing in intensity during the titration
with H2O2 (Figure 54). This behavior of the reaction differs to one described in water
solution and it can be interpreted as the formation of a desired peroxo complex of type
[VO(O2)salhyhb]
−.
Taking into account that the vanadium-catalyzed bromide oxidation is performed
in DMF solution, the UV-Vis monitoring of the reaction of NH4[VO2(salhyhb)] (7) with
H2O2 have also been performed in DMF solution. An increase in intensity of the 385 nm
band has been observed accompanied by a very small red-shift(Figure 55), similarly with
the spectrophotometric titration performed in methanol solution and is consistent with
the formation of the peroxo complex [VO(O2)salhyhb]
−.
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Figure 54: Spectrophotometric titration of NH4[VO2(salhyhb)] with H2O2 (25 mM) in
methanol solution at 20 ◦C. The titration shows the formation of the peroxovanadium
complex with strong absorbance at 392 nm using the conditions quoted in Figure 51.
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Figure 55: Spectrophotometric titration of NH4[VO2(salhyhb)] with H2O2 in DMF so-
lution at 20 ◦C. The titration shows the formation of the peroxovanadium vanadium
complex through addition of 0.5 equivalents of hydrogen peroxide up to 2 equivalents,
followed by at once addition of other two equivalents.
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It can be concluded that the reactivity of the cis-dioxovanadium(v) complex to-
wards H2O2 is strongly dependent on the solvent and this dependence can be caused
especially by the imine-bond presence which is hydrolytically unstable.
Based on the results from the spectrophotometric titrations, the reaction of the
NH4[VO2(salhyhb)] with H2O2 was performed also in large amounts using ethanol-water
4:1 mixture at 0◦ C. This reaction of the ammonium salt of cis-dioxovanadium(v) complex
with 2 equivalents of hydrogen peroxide yielded the neutral oxo-monoperoxovanadium
complex [VO(O2)(Hsalhyhb)H2O]·H2O (9) upon release of ammonia due to the water
presence. The complex crystalizes as orange-red crystals from cold solution overnight and
it is unstable in solution for a prolonged time hydrolyzing to the corresponding neutral
cis-dioxo complex. The oxo-peroxovanadium complex 9 has also been obtained by in situ
reaction of potassium vanadate, hydrogen peroxide and N-salicylidene 4-hydroxy butanoic
acid hydrazides in methanol-water solution at 0 ◦C, in presence of perchloric acid. Due
to the acidic reaction conditions in the latter case, the tridentate Schiff base ligand was
expected to coordinate in its monoanionic form via protonation of the hydrazide nitrogen
atom N2.
Complex 9 is soluble in various organic solvents like alcohols, acetonitrile and DMF
without decomposition. The 51V NMR spectrum recorded in CD3OD reveals a single
resonance in the typical range, i.e. at -551 ppm (∆ν1/2=105 Hz), whereas in DMSO-d6
a fast decomposition takes place immediately after dissolution of the complex, indicated
by the detection of two resonance peaks in the 51V NMR spectrum. The peak at
-539 ppm (∆ν1/2=860 Hz) is attributed to the corresponding cis-dioxocomplex and the
second peak at -572 ppm (∆ν1/2=1100 Hz) is attributed to the corresponding dimeric
cis-dioxocomplex, respectively. The intensity ratio for the two resonance peaks observed
in deuterated DMSO is approximately 10:1. The molecular structure of complex 9 de-
termined by X-ray crystallography reveals a pentagonal-bipyramidal geometry for the
coordination around the vanadium atom as depicted in Figure 56. The ligand coordi-
nates in its monoanionic form, providing an ONO donor set. In the equatorial plane, the
vanadium atom is coordinated by the side-on bonded peroxo group with O2 and O3 as
well as the donor atoms O4, N1 and O5 of the tridentate hydrazide ligand. The axial
positions of the coordination polyhedra are occupied by oxo group O1 and by the oxygen
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atom O7 of the coordinated water molecule. The structural parameters given in Table
8 are consistent with those observed for the vanadium(v) complex with hydrazide lig-
and and in good agreement with those reported for vanadium(v) oxo-peroxo complexes,
which generally feature a coordination at the vanadium atom with the oxo group in axial
position and an equatorial side-on bonded peroxide.111,115,116,177
Figure 56: Molecular structure of 9; displacement ellipsoids are drawn at the 50% prob-
ability level.
Complex 9 crystallizes with one water molecule (O8) leading to an extensive hy-
drogen bonding network in the solid state as depicted in Figure 57. The first sphere of
hydrogen bonding interactions given in Figure 57 is solely located below the planar lig-
and arrangement in a trans orientation with respect to the oxo group O1. Consequently
the oxo group O1 and the carbonyl group O5 of the hydrazide ligand are not involved
in the hydrogen bonding network, which is in agreement with their relatively low donor
ability. Both enantiomers present in the crystal structure of 9·H2O form a hydrogen
bonded chain via the interaction between the protonated hydrazide nitrogen atom N2
and the peroxo group of a neighboring complex with the same enantiomeric symmetry
(N2· · ·O2A 280, N2· · ·O3A 305 pm). These two enantiomeric chains set up a bilayer
which incorporates the hydrogen bonding network shown in Figure 58 and in turn leads
to an one-dimensional hydrogen bonded chain along the [010] direction (Figure 58).
A situation reminescent of the role of the active site lysine residue in VHPO78 is
found by the hydrogen bonding interaction between the peroxo ligand (O2 and O3) and
the acidic N–H group of the hydrazide ligand (N2).
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Figure 57: Hydrogen bonding network for complex 9×H2O. Only hydrogen atoms bonded
to non-carbon atoms are shown, broken lines represent hydrogen bonds, dashed circles
and lines represent symmetry equivalent atoms and bonds between them, respectively
(symmetry operators A: 1-x, -y, -z; B: x, y-1, z; C: 1-x, 1-y, -z; D: x, 1+y, z). Se-
lected hydrogen bond distances (pm): N2· · ·O2D 280.2, N2· · ·O3D 305.2, O6· · ·O8 286.0,
O7· · ·O2A 282.7, O7· · ·O6C 271.1, O8· · ·O2A 306.0, O8· · ·O3 299.8, O8· · ·O4A 295.8.
A second type of hydrogen bonding pathway related to the peroxo group originates
from the hydroxy side chain (O6) of the Schiff base ligand system. This side-chain is
involved in hydrogen-bonding cascade that includes the water oxygen atom O8 (O6· · ·O8
286 pm); this leads to an intramolecular interaction with the oxygen atom O3 of the
peroxo group (O8· · ·O3 299 pm), and an intermolecular interaction with the peroxo
oxygen atom O2 (O8· · ·O2A 306 pm) of a neighboring complex. The later of these
hydrogen bonds is part of a bifurcated interaction between O8 towards O2 (Figure 57).
The hydrogen-bond network is completed by the coordinated water molecule, O7, which
forms intermolecular contacts with the hydroxy side chain oxygen atom O6 (O6C· · ·O7
271 pm) and with the peroxo oxygen atom O2 (O7· · ·O2A 283 pm) from two different
neighboring molecules of opposite enantiomeric chains. The observed hydrogen bonding
interaction are of specific interest due to the presence of the Ser402 in the active site of
vanadium haloperoxidases, in particular, they are of possible relevance for proton transfer
reactions.
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Figure 58: Representation of the hydrogen-bonded bilayer for neutral oxo-peroxo-complex
9, as viewed approximately along the [010] direction.
The structure of the mono-peroxovanadium(v) complex was also confirmed by IR
spectroscopy. Comparison between the IR patterns of the NH4[VO2(salhyhb)] with IR
spectrum of [VO(O2)(Hsalhyhb)] showed different stretching vibration of the vanadate
moiety. While the ν(VO+2 ) vibrates at 909 cm
−1, the V=O group of the peroxo-complex
9 present stretching vibration at 978 cm−1 and the region is completed by the stretching
vibration corresponding to ν(O–Operoxo) at 921 cm
−1 as well as the asym. and sym.
vibration corresponding to ν(V(O)2) group at 765 and 562 cm
−1, respectively. Solution
investigations on anionic oxo-monoperoxovanadium complex has also been performed us-
ing NMR technique as well as UV-Vis spectrophotometry. The 51V NMR performed in
DMSO-d6 solution is indicative of the instability of the complex in solution for a pro-
longed period of time. At room temperature, independent of solvent, the orange-red
solution of the peroxovanadium complex 9 becomes yellow colored from which neutral
cis-dioxovanadium(v) complex is separating in a matter of hours. The UV-Vis spectra
of complex 9 in DMF and MeOH solution presents absorbtion maxima at 392 nm due to
the peroxo-to-metal charge transfer and 278, 288 and 319 nm. The later three absorption
maxima closely resembles the maxima of the free ligand. This UV-Vis spectra is in agree-
ment with the obtained results of the spectrophotometric reaction of the corresponding
ammonium salt of the cis-dioxovanadium(v) with H2O2, confirming the interpretation of
the results.
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Table 8. Selected bond lengths (pm) and angles (◦) for complex 9.
V−O1 157.8(3) V−O7 225.8(3)
V−O2 189.1(3) V−N1 213.2(3)
V−O3 187.6(3) O2−O3 142.9(4)
V−O4 197.6(3) C8−O4 125.7(4)
V−O5 207.6(3) C8−N2 132.3(5)
O1−V−O2 103.48(13) O2−V−O3 44.57(12)
O1−V−O3 101.94(14) O2−V−O4 79.39(12)
O1−V−O4 97.52(15) O2−V−O5 119.93(12)
O1−V−O5 94.26(14) O2−V−O7 86.31(12)
O1−V−O7 170.08(13) O2−V−N1 155.91(12)
O1−V−N1 94.13(13) O3−V−O4 123.41(13)
O4−V−O5 154.21(12) O3−V−O5 75.86(12)
O4−V−O7 82.58(11) O3−V−O7 86.08(12)
O4−V−N1 82.17(12) O3−V−N1 146.81(13)
O5−V−O7 81.95(11) O5−V−N1 74.14(12)
O7−V−N1 76.01(11)
3.2 Reactivity of the oxo-monoperoxovandium(v)
complex
Renirie et all.95 determined spectrophotometrically the stability and reactivity of the
peroxo intermediate of vanadium chloroperoxidases. The peroxo form is very stable at a
pH value of 8 and persists for a long period of time, whereas it is less stable at a pH value
of 5 (the activity optimum for the native enzyme). However in both conditions the peroxo
form of the enzyme is capable to oxidize Cl− ions to hypochloric acid under a pseudo-first
order reaction. To probe the ability of the peroxo complex towards haloperoxidase activ-
ity, the formation of an oxidized bromide species was tested. This was monitored by the
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formation of bromo derivate Br-TMB. The peroxo complex-[VO(O2)HSalhyhb)H2O]·H2O
reacts with one equivalent of TMB in presence of an excess of tetra-n-butylammonium
bromide and one equivalent of perchloric acid to yield 2-bromo-1,3,5-trimetoxybenzene.
About 90% of TMB was converted in the corresponding brominated compound in less
than 30 minutes as monitored by HPLC. In the absence of acid, as well as without the
complex no brominated products could be observed. This could lead to the conclusion
that the oxidation of bromide by hydrogen peroxide involves the formation of an oxo-
monoperoxovanadium complex as intermediate. Due to the requirement of stoichiometric
amounts of acid in the equimolecular reaction between peroxo-complex 9 and organic sub-
strate (here TMB) is most likely that an activation via protonation of the peroxide moiety
is necessary.
For the vanadium haloperoxidases catalyzed sulfide oxidation reaction the mecha-
nism is also proposed to proceed through a peroxo intermediate. To probe the sulfox-
idation reactivity of this peroxo-vanadium(v) complex, an equimolecular reaction with
phenyl-methyl-sulfide have been performed in a dichloromethane-methanol mixture. The
methyl phenyl sulfoxide was oxidized very slowly leading to about 75% conversion in
about 48 hours. It is interesting to note, that this is about the same time usually ob-
served for catalytic turnover in model systems with only 1 mol-% of the vanadium catalyst
present. The oxidative capacity of the peroxo complex was further tested by investigat-
ing its reaction with triphenylphosphane in acetonitrile solution. 31P NMR spectroscopy
monitoring of the reaction showed the phosphane oxide readily formed together with
the corresponding cis-dioxovanadium(v) complex, implying that full conversion of the
reactants had occurred.
3.3 Mono-oxovanadium(v) complexes based on N-
salicylidene hydrazides that contain an hydroxyl-
substituted aliphatic side-chain
Mono-oxovanadium(v) complexes based on hydroxyl-substituted N-salicylidene carbonic
acid hydrazide can be synthesized starting from the corresponding neutral cis-dioxovana-
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dium(v) complexes in reaction with equimolecular amount of 8-hydroxyquinoline in re-
fluxing methanol solution. The second method consists of in situ stoichiometric reaction
of the Schiff base ligands, vanadyl acetyacetonate in refluxing methanol and/or acetoni-
trile, followed by stepwise addition of 8-hydroxyquinoline. The equimolecular reaction of
VO(acac)2 with N-salicylidene hydroxyl-substituted aliphatic acid hydrazide proceed by
aerial oxidation of the vanadium(iv) precursor to yield a brown colored solution. Fur-
ther on, addition of 8-hydroxyquinoline cause a violet colored solution. Variation of the
aliphatic chain length of the Schiff base ligand afforded three oxovanadium(v) complexes
which have a very good solubility in polar solvents (alcohols, DMF and DMSO), halo-
genated solvents (chloroform and dichlormethane) and acetonitrile, behaving very similar
with the corresponding mono-oxovanadium(v) complexes described in Chapter 2.
3.3.1 Structural characterization
Using N-salicylidene hydrazide ligand derived from 4-hydroxy butanoic acid hydrazide
and following the reactions outlined above, the corresponding oxovanadium(v)
[VO(Q)(salhyhb)] (10) complex could be isolated as microcrystalline compound by re-
crystallization from a methanol/acetonitrile 1:1 mixture. The complex crystallize in
the triclinic space group P
−
1 with two very similar molecules per unit cell. The other
two oxovanadium(v) complexes derived from 8-hydroxyquinoline and N-salicylidene of
5-hydroxy-pentanoic [VO(Q)(salhyhp)] (11), and 6-hydroxy hexanoic acid hydrazides
[VO(Q)(salhyhh)] (12), respectively have been spectroscopically characterized and pre-
sented in the experimental part of the chapter. The molecular structure of complex 10
determined by X-ray crystallography features two structurally very similar but crystallo-
graphically distinct oxovanadium(v) moieties in an oxygen and nitrogen rich environment
as depicted in Figure 59. The vanadium atom is six-coordinated in a distorted octahe-
dral geometry. The dianionic N-salicylidenehydrazide acts as tridentate chelate system
coordinating through ONO donor atoms that form a basal plane together with the oxine
oxygen O21 and O41, respectively of the bidentate 8-hydroxyquinoline ligand. Relative
to this plane, the vanadium atom V1 is displaced toward the terminal oxygen atom O11
by 31.5 pm, while the other vanadium atom V3 is distorted towards the oxygen atom
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O31 by 30 pm. Trans to the terminal oxo groups O11 and O31 are located the nitrogen
atom N21 and N41, respectively, of the 8-hydroxyquinoline ligand with the bond length
of around 235 pm, very similar with the corresponding bond lengths found in the previ-
ously described mono-oxovanadium complexes. These bond lengths are around 27.5 pm
longer than the vanadium to imine nitrogen atom of the Schiff base ligand (N11 and N31)
bond distances, due to the trans position of the quinoline nitrogen atom to the terminal
double bonded oxygen atom. The V=O (oxo) bond length of around 159 pm is very
similar with the corresponding bond distance found in the oxovanadium(v) complexes
with non-substituted aliphatic side-chain.
Figure 59: Molecular structure of the two crystallographically distinct [VO(Q)(salhyhb)]
(10) molecules; displacement ellipsoids are drawn at the 50% probability level.
The Schiff base ligand forms a six- and a five-membered chelate ring with bite angles
of 83.8◦ (O12–V1–N11, O32–V3–N31) and around 75◦ (O13–V1–N11 and O33–V3–N31),
respectively, consistent with observed distortion of the vanadium geometry. Selected
bond lengths and angles for complex 10 are given in Table 9. The coordination mode
of the N-salicylidene hydrazide ligand is very similar with that described in vanadium
complexes which contain the enolized form of the amide functionality with the C–O bond
lengths of around 131 pm and V–O3 distance of 195 pm.
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The difference to the mono-oxovanadium(v) complexes described in Chapter 2, is
the presence of a medium-to strong hydrogen bonding network observed in solid state
in complex 10. The two crystallographically distinct oxovanadium(v) moieties are in
hydrogen bonding contact via hydroxyl groups of the side-chain substituted N-salicylidene
hydrazide ligands of 286.0 pm (O14· · ·O31A). Moreover, the terminal oxo group O31 of
the enantiomeric molecule is in hydrogen bonding interaction with hydroxy oxygen atoms
from neighboring molecules (O31· · ·O14A) as depicted in Figure 60.
Figure 60: Representation of the hydrogen bonding interaction of complex 10 (broken
lines represent hydrogen bonds); relevant hydrogen bond distances (pm): O31· · ·O14A
286.0, O14· · ·O31A 287.5 (symmetry operators A: x-1, y, z).
The hydrogen bonding interaction observed leads to the formation of a two-dimen-
sional network along the crystallographic (010) plane as depicted in Figure 61. The
orientation of the oxygen atoms involved in hydrogen bonding results in formation of a
polymeric chain, while the non hydrogen bonded oxo groups are located on outside.
Complex 10 is one of the rare example of oxovanadium(v) complex which contains
a hydrogen bonded terminal oxo moiety. Similar interaction was found in the natural
enzyme where the apical hydroxyl group of the vanadate center is in hydrogen bonding
interaction with an nitrogen atom of an imidazole ring of a His404 residue.6
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Figure 61: Representation of the hydrogen bonding network in crystals of complex 10
as viewed along the [010] direction; broken lines represent hydrogen bonding interactions.
3.3.2 Spectroscopic studies
The IR spectra of the complexes are consistent with the proposed formation of the oxo-
vanadium(v) complexes and presents a strong vibration at 969-972 assigned to ν(VO)
stretching vibrations. The enolized form of the Schiff base ligand is consistent with the
vibration of the conjugated -CH=N–N=C- system observed at 1604 cm−1. In general
the IR patterns of these mono-oxovanadium(v) complexes are very similar with the IR
patterns of the mono-oxovanadium(v) complexes described in Chapter 2. The difference
is the appearance of a broad band at 3443 cm−1 assigned to ν(OH aliphatic) vibration
involved in intermolecular hydrogen bonding interaction. The 1H and 13C NMR data for
all complexes are summarized in the experimental section and are consistent with the
formation of the proposed mono-oxovanadium(v) complexes. The coordination of the
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Table 9. Selected bond lengths (pm) and angles (◦) for complex 10.
V1–O11 159.38(15) V3–O31 159.79(14)
V1–O12 186.09(14) V1–O32 185.04(14)
V1–O13 195.77(14) V1–O33 195.09(14)
V1–O21 184.28(14) V1–O41 184.97(14)
V1–N11 207.89(17) V1–N31 207.91(17)
V1–N21 235.44(17) V1–N41 235.35(16)
O13–C18 130.8(2) O33–C38 131.3(2)
N12–C18 130.3(3) N32–C38 130.1(3)
O11–V1–O12 98.88(7) O31–V3–O32 99.59(7)
O11–V1–O13 99.02(7) O31–V3–O33 97.04(7)
O11–V1–O21 101.26(7) O31–V3–O41 99.21(7)
O12–V1–O13 153.98(6) O32–V3–O33 155.27(6)
O12–V1–O21 103.33(6) O32–V3–O41 101.34(6)
O13–V1–O21 91.50(6) O33–V3–O41 93.89(6)
O11–V1–N11 98.05(7) O31–V3–N31 99.95(7)
O11–V1–N21 176.51(7) O31–V3–N41 173.81(7)
O12–V1–N11 83.83(6) O32–V3–N31 83.79(6)
O12–V1–N21 84.26(6) O32–V3–N41 85.47(6)
O13–V1–N11 75.09(6) O33–V3–N31 75.37(6)
O13–V1–N21 78.51(6) O33–V3–N41 79.33(6)
O21–V1–N11 158.01(6) O41–V3–N31 159.03(6)
O21–V1–N21 76.46(6) O41–V3–N41 76.18(6)
N11–V1–N21 83.73(6) N31–V3–N41 84.05(6)
8-hydroxyquinoline ligand, used here as a coligand is in agreement with observed reso-
nances corresponding to its aromatic protons. 51V NMR measurements present a single
resonances at -472 ppm (∆ν1/2 = 350 Hz) in DMSO-d6 solutions and -482 ppm (∆ν1/2 =
145 Hz) in deuterated chloroform solutions being similar with previously described VO3+
complexes with N2O4 environment. A similar reactivity towards NaOH in solution have
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been found (see Chapter 2). 51V NMR monitoring of the reaction shows two vanadium
species which resonate at -472 ppm (∆ν1/2 = 350 Hz) and -535 ppm (∆ν1/2 = 600 Hz)
when 0.5 equivalents of base were used. These two resonances were attributed to the oxo-
vanadium(v) complex and cis-dioxovanadium(v),135 respectively. Further increase of the
amount of base to one equivalent, generated only the cis-dioxovanadium complex which
resonates at -536 ppm (∆ν1/2 = 600 Hz). No further change of the resonance shift was
observed when up to two equivalents of base were used. The reaction with NaOH, when
cis-dioxovanadium(v) complexes are generated, is very similar with corresponding one
described in Chapter 2, proving the similarities in reactivity of the mono-oxovanadium(v)
species.
3.3.3 Electrochemical investigations
The mono-oxovanadium(v) complexes were also electrochemically investigated by cyclic
voltmametry experiments in acetonitrile solutions using Ag/AgCl as reference electrode.
All three complexes presented here showed the same electrochemical behavior and very
similar with previous described in Chapter 2, in particular the potential of the charge
transfer processes. The square wave voltammogram (SWV) measured with a drop hang-
ing mercury electrode were obtained using 0.25 M Bu4NCl as electrolyte and square wave
frequencies of 25, 50, 100, 200, 400, 800 and 1500 Hz, respectively. The potential values
for the three mono-oxovanadium(v) complexes are tabulated in Table 10 and the cyclic
voltametry experiment for complex 12 is shown in Figure 62.
Table 10. Potential values (in V) for cyclic voltametry measurements
1st reduction 2nd reduction
complex 10 + 0.403 - 1.575
complex 11 + 0.393 - 1.582
complex 12 + 0.388 - 1.580
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Figure 62: Square wave voltammogram of complex 2 using square wave frequencies of
25, 50, 100, 200, 400, 800 and 1500 Hz.
The first electron reduction step (ML + e− ⇀↽ ML−) occurs at higher positive
potential (E◦ = 0.393 V) in comparison with 0.355 V reported previously, while the second
reduction step occurs at negative potential of E◦ = - 1.582 V and is also accompanied by
a pre-wave (ML− + e− ⇀↽ ML2−). As depicted in Figure 62, the two reduction processes
take place preferentially with the first reduction step occurring with higher current values.
This differs from previous square wave voltammograms of oxovanadium complexes based
on non-substituted aliphatic side-chain, where the two reduction processes occurred with
equal current rates.
Nevertheless, the frequency dependence of the two reduction peaks and of the ac-
companying pre-wave also shows a linear behavior versus time indicating that the second
reduction process remains diffusion controlled over the entire frequency range. As can be
seen from Figure 63, the accompanying pre-wave tends to become equal to the diffusion
controlled current when the square wave frequency moves towards zero, while a steady
state current seems to be reached for very high square wave frequencies. This is a similar
situation with previously described cyclic voltammetry experiment, suggesting analogue
electrochemical behavior in the given conditions.
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Figure 63: Height of the peak current at positive potential (white rhombus), at negative
potential (white circles) and the plateau of the accompanying pre-wave (black circles)
associated with the second reduction processes in complex 12
The pre-wave which accompanies the second reduction process can be an effect of a
chemical reaction involving the 8-hydroxyquinoline anion, which also shows a reversible
reduction process at -1.52 V. Therefore a split off/addition reaction of this coligand in the
mono-oxovanadium complexes might be responsible for the appearance of the pre-wave.
The reaction can be expressed as:
ML− ⇀↽ M + L−
where L− is the reduced 8-hydroxyquinoline ligand as a radical anion. The equilibrium
of this reaction is slightly pushed to the right side, only because infinitesimal amount of
L− is immediately re-oxidized to L if the potential is moving between the first reduction
step and the pre-wave.
However, since the production of the species L− consumed in the pre-wave goes at
the consuming of ML− which is coupled with L− following the last equilibrium, the above
finding is not in agreement with the observation that the reduction of ML− at about -1.58
V remains fully diffusion-controlled over the entire frequency range. This disagreement
is also supported by the shift of the pre-wave to more positive potentials by increasing
the time window of the underlying electrochemical method (i.e. the lower the square
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wave frequency), because the opposite shift would be theoretically expected. Reasonable
agreement with the experimental data was obtained when an additional ligand addi-
tion/elimination reaction was taking into consideration for the mono-oxovanadium(v)
complex:
ML ⇀↽ M + L
where L is the deprotonated quinoline anion.
The equilibrium for this last reaction is far moved towards the left. Although L
reacts with M, so that the resulting ML is immediately reduced again, the difference
in the equilibrium/rate constants of the last two reactions (as well as the differences of
the diffusion coefficients of the underlying species) results in an accumulation of effects.
This means that the second reduction step is accompanied by a pre-wave exhibiting an
unusual frequency dependence of the potential shift and an almost diffusion-controlled
growth of the peak current associated with the charge transfer process.
At this point, it can be concluded that the quasi-reversible cyclic voltammograms
showed two one-electron reduction steps. The first one consists of the formation of
a vanadium(iv) complex and occurs at positive potential, while the second reduction
process takes place at negative potential and is accompanied by a pre-wave. The pre-
wave seems to be most likely generated by the reduction of the splitted off coligand.
3.4 Conclusions
Vanadium(v) complexes with N-salicylidenehydrazide ligands that contain hydroxyl sub-
stituted aliphatic side chain represent a functionalized side-chain model complexes for
vanadium haloperoxidase. The structural model complexes obtained with these Schiff
base ligands are based on both mono-oxo- and cis-dioxo-vanadium(v) complexes. Reac-
tivity of the ammonium salts of cis-dioxovanadium(v) complexes towards HCl in aqueous
solution showed a single protonation step which occurs at the more basic hydrazide ni-
trogen atom, resulting in the formation of the corresponding neutral cis-dioxovanadate
complex. Furthermore, investigations regarding the mechanism of vanadium-catalyzed
bromide oxidation reaction by hydrogen peroxide proved the formation of a peroxo-
intermediate when the reaction is performed in nonaqueous solutions. Reactivity of a
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neutral oxo-monoperoxovanadium(v) towards its capacity to function as active interme-
diate of the cis-dioxovanadium-catalyzed oxidation reaction showed the necessity of a
stoichiometric amount of acid for proceeding the reaction, manifesting a similar behavior
with the one described for the natural system.
The neutral cis-dioxovanadium(v) complexes can react with 8-hydroxyquinoline to
form the mono-oxovanadium complexes. In both oxo- and dioxo- vanadium complexes
relevant hydrogen bonding interaction for the enzymatic system have been observed.
The mono-oxovanadium(v) complex represents the first example of an oxo-vanadium
compound with hydrogen bonded apical oxo-group. Moreover, the inter-conversion of
the oxovanadium(v) complexes in the corresponding cis-dioxovanadium complexes have
also been shown to be possible. Monitoring of the reaction by 51V NMR showed that
one equivalent of NaOH yield the splitting off of the coligand, resulting in re-formation
of the cis-dioxovanadium complex.
3.5 Experimental Part
Abbreviations used throughout the text: H2salhyhb = 4-hydroxy butyric acid (2-hydroxy
benzylidene) hydrazide, H2salhyhp = 5-hydroxy pentanoic acid (2-hydroxy benzylidene)-
hydrazide, H2salhyhh = 6-hydroxy hexanoic acid (2-hydroxy benzylidene) hydrazide,
HQ = 8-hydroxyquinoline, TMB = 1,3,5-trimethoxybenzene, Br-TMB = 2-bromo 1,3,5-
trimethoxybenzene.
3.5.1 Synthesis of ω-hydroxy aliphatic acid hydrazide
H2N
N
H
O
OH
n
Hydrazide hydrate (2 equiv.) was added to 25 g lactone and the resulting solution
was refluxed under continuous stirring for about 4 hours. The solution was cooled down
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at room temperature when a colorless precipitate was formed. The resulting precipitate
was filtered and recrystallized from absolute ethanol.
Synthesis of 4-hydroxy butanoic acid hydrazide
This compound was prepared from γ-butyrolactone (0.29 mol) and hydrazine hydrate
(29.0 g 0.6 mol) following the general method described above. Yield: 26.8 g (0.2 mol,
76%).
Synthesis of 5-hydroxy pentanoic acid hydrazide
This hydrazide was synthesized from δ-valerolactone (0.25 mol) and hydrazine hydrate
(25.0 g 0.5 mol) following the general method described above. Yield: 21.3 g (0.15 mol,
64%).
Synthesis of 6-hydroxy hexanoic acid hydrazide
-Caprolactone (0.22 mol) and hydrazine hydrate (22.00 g 0.44 mol) were reacted following
the general method described above. Yield: 27.04 g (0.18 mol, 82%).
3.5.2 Synthesis of N-salicylidene ω-hydroxyl aliphatic hydrazides
N
OH
N
H
O
OH
n
Synthesis of N-salicylidene 4-hydroxy butanoic acid hydrazide (n=1) H2salhyhb
To a solution of 4-hydroxy-butanoic acid hydrazine (7.8 g, 66.0 mmol) in 50 mL methanol,
salicylaldehyde (8.10 g, 14.3 mL, 66.0 mol) was added dropwise under continuous stirring
at room temperature. The resulting slightly yellow solution was stirred at r.t. for an
additional 12 hours. The formed precipitate was filtered and the solvent removed under
reduced pressure. Yield: 10.3 g (59.1 mmol, 69%). 1H NMR (200 MHz, DMSO-d6): δ =
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1.71 (q, 2H, CH2,
3J=7.3 Hz), 2.26 and 2.60 (t, 2H, CH2CO,
3J=7.5 Hz, ratio 1.3:0.7),
3.46-3.48 (m, 2H, CH2OH), 4.50-4.54 (m, 1H, OH ), 6.84-6.91 (m, 2H, arom. CH ), 7.21-
7.26 (m, 1H, arom. CH ), 7.44-7.66 (m, 1H, arom. CH ), 8.24 and 8.32 (s, 1H, CH=N,
ratio 0.4:0.6), 10.12, 11.18, 11.59 (NH, OH, total 2H in ratio 0.3:1.0:0.6) ppm. 13C NMR
(50 MHz, DMSO-d6): δ = 27.5, 28.2 (all CH2), 28.7, 30.6 (both CH2CO), 60.0, 60.2
(both CH2OH), 116.1, 116.3, 118.6, 119.2, 119.4, 120.0, 126.8, 129.5, 130.8, 131.1 (all
arom.CH and C ), 140.8, 146.4 (both CH=N), 156.3, 157.3, 168.5 (all arom.C ), 173.9
(C=O). Selected IR data (cm−1): ν= 3185 (s; NH, OHass), 1673 (s, C=O), 1623 (s,
CH=N).
Synthesis of N-salicylidene 5-hydroxy pentanoic acid hydrazide (n=2) H2salhyhp
The N-salicylidene-5-hydroxy-pentanoic acid hydrazide (H2salhyhp) ligand has been syn-
thesized by Schiff base condensation of salicylaldehyde (17.6 g, 1.44 mol) with 5-hydroxy-
pentanoic acid hydrazide (19.1 g, 1.44 mol) in 100 mL methanol. Yield: 30.7 g (1.3 mol,
90%). 1H NMR (200 MHz, DMSO-d6): δ = 1.32-1.62 (m, 4H, CH2), 2.17 and 2.53 (t, 2H,
CH2CO,
3J=7.3 Hz, ratio 1.4:0.6), 3.33-3.44 (m, 2H, CH2OH), 4.37-4.40 (m, 1H, OH ),
6.78-6.87 (m, 2H, arom. CH ), 7.13-7.26 (m, 1H, arom. CH ), 7.41-7.57 (m, 1H, arom.
CH ), 8.24 and 8.33 (s, 1H, CH=N, ratio 0.4:0.6), 10.11, 11.14, 11.53 (NH, OH, total 2H
in a ratio 0.3:1.0:0.7) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 20.8, 21.6, 31.8 (CH2),
32.0, 32.1 (both CH2CO), 60.4, 60.5 (both CH2OH), 116.1, 116.3, 118.6, 119.3, 119.4,
120.0, 126.8, 129.4, 130.9, 131.1 (arom.CH and C ), 140.8, 146.4 (CH=N), 156.3, 157.3,
168.5 (arom.C ), 173.9 (C=O). Selected IR data (cm−1): ν= 3185 (s; NH, OHass), 1673
(s, C=O), 1623 (s, CH=N). UV/Vis (CH3CN solution, λmax in nm (ε in 10
3 M−1 cm−1)):
278 (16.4), 288 (14.9), 319 (7.7).
Synthesis of N-salicylidene 6-hydroxy hexanoic acid hydrazide (n=3) H2salhyhh
The H2salhyhh ligand has been synthesized from salicylaldehyde (15.6 mL, 1.5 mol) and
6-hydroxy-pentanoic acid hydrazide (21.6 g, 1.5 mol) in 100 mL methanol. Yield: 30.0 g
(1.20 mol, 80%). 1H NMR (200 MHz, DMSO-d6): δ = 1.23-1.65 (m, 6H, CH2), 2.21 and
2.55 (t, 2H, CH2CO,
3J=7.3 Hz, ratio 1.4:0.7), 1.32-3.42 (m, 2H, CH2OH), 4.36 (br, 1H,
OH ), 6.81-6.91 (m, 2H, arom. CH ), 7.16-7.30 (m, 1H, arom. CH ), 7.44-7.60 (m, 1H,
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arom. CH ), 8.24 and 8.32 (s, 1H, CH=N, ratio 0.3:0.7), 10.15, 11.18, 11.57 (NH, OH,
total 2H in ratio 0.3:1.0:0.7) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 24.1, 24.9, 25.2,
25.4 (all CH2), 32.3, 34.0 (both CH2CO), 60.6 (CH2OH), 116.1, 116.3, 118.6, 119.2,
119.5, 120.0, 126.8, 129.5, 130.8, 131.1 (arom.CH and C ), 140.9, 146.5 (CH=N), 156.4,
157.3, 168.5 (arom.C ), 173.9 (C=O). Selected IR data (cm−1): ν= 3185 (s; NH, OHass),
1673 (s, C=O), 1623 (s, CH=N).
3.5.3 Synthesis of ammonium salts of cis-dioxovanadium(v) com-
plexes
N
O
N
O
OH
n
V
O O NH4+
To a solution of 2 g of Schiff base ligand in 50 mL methanol, ammonium metavana-
date in stoichiometric amount was added. The resulting mixture was refluxed for one
day with vigourous stirring, when the color of the solution turned brown. After filtration
of the unreacted inorganic salt, the solution volume was reduced under reduced pressure
to about half. From this mother liquor, yellow product precipitated by slow evaporation
of the solvent at room temperature. Additional material can be obtained by removal of
the solution volume to dryness when a brown-yellowish residue is formed. This residue
can be purified by extraction with chloroform.
NH4[VO2(salhyhb)](7); Yield: 1.72 g (5.3 mmol, 59%).
1H NMR (200 MHz, DMSO-
d6): δ = 1.70-1.73 (m, 2H, CH2), 2.32 (t, 2H, CH2CO), 3.33 (br, H2O), 3.38-3.42 (m, 2H,
CH2OH), 4.36 (br, 1H, OH ), 6.73-6.88 (m, 2H, arom. CH ), 7.08 (br, 4H, arom. NH
+
4 ),
7.30-7.61 (m, 2H, arom. CH ), 8.74 (s, 1H, CH=N) ppm. 13C NMR (50 MHz, DMSO-
d6): δ = 28.5 (CH2CO), 29.4 (CH2CH2OH), 60.5 (CH2OH), 116.6, 119.4, 120.1, 132.3,
132.8 (all arom.CH and C ), 154.1 (C=N), 164.2 (arom.CO–V), 176.3 (CO–V) ppm. 51V
NMR (105 MHz, DMSO-d6): -534.4 ppm (ν1/2 = 575 Hz).
51V NMR (105 MHz, D2O):
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-538.1 (ν1/2 = 575 Hz). Selected IR data (cm
−1): ν= 3400 (br, NH+4 , H2O), 1613 (s, -
CH=N-N=CH-), 909 (s, VO2). MS (ESI-negative mode in MeOH): 303.1 (M
−-NH+4 -H
+)
(100%), 590(10%), 629.0 (2M−-NH+4 -H
++Na) (10%). UV/Vis (CH3OH solution, λmax
in nm (ε in 103 M−1 cm−1)): 235 (13.7), 278 (9.2), 288 (8.3), 310 (shoulder), 384 (2.5).
UV/Vis (DMF solution, λmax in nm (ε in 10
3 M−1 cm−1)): 308 (9.7), 389 (6.2).
NH4[VO2(salhyhp)]; Yield: 1.88 g (5.6 mmol, 62%). Anal. Calc. for C12H19N3O5V
(336.24): C 42.87, H 5.70, N 12.50. Found: C 42.85, H 5.41, N 12.51. 1H NMR (200
MHz, DMSO-d6): δ = 1.41-1.63 (m, 4H, CH2), 2.24 (t, 2H, CH2CO,
3J=7.1 Hz), 3.36-
3.41 (m, 2H, CH2OH), 4.40 (br, 1H, OH ), 6.70-6.77 (m, 2H, arom. CH ), 7.13 (br, 4H,
arom. NH+4 ), 7.25-7.49 (m, 2H, arom. CH ), 8.74 (s, 1H, CH=N) ppm.
13C NMR (50
MHz, DMSO-d6): δ = 22.7 (CH2), 31.7 (CH2C=O), 32.3 (CH2CH2OH), 60.5 (CH2OH),
116.7, 119.4, 119.8, 132.3, 132.7 (all arom.CH and C ), 154.2 (CH=N), 164.3 (arom.CO–
V), 176.4 (CO–V) ppm. 51V NMR (105 MHz, DMSO-d6): -533.3 (ν1/2=600 Hz) ppm;
51V NMR (105 MHz, D2O): -537.5 (ν1/2 = 638 Hz). Selected IR data (cm
−1): ν= 3400
(br, NH+4 ), 1614 (br, -CH=N-N=CH-), 927 and 887 (s, VO2). MS (ESI-negative mode
in MeOH): 317 (M−-NH+4 -H
+) (100%), 657 (2M−-NH+4 -H
++Na) (10%).
NH4[VO2(salhyhh)]; Yield: 0.42 g (1.2 mmol, 13%).
51V NMR (105 MHz, DMSO-
d6): -533.4 (ν1/2=615 Hz) ppm. Selected IR data (cm
−1): ν= 3434 (br, NH+4 ), 1612 (s,
-CH=N-N=CH-), 895 and 908 (s, VO2).
3.5.4 Synthesis of neutral cis-dioxovanadium(v) complexes
N
O
N
H
O
OH
n
V
O O
The synthesis and and purification of the neutral cis-dioxoxvanadium(v) complexes
follows the same procedure described above with the difference of the reaction time which
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was prolonged for about three days.
[VO2(Hsalhyhb)](8); Yield: 1.2 g (3.9 mmol, 43%).
51V NMR (105 MHz, DMSO-d6):
-533.3 (ν1/2=600 Hz) ppm. Selected IR data (KBr): ν = 3435 (br, NH), 1628 (s, CO),
1612 (s, br; HC=N), 910 (VO2), 892 (s, VO2).
[VO2(Hsalhyhh)]; Yield: 0.80 g (2.4 mmol, 27%). Anal. Calc. for C13H17N2O4V
(333.22): C 47.00, H 5.16, N 8.43. Found: C 46.83, H 4.88, N 8.30. 51V NMR (105 MHz,
DMSO-d6): -534.2 (ν1/2=645 Hz). Selected IR data (cm
−1): ν= 3435 (br, NH, OH), 1627
(s, CO), 1610 (s, -CH=N), 892 (s, VO2). MS (ESI-negative mode): m/z = 331 (M
−)
(100%), 685 (2M−+Na)(20%).
3.5.5 Synthesis of neutral oxo-monoperoxovanadium(v) com-
plexes
N
O
N
H
O
OH
n
V
O O
O
To an aqueous solution of KVO3 (0.69 g, 5 mmol) in 20 mL water and H2O2 (0.75 mL
30% aqueous solution), the Schiff base ligand (5 mmol) dissolved in 25 mL methanol was
added dropwise at 0◦ C under constant stirring. The pH of the resulting orange-red solu-
tion was adjusted to about pH∼2 with HClO4 0.1M solution. The solution was stirred on
ice-bath for an additional 30 minutes while an orange solid precipitate. This was filtered
off and washed with cold methanol. The filtrate solution was kept at 5◦ C in a closed
vessel for about one week when additional solid is formed.
[VO(O2)(Hsalhyhb)H2O]·H2O(9); Yield: 1.38 g (3.9 mmol, 77%) general method and
0.9 g (2.5 mmol, 33%) second method. Anal. Calc. for C11H17N2O8V (9·H2O) (356.21):
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C 37.09, H 4.81, N 7.86; Found C 37.73, H 4.71, N 8.09. 1H NMR (400 MHz, CD3OD):
δ = 1.96 (tt, 2H, CH2,
3J=6.8 Hz), 2.52 (t, 2H, CH2CO,
3J=7.6), 3.67 (t, 2H, CH2OH,
3J=6.4), 4.83 (s, H2O), 6.91-7.01 (m, 2H, arom. CH ), 7.49-7.58 (m, 2H, arom. CH ),
8.56 (s, 1H, CH=N) ppm. 13C NMR (50 MHz, CD3OH): δ = 29.0 (CH2CO), 30.5
(CH2CH2OH), 62.4 (CH2OH), 117.7, 121.4, 121.5, 133.4, 133.7 (all arom.CH and C ),
153.2 (C=N), 165.1 (arom.CO–V), 179.7 (C=O) ppm. 51V NMR (105 MHz, CD3OD):
-551.4 ppm (ν1/2 = 105 Hz). Selected IR data (cm
−1): ν= 3400 (br, NH, H2O), 978 (s,
V=O), 921 (s, O–O, peroxo), 765 (asym. V(O)2), 562 (sym. V(O)2). MS (ESI-negative
mode in MeOH): m/z = 318.9 (M−-H+-H2)(100%).
[VO(O2)(Hsalhyhp)]; Yield: 0.87 g (2.6 mmol, 52%). Anal. Calc. for C12H15N2O6V
(334.22): C 43.13, H 4.52, N 8.38; Found C 43.47, H 4.77, N 8.51. 1H NMR (200
MHz, CD3OD): δ = 1.65-1.85 (m, 4H, CH2) 2.46 (t, 2H, CH2CO,
3J=7.2), 3.60 (t, 2H,
CH2OH,
3J=6.4), 6.89-7.01 (m, 2H, arom. CH ), 7.44-7.58 (m, 2H, arom. CH ), 8.55
(s, 1H, CH=N) ppm. 13C NMR (50 MHz, CD3OH): δ = 23.9 (CH2), 32.0 (CH2CO),
33.2 (CH2), 62.5 (CH2OH), 117.7, 121.3, 121.4, 133.6, 135.3 (all arom.CH and C ), 153.2
(C=N), 166.9 (arom.CO–V), 179.9 (C=O) ppm. 51V NMR (105 MHz, CD3OD): -550.7
ppm (ν1/2 = 105 Hz). Selected IR data (cm
−1): ν= 3400 (br, NH, OH), 978 (s, V=O),
921 (s, O–O, peroxo), 765 (asym. V(O)2), 562 (sym. V(O)2). MS (ESI-negative mode in
MeOH): 318.9 (M−-H+-H2)(100%).
[VO(O2)(Hsalhyhh)]·2H2O; Yield: 0.42 g (1.2 mmol, 24%). Anal. Calc. for
C13H21N2O8V (complex·H2O) (384.26): C 40.06, H 5.50, N 7.29; Found C 39.89, H 5.41,
N 7.08. 51V NMR (105 MHz, CD3OD): -551.4 ppm (ν1/2 = 110 Hz). Selected IR data
(cm−1): ν= 3400 (br, NH, H2O, OH), 978 (s, V=O), 921 (s, O–O, peroxo), 765 (asym.
V(O)2), 562 (sym. V(O)2).
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Alternative method for synthesis of [VO(O2)(Hsalhyhb)H2O]·H2O(9)
To a solution of NH4[VO2(salhyhb)] (7) (2.4 g, 7.5 mmol) in 25 mL mixture ethanol:water
4:1, hydrogen peroxide (1.5 ml 30%, 15 mmol) was added dropwise at 0◦C under con-
tinuous stirring. The resulting clear, orange colored solution was stirred for additional
15 minutes. 5 mL cold ethanol were added additionally to the reaction mixture and the
solution was kept in the refrigerator where overnight orange crystals were formed. Yield:
0.90 g (2.5 mmol, 33%). Anal. Calc. for C11H17N2O8V (9·H2O) (356.20): C 37.09, H
4.81, N 7.86; Found C 37.82, H 4.82, N 8.03. 51V NMR (105 MHz, CD3OD): -551.4 ppm
(ν1/2 = 125 Hz).
3.5.6 Reactivity of the oxo-monoperoxovanadium(v) complex
Bromide oxidation
The oxidative bromination of 1,3,5-trimethoxybenzene (25 mg, 0.15 mmol) with complex
9 (54 mg, 0.15 mmol) in the presence of 10-fold excess of tetrabutylammonium bromide
(0.483 g, 1.5 mmol) and one equivalent perchloric acid, was performed in DMF (30 mL).
The brominated derivative (Br-TMB) was monitored by HPLC measurement using a
Sperisorb ODS-2 column and a mixture H2O:MeOH (50:50 v/v) as eluent.
Sulfuroxidation reaction
A solution of complex 9 (19 mg, 0.05 mmol) in a dichloromethane:methanol (7:3 v/v) mix-
ture (10 mL) was reacted with one equivalent phenyl methyl sulfide at room temperature.
The progress of the reaction was monitored qualitatively using thin layer chromatography
(eluent mixture: ethyl acetate/chloroform/methanol-5:10:3 (v/v/v)) and quantitatively
by gas chromatography.
Reaction with triphenylphosphine
Triphenyl phosphine (13 mg, 0.05 mmol) was added to a solution of 9 (19 mg, 0.05 mmol)
in acetonitrile (15 mL) and the resulting solution was refluxed for around one hour. Upon
cooling at room temperature, a yellow precipitate was formed. This was removed by
filtration and, the mother liquor kept at 5 ◦C when additional precipitate is formed. The
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overall yield is 9.8 mg (0.03 mmol, 64%) of the cis-dioxovanadium(v) complex 8. 51V
NMR (105 MHz, DMSO-d6): -539.0 ppm.
3.5.7 Synthesis of mono-oxovanadium(v) complexes
N
O
N
O
OH
n
V
O O N
Method 1: To a suspension of neutral cis-dioxovanadium(v) omplex (1.71 mmol) in
30 mL methanol was added dropwise (over 15 minutes) under reflux and continuous
stirring a solution of 8-hydroxyquinoline (0.24 g, 1.70 mmol) in 10 mL methanol. The
resulting dark-violet solution was refluxed for an additional 2 hours and the solution
was filtered hot. The solvent was removed to dryness under reduced pressure and the
obtained solid redissolved in 5 mL methanol.
Method 2: A solution of Schiff base ligand (2 mmol) in 25 mL methanol was added to
a suspension of VO(acac)2 (0.53 g, 2 mmol) in 10 mL methanol. The resulting reaction
mixture was refluxed for 2 hours with continuous stirring when the color changed from
green to brown. 8-Hydroxyquinoline (0.29 g, 2 mmol) dissolved in 10 mL methanol was
added dropwise over a period of 30 minutes and the reaction solution was refluxed and
stirred for an additional 2 hours. The solvent was removed under pressure to dryness
and the resulting solid dried under strong vacuum.
Method 3: The same procedure as Method 2 has been repeated using acetonitrile as
reaction solvent.
[VO(salhyhb)(Q)] (10): Yield: Method 1 : 0.40 g (1.06 mmol, 62%); Method 2 :
0.32 g (0.77 mmol, 77%) and Method 3 : 0.63 g (1.42 mmol, 71.0%). Anal. Calc. for
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C20H18N3O5V (443.40): C 56.69, H 4.21, N 9.74. Found: C 56.29, H 4.26, N 9.92.
1H
NMR (400 MHz, DMSO-d6): δ = 1.26 (q, 2H, CH2,
3J=6.95 Hz), 2.09 (tt, 2H, CH2CO,
3J=7.39 Hz), 3.09 (t, 2H, CH2OH,
3J=6.28 Hz), 4.26 (br, 1H, OH ), 6.72-6.74 (m, 1H,
arom. CH ), 6.98-7.00 (m, 1H, arom. CH ), 7.17-7.18 (m, 1H, arom. CH ), 7.45-7.80 (m,
5H, arom. CH ), 8.09-8.10 (m, 1H, arom. CH ), 8.50-8.52 (m, 1H, arom. CH ), 9.14 (s,
1H, CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 26.3 (CH2CO), 29.1 (CH2),
59.6 (CH2OH), 110.9, 115.4, 119.5 (arom.C and CH), 120.4, 122.5, 123.0, 128.2, 129.0,
133.2, 135.2, 138.2, 138.5, 146.1 (arom.CH and C ), 154.2 (CH=N) ppm), 162.3, 163.3
(arom.CO–V), 176.1 (CO–V). 51V NMR (105 MHz, DMSO-d6): - 471.4 ppm ;
51V NMR
(105 MHz, CDCl3): - 482.8 ppm. Selected IR data (cm
−1): 3446 (sh, OH), 3048 (arom.
CH), 2935, 2869 (CH2 aliphatic), 1605 (s, -CH=N-N=C-), 969 (s, VO). UV/Vis (CH3CN
solution, λmax in nm (ε in 10
3 M−1 cm−1)): 241 (43.5), 273 (20.8), 321 (9.1), 540 (6.8).
[VO(salhyhp)(Q)] (11): Yield: Method 1 : 0.38 g (0.85 mmol, 49%); method 2 0.41 g
(0.95 mmol; 95 %) and Method 3 : 0.69 g (1.55 mmol, 77.5%). Anal. Calc. for
C21H20N3O5V (445.346): C 56.64, H 4.53, N 9.44. Found: C 57.00, H 4.43, N 8.97.
1H NMR (200 MHz, DMSO-d6): δ = 1.04-1.17 (m, 4H, CH2), 2.07 (t, 2H, CH2CO,
3J=6.60 Hz), 3.09 (t, 2H, CH2OH,
3J=6.28 Hz), 4.26 (br, 1H,OH ), 6.72-6.76 (d, 1H,
arom. CH ), 6.97-7.04 (m, 1H, arom. CH ), 7.16-7.21 (m, 1H, arom. CH ), 7.45-7.60 (m,
2H, arom. CH ), 7.70-7.73 (m, 3H, arom. CH ), 7.79-7.82 (m, 1H, arom. CH ), 8.08-8.11
(m, 1H, arom. CH ), 8.50-8.54 (m, 1H, arom. CH ), 9.15 (s, 1H, CH=N) ppm. 13C NMR
(50 MHz, DMSO-d6): δ = 22.3 (CH3), 29.2 (CH2CO), 31.3 (CH2), 59.9 (CH2OH),
110.8, 115.4, 119.4 (arom.C and CH), 120.4, 122.5, 123.0, 128.2, 129.0, 133.2, 135.2,
138.3, 138.5, 146.2 (arom.CH), 154.2 (CH=N), 162.3, 163.2 (arom.CO–V), 176.0 (CO–
V). 51V NMR (105 MHz, DMSO-d6): - 472.4 ppm;
51V NMR (105 MHz, CDCl3): - 483.0
ppm. Selected IR data (cm−1): 3435 (sh, OH), 3048 (arom. CH), 2936, 2930, 2862 (CH2
aliphatic), 1604 (s, -CH=N-N=C-), 973 (s, VO). UV/Vis (CH3CN solution, λmax in nm
(ε in 103 M−1 cm−1)): 241 (43.9), 273 (21.4), 321 (9.5), 540 (6.8).
[VO(salhyhh)(Q)] (12): Yield: Method 1 : 0.62 g (1.35 mmol, 79%); Method 2 : 0.38 g
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(0.85 mmol; 85 %) and Method 3 : 0.67 (1.43 mmol, 71.5%) (method 2 ). Anal. Calc.
for C22H22N3O5V (459.372): C 57.52, H 4.83, N 9.15. Found: C 57.33, H 4.83, N 8.37.
1H NMR (400 MHz, DMSO-d6): δ = 0.80-0.92 (m, 2H, CH2), 1.02-1.10 (m, 4H, CH2),
1.99-2.31 (m, 2H, CH2CO,
3J=6.28 Hz), 3.10 (t, 2H, CH2OH,
3J=6.80 Hz), 4.26 (br, 1H,
OH ), 6.73-6.75 (d, 1H, arom. CH ), 6.97-7.03 (m, 1H, arom. CH ), 7.16-7.21 (m, 1H,
arom. CH ), 7.39-7.51 (m, 1H, arom. CH ), 7.56-7.59 (m, 1H, arom. CH ), 7.59-7.69 (m,
2H, arom. CH ), 7.69-7.79 (m, 1H, arom. CH ), 8.09-8.10 (m, 1H, arom. CH ), 8.51-8.53
(m, 1H, arom. CH ), 9.15 (s, 1H, CH=N) ppm. 13C NMR (50 MHz, DMSO-d6): δ =
24.6, 25.6 (CH2), 29.5 (CH2CO), 31.9 (CH2), 60.3 (CH2OH), 110.9, 115.4, (arom. CH),
119.5 (arom.C ), 120.4, 122.4, 122.9, 128.2 (arom. CH), 129.1 (arom. C ), 133.2, 135.2,
138.2 (arom. CH), 138.6 (arom. C ), 146.2 (arom.CH), 154.1 (CH=N) ppm), 162.3,
163.3 (arom.CO–V), 176.0 (CO). 51V NMR (105 MHz, DMSO-d6): - 472.0 ppm;
51V
NMR (105 MHz, CDCl3): - 482.9 ppm. Selected IR data (cm
−1): 3430 (sh, OH), 3060
(arom. CH), 2930, 2859 (CH2 aliphatic), 1605 (s, -CH=N-N=CH-), 973 (s, VO). UV/Vis
(CH3CN solution, λmax in nm (ε in 10
3 M−1 cm−1)): 241 (43.2), 273 (20.1), 321 (9.1),
540 (6.6).
3.5.8 Catalytic oxidative bromination of TMB
TMB (25mg, 0.15 mmol) was dissolved in 10 mL DMF. 10 mL of stock solution of
tetrabutylammonium bromide (48.3g/L) (1.5 mmol, 10 equiv.) was added, followed by
addition of 1 mL of vanadium complex, 0.15 mol% in DMF (0.015 mmol), HClO4 (0.15
mmol) and H2O2 (0.15 mmol) in this order. Aliquots of the reaction (250 µL) were
quenched in 2 mL of NaOH 0.002 M aqueous solution and extracted with 3 mL ethyl
acetate. The reaction products were identified by gas-chromatography using the temper-
ature programme described in Chapter 2.
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Chapter 4
Vanadium(v) complexes based on
N-salicylidene hydrazides that
contain an amino-functionalized
aliphatic side-chain
Investigations concerning the actual structure of the vanadate in vanadium dependent
haloperoxidases were performed on the native enzyme as well as its reduced vanadium(iv)
form.101 Recent theoretical studies on models in comparison with spectroscopic data
of vanadium haloperoxidases propose the vanadate moiety to be double protonated
[VO2(OH)2]
−, which makes the cis-dioxovanadium(v) complexes, appropriate model
complexes for the enzymatic system.178,179 The amino-functionalization of the aliphatic
side-chain of the used tridentate chelate system has been achieved in order to mimic
the hydrogen bonding interaction of the prosthetic group of the V-HPOs and the lysine
residue.38 A vital role for the catalytic chloride oxidation reaction has been attributed
to Lys353, an amino acid hydrogen bonded to one of the equatorial oxygen atom of the
prosthetic group in the native enzyme.63,180 Mutagenesis studies, performed by replace-
ment of Lys353 amino acid with alanine, leaded to a drastic loss of the enzyme activity.63
Additionally this vital role of the lysine amino acid is sustained by X-ray crystal struc-
ture determined for the peroxide-form of V-CPO that reveals lysine in hydrogen bonding
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interaction with the peroxo-oxygen atom via its protonated amino group.6 The catalytic
cycle is proposed to proceed through hydrogen bonding network, e.g. the peroxide in-
termediate is activated by hydrogen bonding interaction with the lysine residue. In this
manner the electrophilicity on the peroxo group is increased favoring the subsequent
attack of the halide.111
The synthesis of the amino-functionalized N-salicylidene hydrazide ligand system
follows the pathway depicted in Figure 64. The amino aliphatic esters as hydrochloride
salts react with hydrazine hydrate in equimolecular amounts, resulting in the formation
of ω-amino aliphatic acid hydrazide hydrochloride. Subsequent reaction with salicylalde-
hyde affords almost quantitatively the desired N-salicylidene hydrazide that contain a
”protected amino” functionalized aliphatic side-chain.
H2N
NH2
O
OH
N
OH
N
H
O
NH2 x HCl
+
RO
O
NH2 x HCl+
- H2O - ROH
n
n
Figure 64: Schematic representation of the synthesis of amino functionalized N-
salicylidene hydrazides. n=1 H2salhab×HCl and n=3 H2salhah×HCl.
The important step of the ligand synthesis is the stoichiometric reaction between
the aliphatic amino ester hydrochloride and hydrazine hydrate. The protection of amino
functionality in the carbonic acid hydrazide prevents the second Schiff base condensation
reaction between the salicylaldehyde and the aliphatic amino group. At this point should
be mentioned that, 6-amino hexanoic acid was recommended as a specific reagent for
aldehydes recognition, giving better recovery than bisulphite.181 Moreover, it is known
that the amino acids in general can very easy eliminate water through reaction between
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the carboxylate functionality and the free amino group resulting in the formation of
lactam. If excess of hydrazide is used in the reaction with the amino acid esters, a
mixture of lactam and hydrazide-hydrochloride was isolated as a consequence of the ester
hydrolysis in strong basic medium.
Stoichiometric reactions of these new Schiff base ligands with ammonium meta-
vanadate yield cis-dioxovanadium(v) complexes which can be regarded as appropriate
structural models for the enzymatic system. The synthesis pathway of vanadium com-
plexes is very similar with previous described procedure, but nevertheless, significant
differences are obvious since, the presence of the amino-functionality makes possible cy-
clisation reactions. Moreover, a different reactivity of the two Schiff base ligands upon
vanadium coordination have been observed, varying from favored nitrogen-containing
ring closure in the case of N-salicylidene 4-amino butanoic acid hydrazide hydrochlo-
ride H2salhab×HCl, to an intact ligand in the anionic cis-dioxovanadium complexes of
N-salicylidene 6-amino hexanoic acid hydrazide H2salhah×HCl.
4.1 cis-Dioxovanadium(v) complexes based on N-sa-
licylidene 4-amino butanoic acid hydrazide
hydrochloride
Stoichiometric reaction of the Schiff base ligand H2salhyab×HCl, with ammonium meta-
vanadate in refluxing methanol solution for about two days, results in the formation of
neutral cis-dioxovanadium(v) complex as a dimeric compound-[VO2(Hsalhycab)]2. The
reaction takes place by an intramolecular imine bond formation accompanied by a five-
membered ring closure resulting in a dihydro-pyrrole structure (Figure 65).
Although, alternatives to prepare the in situ formed hydrazide have been re-
ported,182 the knowledge about ring closure upon ligand complexation in vanadium chem-
istry is rather scarce. A lactone ring closure has been formed by reaction of peroxovana-
date with N-(2-hydroxyethyl) ethylenediaminetriacetic acid in acidic aqueous solution,183
whereas more recently an imidazole ring formation upon vanadium coordination has been
also reported.106,184
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Figure 65: Mechanism for the formation of the dimeric cis-dioxovanadium(v)
complex from N-salicylidene hydrazides-4-amino-butanoic hydrazide hydrochloride
(H2salhab×HCl).
The herein described cis-dioxovanadium(v) complex is the first vanadium com-
pound with in situ formed pyrrole-like structure. The complex crystallizes from the
mother liquor, within a week, as yellow needle crystals, suitable for X-ray measurement.
Molecular structure determination reveals a dimeric structure [VO2(Hsalhycab)]2 13,
when the complex is crystallized from methanol, and a monomeric structure
[VO2(Hsalhycab)] 14, when it is crystallized from water-methanol mixture. Molecular
structure determination of complex 13 is depicted in Figure 66 and it shows two cis-VO+2
units forming a bis-(µ-oxo)-bridged vanadium(v) Schiff base dimer. Each vanadium atom
is six-coordinated in a distorted octahedral geometry. The two oxo groups of the vanadate
center are distinct and occupy different positions. The first of these O1 is placed in the
apical position with a typical V=O bond distance of 161.6 pm, while the second is part
of the basal plane and it is involved in the bridge between V and V0A where, it is
strongly coordinated to V (V=O2 169.3 pm) and weakly associated with V0A (V0A–O2
245.8 pm). The coordination sphere of vanadium atom is completed by the phenolate
oxygen atom O3 and two imine nitrogen atoms (N1 and N3) which fulfill the basal plane
of the octahedra. The vanadium to nitrogen bond lengths are also distinct, varying from
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a typical vanadium to imine nitrogen atom distance V–N1 of 222 pm to V–N3 bond
length of about 14.5 pm shorter. The shortness of V–N3 bond length (207.5 pm) is a
consequence of more covalent bonded nitrogen atom which is part of a conjugated system
and which can be protonated and deprotonated due to the lability of the double bond
(Figure 67). An additional reason for the observed difference in V–N bond lengths is
given by their position in the coordination sphere of vanadium. For example, the N1
atom is place in trans position to double bonded oxygen atom O2, whereas the N3 atom
is located trans to a weaker coordinated oxygen atom, namely the phenolate oxygen O3
atom.
Figure 66: Molecular structure and numbering scheme of the dimeric complex
[VO2(Hsalhycab)]2 (13); displacement ellipsoids are drawn at 50% probability level.
N
OH
N
H
N
N
OH
N
HN
Figure 67: Tautomeric forms of the in situ formed cyclic ligand.
The two cis-dioxovanadium units, observed in the crystal structure of 13, are related by
an inversion center with the two vanadium atoms apart from each other by 327.3 pm.
This separation distance is 20 pm longer than similar vanadium separation found in
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reported binuclear-(µ-hydroxy)-bridged vanadium(iv) pyrazolyl complexes.169 The O2–
V–O2A angle is around 77.5◦, while the V–O2–V0A is obtuse and it has a value of
102.4◦ as it is expected for an oxo-bridged dimer.102,184 The O1–V–O2 angle of 106.9◦ is
similar with corresponding angle in previous described cis-dioxovanadium(v) complexes,
while the O1–V–O2A angle is larger and has a value of 174.5◦. Although numerous cis-
dioxovanadium(v) complexes have been reported, the reports of dimeric vanadium(v)
structures are rather scarce. Nevertheless, Pecoraro et al. published in 1988 a similar
dimeric cis-dioxovanadium complexes formed with N-salicylidene-N‘-(2-hydroxyethyl)-
ethylenediamine (H2SHED) ligand
102 and more recently, Parajo´n-Costa reported a bis-
(oxo-bridged) binuclear vanadium(v) complex based on dipicolinic acid.185 The reported
bond lengths and angles characteristic for the vanadium atoms are in good agreement
with the parameters found in similar complex 13. Selected bond lengths and angles in
dimeric cis-dioxovanadium(v) complex 13 are given in Table 11.
The N-salicylidene dihydro-pyrrole hydrazide coordinates in its monoanionic form
containing a protonated hydrazide nitrogen atom N2 that is involved in hydrogen bonding
interaction with the oxo bridging oxygen atom (N2· · ·O2 268.4 pm), leading to a polymer-
like association (Figure 68).
Figure 68: Representation of the hydrogen bonding interactions represented by broken
lines, in complex 13 as viewed along the [001] axis.
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This is a similar situation to one found in the neutral cis-dioxovanadium complexes
obtained with N-salicylidene hydrazide that contain a hydroxyl and/or non-substituted
aliphatic side-chain, where the protonated hydrazide nitrogen atom establishes hydrogen
contacts with the equatorially double-bonded oxygen atom.
When the stoichiometric reaction of the N-salicylidene 4-amino butanoic acid hy-
drazide hydrochloride with ammonium metavanadate was performed in a mixture metha-
nol-water (2:1 v/v), the monomeric cis-dioxovanadium(v) complex [VO2(Hsalhycab)]
(14) has been isolated. The molecular structure determination is shown in Figure 69,
while selected bond lengths and angles are listed in Table 11. The vanadium atom is
five-coordinated in a distorted square pyramidal geometry. The in situ formed ligand
coordinates via ONN donor atoms forming the equatorial plane together with the double
bonded oxygen atom O2, while the other oxo group O1 occupies the apical position. The
N-salicylidene dihydro-pyrrole hydrazide ligand lies in one plane with the vanadium atom
displaced out of the plane by 25 pm towards the apical oxo-group O1.
Figure 69: Molecular structure and numbering scheme of the monomer complex
[VO2(Hsalhycab)] (14); displacement ellipsoids are drawn at 50% probability level).
The equatorial oxo group O2, is distorted by 69 pm in the opposite direction to
vanadium. This results in a τ value of 0.20 pm, consistent with a slight distortion to
an ideal square pyramidal geometry of the vanadium atom. The vanadium to oxo group
distances V–O1 and V–O2 are almost equal with the two oxygen atoms in cisoid positions
forming a O1–V–O2 angle of 107◦. On the other hand, the vanadium to nitrogen atom
bond lengths, as well as vanadium to phenolate oxygen atom (O3) bond distance are
shortened compared to those distances in the dimeric structure 13, due to a different
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coordination number of the vanadium atom.
A vital role for the catalytic activity of V-HPOs enzyme has been attributed to
histidine residue (His486V-BPO and His496V-CPO) as the single amino acid residue
covalently bonded to the vanadium atom. The described herein complex contain also
a vanadium to nitrogen-containing heterocycle bond of 222 pm, that can be regarded
as similar bond structure with the one found in enzymatic system. A net difference
between these two bond lengths is obvious, varying from a strong covalent bond in the
native V-CPO of around 211 pm to a weaker V–N bond distance of around 11 pm
longer in complex 14. However, complex 14 presents also important hydrogen bonding
interactions. The protonated hydrazide nitrogen atom is in hydrogen bonding interaction
with the equatorial oxo ligand resulting in the formation of a 1D-polymer build up by
hydrogen bonding interactions (N2· · ·O2 282.9 pm).
Figure 70: One dimensional polymer build up by hydrogen bonding interactions (broken
lines) in crystals of complex 14.
4.1.1 Spectroscopic characterization
The spectroscopic characterization of the two cis-dioxovanadium(v) complexes is in
agreement with the crystallographically determined structure, although no difference can
be made among them in solution. No difference between the 1H NMR and the 51V NMR
spectra of the two complexes has been observed. The 1H NMR spectrum of the free
ligand exhibits specific R-NH+3 Cl
− resonance at 8.04 ppm, which was absent in the 1H
NMR spectra of complexes. This is consistent with the cyclisation of the ligand system
upon vanadium coordination. Moreover, the imine protons of the Schiff base ligand are
deshielded by around 0.3 ppm as a consequence of their involvement in coordination.
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Table 11. Selected bond lengths (pm) and angles (◦) in complexes 13 and 14.
13 14 13 14
V−O1 161.67(17) 161.97(18) V−N1 222.0(2) 221.5(2)
V−O2 169.34(17) 162.98(19) V−N3 207.5(2) 204.2(2)
V−O3 191.32(2) 189.75(18) N1−N2 139.0(3) 131.0(3)
V−O2A 245.88(16) - C8−N3 131.4(3) 131.0(3)
C8−N2 134.6(4) 129.9(3)
O1−V−O2 106.89(9) 107.41(10) O2−V−O3 102.27(8) 99.93(9)
O1−V−O3 99.62(9) 102.51(9) O2−V−N1 153.92(7) 137.97(9)
O1−V−N1 97.77(8) 113.53(9) O2−V−N3 94.94(8) 91.95(9)
O1−V−N3 95.64(9) 99.77(9) O2−V−O2A 77.54(7) -
O1−V−O2A 174.54(7) - N3−V−N1 73.94(8) 72.55(8)
O3−V−N1 81.37(8) 80.49(7) N3−V−O2A 80.65(7) -
O3−V−N3 152.48(8) 150.20(9) N1−V−O2A 77.40(6) -
O3−V−O2A 82.30(7) - V−O2−V0A 102.46(7) -
While in the 1H NMR spectra of the free ligand, this group exhibits two sets of signals,
the vanadium complexation yielded only one conformer of the imine bound illustrated
in the resonance of its proton as a single singlet. Unfortunately, due to their neutral
character, these complexes have a poor solubility in organic solvents and the 13C NMR
measurements requires a large number of scans. Nevertheless, a comparison between the
13C NMR patterns of the free ligand and the corresponding 13C NMR spectra of complex
14 proved the coordination mode of the ligand. The most indicative resonance is the
down field shift at 152 ppm of the imine carbon atom (CH=N), that resonate around
140 ppm and 146 ppm, respectively in the free N-salicylidene amino-functionalized acid
hydrazides as a consequence of the E-Z isomers. The 173 ppm specific carbonyl reso-
nance is absent in the 13C NMR spectrum of the complexes owing to dihydro-pyrrole
formation with the CH=N resonance at 169 ppm. The formation of the cis-VO+2 is ap-
parent by 51V NMR measurements performed in DMSO-d6 and DMF-d7 solutions. Both
the dimeric and the monomeric cis-dioxovanadium complexes resonate at -577 (ν1/2=316
133
Hz) in DMSO-d6 and -574 (ν1/2=450 Hz) ppm in DMF-d7, respectively. As can be seen
no solvent dependence have been observed, the two resonances in deuterated DMSO and
DMF solutions being very similar. The existence of the monomeric structure in solution
is more likely and MS measurements performed on dimer 13 in methanol solution, using
ESI positive mode, shows as major species the monomer complex with m/z 286.2 (50%)
and 308.0 (100%) signals attributed to [14+H+] and [14+Na], while the m/z signal cor-
responding to the molecular weight of the dimeric structure are less abundant: 575.0
(5%) [13+H+] and 593.3 (10%) [13+Na].
The IR spectrum of the complexes is indicative of the proposed structures. Two
strong vibrations are observed in the IR spectra of complex 14 at 902 and 936 cm−1
assigned to stretching vibrations of the cis-VO+2 group, comparable with the stretching
vibrations found for the previous described cis-dioxovanadium(v) with N-salicylidene hy-
drazide ligands. For the dimeric complex 13 the corresponding strong vibrations appear
at 885 and 943 cm−1, respectively being in according with a six coordinated vanadate
stretching vibrations in dimeric complexes.102,185 Furthermore, a comparison between the
IR patterns of the free ligand and the IR spectrum of complexes are consistent with the
proposed coordination mode of the ligand. The IR spectrum of the free ligand exhibits
strong vibration at 3450 cm−1 and 1690 cm−1 attributed to the stretching vibrations
of the amino functionality and to carbonyl group, respectively. These vibrations were
absent in the IR spectrum of the complexes, but instead two strong vibrations, equal in
intensity were observed at 1656-1622 and 1610-1613 cm−1 attributed to the asymmetric
vibration of the two conjugated -C=N- groups. In both type of complexes stretching
vibration owing to the protonated hydrazide nitrogen atom, N2H, have been detected at
around 3435-3447 cm−1.
4.1.2 Peroxidative bromination of TMB
The catalytic bromide-oxidation reaction performed by complex 14 has also been ex-
amined. Following the established procedure, the oxidative bromination of TMB by
H2O2/Br
− system was performed with 20 mol% catalyst 14 in acidified DMF solution.
The progress of the reaction was proved to be, in this case, very slow. The conversion of
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TMB to the corresponding Br-TMB took place with around 15% conversion in the first
two minutes of reaction time and developing maximum 36% Br-TMB within 5 minutes.
The catalytic activity of complex 14 is lower than previous examples, taking into account
that double amount of catalyst has been used for proceeding the reaction. The maximum
turnover rate is 22 mol Br-TMB×(mol catalyst×h)−1. Therefore, complex 14 catalyze
the oxidative bromination of TMB, similarly to the inorganic salts, such as vanadyl acety-
lacetonate and ammonium metavanadate, for which a turnover rate of maximum 15 mol
Br-TMB×(mol catalyst×h)−1 was found.117 The vanadium-catalyzed oxidative bromi-
nation of TMB was also followed by 51V NMR. The 51V resonance of 50mM DMSO-d6
solution complex 14 is -577 ppm (ν1/2=315 Hz). Addition of H2O2, up to five equiva-
lents, caused no change of the chemical shift. When six equivalents of H2O2 have been
reacted with the cis-dioxovanadium complex, two additional resonances appeared at -
608 (ν1/2=410 Hz) and -619 ppm (ν1/2=505 Hz), but with the -579 ppm (ν1/2=410 Hz)
resonance still predominant. Increased amount of H2O2, up to 10 equivalents, caused
a decrease in intensity of the -579 ppm resonance and the increasing of the other two
resonances with the -622 ppm one being predominant. The latter predominant resonance
can be attributed to oxo-peroxovanadium complex formation [VO(O2)(Hsalhycab)]. The
observed upfield shifts for peroxovanadium complex is in accordance with reported up-
field resonances by Tracey et al. who examined the aqueous formation of complexes of
type [VO(O2)L] where L was an amino acid ligand.
186 The presence of the resonance
corresponding to the starting cis-dioxovanadium(v) complex, when excess of hydrogen
peroxide was used, it is not surprising. The isolated oxo-peroxovanadium complex 9,
showed a high instability in DMSO-d6 solution, with a very fast decomposition to the
corresponding dioxovanadium complex. Therefore, the observed reactivity of 14 towards
H2O2 can be interpreted as the formation of an unstable peroxovanadium complex. Fur-
ther increase of the added amount of H2O2 to 30 equivalents, caused completely new
species. This is sustained by the disappearance of all previous detected 51V resonances
and the appearance of a two overlapped resonances at -636 and -640 ppm, respectively.
The latter 51V shifts might be given by vanadate oligomers, formed by decomposition of
the peroxo species when excess of hydrogen peroxide is used. Another possible reason
for the last two observed resonances in DMSO-d6 solution might be due to the known
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high hygroscopicity of the solvent. Therefore, the existence of excess of water leads to
decomposition of the peroxovanadium complex as was described in Chapter 3.
On the other hand, the 51V NMR monitoring of the reaction of cis-dioxovanadium(v)
complex with HClO4 was also performed, in deuterated DMF and DMSO solutions. Ad-
dition of 10 equivalents of HClO4 to a DMF-d7 solution of 14 caused an upfield reso-
nance of vanadium nucleus, shifted from -574 ppm (ν1/2=450 Hz) to -487 ppm resonance
(ν1/2=1907 Hz); whereas in DMSO-d6 solution the resulting resonance was detected at
-474 ppm (ν1/2=1160 Hz), respectively. At this point, it is tempting to assume that a
[VO(OH)(Hsalhycab)] complex is formed through protonation reaction of the vanadate
center. This assumption will be further supported by reported -483 ppm resonance of the
[VO(OH)Q2] complex in CDCl3 solution.
11 Further investigation of the reactivity of the
complex has been performed by UV-Vis monitoring of the reaction. In this case, HClO4
aqueous solution 9.2 M was diluted in DMF and, therefore the amount of water intro-
duced in the system was reduced. Spectrophotometric titration of 70µM DMF solution
of complex 14 with HClO4 has been performed, using different acid concentrations. The
UV-Vis spectra of the cis-dioxovanadium(v) complex exhibits two absorption maxima;
at 418 nm (ε=7.4×103 M−1 cm−1) and 332 nm (ε=5.8×103 M−1 cm−1). Addition of 0.5
equivalents of HClO4 0.09 M DMF solution caused a blue shifts of both maxima, at 406
(ε=5.7×103 M−1 cm−1) and 311 (ε=6.7×103 M−1 cm−1) nm, respectively. The spectrum
exhibits further formation of the new species and 1.5 equivalent of acid caused the ap-
pearance of a new band at 394 nm (ε=3.5×103 M−1 cm−1) and an increase of intensity
of the 310 nm absorption maxima (ε=5.7×103 M−1 cm−1). Further addition of acid, up
to two equivalents caused a new shift of the 394 nm band to 389 nm. The final UV-Vis
spectrum exhibits, therefore two new absorption maxima, at 389 nm (ε=5.0×103 M−1
cm−1) and 310 nm (ε=8.5×103 M−1 cm−1) (Figure 71). The isosbestic point at 330 nm,
is indicative of an equilibrium between the existing species in solution. The resulting
spectra closely resembles the characteristic absorption of cis-dioxovanadium(v) complex
7 which contains an intact N-salicylidene hydrazide ligand. Therefore, a possible hy-
drolysation of the in situ formed ligand might occur. The proposed reaction of complex
14 with HClO4 is shown in Figure 72.
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Figure 71: Spectrophotometric titration of 14 with two equiv. HClO4 in DMF solution
at 18 ◦C; 0.50 equivalents acid 0.09 M solution were added successively from two to two
minutes under continuous stirring (black spectrum represents the starting point of the
titration). The titration shows the proposed equilibrium depicted in Figure 72.
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Figure 72: Proposed reactivity of [VO2(Hsalhycab)] (14) with 2 equivalents of HClO4 in
DMF solution.
The reaction is fully reversible and backwards titration with NaOH 0.1 M, aqueous
solution, generates the initial spectra of complex 14. The requirement of base for a
complete recovering was instead higher compared to the used amount of acid and three
equivalents of base were necessary to regenerate the initial spectra of complex 14 (Figure
73).
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Figure 73: Spectrophotometric backwards titration with NaOH 0.1 M aqueous solution;
base was added as indicated in the legend from two to two minutes at 18 ◦C under
continuous stirring.
A detailed monitoring of the reaction was achieved by stepwise addition of 0.1
equivalents HClO4 9 mM solution. In this case, the gradually generation of the new
species was more obvious, with the isosbestic point clearly present (Figure 74). The
less intense absorption maxima, observed at 310 nm, compared to previous described
spectrophotometric titration (Figure 71), could be caused by a high dilution of the final
complex as a consequence of the used diluted acid solution.
If an excess of HClO4 0.09 M solution (five equivalents) is stepwise added, the UV-
Vis spectrum of the resulting solution does not exhibit significant changes (Figure 75)
compared to spectrophotometric titration performed with only two equivalents of acid.
The progress of the reaction, from about two equivalents to five equivalents of acid, is
insignificant and few amount of the new species is generated. The UV-Vis spectra exhibits
a constant decrease of the 389 nm absorption maxima and an increase in intensity of the
310 nm maxima (Figure 75, right pictogram). Therefore, the hydrolysis of the dihydro-
pyrrole ring to form N-salicylidene amino acid hydrazide is most likely to occur.
138
300 325 350 375 400 425 450 475 500
0,1
0,2
0,3
0,4
0,5
0,6
A
b
s
o
rb
a
n
c
e
Wavelength (nm)
Figure 74: Spectrophotometric titration of 14 with two equiv. diluted HClO4 in DMF
solution at 18 ◦C; 0.1 equivalents acid 9 mM solution were added successively from 1.3
to 1.3 minutes under continuous stirring.
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Figure 75: Spectrophotometric titration of 14 with five equiv. HClO4 in DMF solution
at 18 ◦C; 0.5 equivalents of acid 0.09 M solution were added successively from two to
two minutes.
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Unfortunately, when five equivalents of HClO4 were used for the titration, the back-
reaction with NaOH did not yield the complete recovering of the initial spectra of the
complex. The addition of NaOH gave the initial absorption maxima, characteristic for
complex 14, but the intensity is much lower and the amount of required base is of around
eight equivalents. Therefore, maybe some decomposition of complex might occur when
excess of acid is present with the complex partially reformed in basic conditions.
Therefore, the reactivity of complex 14 towards HClO4 in DMF solution take place,
most likely by hydrolysation of the in situ formed dihydropyrrole structure to form an
amino-substituted N-salicylidene hydrazide which contains a protonated hydrazide nitro-
gen atom (Figure 72). A 51V NMR monitoring of the reaction, following the conditions
of the UV-Vis spectrophotometric titration is expected to give further insight into the
system.
4.2 cis-Dioxovanadium(v) complexes derived from
N-salicylidene 6-amino hexanoic acid hydrazides
Further extension of the aliphatic side-chain of the starting amino acid ester with two
methylene groups afforded the N-salicylidene 6-amino hexanoic acid hydrazide. The
ligand is capable to react with ammonium metavanadate in refluxing methanol solu-
tion to yield the anionic cis-dioxovanadium(v) complex. By comparison to the shorter
amino-functionalized N-salicylidene hydrazide, no cyclization has been occurred during
the reaction with ammonium metavanadate. This can be explained due to the instability
of the possible 7-membered ring closure. According with the used solvent of crystal-
lization, two types of crystals could be isolated. Crystallization from methanol affords
complex [VO2(salhyah)] (15a) (see Figure 76), while crystallization from a 1:1 mixture
methanol-water leads to complex [VO2(salhyah)]·0.5H2O (15b) (see Figure 77). The
latter mentioned compound contains half molecule of water of crystallization per for-
mula unit. In both cases the protonated amino functionalized side-chain compensates
the negative charge on the vanadate moiety, similar to the lysine residue in the vanadium
dependent haloperoxidase enzymes.
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Figure 76: Molecular structure of [VO2(salhyah)] (15a); displacement ellipsoids are drawn
at the 50% probability level.
The molecular structure of both complexes determined by X-ray crystallography fea-
ture a cis-dioxovanadium(v) moiety in a distorted square pyramidal environment with
a τ value of 0.14 for complex 15a and 0.18 for complex 15b. The distortion to the
ideal square pyramidal geometry is similar with previous described geometry of the vana-
dium atom in cis-dioxovanadium(v) complexes based on N-salicylidene hydrazide ligand.
The Schiff base ligand coordinates in its dianionic form, providing an ONO donor set
which form the equatorial plane together with one of the double bonded oxygen atom
O2, whereas the other oxo group O1 occupies the apical position. The V=O (O1 and
O2) bond lengths, as well as the V-N1 and V-O (O3 and O4) bond distances are al-
most the same for both complexes (see Table 12) and within the expected range for
cis-dioxovanadium(v) complexes.103,187 Complex 15a crystalizes in the monoclinic space
group P21/n, whereas complex 15b crystallizes in the orthorhombic space group Pbcn.
The two crystal structures shows high similarity. The anionic nature of the complex and,
therefore the presence of the iminole form of the ligand is consistent with the observed
V-O4 and C8-O4 bond lengths of around 195.5 and 130 pm, respectively.
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Figure 77: Molecular structure of [VO2(salhyah)]·0.5H2O (15b); displacement ellipsoids
are drawn at the 50% probability level.
The nitrogen atom and the three coordinated oxygen atoms at the pyramid base are nearly
in the plane with the relative deviation of O3N atoms from the least-square plane of 9.2 pm
in complex 15a and 12.2 pm in complex 15b with the vanadium atom around 50 pm
apart from this plane towards the apical oxo group O1. In both cases the protonated
amino group compensates the negative charge of the vanadate center and is involved in
strong hydrogen bonding interaction.
Figure 78: Hydrogen bonding interaction in crystals of complex 15a (broken lines rep-
resent hydrogen bonds); relevant distances (in pm): N3· · ·O2D 284.1, N3· · ·N2F 302.4,
N3· · ·O1E 279.1 (symmetry transformations: A: 0.5 - x, 0.5 + y, 1.5 - z; B: 1.5 - x, 0.5
+ y, 1.5 - z; C: 0.5 + x, - 0.5 - y, 0.5 + z; D: 0.5 - x, - 0.5 + y, 1.5 - z; E: 1.5 - x, - 0.5 +
y, 1.5 - z; F: - 0.5 + x, - 0.5 - y, - 0.5 + z).
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In complex 15b an intermolecular hydrogen interaction is established between the
protonated amino group and the water of crystallization (N3· · ·O1w 283.4 pm), which is
hydrogen bonded towards a nitrogen atom N2 of the hydrazide group from a neighboring
molecule (Figure 79). In complex 15a, this hydrogen interaction is established directly
between the amino group and the nitrogen atom of the hydrazide from a neighboring
molecule (Figure 78).
Figure 79: Hydrogen bonding interaction in crystals of complex 15b (broken lines rep-
resent hydrogen bonds); relevant distances (in pm): N3· · ·O2E 278.9, N3· · ·O1F 276.3,
N3· · ·O1W 283.4, O1W· · ·N2C 276.4 (symmetry transformations: A: 0.5 - x, 1.5 + y, -
0.5 - z; B: 0.5 + x, 0.5 - y, 0.5 + z; C: - 0.5 + x, 0.5 - y, 0.5 + z; D: 0.5 + x, - 0.5 - y, 0.5
+ z; E: 0.5 - x, 1.5 + y, 0.5 - z; F: - 0.5 + x, - 0.5 - y, 0.5 + z).
A vital role for the catalytic activity of the vanadium chloroperoxidase enzyme is
attributed to the lysine residue that is hydrogen bonded to the equatorial oxygen atom
of the prosthetic group. A similar situation has been found in cis-dioxovanadium(v)
complex with N-salicylidene 6-amino hexanoic acid hydrazide. In both complexes the
protonated amino group is in hydrogen bonding interaction with the oxo groups O1
(N3· · ·O1 279.1 pm in complex 15a and N3· · ·O1 276.3 pm in complex 15b) and O2
(N3· · ·O2 284.1 pm in complex 15a and N3· · ·O2 280 pm in complex 15b). Moreover,
the compensation of the negative charge on vanadium center by protonated functionalities
of the ligand system is quite rare and only one more example is known in the literature.
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This is represented by a similar described cis-dioxovanadium(v) complex based on N-
salicylidene dimethyl-amino acetic hydrazide, which contains a substituted quaternary
amine group.188
Table 12. Selected bond lengths (pm) and angles (◦) in complexes 15a and 15b.
15a 15b 15a 15b
V−O1 163.26 163.04 V−N1 214.76 213.77
V−O2 164.39 163.31 C8−O4 130.13 129.48
V−O3 189.87 190.44 C8−N2 130.61 130.48
V−O4 195.46 195.57 N1−N2 131.4(3)
O1−V−O2 111.25(6) 110.18(8) O2−V−O3 96.11(5) 94.03(7)
O1−V−O3 103.30(5) 102.38(7) O2−V−O4 90.33(5) 93.79(7)
O1−V−O4 102.22(5) 101.17(7) O2−V−N1 140.49(5) 140.19(8)
O1−V−N1 107.24(5) 109.32(8) O3−V−N1 82.96(5) 82.22(6)
O3−V−O4 148.73(5) 150.82(7) O4−V−N1 72.96(4) 73.87(6)
4.2.1 Spectroscopic studies
The IR spectra of the complexes are consistent with the determined molecular struc-
tures and presents the strong bands related to cis-VO+2 stretching vibrations at 931 and
909 cm−1. The enolization of the amide functionality is consistent with the observed
1610 cm−1 vibration assigned to the conjugated -CH=N–C=N- group. Strong vibra-
tion, but rather broad have been detected at 3435 cm−1 corresponding to amino group.
The intact coordination mode of the ligand was further confirmed by comparison of the
1H NMR patterns of the ligand with the complexes as well as with the NMR patterns
of complex 14. By comparison with 1H NMR spectra of complex 14 the specific R-
NH+3 resonance has been observed at 7.59 ppm as a broad signal with the integration
area corresponding of 3H+, in agreement with crystallographically solved structure. The
azomethine proton is deshielded by 0.3 ppm comparing to its original resonances in the
free ligand in accordance with the weakly coordinated nitrogen atom at the vanadium
atom. While the -CH=N proton is present as E and Z isomer in the free Schiff base ligand
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in a ratio 1.6:1, the coordination of the metal atom leads a single isomer consistent with
observed one resonance in the 1H NMR of the complexes. Consequently, the resonance
of the methylene group CH 2CO which also exhibits two resonances in
1H NMR spectra
of the free ligand at 2.26 and 2.54 ppm due to a amide-iminole equilibrium, shows only
one resonance for the iminole form at 2.26 ppm in 1H NMR spectra of the complex. The
other methylene protons, as well as the aromatic protons resonate in the expected regions
(see Experimental Section) with minor variations in their positions. The formation of
the cis-dioxovanadium complex is further given by the -532 ppm resonance (∆ν1/2 = 600
Hz) in 51V NMR spectra recorded in DMSO-d6. This resonance is upfield shifted by -45
ppm comparing to previous cis-dioxovanadium (v) complex obtained with N-salicylidene
4-butanoic acid hydrazide, but it is very similar with previous found 51V resonances for
cis-dioxovanadium(v) complexes with an intact N-salicylidene aliphatic acid hydrazides.
4.2.2 Reactivity of the complex
The reactivity of complex 15a was tested in solution by reaction with standard hydrochlo-
ric acid aqueous solutions, as well as its capacity to form a monoperoxovanadium complex,
postulated as active intermediate for the reaction catalyzed by vanadium compounds as
model for vanadium-dependent haloperoxidases.121
Protonation Reaction
The protonation reaction of complex 15a was monitored by spectrophotometric titration
of an aqueous solution of the complex with standard HCl solutions. Titration of 50 µM
solution of the complex with two equivalents of HCl 0.1 M, monitored by stepwise addition
of 0.5 equivalents acid, yields gradually a decrease in intensity of the 370 nm band and
an increase in intensity of 282 nm band accompanied by a slight splitting (Figure 80).
The isosbestic point at 297 nm demonstrates the existence of an equilibrium between
components in solution. The reversibility of the reaction was accomplished by titration
with NaOH 0.1 M (Figure 81) and two equivalents were required for recovering of the
initial spectra. This differs to the situation found for the similar complex 7 described in
Chapter 3, were a slight excess of base comparing to used amount of acid was necessary
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Figure 80: Spectrophotometric titration of [VO2(salhyah)] (50µM) with two equivalents
HCl 0.1 M in water; 0.5 equivalents of acid were added successively from two to two
minutes at 18 ◦C. Isosbestic point is observed at 297 nm for the proposed equilibrium
depicted in Figure 82.
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Figure 81: Spectrophotometric backwards titration of protonated [VO2(Hsalhyah)] with
two equivalents NaOH 0.1 M in water; 0.5 equivalents of base were added successively
from two to two minutes at 18 ◦C.
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to recover the anionic complex.
Despite this difference in the amount of required base for the back-titration, the
UV-Vis spectra presents very high similarities and the interpretation of the results is
analogues with previous described in Chapter 3. One protonation reaction occurs that
takes place at the hydrazide nitrogen atom N2 which is the most basic site compared to
the oxo groups of the vanadium ion (Figure 82).
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Figure 82: Proposed protonation reaction of complex 15 with HCl in water solution.
For a more closer investigation on the used system, the spectrophotometric titration
has been performed on a diluted complex solution (33.4 µM) with 0.01 M HCl solution
using a higher excess of acid, similarly with the used conditions for spectrophotometric
titration of complex 7 with hydrochloric acid. The reaction was monitored by stepwise
addition of 0.25 equivalents of HCl 0.01 M aqueous solution and performed first with five
equivalents of acid and further addition of acid up to 10 equivalents (Figure 83). The
initial spectra of the complex presents three absorbtion maxima at 214 (ε= 21.00×103
M−1cm−1), 282 (ε= 9.93×103 M−1cm−1) and 370 (ε= 3.30×103 M−1cm−1) nm. When
five equivalents of acid have been added to the aqueous solution of the complex, an
increase in intensity of the 282 nm band was observed (ε= 10.64×103 M−1cm−1), while
the absorption maxima of 370 nm is constantly decreasing in intensity (ε= 3.02×103
M−1cm−1). Further addition of acid up to 10 equivalents caused a constant decrease of
the intensity of the absorption maxima of the 370 nm band (ε= 2.79×103 M−1cm−1) and
no shift of the wavelengths in general (Figure 83). The reaction is also fully reversible and
the back-titration with base (10 equivalents), added stepwise affords the initial spectrum
of the complexes (Figure 84).
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Figure 83: Spectrophotometric titration of [VO2(salhyah)] (33.4µM) with 10 equivalents
HCl 0.01 M in water; 0.25 equivalents of acid were added successively from two to two
minutes at 18 ◦C.
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Figure 84: Spectrophotometric backwards titration of protonated [VO2(Hsalhyah)] com-
plex through reaction with 1o equivalents HCl 0.01 M. The titration is shown through
addition of 10 equivalents NaOH 0.01 M aqueous solution; 0.25 equivalents of base were
added successively from two to two minutes at 18 ◦C.
The obtained final UV-Vis spectra of the mixture complex 15 with acid, were also
theoretically interpreted with the programm based on Zuberbu¨hler mathematical back-
ground.173,174 The formation of the protonated species at the hydrazide nitrogen atom
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was confirmed for both five and ten equivalents of HCl titration data. A reasonable fit of
the measured data, when five equivalents of acid have been used, was obtained by taking
into account one protonation step. This gives a value of 630 for the equilibrium constant
with a standard deviation of 5×10−4. Further addition of acid up to 10 equivalents leads
an decrease of the equilibrium constant to 580 and also an increase of the standard de-
viation to 8×10−4, value which could not be improved by calculations with a possible
second equilibrium process. The calculated pKb value is 11.2±0.2 for the spectrophoto-
metric titration depicted in Figure 83. This confirmed once again the proposed process
shown in Figure 82 and it leads the conclusion that, for this system, in aqueous solution,
there is no protonation at the di-oxo groups of the vanadium atom. Moreover up to date,
there have been crystallographically characterized only the corresponding oxo-hydroxo
vanadium(iv) complexes.167,169 For the N-salicylidene carbonic acid hydrazide system
used here, the protonation of the hydrazide nitrogen atom is further in agreement with
a similar reported cis-dioxovanadium system.131
Reaction with hydrogen peroxide
The formation of a peroxovanadium complex in solution has also been established by
electronic absorption spectroscopy. Stepwise addition of 0.5 equivalents of H2O2 25 mM
methanol solution to 40 µM methanol solution of the complex yields the progressive
generation of an orange material (λ = 392 nm) (Figure 85). The titration reaction of 15
with 10 equivalents of hydrogen peroxide exhibits an isosbestic behavior. The spectral
changes consist in a red shift of the 380 nm (ε= 2.6×103 M−1cm−1) band to 392 nm (ε=
2.9×103 M−1cm−1) accompanied by an increase of the absorption maxima due to the
peroxo-to-vanadium charge transfer band. The 278 nm (ε= 8.2×103 M−1cm−1) broad
band of the cis-dioxovanadium complex is also increasing in intensity with sharpening
and splitting into two new bands (278 (ε= 11.7×103 M−1cm−1) and 288 (ε= 11.5×103
M−1cm−1) nm).
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Figure 85: Spectrophotometric titration of [VO2(salhyah)] (40µM) with 10 equivalents
H2O2 25 mM in methanol; 0.5 equivalents of hydrogen peroxide were added successively
at every two minutes at 20 ◦C. The titration shows the formation of the peroxovanadium
complex with specific absorbance at 392 nm.
The final spectra pattern is similar to that of the isolated peroxovanadium complex
9 recorded in methanol solution. This is a very important observation, since a peroxo-
vanadium complex has been postulated as active intermediate of the catalytic reactions,
not only for the enzymatic system,95 but also for the vanadium model complexes.111
The oxidative-bromination reaction of TMB catalyzed by cis-dioxovanadium(v)
complex (15), has also been performed. Following the typical experiment, 10 mol% cata-
lyst has been reacted with hydrogen peroxide in acidified DMF solution, to yield an active
peroxo-intermediate able to catalyze bromide oxidation. This resulting oxidized bromide
has been monitored by GC dosage of mono-brominated TMB product compared with non-
reacted TMB. The reaction has been initiated by succesive addition of perchloric acid and
hydrogen peroxide to a DMF solution containing 1,3,5-trimethoxybenzene, catalyst and
excess of tetra-butylammonium bromide. A 41.8% conversion of the TMB to BrTMB has
been achieved within 5 minutes, corresponding to a turnover rate of 50 mole of brominated
TMB per mol of catalyst and hour, which is about 3 times faster than the reported am-
monium vanadate117 and two times faster than complex 14. The amount of brominated
TMB increase to 79.3% after 10 minutes of reaction time, similar catalytic activity to
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previous described anionic cis-dioxovanadium(v) complexes with hydroxyl-functionalized
N-salicylidene hydrazide. Thus, the bioinspired cis-dioxovanadium(v) complex with N-
salicylidene hydrazide which contains an amino substituted aliphatic side-chain catalyze
the oxidative bromination of TMB following analogous pathway to vanadium bromopero-
xidases. The vanadium complex reacts with H2O2 to form a peroxovanadium species as
was proved by spectrophotometric titration with hydrogen peroxide. The synthetic com-
plex 15a requires instead more acidic conditions and also performs lower turnover rate
compared to the natural system.
4.3 Oxidation of sulfides catalyzed by cis-dioxovana-
dium(v) complexes
Vanadium haloperoxidase enzymes are also capable to catalyze the oxidation of sulfides to
sulfoxides, varying from an enantioselective behavior in the case of vanadium bromoper-
oxidases to a non-selective reaction when vanadium chloroperoxidase has been used to
mediate the reaction.88,89 Various vanadium complexes have been also reported189,190
as catalysts for sulfides oxidation reaction with the complexes involving mainly Schiff
base ligation. The capacity of the new cis-dioxovanadium(v) complexes to function as
catalysts for the oxidation reaction of methyl phenyl sulfide by hydrogen peroxide was
also investigated. Following the reported procedure,191 1 mol-% catalyst has been used
for the reaction and a slight excess (1.2 equivalents) of hydrogen peroxide, in a mix-
ture CH2Cl2/CH3OH 7:3. Methanol was used as co-solvent due to the bad solubility of
the complex in non-polar solvents and moreover, for a better miscibility of the aqueous
oxidant with the halogenated solvent. After 16 hours of reaction time, 100% of the cor-
responding sulfoxide was obtained when complex 14 was used as catalyst, whereas 89%
conversion was established by the catalyst 15a within 18 hours. Reports of vanadium-
catalyzed sulfur oxidation reactions range from 58 to 92% conversion in the period of time
of 14-16 hours189–192 when oxo- or cis-dioxovanadium(v) complexes were used as catalysts.
The yields of the catalytic reaction raise to 60% conversion of sulfide within two hours,
when peroxovanadium (v) complexes catalyzed the reaction.193 Efficient vanadium-based
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catalyst for the sulfide oxidation reaction was reported as salan-type oxovanadium(iv)
complex which accomplished 91% conversion after six hours of reaction in acetonitrile
solution.189
4.4 Conclusions
The new cis-dioxovanadium(v) complexes with N-salicylidene-hydrazides that contain
an amino-functionalized side-chain have been synthesized and fully characterized. These
complexes can be regarded as structural model for the enzymatic system due to the
relevant hydrogen bonding interaction which involves the oxygen atoms of the vanadate
moiety. When N-salicylidene 4-amino butanoic hydrazide has been used as ligand system,
dimeric and monomeric cis-dioxoanadium(v) complexes have been isolated. The reac-
tion took place by an intramolecular cyclisation reaction, resulting in the formation of
neutral cis-dioxovanadium complexes based on dihydro-pyrrole N-salicylidene hydrazide.
Complex 14 showed instead a low efficiency as catalyst of the bromide oxidation reac-
tion. Reactivity of the complex towards HClO4 in DMF solution showed the hydrolysis
of the dihydro-pyrrole formed structure, resulting in the formation of 4-amino aliphatic
acid hydrazide which contains a protonated hydrazide nitrogen atom. However, 14 was
instead capable to catalyze the oxidation of sulfides with a quantitative conversion of
methyl phenyl sulfide into the corresponding sulfoxide after 16 hours.
Further increase of the aliphatic side chain with two methylene groups yield the for-
mation of anionic cis-dioxovanadium(v) complexes. The compensation of the negative
charge at the vanadium atom is now achieved by the protonated amino group that takes
the place of the ammonium cation found in the previous examples. The complex allows
for a variation of the protonation state that occurs at the basic amide nitrogen. Spec-
troscopic investigations regarding the reactivity of the complex towards HCl showed that
the protonation in aqueous solution occurs only at the hydrazide nitrogen atom. Per-
oxidative bromination of TMB in acidified DMF solution showed high efficiency of the
complex to function as catalyst of the reaction. Therefore, complex 15 can be regarded
as both structural and functional model complex for vanadium haloperoxidases. More-
over, 15 showed significant catalytic capacity for sulfide oxidation reaction accomplishing
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89% conversion of thioanisole within 18 hours. Thus, using very simple conditions (room
temperature and no exclusion of air) together with low excess and inexpensive oxidant
(hydrogen peroxide) these complexes were capable of oxidizing thioanisole to the corre-
sponding thioanisole sulfoxide with high efficiency.
4.5 cis-Dioxomolybdenum(vi) complexes based on
N-salicylidene hydrazides that contain an amino-
functionalized aliphatic side-chain
Molybdenum has been reported as an important metal in biological systems and, nu-
merous molybdenum containing enzymes are known.194 The existence of molybdenum
in oxotransferase enzymes had increased the interest for the reactivity and coordination
chemistry of cis-dioxomolybdenum complexes.92,195 Moreover, various molybdenum(vi)
complexes have been reported as efficient catalysts for epoxidation and hydroxylation of
olefines,196–199 oxidation of sulfides200 and alcohols201 and as catalysts of oxygen trans-
ferring reaction.202,203 In addition, MoO3(aq)
204,205 and [MoO(O2)2(oxalate)]
2−206 are
known as functional mimics for V-HPOs enzyme, being capable to catalyze the oxidation
of halides by hydrogen peroxide. At this point should be mentioned that, molybdate
showed a higher catalytic activity, compared to the inorganic vanadate. The reported
turnover rate for the catalytic bromide oxidation reaction is ca. 180 mol Br-TMB×(mol
Mo catalyst×h)−1 which is about 45 times faster than ammonium metavanadate.205 How-
ever, the number of molybdenum-based catalyst for the haloperoxidase reaction is very
limited and there are reports of molybdenum coordination compounds as analogs of vana-
dium complexes, which were incapable to mediate the catalytic halide oxidation.207 The
vanadate as the prosthetic group of vanadium haloperoxidases, has been found to be vital
for the catalytic reaction, since its removal or reduction leads an inactive (apo)protein
derivate.2,101 Replacement of vanadate with molybdate did not restore the haloperoxi-
dase activity of the enzyme,101 although the protein environment of the V-HPO enzymes
was capable of binding molybdate.62
In order to address the question whether cis-dioxomolybdenum complexes with
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N-salicylidene hydrazide ligand can serve as catalysts of the oxidative bromination reac-
tion, the corresponding cis-dioxomolybdenum(vi) complexes were also isolated. Based
on similar chemistry of molybdate and vanadate, there are already reports which proved
the versatility of the used Schiff base system towards molybdenum accommodation.151
Therefore, the N-salicylidene hydrazide that contain an amino functionalized side chain
were also reacted, in equimolecular amounts, with molybdenyl acetylacetonate in pres-
ence of one equivalent of sodium hydroxide. The presence of base was a compulsory
requirement for the reaction to proceed as a consequence of the used Schiff base lig-
and as hydrochloride salt. The reaction was performed in refluxing methanol when cis-
dioxomolybdenum(vi) complexes were isolated. Using the short aliphatic side chain of
the amino-funtionalized N-salicylidene hydrazide precursor, suitable crystals for X-ray
measurement of the cis-dioxomolybdenum(vi) complex 16, were obtained. The molecu-
lar structure determination reveals a cis-dioxomolybdenum moiety (Figure 86) with the
molybdenum atom in a distorted octahedral geometry. Due to the base presence for
the reaction, the ligand is also present as N-salicylidene dihydropyrrole hydrazide and
coordinates via the phenolate oxygen atom O3 and the two imine nitrogen atoms (N1
and N3). A net difference conservely to corresponding cis-dioxovanadium(v) complexes
is the deprotonation of the hydrazide nitrogen atom of the in situ formed ligand. This
consist with the observed Mo–N3 bond length of 201 pm that is shortened comparing
to the corresponding V–N3 of 222 pm found in complex 14. The coordination sphere
of the molybdenum atom is completed by the two oxo groups placed in cis-position to
each other and a coordinated methanol molecule (Figure 86). The molybdenum to oxo
group bond distances are almost equal (Mo–O1 of 169.8 pm and Mo–O2 of 170.3 pm)
and similar with corresponding bond distances reported for cis-dioxomolybdenum com-
plexes.202,203,208 The coordinated oxygen atom O1M of the methanol molecule, located
trans to oxo group O1, is weakly bonded at the molybdenum center (Mo–O1M 215 ppm).
The structural differences between the cis-dioxomolybdenum complex 16 and the analog
vanadium complex 14 is that the molybdenum atom has a six-coordination number, ful-
filling, in general its sixth coordination site with solvent molecule. Selected bond lengths
and angles for complex 16 are given in Table 13.
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Figure 86: Molecular structure and numbering scheme of complex
[MoO2(salhycab)(MeOH)] (16); displacement ellipsoids are drawn at 50% proba-
bility level.
However, hydrogen bonding interaction in complex 16 were also observed, but with
the involvement of different donor patterns. The coordinated methanol molecule is in hy-
drogen bonding interaction with the hydrazide nitrogen atom N2 of neighboring molecule
(N2· · ·OC 289 pm), whereas in the corresponding cis-dioxovanadium complex the hydro-
gen bonding interaction involved the strong covalently bonded oxo group. The hydrogen
bonding interaction established in the crystal packing of cis-dioxomolybdenum complex
results in the formation of layered polymeric structure (Figure 87).
Figure 87: Representation of the hydrogen bonding network (drawn as broken lines)
observed in the crystals of the cis-dioxomolybdenum complex 16 viewed along the [100]
axis.
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Table 13. Selected bond lengths (pm) and angles (◦) in complex 16.
Mo−O1 169.84(15) Mo−N1 227.67(16)
Mo−O2 170.29(14) Mo−N3 206.09(18)
Mo−O3 195.42(15) C8−N2 131.0(3)
Mo−O1M 231.36(14) C8−N3 134.0(3)
O1−Mo−O2 105.19(7) O2−Mo−O3 106.44(7)
O1−Mo−O3 96.27(7) O2−Mo−N1 159.02(7)
O1−Mo−N1 93.43(6) O2−Mo−N3 95.94(7)
O1−Mo−N3 100.43(7) O2−Mo−O1M 83.20(6)
O1−Mo−O1M 170.81(7) N3−Mo−N1 70.79(6)
O3−Mo−N1 80.49(6) N3−Mo−O1M 82.12(6)
O3−Mo−N3 147.40(7) N1−Mo−O2A 79.00(5)
O3−Mo−O1M 77.46(6)
4.5.1 Spectroscopic characterization
The formation of the cis-dioxomolybdenum(vi) complex has been also confirmed by
spectroscopic methods. The 1H NMR of the complex is in agreement with the proposed
coordination of the ligand, in particular the absence of the down field resonance corre-
sponding to NH proton found in the corresponding 1H NMR spectrum of vanadium(v)
complexes. The azomethine proton (-CH=N) is upfield shifted by around two ppm com-
pared to vanadium complexes. A similar effect, but in opposite direction of the NMR
scale, was observed for the methylene protons placed in vicinity of the molybdenum atom,
namely CH2N–Mo. The other aliphatic and aromatic protons resonate in expected region
with insignificant differences. The 13C NMR presents instead strong differences regard-
ing the position of the resonances of the carbon atoms close to the nitrogen and oxygen
atoms which are covalently bonded at molybdenum atom. A resonance at 176.5 ppm
corresponding to CH2 group place in vicinity of the coordinated nitrogen atom has been
observed in the case of cis-dioxomolybdenum complex; this is about seven ppm down-
fielded compared with the resonance found in vanadium complex 14. On the other hand,
the phenolic carbon atom is four ppm shifted upfield, whereas the azomethine carbon
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resonate in similar region according to a weak covalently bonded nitrogen atom. The
presence of the coordinated methanol is confirmed by the specific resonances of the CH3
protons at 3.15-3.16 ppm and 4.08 pmm for the OH proton with the 13C resonance
at 48.6 ppm. Furthermore, the IR spectrum is consisting with the crystallographically
determined structure and contains strong stretching vibration at 909 and 930 cm−1 cor-
responding to cis-MoO2 group. Contrary to the IR spectrum of cis-dioxovanadium(v)
complex only one vibration was observed at 1605 cm−1 assigned to the -CH=N-N=C
group and thus, is confirmed the deprotonation of the hydrazide nitrogen atom N2 on
molybdenum coordination.
Similar spectroscopic patterns were detected for the cis-dioxomolybdenum(vi) com-
plex 17, obtained with N-salicylidene 6-amino hexanoic acid hydrochloride ligand. Com-
parison between 1H and 13C NMR of 17 with the 1H and 13C NMR patterns of the
corresponding vanadium complex 15a, follows in general the differences described above.
The molybdenum atom is also six-coordinated as a consequence of the specific NMR
resonances of the methanol nuclei detected in both the 1H and 13C NMR of complex 17.
Similarly to the corresponding cis-dioxovanadium(v) complex, the molybdenum com-
plex 17 contains an intact N-salicylidene 6-amino hexanoic acid hydrazide showed by
characteristic resonances detected in both 1H and 13C NMR spectra of the molybdenum
complex. By comparison with the vanadium complex 15a, the cis-dioxomolybdenum
complex 17 has a neutral character with the amino functionality resonating at 7.58 ppm
with the integration area corresponding to two protons. The other aliphatic and aromatic
protons of the tridentate ligand coordinates in the expected regions with insignificant dif-
ferences compared with their resonances in the cis-dioxovanadium(v) complex 15a.
4.5.2 Catalytic tests
The haloperoxidase activity of the cis-dioxomolybdenum complex 16, has been performed
following the procedure described for vanadium complexes. Unfortunately no catalytic
activity of the molybdenum complex has been found towards the peroxidative bromi-
nation of 1,3,5-trimethoxybenzene, although the ligand system is capable to coordinate
molybdenum in a similar manner with vanadium complexes. This observation is in agree-
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ment with the results reported for vanadium haloperoxidase enzyme where the molybdate
bonded enzyme was reported as inactive.62 Compared to the inorganic molybdate and
vanadate, were the molybdate proved to be an efficient catalyst of the haloperoxidase
reaction, the replacement of vanadate with molybdate in this case did not afford the
same positive effect. Instead, the cis-dioxomolybdenum(vi) complex (16) functions as
efficient catalyst for the sulfide oxidation. 1 mol% complex in a dichlormethane-methanol
mixture catalyzed the oxidation of phenyl methyl sulfide to around 83% sulfoxide after
18 hours using H2O2 as oxidant. Contrary to vanadium-catalyzed reaction, sulfone as
over oxidation product, has been obtained. Every attempt to decrease and/or to avoid
completely the sulfone formation failed and an decrease from around 25% to 10% was
achieved by stepwise addition of hydrogen peroxide over a period of at least 5 minutes
at 0 ◦C.
Thus, it can be concluded that cis-dioxomolybdenum(vi) complex with N-salicylide-
ne hydrazide that contain an amino functionalized side-chain can be prepared in a similar
manner with vanadium complexes, resulting in dihydropyrrole hydrazide sequence formed
in situ upon reaction with metal salts when 4-amino butanoic substituted Schiff base is
used as ligand system. This molybdenum complex showed no catalytic activity of the
oxidative bromination of 1,3,5-trimethoxybenzene by hydrogen peroxide, contrary to the
cis-dioxovanadium(v) complexes. Instead the cis-dioxomolybdenum complex is capable
to catalyze the oxidation of sulfides to corresponding sulfoxides with a slight over oxi-
dation capacity. When N-salicylidene 6-amino hexanoic acid hydrazide had been used
as ligand system, the resulting cis-dioxomolybdenum(vi) complex has been spectroscopi-
cally characterized. The reaction between the Schiff base ligand as hydrochloride salt and
molybdenyl acetylacetonate as a source of molybdenum salt takes place with a very low
yield and requires the presence of one equivalent of base. When no base have been used
for reaction mixture to proceed, a molybdenum(v) complex as a greenish-blue material
could be isolated, which presents an specific one-line EPR signal with a g value of 1.92,
as a specific characteristics for paramagnetic molybdenum(v) complex.209
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4.6 Experimental Section
Materials: Diluted perchloric acid (0.09 M) for spectrophotometric titration was ob-
tained by dilution of a standard HClO4 9.21 M (aqueous solution) in DMF. NaOH and
HCl 0.1 M and 0.001 M were used as standardized aqueous solutions. All other reagents
were used as received, without further purification. Abbreviations used throughout the
text: H2salhyab = 4-amino butyric acid (2-hydroxy-benzylidene) hydrazide hydrochlo-
ride, H2salhyah = 6-amino hexanoic acid (2-hydroxy-benzylidene) hydrazide, Hsalhycab
= 2-(2-hydroxy-benzylidene) 4,5-dihydro-pyrrole hydrazide, TMB = 1,3,5-trimethoxyben-
zene, Br-TMB = 2-bromo 1,3,5-trimethoxybenzene, Q = 8-hydroxyquinoline.
The programm used for theoretical interpretation of UV-Vis data was an C++
adaption of the original SPECFIT-32, which was initially developed in Basic. The used
programm keeps the original mathematical background and is capable using ASCII files
to calculate the equilibrium constants from multiwavelength spectroscopic data based on
a factor analysis.
4.6.1 Synthesis of amino-aliphatic hydrazide as hydrochloride
salts
Synthesis of 4-amino butanoic acid hydrazide hydrochloride
To a solution of ethyl 4-aminobutanoate hydrochloride (7.68 g, 0.05 mmol) in absolut
ethanol (10 mL), hydrazine hydroxide 100 % (2.50 g, 2.50 mL, 0.05 mmol) was added
under continuous stirring, followed by addition of ethanol (40 mL) and water (5 mL).
The resulting solution was refluxed under continuous stirring overnight. After cooling
at room temperature diethyl ether (50 mL) was added which caused a turbulence of the
solution. Stirring at room temperature for 12 hours yields a colorless precipitate. (Note:
in the case of an oil formation, the reaction mixture is dried under strong vacuum and it
is extracted three times with hot absolut ethanol and precipitated by stirring with diethyl
ether (100 mL)). Yield: 6.45 g (0.04 mol; 84 %). Anal. for C4H12N3OCl (153.61): calcd.
C 31.28, H 7.87, N 27.36; found C 32.20, H 7.68, N 26.37.
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Synthesis of 6-amino hexanoic acid hydrazide hydrochloride
To a solution of methyl 6-aminohexanoate hydrochloride (9.08 g, 0.05 mmol) in absolut
ethanol (25 mL), hydrazine hydroxide 100 % (2.50 g, 2.45 mL, 0.05 mmol) was added with
reflux and stirring overnight. The resulting solution was rotary evaporated to dryness and
extracted five times with absolut ethanol (50 mL) when an oily compound was formed.
Titruration with diethyl ether (150 mL) yields the desired solid product. Yield: 8.30 g
(0.04 mol; 91 %). Anal. for C6H16N3OCl (181.66): calcd. C 39.67, H 8.87, N 23.13;
found C 39.90, H 8.72, N 23.13. 1H NMR (200 MHz, D2O): δ = 1.06-1.28 (m, 2H, CH2),
1.34-1.59 (m, 4H, CH2), 2.08 (t, 2H, CH2CO,
3J= 7.22 Hz), 2.83 (t, 2H, CH2NH2×HCl,
3J= 7.50). 13C NMR (50 MHz, D2O): δ = 24.4, 24.9, 26.3 (all CH2), 33.3 (CH2CO),
39.2 (CH2NH2×HCl), 175.4 (C=O).
4.6.2 Synthesis of Schiff base ligands as hydrochloride salts
Synthesis of N-salicylidene 4-amino butanoic acid hydrazide hydrochloride
(H2Salhyab×HCl)
To a solution of 4-amino butanoic acid hydrazide hydrochloride (3.20 g, 0.02 mol) in
refluxing absolut ethanol (50 mL), salicylaldehyde (2.42 g, 0.02 mol, 2.07 mL) was added
dropwise. The resulting yellow solution was cooled down and stirred at room temperature
overnight. The formed precipitate was filtered off and dried in vacuo. Additional material
can be obtained by reduction under strong vacuum of the solution to about half followed
by addition of diethylether (100 mL). Total yield: 4.12 g (0.016 mol; 80 %). Anal. for
C11H16N3O2Cl (257.72): calcd. C 51.27, H 6.26, N 16.30; found C 51.81, H 6.31, N 15.96.
1H NMR (400 MHz, DMSO-d6): δ = 1.80-1.90 (m, 2H, CH2), 2.36 and 2.70 (t, total 2H,
CH2CO,
3J= 7.20 and 3J= 7.28 Hz, ratio 1.2:0.9), 2.79-2.85 (m, 2H, CH2NH
+
3 Cl
−), 6.87-
6.99 (m, 2H, arom. CH ), 7.19-7.40 (m, 1H, arom. CH ), 7.46-7.69 (m, 1H, arom. CH ),
8.04 (br, 3H, NH+3 Cl
−), 8.28 and 8.42 (s, 1H total, CH=N, ratio 0.4:0.6), 10.16, 11.17,
11.29 and 12.02 (NH, OH, total 2H in ratio 0.4:0.6:0.4:0.6) ppm. 13C NMR (50 MHz,
DMSO-d6): δ = 21.8, 22.8 (all CH2), 29.0 and 30.6, (CH2CO), 38.2 (CH2NH
+
3 Cl
−),
116.1, 116.3, 118.6, 119.2, 120.0, 126.5, 130.6, 130.9, 131.1, 133.1 (all arom. CH and C ),
140.8, 146.5 (both CH=N), 156.4, 157.3, 158.6, 162.5, 167.6 (arom. C ), 172.9 (C=O)
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ppm. Selected IR data (cm−1): ν= 3461 (NH+3 Cl
−), 3169 (NH); 1689 (s; C=O), 1621
and 1606 (C=N).
Synthesis of N-salicylidene 6-amino-hexanoic acid hydrazide hydrochloride
(H2Salhyah×HCl)
To a solution of 6-amino hexanoic acid hydrazide hydrochloride (7.27 g, 0.04 mol) in
refluxing absolut ethanol (100 mL), salicylaldehyde (4.84 g, 0.04 mol, 4.15 mL) was added
dropwise. The resulting yellow solution was cooled down and stirred at room temperature
overnight. The formed precipitate was filtered off and dried in vacuo. Additional material
can be obtained by reduction under reduce pressure of the solution to about half of
its initial volume followed by addition of diethylether (100 mL). Total yield: 11.25 g
(0.04 mol; 97.5 %). Anal. for C13H19N3O2Cl (284.765): calcd. C 54.83, H 6.72, N 14.75;
found C 55.05, H 6.62, N 14.25. 1H NMR (200 MHz, DMSO-d6): δ = 1.31-1.41 (m,
2H, CH2), 1.50-1.61 (m, 4H, CH2), 2.35 and 2.57 (t, 2H, CH2CO,
3J= 7.22 Hz, ratio
1.2:0.8), 2.66-2.82 (m, 2H, CH2NH
+
3 Cl
−), 6.80-6.93 (m, 2H, arom. CH ), 7.17-7.29 (m,
1H, arom. CH ), 7.42-7.60 (m, 1H, arom. CH ), 7.94 (br, 3H, NH+3 Cl
−), 8.26 and 8.41 (s,
1H total, CH=N, ratio 0.3:0.6), 10.18, 11.22, 11.89 (NH, OH, total 2H a ratio 0.3:1.0:0.6)
ppm. 13C NMR (50 MHz, DMSO-d6): δ = 23.4, 24.3, 25.4, 25.5 26.6 (all CH2), 31.6,
33.6 (both CH2CO), 38.2 (CH2NH
+
3 Cl
−), 116.1, 116.2, 118.5, 119.1, 119.3, 120.0, 126.5,
129.2, 130.7, 131.0 (all arom. CH and C ), 140.7, 146.3 (both CH=N), 156.3, 157.2, 158.6,
168.2 (arom. C ), 173.6 (C=O) ppm. Selected IR data (cm−1): ν= 3461 (NH+3 Cl
−), 3169
(NH); 1689 (s; C=O), 1621 and 1606 (C=N).
4.6.3 Synthesis of cis-dioxovanadium(v) complexes
Synthesis of complex [VO2(Hsalhycab)]2 (13)
To a solution of Schiff base ligand-H2Salhyab×HCl (0.50 g, 1.94 mmol) in methanol
(25 mL) was added NH4VO3 (0.23 g, 1.96 mmol) when a brown colored mixture was
formed. The resulting mixture was refluxed for around 2 days when a clear solution
was obtained. The volume of the solution was concentrated to about half under reduce
pressure and left at room temperature when a yellow precipitate is formed overnight.
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The resulting precipitate was filtered off and the solution volume removed under reduce
pressure for additional material. Recrystallization of the yellow precipitate from methanol
afford suitable crystals for X-ray measurement. Yield: 0.60 g (1.05 mmol; 54 %).Anal.
for C22H24N6O6V2 (570.35): calcd. C 46.33, H 4.24, N 14.73; found C 45.57, H 3.81,
N 14.58. 1H NMR (400 MHz, DMSO-d6): δ = 2.17-2.21 (m, 2H, CH2), 2.63-2.82 (m,
2H, CH2C=N), 3.67-3.71 (m, 2H, CH2C-N-V), 6.81-6.83 (m, 2H, arom. CH ), 7.40-7.56
(m, 2H, arom. CH ), 8.64 (s, 1H, CH=N), 12.9 (br, 1H, NH ) ppm. 51V NMR (105
MHz, DMSO-d6): δ = -577.2 ppm (∆ν1/2 = 325 Hz). ESI-MS (positive mode): m/z =
286.2 [monomer + H+](45%), 308.2 286.2 [monomer + Na](100%), 553.3 [M - O2−](90%),
593.3 [M + Na](20%). Selected IR data (cm−1): ν= 3447 (br, NH), 1656 and 1610 (s,
-C=N-N=C-), 944 and 885 (s, VO2).
Synthesis of complex [VO2(Hsalhycab)] (14)
To a solution of Schiff base ligand-H2Salhyab×HCl (0.50 g, 1.94 mmol) in methanol
(25 mL) was added a slurry solution of NH4VO3 (0.23 g, 1.96 mmol) suspended in 10 mL
water. The resulting mixture turned brown colored and it was refluxed for around 2 days
under continuous stirring until the majority of the inorganic salt was reacted. The volume
of the solution was concentrated to about half under reduce pressure and left at room
temperature when a yellow precipitate is formed. The resulting precipitate was filtered
off and washed with at least 5 mL water, whereas the filtrate solution was kept in an open
flask at room temperature when yellow needles crystalize within less than a week. (Note:
Recrystallization of the yellow precipitate from methanol:water=1:1 mixture affords also
suitable crystals for X-ray measurement.) Yield: 0.47 g (1.64 mmol; 84.5 %).Anal. for
C11H12N3O3V (285.17): calcd. C 46.33, H 4.24, N 14.73; found C 46.14, H 4.15, N
14.57. 1H NMR (400 MHz, DMSO-d6): δ = 2.29 (t, 2H, CH2,
3J=6.8 Hz), 2.78-2.82 (m,
2H, CH2C=N), 3.66-3.69 (m, 2H, CH2C-N-V), 6.81-6.83 (m, 2H, arom. CH ), 7.37-7.55
(m, 2H, arom. CH ), 8.65 (s, 1H, CH=N), 12.9 (br, 1H, NH ) ppm. 13C NMR (50 MHz,
DMSO-d6): δ = 23.9 (CH2), 27.7 (CH2C=N), 57.3 (CH2N–V), 117.6, 118.7, 119.9, 130.1,
134.3 (all arom.CH and C ), 151.9 (C=N), 164.3 (arom.CO–V), 169.8 (C=N) ppm. 51V
NMR (105 MHz, DMSO-d6): δ = -577.4 ppm (∆ν1/2 = 365 Hz) and
51V NMR (105 MHz,
DMF-d7): δ = -574.1 ppm (∆ν1/2 = 450 Hz). ESI-MS (negative mode): m/z = 284.0 [M
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- H+](100%), 552.0 [2M−-O2−](20%), 591.1 [2M− + Na](5%). Selected IR data (cm−1):
ν= 3435 (br, NH), 1622 and 1613 (s, -C=N-N=C-), 936 and 902 (s, VO2). UV/Vis (DMF
solution, λmax in nm (ε in 10
3 M−1 cm−1)): 332 (5.8), 418 (7.4).
Synthesis of complex [VO2(salhyah)] (15)
To a solution of Schiff base ligand-H2Salhyah×HCl (1.00 g, 3.50 mmol) in methanol
(50 mL) was added NH4VO3 (0.41 g, 3.50 mmol). The resulting mixture was refluxed
for 3 hours when a yellow precipitate was formed. This precipitate was filtered off and
dried in vacuo. Additional material can be obtain by reduction of the solution volume
under reduce pressure to about half of the initial volume. There were totally obtained
0.85 g (2.56 mmol; 73 %). Anal. for C13H18N3O4V (331.24) (15a): calcd. C 47.14,
H 5.48, N 12.69; found C 47.06, H 5.25, N 12.35 and C13H19N3O4.5V (340.25) (15b):
calcd. C 45.89, H 5.63, N 12.34; found C 45.90, H 5.48, N 12.48. 1H NMR (400 MHz,
DMSO-d6): δ = 1.333-1.38 (m, 2H, CH2), 1.51-1.61 (m, 4H, CH2), 2.27 (t, 2H, CH2CO,
3J= 6.77 Hz), 2.77 (t, 2H, CH2NH
+
3 ,
3J= 7.13 Hz), 6.72-6.74 (m, 2H, arom. CH ), 7.27-
7.30 (m, 1H, arom. CH ), 7.45-7.47 (m, 1H, arom. CH ), 7.59 (br, 3H, NH+3 ), 8.72 (s,
1H, CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 25.1 (CH2), 25.5 (CH2), 26.6
(CH2), 31.5 (CH2CO), 38.7 (CH2NH
+
3 ), 116.6, 119.3, 119.7 (arom.CH and C ), 132.3,
132.8 (arom.CH), 154.2 (CH=N), 164.3 (arom.C –OV), 175.9 (C –OV) ppm. 51V NMR
(105 MHz, DMSO-d6): δ = -532.4 ppm (∆ν1/2 = 600 Hz). ESI-MS (negative mode): m/z
= 330.3 [M - H+](100%), 683.2 [2M + Na](20%). Selected IR data (cm−1): ν= 3435 (s,
NH+3 ), 1610 (br, -C=N-N=C-), 931 and 907 (s, VO2). UV/Vis (H2O solution, λmax in nm
(ε in 103 M−1 cm−1)): 214 (21.03), 282 (9.93), 370 (3.30) and UV/Vis (CH3OH solution,
λmax in nm (ε in 10
3 M−1 cm−1)): 235 (12.59), 278 (8.19), 288 (7.90), 315 (shoulder),
381 (2.66).
4.6.4 Synthesis of cis-dioxomolybdenum(vi) complexes
Synthesis of complex [MoO2(salhycab)(CH3OH)] (16)
To a solution of Schiff base ligand-H2Salhyab×HCl (0.80 g, 3.10 mmol) in methanol
(60 mL) was added NaOH (0.12 g, 3.10 mmol), followed by addition of MoO2(acac)2
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(1.00 g, 3.10 mmol). The resulting red solution was refluxed for one hour when under
continuous stirring. The volume of the solution was concentrated to about half under re-
duce pressure and left at room temperature when a orange-reddish precipitate is formed.
The resulting precipitate was filtered off and the filtrate kept in an open flask at room
temperature. After slow evaporation of the solvent suitable crystals for X-ray measure-
ment were isolated. Yield: 0.72 g (1.99 mmol; 64 %).Anal. for C12H15N3O4Mo (361.20):
calcd. C 39.90, H 4.19, N 11.63; found C 40.20, H 4.16, N 11.55. 1H NMR (400 MHz,
DMSO-d6): δ = 2.06-2.14 (m, 2H, CH2), 2.48-2.50 (m, CH2C=N, overlap with the sol-
vent signal), 3.15-3.16 (d, 3H, CH3OH,
2J= 5.16 Hz)), 3.82-3.86 (t, 2H, CH2C-N-Mo,
3J=6.86 Hz), 4.06-4.10 (quartet, 1H, CH3OH, J=5.25 Hz), 6.79-6.98 (m, 2H, arom. CH ),
7.36-7.40 (m, 1H, arom. CH ), 7.53-7.55 (m, 1H, arom. CH ), 8.47 (s, 1H, CH=N. 13C
NMR (100 MHz, DMSO-d6): δ = 25.4 (CH2), 26.3 (CH2C=N), 48.6 (CH3OH), 58.3
(CH2N–Mo), 118.1, 120.3, 120.8, 133.3, 133.6 (all arom.CH and C ), 151.5 (CH=N),
160.2 (arom.CO–Mo), 176.5 (C=N) ppm. Selected IR data (cm−1): ν= 3436 (br, OH
(MeOH)), 1606 (s, -C=N-N=C-), 930 and 909 (s, MoO2).
Synthesis of complex [MoO2(salhyah)(CH3OH)] (17)
To a solution of Schiff base ligand-H2Salhyah×HCl (0.40 g, 1.40 mmol) in methanol
(40 mL) was added one equivalent of NaOH (0.06 g, 1.40 mmol), followed by addition of
MoO2(acac)2 (0.45 g, 1.40 mmol). The resulting clear orange solution was refluxed for 4
hours under continuous stirring. The hot solution was cooled down at room temperature
and the solvent removed under strong vacuum. Initially an orange oil was formed which
was slowly solidified to a yellow-orange powder. Yield: 0.12 g (0.29 mmol; 20 %). 1H
NMR (400 MHz, DMSO-d6): δ = 1.30-1.37 (m, 2H, CH2), 1.51-1.63 (m, 4H, CH2), 2.35
(t, 2H, CH2CO,
3J= 7.60 Hz), 2.75 (t, 2H, CH2NH
+
3 ,
3J= 7.60 Hz), 3.15, 3.16 (d, 3H,
CH3OH,
2J= 5.20 Hz), 4.05-4.09 (quartet, 1H, CH3OH, J=5.60 Hz), 6.89-6.91 (m, 1H,
arom. CH ), 7.02-7.06 (m, 1H, arom. CH ), 7.47-7.51 (m, 1H, arom. CH ), 7.58 (br, 2H,
NH2) 7.65-7.67 (m, 1H, arom. CH ), 8.72 (s, 1H, CH=N) ppm.
13C NMR (100 MHz,
DMSO-d6): δ = 25.1 (CH2), 25.3 (CH2), 26.6 (CH2), 30.6 (CH2CO), 38.7 (CH2NH
+
3 ),
48.5 (CH3OH), 118.5, 120.0, 121.5 (arom.CH and C ), 134.1, 134.7 (arom.CH), 155.1
(CH=N), 159.3 (arom.C –OMo), 174.8 (C –OMo) ppm.
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4.6.5 Reactivity of the cis-dioxovanadium(v) complexes
Spectrophotometric titration of complex 14 with HClO4
1.05 mM stock solution of the vanadium complex was prepared by dissolving the complex
(VO2(Halhycab)(15.00 mg, 0.05 mmol) in DMF (50 mL). 200 µL were ulteriorly diluted
with 2.8 mL DMF in the cuvette and used for measurements. The HClO4 9.2 M solution
was diluted with DMF to a final concentration of 0.09 M and added in aliquots of 0.5
equivalents at 18 ◦C with continuous stirring. The spectra were collected from two to two
minutes using as reference DMF (3mL). UV/Vis in DMF of complex + 2 equiv. HClO4
(λmax in nm (ε in 10
3 M−1 cm−1)): 310 (8.5), 389 (5.0).
Spectrophotometric titration of complex 15 with HCl
1 mM stock solution of the vanadium complex was prepared by dissolving the complex
(VO2Salhyah)(33.0 mg, 0.1 mmol) in water (100 mL). 100 µL were ulteriorly diluted
with 2.1 mL water in the cuvette and used for measurements. The aliquots of HCl (as
is described in Protonation reaction section) were added from to 2 to 2 minutes under
continuous stirring at 18 ◦C. Fitting of the experimental data have been performed on the
titration with 5 and 10 equivalents of HCl, when the reaction was monitored by stepwise
addition of 0.25 equivalents acid. UV/Vis of the aqueous mixture of complex + 10 equiv.
HCl (λmax in nm (ε in 10
3 M−1 cm−1)): 212 (19.43), 287 (11.03), 370 (2.79).
Spectrophotometric titration of complex 15 with H2O2
1.2 mM stock solution of the vanadium complex was prepared by dissolving the complex
(VO2Salhyah)(10.0 mg, 0.03 mmol) in methanol (25 mL). 100 µL were ulteriorly diluted
with 2.9 mL methanol in the cuvette and used for measurements. The H2O2 30% solution
was diluted with methanol to a final concentration of 25 mM and added in aliquots of
0.5 equivalents at 20 ◦C with continuous stirring. The spectra were collected from 2 to
2 minutes using as reference a mixture of H2O (50µl) and methanol (3mL). UV/Vis in
CH3OH of complex + 10 equiv. H2O2 (λmax in nm (ε in 10
3 M−1 cm−1)): 278 (11.77),
288 (11.54), 315 (15), 392 (2.93).
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4.6.6 Catalytic oxidative bromination of TMB
TMB (25 mg, 0.15 mmol) was dissolved in 10 mL DMF. 10 mL of stock solution of
tetrabutylammonium bromide (48.3g/L) (1.5 mmol, 10 equiv.) was added, followed by
addition of 1 mL of cis-dioxovanadium(v) complex and/or cis-dioxomolybdenum complex
0.15 mol% in DMF (0.015 mmol), HClO4 (0.15 mmol) and H2O2 (0.15 mmol) in this
order. Aliquots of the reaction (250 µL) were quenched in 2 mL of NaOH 0.002 M
aqueous solution and extracted with 3 mL ethyl acetate. The reaction products were
identified by gas-chromatography using the following temperature programme: 80 ◦C to
240 ◦C with a heating rate of 15 ◦C per minute, followed by 5 minutes holding of 240 ◦C
temperature. The amount of formed Br-TMB was calculated by ratio with the unreacted
TMB.
4.6.7 Catalytic oxidation of methyl phenyl sulfide
Vanadium and molybdenum complexes (0.025 mmol) were dissolved at room temperature
in a mixture CH2Cl2/CH3OH 7:3 (25 mL) and phenyl methyl sulfide (0.29 ml, 2.5 mmol)
was added. The resulting solution was cooled down on an ice-bath and H2O2 26 % (1.2
equiv., 0.35 mL, 3 mmol) was added dropwise. The reaction solution was stirred at
room temperature in a capped flask and monitored by gas-chromatography technique.
After 16 and 18 hours, respectively the solvent was removed in vacuo and the products
were separated by column chromatography on silica gel using diethyl ether/pentane 9:1
mixture for the unreacted sulfide and ethyl acetate for the corresponding sulfoxide.
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Chapter 5
Vanadium(v) complexes based on
N-salicylidene hydrazides that
contain an guanidino-functionalized
aliphatic side-chain
The guanidine functionality has a special importance from a biological and pharmaco-
logical point of view. First is a specific component of arginine, a protein amino acid
hydrolyzed by arginase in the Krebs-Henseleit cycle and is responsible for detoxification
of ammonia formed during the nitrogen catabolism of amino acids in organism via the
formation of urea. An important role was also attributed to synthetic guanidino-amino
acids, such as 3-guanidinopropionic acid which was reported to posses antidiabetic activ-
ity. The compound induces weight loss selectively from adipose tissue in obese animals
with a non-insulin-dependent diabetes mellitus.210 Moreover, N’,N’-dimethylbiguanidine
hydrochloride known as metformin, is used worldwide as hypoglycemic drugs for dia-
betes type 2, disease caused by a defective insulin utilization.211,212 Vanadium com-
plexes are also known as insulin-enhancing compounds.9,213 In this direction a possible
synergistic effect of vanadium complexes with metformin ligand has been studied. Al-
though coordination of vanadium did not increase the effect of the biguanidine ligand
by associative effects, the reported vanadium(iv)-metformin complex lowered the blood
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glucose level similarly with previous reported bis(maltolato)-oxovanadium(iv) complex
BMOV.214 Here it is worth to mention that the BMOV complex is known as the most
potent insulin-enhancing vanadium compound.215
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Figure 88: Vanadium complexes with insulin-like mimetic properties.
In addition, arginine is an important component of several enzymes, among these
vanadium-containing haloperoxidases38,70,128 and phosphatases.66,97,216,217 In vanadium
chloroperoxidase enzyme, two arginine residues are part of the active binding site6 and
they play an important role in catalytic reactions. The first one, Arg360 is hydrogen
bonded to one of the equatorial oxygen atoms of the vanadate moiety and is supposed
to compensate the negative charge of the vanadium atom through its protonated guani-
dinium site.38 Mutagenesis studies performed on vanadium chloroperoxidase, by replace-
ment of Arg360 with alanine, yielded a drastic decrease of the catalytic oxidation reaction
of chloride to only 6%. Crystal structure determination of this active mutant showed a
loss of hydrogen bonding rigidity around the prosthetic group which can be responsible
for the loss of activity.63,180 A vital role for the catalyzed oxidation reaction of chloride
has been found for the second arginine residue, namely Arg490, which forms a salt bridge
with an aspartate residue. The role of the aspartate residue is to maintain the argi-
nine amino acid in a favorable conformation to be in hydrogen bonding interaction with
the equatorial oxygen atoms of the vanadate group.63 Alanine mutant, R490A showed
no chloroperoxidase activity but still the mutant functioned as bromoperoxidase, able
to catalyze the less electronegative bromide by hydrogen peroxide. To probe the role
of the arginine residues in the reactivity of the prosthetic group, cis-dioxovanadium(v)
complexes based on guanidino functionalized N-salicylidene hydrazide have also been iso-
lated. Having into attention that a short aliphatic side-chain might increase the reactivity
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of the vanadium complexes towards catalytic bromide oxidation by hydrogen peroxide,
the synthesis of N-salicylidene guanidino acetic acid hydrazide has been performed. Al-
ternatively, a direct guanilation reaction performed on a coordination compound, namely
complex 15, yielded the corresponding cis-dioxovanadium(v) complex which contains a
6-guanidino aliphatic side chain.
5.1 cis-Dioxovanadium(v) complex based on N-sa-
licylidene guanidino acetic acid hydrazide hydro-
chloride ligand
The synthesis of the title ligand system follows the pathway described for the corre-
sponding amino-functionalized N-salicylidene hydrazides depicted in Chapter 4, Figure
64. Starting from commercially available guanidino-acetic acid hydrochloride via in-
tramolecular nucleophilic substitution, the corresponding guanidino-acetic methyl ester
hydrochloride was isolated. This ester reacts stoichiometrically with hydrazine hydrate
to form the corresponding 2-guanidino acetic acid hydrazide hydrochloride. The latter
compound undergoes Schiff base condensation of the hydrazide site when reacted with
salicylaldehyde, yielding the desired N-salicylidene guanidino acetic hydrazide as hy-
drochloride salt. Stoichiometric reaction of this new Schiff base ligand with ammonium
metavanadate in refluxing methanol, yields the anionic cis-dioxovanadium(v) complex
[VO2(salhyga)] (18). The compensation of the negative charge of the vanadate center is
done by the positively charged guanidine functionality. This is a similar situation to one
found in the cis-dioxovanadium(v) complex which contains an amino-functionalized side
chain. Crystallization of 18 from a methanol-water mixture (1:1) afforded within less
than a week suitable crystals for X-ray measurement. The molecular structure determi-
nation and numbering scheme for complex 18 is depicted in Figure 89.
The complex crystallize in the orthorhombic space group P212121 with a five coordi-
nated vanadium center in a distorted square pyramidal geometry. The angular parameter,
τ , has a value of 0.41 which makes the distortion to an ideal square pyramid larger and
place the complex close to the edge for a trigonal bipyramidal geometry. Similar geometry
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has been reported for a cis-dioxovanadium(v) complex derived from 2-acetyl-pyridyl-S-
benzylidene-thiohydrazides, where a VN2SO3 moiety was formed.
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The tridentate chelate ligand coordinates in the typical dianionic form providing
an ONO donor set, while the coordination sphere of the vanadium atom is completed by
two oxo-groups almost symmetrical and in cisoid positions with the V=O bond length
of around 163 pm. The vanadium to phenolate oxygen atom bond distance (V–O3),
as well as the V–N1 bond length are similar with corresponding distances in previous
described anionic cis-dioxovanadium(v) complexes with N-salicylidene hydrazide ligands.
Instead the vanadium to iminole oxygen atom bond length (V–O4) is longer compared to
previous described cis-dioxovanadium(v) to around 199.4 pm. The lengthening of this
bond distance with about 4 pm is a consequence of a more conjugated system existent
in complex 18. Selected bond lengths and angles in complex 18 are given in Table 14.
The enolization of the amide functionality is in agreement with observed 130 pm bond
length for C8–O4 and further confirmed by partial double bond character of the C8–N2
bond of 129 pm.
Figure 89: Molecular structure and numbering scheme of the complex
[VO2(salhyga)]·3H2O (18); displacement ellipsoids are drawn at 50% probability
level).
Complex 18 crystalizes with three water molecules which form an extensive hy-
drogen bonding interaction with the double bonded oxygen atoms and guanidine group.
170
Figure 90: Schematic representation of hydrogen bonding interaction in complex
[VO2(sahyga)]·3H2O (18) (broken lines represent hydrogen bonds); relevant distances
(in pm): O1· · ·O1WA 279.7, O1· · ·O2WB 278.0, O2WB· · ·O3W 275.7, O2· · ·O1W
278.3, O1W· · ·N5D 293.4, O2W· · ·N4 288.9, O1E· · ·O2W 278.0, O3WF· · ·O2W 275.7,
N5· · ·O1WC 293.4 (symmetry transformations: A : x-1, y, z; B: -x+2, 0.5+y, -0.5-z; C:
x-0.5, -y-0.5, -z-1; D: 0.5+x, -0.5-y, -1-z; E: -x+2, y-0.5, -z-0.5, F: 1.5-x, -y, 0.5+z).
Both oxo groups are involved in intermolecular hydrogen bonding interactions with two
different water of crystallization with the shortest bond length of 278 pm and the longest
hydrogen bond distance of 279.7 pm (Figure 90). The observed strong hydrogen bonding
interaction forms a two dimensional polymer along the [010] axis (Figure 91). The water
molecules establish the intermolecular connection between the cis-dioxovanadate moi-
eties through direct hydrogen bonding interaction with the doubly bonded oxygen atoms
on one hand, and further by bifurcated hydrogen bonding interaction with guanidine
functionality (OW· · ·N4 288.9 and OW· · ·N5 293.4 pm) and interstitial water molecules
(OWB· · ·OW 275.7 pm) (Figure 90).
171
Figure 91: Representation of the hydrogen bonding network in crystals of complex
[VO2(sahyga)]·3H2O (18) (view along the [010] direction; broken lines represent hydrogen
bonding interactions).
Figure 92: Representation of the hydrogen bonding network in crystals of complex
[VO2(sahyga)]·3H2O (18) as viewed along the [100] direction; broken lines represent
hydrogen bonding interactions.
In the native form of vanadium-chloroperoxidase, interstitial water molecules were
found near the Ser402 residue as well as in the vicinity of the apical oxygen atom of the
vanadate moiety. The last mentioned solvent molecules form a long hydrogen bonded wa-
ter channel. Thus, complex 18 presents a similar hydrogen bonding network established
between water molecules, and additionally it contains a relevant side chain substitution
which is also part of the hydrogen bonding network (Figure 92).
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5.1.1 Spectroscopic studies
The determined crystal structure is also confirmed by spectroscopic characterization
of the cis-dioxovanadium(v) complex, both in solid state as well as in solution. 51V
NMR spectra recorded in DMSO-d6 solution presents the resonance peak at -534 ppm
(∆ν=940 Hz) indicative of cis-VO+2 formation. The
1H NMR spectra of the free N-
salicylidene 2-guanidine acetic acid hydrazide hydrochloride exhibits, as in all other pre-
vious cases, double sets of resonances at 8.32 and 8.48 ppm, respectively, associated to
the azomethine protons due to the E-Z isomers in a ratio of 2.1:1. Furthermore, the
methylene protons present also two sets of resonances in a shape of two dublets at 4.01-
4.02 and 4.34-4.35 ppm due to the same isomerism effect manifested by the amide bound.
The coordination of the vanadium atom is reflected in the down field shifts of the imine
protons at 8.80 ppm as a single resonance; whereas the influence of the vanadate coordi-
nation to the CH2 resonances is less drastic. A single multiplet centered at 4.05 ppm is
observed in the 1H NMR spectrum of the complex consistent with the existence of one
conformer of the amide functionality. However, the most indicative NMR isotope for a
better differentiation between the free ligand and the coordinated one, is given by 13C
NMR spectra. The most affected resonances are again corresponding to imine group.
A deshielding effect of 14 ppm was observed in the 13C NMR spectra of the complex,
whereas the phenol carbon atom and the iminol one are also shifted to around 164 ppm
and 170 ppm comparing to around 157 and 168 ppm resonances in the free ligand. All the
other carbon atoms are resonating in the expected region with insignificant differences.
The IR spectra of the complex, performed as KBr pellets, present the specific ν(VO+2 )
stretching vibrations at 910 and 921 cm−1 in accordance with precedent described char-
acteristic IR vibrations. Additionally, the IR spectrum of both, the free ligand and the
vanadium complex, presents rather broad bands at 3405-3390 and 3390-3211 cm−1 at-
tributed to the N–H stretching mode of the guanidine functionality. The IR spectra of
the complex exhibits also the characteristic vibration corresponding to C=NH bands of
the guanidine group, detected at 1668 and 1659 cm−1, almost equal in intensity. The
characteristic stretching vibration of the -CH=N–N=C- group, due to the enolization of
the amide functionality on vanadium coordination is also seen at 1612 cm−1 as a sharp
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and strong band. Additionally, the IR spectra of the complex exhibits a broad band at
3524 cm−1 due to the presence of water of crystallization. Selected IR data for both the
free ligand and the cis-dioxovanadium(v) complex 18 are presented in the experimental
part of the chapter. Thermogravimetric measurement, performed on the elementary ana-
lyzed complex [VO2(salhyag)]·H2O, shows a 5.6% loss in weight in the temperature range
232-263 ◦C with no loss of weight up to this temperature. This loss corresponds to a
calculated mass of 18.77 g which is around the molecular weight of a water molecule. This
observation can be interpreted as a strong bonded water molecule which is present in the
solid state form of complex 18 and it is based on the higher temperature required to loose
its corresponding weight. Further heating up to 350 ◦C cause a loss of 9.13% correspond-
ing to a calculated mass of 30.6 g. This last loss might be generated by decomposition
of the guanidine functionality to the corresponding amino group.
5.2 cis-Dioxovanadium(v) complex based on N-sa-
licylidene 6-guanidino hexanoic acid hydrazide
Stoichiometric reaction of cis-dioxovanadium(v) complex 15, with 1-guanyl-3,5-dimethyl
pyrazole nitrate in refluxing ethanol yields the corresponding guanidino-functionalized
vanadium complex. The reaction takes place by direct guanilation of the amino func-
tionality using a very reactive agents, such as guanyl-3,5-dimethylpyrazole. The actual
reaction requires the formation of the free-base guanyl-3,5-dimethylpyrazole, by reaction
of the corresponding nitrate compound with NaOH, followed by extraction with ethyl
acetate. The guanilation reaction of the coordination compound 15 takes place under
reflux and basic conditions.218 The reaction leads to a yellow precipitate which represents
the guanidine functionalized cis-dioxovanadium(v) complex, whereas the resulting pyra-
zole remains in solution. Attempts to use cyanamide as guanilation agent failed, while
the S-methyl-isothiourea sulfate gave unsatisfactory results.
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Recrystallization of the obtained cis-dioxovanadium(v) complex 19 from a mixture
methanol-water yields yellow needle-shape crystals suitable for X-ray measurement. The
molecular structure of complex 19 together with numbering scheme is depicted in Figure
93. The complex crystalizes in the monoclinic space group I2/a with the vanadium atom
in a distorted square pyramidal geometry. The aromatic system and the hydrazide group
lie in the one plane, whereas the vanadium atom is displaced out of this plane by 25 pm
towards the apical oxygen atom. The distortion to an ideal square-pyramidal geometry
is very small with a calculated τ value of 0.04. The Schiff base ligand maintains the
coordination mode found in complex 15. The vanadium to oxygen atom bond lengths
and vanadium to nitrogen distance are also very similar with the corresponding distances
found in the starting complex 15. Selected bond lengths and angles in complex 19 are
given in Table 14. The bond lengths N2–C8 and O4–C8 of the coordinated ligand system
are consistent with the enolate form of the amide functionality and in good agreement
with the bond distances found for the amino-substituted analog.
Due to the enolization of the ligand system, the resulting complex 19 has also
an anionic character. Similarly to complex 18 the guanidine group is also protonated,
compensating the negative charge of the cis-dioxovanadate moiety. Therefore, complex
19 retains very closely the characteristics of the starting compound 15.
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Figure 93: Molecular structure of [VO2(salhygh)] complex 19; displacement ellipsoids are
drawn at the 50% probability level.
Nevertheless, a slight different orientation of the guanidine substituted aliphatic
side chain has been observed in complex 19 by comparison to the corresponding amino-
substituted chain in complex 15. This is illustrated by the torsion angle C8–C9–C10–
C11 which has a value of 173◦ in complex 19 with the alkyl side chain orientated on
the same side with the vanadate center; whereas in complex 15 the amino-substituted
side chain is orientated on opposite direction with the torsion angle of 176◦. This is
also obvious by the overlay of the two molecular structures of complexes 15 and 19
(Figure 94) when a different orientation of the alkyl side chain of the ligand systems
was observed. The overlay of the two molecular structures was done by method of least
square refinement fitting the covalent parts of the two vanadium complexes, except the
functionalized alkyl side-chain. This observation indicates the importance of the hydrogen
bonding interactions patterns on the actual molecular structure.
However, complex 19 represents the first example of a coordination compound
obtained via direct guanilation of another coordination compound. Therefore, it has been
proved that functionalization of the aliphatic side chain in the N-salicylidene hydrazides
is possible even, when a cis-dioxovanadium(v) complex is used as starting reagent.
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Figure 94: Overlay of the molecular structures of complex 19 (thick lines) and complex 15
(atom numbering extension A, broken lines) obtained by least-square refinement method
on the coordinates of the atoms without the alkyl side-chains.
A very important role in native haloperoxidase enzymes is played by the arginine
residues which compensate the negative charge on the vanadate moiety and is able to
stabilize the prosthetic group by electrostatic interaction through hydrogen bonding inter-
action with the equatorial oxygen atoms. A similar situation has been found in complex
19 where the guanidine functionality of the aliphatic side-chain besides that compen-
sates the negative charge of the cis-dioxovanadate center, it is also establishing hydrogen
bonding interaction with the two oxo groups. The involvement of both oxo groups in
hydrogen bonding interaction proved to be a general feature for the described anionic
cis-dioxovanadium(v) complexes with N-salicylidene hydrazide ligands. In the case of
complex 19, the guanidine functionality establishes the hydrogen bonding contacts with
the double bonded oxygen atoms. First, the equatorial oxo group O2 is in hydrogen
bonding interaction with the acidic guanidine nitrogen atoms of similar chemical struc-
ture from two neighboring molecules (O2· · ·N5B 299.9 and O2· · ·N5C 282.6 pm). The
apical double bonded oxygen atom O1 is hydrogen bonded to the other acidic guanidine
nitrogen atom (O1· · ·N4A 285.6 ppm) which is further in hydrogen bonding contact with
the hydrazide nitrogen atom N2 from another molecule (N4B· · ·N2 299.4 ppm) (Figure
95).
177
Figure 95: Schematic representation of hydrogen bonding interaction in complex
[VO2(sahygh)] (19) (broken lines represent hydrogen bonds); relevant distances (in pm):
O1· · ·N4A 285.6, O2· · ·N5B 299.9, O2· · ·N5C 282.6, N4A· · ·N2D 299.4 (symmetry trans-
formations: A : x, -y-1.5, z+0.5; B: x-0.5, y-0.5, z+0.5; C: -x-1, -y-1, -z-1; D: -x-1, -y-1.5,
-z-1; E: -x-1, y-0.5, -z-1.5, F: x, -y-1.5, z-1.5, G: -x-1, y+0.5, -z-1.5, H: x+0.5, y-0.5,
z-1.5).
Table 14. Selected bond lengths (pm) and angles (◦) for complexes 18 and 19.
18 19 18 19
V−O1 163.2(2) 162.1(2) V−N1 212.8(2) 214.4(2)
V−O2 162.94(19) 164.05(19) C8−O4 130.1(3) 129.4(3)
V−O3 188.34(19) 190.00(19) C8−N2 129.4(3) 130.7(4)
V−O4 199.39(17) 195.14(19) N1−N2 1.407(3) 140.0(3)
O1−V−O2 108.86(10) 107.27(11) O2−V−O3 97.86(12) 95.45(9)
O1−V−O3 101.47(12) 105.46(10) O2−V−O4 92.84(12) 92.39(9)
O1−V−O4 95.83(12) 104.46(10) O2−V−N1 130.75(11) 147.69(10)
O1−V−N1 119.42(11) 104.37(10) O3−V−N1 82.30(8) 82.16(8)
O3−V−O4 155.43(8) 145.14(9) O4−V−N1 74.00(7) 73.41(8)
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5.2.1 Spectroscopic studies
The formation of complex 19 was also confirmed by spectroscopic characterization. Com-
parison of the 1H and 13C NMR patterns between the starting complex 15 and complex
19 confirmed the guanilation of the aliphatic side-chain. Specific guanidine resonances
have been observed in both 1H and 13C NMR spectra, whereas the other groups resonate
in similar positions with insignificant differences comparing with their resonances in com-
plex 15. The existence of the intact cis-dioxovanadate center is further established by
51V NMR spectra which present a single resonance at -534 ppm (∆ν1/2 = 620 Hz) in
deuterated DMSO solution, a resonance specific for VO2ONO entity. Furthermore, com-
parison of IR patterns of the two complexes sustains the proposed structure. Besides the
specific IR frequencies characteristic for a cis-dioxovanadium moiety which appears at
937 and 893 cm−1, there are also specific stretching vibrations of the guanidinium group.
This vibrates at 3333 cm−1 as a broad and irregular band, due to their involvement in
hydrogen bonding interaction. The C=NH vibration was also detected at 1664 cm−1, as
a strong band.
5.3 Oxidative bromination of 1,3,5-trimethoxybenzene
The capacity of the cis-dioxovanadium(v) complexes based on guanidine-functionalized
N-salicylidene hydrazide system to catalyze the oxidation of bromide by H2O2 has been
performed following the previuos established catalytic system. The monitoring of the
reaction was achieved by GC analysis of the ethyl acetate extracts which contain only
TMB and bromo-TMB compounds. The results of the catalytic reaction are summarized
in Table 15. From the entries, it is clear that the cis-dioxovanadium(v) complex based on
N-salicylidene 2-guanidino acetic acid hydrazide [VO2(salhyga)]·H2O, is the most potent
catalyst for the oxidative bromination reaction. The complex catalyze the oxidation of
bromide by H2O2 with a turnover rate of 75 mol product×(mol catalyst×h)−1 when
HClO4 is added in stoichiometric amounts. This catalytic activity is net superior not
only compared to similar complex 19, but is also more efficient compared to all previous
described cis-dioxovanadium(v) catalysts based on N-salicylidene hydrazides.
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Table 15. Catalytic oxidation experiments using anionic cis-dioxovanadium(v)
complexes-18 and 19 as catalysts. The results are given in % Br-TMB obtained and
as µmol Br-TMB within parenthesis.
Complex 2 min. 5 min. 10 min. TON
1. [VO2(salhyga)] (18) 25.0(37.5) 62.0(93.0) 75.4(113.1) 75
2. [VO2(salhygh)] (19) 15.5(23.3) 51.7(77.5) 67.1(100.6) 63
Note: The turnover number was calculated, as in all other cases, for 5 minutes reaction
time.
The increase of the catalytic activity of complex 18 is indicative of an increased
reactivity of the vanadate center. The Schiff base ligand behaves as a conjugated sys-
tem with a high electron delocalization which will increase the reactivity on the metal
center. The guanidine part of the ligand system presents strong electron withdrawing
effect responsible for the electronic density decrease on the vanadate site and therefore,
an increased reactivity of cis-dioxovanadium complex 18. Nevertheless, it seems that
the guanidine substitution of the aliphatic side chain has in general, a potent effect
on the activation of vanadate moiety. The catalytic reaction proceed very fast in the
first 5 minutes compared with previous described catalysts. The increased basicity of
the guanidine functionality might enable the increased Lewis acid properties of the cis-
dioxovanadium(v) center. This observation is in agreement with the observed important
role of the hydrogen bonding interaction of the prosthetic group with the nearby arginine
residues in vanadium chloroperoxidase enzyme.
5.4 Oxidation of sulfides catalyzed by cis-dioxovana-
dium(v) complexes based on guanidine functio-
nalized N-salicylidene hydrazides
The new cis-dioxovanadium(v) with N-salicylidene hydrazide that contain a guanidino-
functionalized side chain to function as catalyst for the oxidation of methyl phenyl sulfide
when hydrogen peroxide is used as oxidant was also investigated. Following the typical
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procedure described in Chapter 3, 1 mol-% catalyst have been used for the reaction
with a slight excess (1.2 equivalents) of hydrogen peroxide, in a mixture CH2Cl2/CH3OH
7:3. The reaction was monitored qualitatively using thin layer chromatography technique
comparing the Rf values of the reaction mixture with standard solution of phenyl methyl
sulfide and its sulfoxide. After 18 hours of reaction when the amount of sulfide decreased
apparently, the reaction was assayed by GC determination. Comparison between areas
of the two organic products yielded 85% sulfoxide when complex 18 was used as catalyst,
whereas 82% conversion was established by the catalyst 19. This results are similar with
previous found catalytic activity of complex 15 and also similar with reported capacity
of vanadium complexes to catalyze the sulfur oxidation reaction.189–192 Therefore it can
be concluded that cis-dioxovanadium(v) complexes with intact N-salicylidene hydrazide
ligand catalyze the oxidation of organic sulfide following a common reaction pathway.
5.5 Conclusions
cis-Dioxovanadium(v) complexes with a O4N-coordination environment have been syn-
thesized and characterized. These complexes contain a guanidine functionalized aliphatic
side chain and therefore, they can model the hydrogen bonding interaction of the pros-
thetic group of the native enzymes with the arginine residues. A different reactivity of
these complexes towards catalytic bromide oxidation has been observed as a consequence
of a different aliphatic chain length. Using N-salicylidene acetic acid hydrazide hydrochlo-
ride as ligand system, the resulting anionic cis-dioxovanadium(v) complex proved to
function as the most potent catalyst of the enzymatic reaction. The increased reactivity
of complex 18 might be a consequence of the electron delocalization found in the ligand
system. Furthermore, the first example of a direct guanilation reaction of a coordina-
tion compound has been also described. Starting from the anionic cis-dioxovanadium(v)
complex that contains an amino-functionalized side-chain, via reaction with 1-guanyl-
3,5-dimethylpyrazole in basic medium, the corresponding guanidino-functionalized diox-
ovanadium(v) complex was obtained. The latter vanadium complex is also able to cat-
alyze efficiently the oxidative bromination of 1,3,5-trimethoxybenzene. Moreover, both
cis-dioxovanadium(v) complexes described herein catalyze the sulfoxidation reaction sim-
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ilarly with the corresponding vanadium complex which contains an amino-functionalized
aliphatic side chain.
5.6 Experimental Section
Materials: Methanol was dried using sodium/bezophenone system. All other reagents
were used as received, without further purification. Abbreviations used throughout the
text: H2salhyga = 2-guanidino acetic acid (2-hydroxy-benzylidene) hydrazide hydrochlo-
ride, salhygh = 6-guanidino hexanoic acid (2-hydroxy-benzylidene) hydrazide.
Synthesis of 2-guanidino-acetic acid methyl ester hydrochloride
A mixture of guanidino-acetic acid (4.03 g, 34.4 mmol) and SOCl2 (50 mL) was stirred
at room temperature for around 24 hours. The resulting solution was cooled down at -70
◦C and dried methanol (150 mL) was added dropwise with a permanent control of tem-
perature. After the addition of methanol was finished the resulting solution was stirred
for an additional 15 minutes at -70 ◦C and then warmed slowly at room temperature.
The volume of the solution was reduced under vacuum to around 1/4 and diethylether
(150 mL) added for precipitation of the ester. A colorless solid is formed which is washed
with diethylether and dried under strong vacuum. Yield: 1.30 g (7.75 mol; 22.5 %). 1H
NMR (200 MHz, DMSO-d6): δ = 3.65 (s, 3H, CH3), 4.06-4.09 (m, 2H, CH2), 7.54 (br,
2H, NH2), 7.86 (t, 1H, NH×HCl), 8.95 (br, 2H, NH ) ppm. 13C NMR (50 MHz, DMSO-
d6): δ = 42.5 (CH2), 48.3 (CH3 (MeOH)), 52.2 (CH3), 157.9, 158.9 (both CH-N), 169.4
(C=NH×HCl), 172.7 (C=O).
Synthesis of 2-guanidino acetic acid hydrazide hydrochloride
To a solution of methyl 2-guanidino-acetic ester hydrochloride (1.20 g, 7.16 mmol) in
absolut ethanol (40 mL), hydrazine hydroxide 100 % (0.39 g, 0.37 mL, 7.79 mmol) was
added, followed by addition of other 10 mL ethanol. The resulting solution was refluxed
with stirring for 24 hours. After cooling at room temperature, the solvent was removed
under reduce pressure when an oily compound is formed. After extraction two times with
hot absolut ethanol (10 mL) a colorless solid is formed. Yield: 1.20 g (6.70 mol; 94 %).
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1H NMR (400 MHz, DMSO-d6): δ = 1.01 (t, 3H, CH3 (EtOH)), 3.39 (q, H2 (EtOH)),
3.40-4.20 (m, 4H, CH2 and NH2), 7.34 (br, 3H, NH2 and NH×HCl), 7.74 (b, 1H, NH )
ppm. 13C NMR (100 MHz, DMSO-d6): δ = 18.5 (CH3 (EtOH)), 42.4 and 49.1 (CH2),
56.0 (CH2 (EtOH)), 157.4, 157.7 (both CH-N), 169.7 (C=O). MS (EI in MeOH): m/z
= 130 [M - H+ - HCl](100%), 99 [(NH=C-NH (NH2)-CH2CO)]
2−(20%), 37 [HCl] (80%).
Synthesis of N-salicylidene 2-guanidino-acetic acid hydrazide hy-
drochloride (H2salhyga×HCl)
To a solution of 2-guanidino acetic acid hydrazide hydrochloride (1.10 g, 6.56 mol) in
refluxing absolut ethanol (50 mL), salicylaldehyde (0.80 g, 6.56 mol, 0.70 mL) was added
dropwise. The resulting yellow solution was refluxed overnight. After cooling down at
room temperature a colorless solid precipitates. The solid was filtered off while the solvent
of the filtrate removed under reduce pressure. Yield: 0.85 g (3.00 mol; 45 %). Anal. for
C10H13N5O2Cl×H2O (289.72): calcd. C 41.46, H 5.57, N 24.17; found C 41.40, H 5.64, N
23.76. 1H NMR (400 MHz, DMSO-d6): δ = 3.33 (H2O), 4.01-4.04 and 4.34-4.35 (d, total
2H, CH2), 6.82-6.94 (m, 2H, arom. CH ), 7.20-7.29 (m, total 2H, arom. CH (1H) and NH
guanidine (1H)), 7.40 (br, 2H, NH2), 7.50-7.52 (2H, CH=NH guanidine), 7.73-7.75 (m,
1H, arom. CH ), 8.32 and 8.48 (s, total 1H, CH=N, ratio 1:0.5), 10.12, 10.99, 11.62 and
12.17 (NH, OH, total 2H in ratio 1.0:0.5:1.0:0.5) ppm. 13C NMR (50 MHz, DMSO-d6):
δ = 42.4, 42.6 (both for CH2CO), 116.1, 116.3, 118.6, 119.2, 119.9, 126.2, 128.9, 131.1,
131.3 (all arom. CH and C ), 141.3, 147.0 (both CH=N), 156.4, 157.2, 157.5, 157.7,
(arom. C -OH), 163.9 (guanidine C=NH), 168.5 (C=O) ppm. Selected IR data (cm−1):
ν= 3587 (H2O), 3404 (NH2 guanidine), 3330 (br, NH guanidine), 3178 (br, NH), 1663 (s,
C=O), 1640 (s, HC=N, guanidine), 1616 (-CH=N). ESI-MS (positive mode in MeOH):
m/z = 236.1 [M + H+ - HCl] (100%), 258.0 [M + Na - HCl] (10%). ESI-MS (negative
mode in MeOH): m/z = 236.2 [M + H+ - HCl] (90%), 293.0 [M + Na - H+] (100%).
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Synthesis of cis-dioxovanadium(v) complex [VO2(salhyga)]·H2O
(18)
To a solution of Schiff base ligand-H2Salhyga×HCl (0.5 g, 1.84 mmol) in methanol (50
mL) was added NH4VO3 (0.22 g, 1.84 mmol) when a brown colored mixture was formed.
The resulting mixture was refluxed for around 4 hours when a yellow precipitate was
formed. The volume of the filtrate solution was concentrated to about half under re-
duce pressure and left at room temperature when aditional yellow precipitate is formed
overnight. Recrystallization of the yellow precipitate from methanol:water mixture af-
forded suitable crystals for X-ray measurement. Yield: 0.32 g (0.95 mmol; 52 %).Anal.
for C10H14N5O5V (335.19): calcd. C 35.83, H 4.21, N 20.89; found C 35.89, H 4.35,
N 20.43. 1H NMR (400 MHz, DMSO-d6): δ = 3.36 (br, H2O), 4.08-4.09 (m, 2H, CH2),
6.75-6.76 (m, 2H, arom. CH ), 7.18 (br, NH2), 7.32 (t, 2H, NH
+
2 ), 7.51-7.53 (m, 2H, arom.
CH ), 7.59 (br, 1H, NH ), 8.80 (s, 1H, CH=N) ppm. 13C NMR (50 MHz, DMSO-d6): δ
= 41.7 (CH2), 116.8, 119.5, 132.7, 133.4 (all arom. CH and C ), 156.1 (C=NH
+
2 ), 157.0
(CH=N), 164.5, (arom. C –OV), 170.7 (C –OV) ppm. 51V NMR (105 MHz, DMSO-d6):
δ = -534.3 ppm (∆ν1/2 = 940 Hz). Selected IR data (cm
−1): ν= 3525 (br, H2O), 3390
(br, NH2 guanidine), 3281 (br, NH guanidine), 1668, 1659 (s, -CH=N guanidine), 1612
(s, -CH=N–N=C-), 910 and 921 (s, VO2). ESI-MS (negative mode in MeOH): m/z =
316.0 [M + H+] (100%), 633.0 [2M - H+] (70%).
Synthesis of complex [VO2(salhygh)] (19)
To 100 mL NaOH 1M aqueous solution was added 1-guanyl-3,5-dimethylpyrazole nitrate
(4.90 g, 24.40 mmol). The resulting clear solution was stirred at room temperature for 15
minutes and the formed free base extracted three times with ethyl acetate (100 mL). The
organic extracts were dried over Na2SO4 and the solvent removed under reduced pressure.
The resulting residue was redissolved in H2O (20 mL) and complex 15 (1.65 g, 5.00 mmol)
was added followed by 150 mL ethanol and triethylamine (1.40 mL, 9.80 mmol). The clear
solution was refluxed under stirring for 4 hours, when a yellow precipitate was formed.
This precipitate was filtered off and dried in vacuo. Yield: 1.43 g (3.83 mmol; 77.5 %).
Anal. for C14H20N5O4V (373.28): calcd. C 45.05, H 5.40, N 18.76; found C 44.99, H
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5.42, N 18.62. 1H NMR (400 MHz, DMSO-d6): δ = 1.30-1.33 (m, 2H, CH2), 1.47-1.50
(m, 2H, CH2), 1.57-1.61 (m, 2H, CH2), 2.27 (t, 2H, CH2CO,
3J= 6.77 Hz), 3.07-3.11 (m,
2H, CH2NH), 6.72-6.74 (m, 2H, arom. CH ), 6.91 (br, 5H, NH and NH2), 6.27-7.29 (m,
1H, arom. CH ), 7.46-7.48 (m, 1H, arom. CH ), 8.74 (s, 1H, CH=N) ppm. 13C NMR (50
MHz, DMSO-d6): δ = 25.3 (CH2), 25.6 (CH2), 27.9 (CH2), 26.6 (CH2), 31.6 (CH2CO),
38.2 (CH2-guanidine), 116.5, 119.1, 119.7 (arom.CH and C ), 132.2, 132.7 (arom.CH),
154.2 (C=NH+2 ), 156.5 (CH=N), 164.2 (arom.C –OV), 175.9 (C –OV) ppm.
51V NMR
(105 MHz, DMSO-d6): δ = -533.8 ppm (∆ν1/2 = 620 Hz). ESI-MS (positive mode in
MeOH): m/z = 355.8 [15 + Na] (35%), 395.8 [M + Na] (100%), 729.1 (20%), 768.8 [2M +
Na] (80%). Selected IR data (cm−1): ν= 3334 (s, NH+2 ), 3164 (br, NH), 1664 (s, C=NH
guanidine), 1613 (s, -CH=N-N=C-), 937 and 893 (s, VO2).
Catalytic oxidative bromination of TMB
TMB (25mg, 0.15 mmol) was dissolved in 10 mL DMF. 10 mL of stock solution of
tetrabutylammonium bromide (48.3g/L) (1.5 mmol, 10 equiv.) was added, followed by
addition of 1 mL of cis-dioxovandium(v) complex 0.15 mol% in DMF (0.015 mmol),
HClO4 (0.15 mmol) and H2O2 (0.15 mmol) in this order. Aliquots of the reaction (250 µL)
were quenched in 2 mL of NaOH 2 mM aqueous solution and extracted with 3 mL ethyl
acetate. The reaction products were identified by gas-chromatography using the following
temperature programm: 80 ◦C to 240 ◦C with a heating rate of 15 ◦C per minute, followed
by five minutes holding of 240 ◦C temperature.
Catalytic oxidation of methyl phenyl sulfide
Vanadium complex (0.025 mmol) was dissolved at room temperature in a mixture CH2Cl2-
CH3OH 7/3 (25 mL) and phenyl methyl sulfide (0.29 ml, 2.5 mmol) was added. The
resulting solution was cooled down on an ice-bath and H2O2 26 % (1.2 equiv., 0.35 mL,
3 mmol) was added dropwise. The reaction solution was stirred at room temperature in
a capped flask and monitored by thin layer chromatography using as eluent a mixture of
ethyl acetate/chloroform/methanol-5:10:3 (v/v/v)). After 18 hours 1 µL of the solution
mixture was assayed by gas-chromatography technique. Temperature programm: 55 ◦C
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hold for one minute, then increasing with a heating rate of 15 ◦C per minute until 200 ◦C
followed by heating rate of 15 ◦C per minute until 240 ◦C.
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Chapter 6
Binuclear vanadium(v) and
molybdenum(vi) complexes as
catalysts for sulfoxidation reaction
Transition-metal complexes are of general use as catalysts for the oxidation reactions of
various organic substrates.201 Among these reactions, the oxidation of sulfides to the cor-
responding sulfoxides has attracted a renewed attention. Compounds containing chiral
sulfoxide moiety are useful intermediates for the synthesis of chemically and biologically
significant molecules.86 The procedures for synthesis of enantiopure sulfoxides involve
either the synthesis of a sulfinylating agent which contains an electrophilic sulfur site
capable to react with an organometallic compound219–221 and/or the asymmetric oxi-
dation of the commercially available prochiral sulfides. The last method is based on
direct oxidation by use of enantiomerically pure oxidant222–224 and more appealing pos-
sibility is the use of prochiral oxidants and a chiral catalyst. While the first approach
requires expensive and unstable oxidation agents, a most efficient method to prepare
sulfoxides is represented by catalytic reaction utilizing metal complexes. The reported
systems able to perform the asymmetric oxidation of sulfides, involve mainly complexes
of titanium,225,226 chromium,227,228 manganese,229 iron230,231 and rhenium.232,233 More
recently vanadium complexes have also been reported as competitive catalysts of sul-
foxidation reaction189,193,234–236 whereas enzymatic systems such as vanadium haloper-
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oxidases are known as catalyst capable of catalyzing enatioselctively sulfide oxidation
reaction.87,89,90,175 The first report of a vanadium-catalyzed asymmetric sulfoxidation
reaction date from 1986. The system was developed by Fujita and is based on a vana-
dium(iv) complex, whereas phenyl methyl sulfide was used as substrate.237 The catalytic
system used cumyl hydroperoxide as oxidant and dichlormethane as reaction solvent and
it afforded 96% sulfoxide after 120 hours reaction time. Subsequently, Bolm reported a
highly selective vanadium catalyst based on bulky chiral Schiff base ligand formed be-
tween tert-butyl salicylaldehyde derivatives and tert-leucinol.191 In the later case the
catalyst was generated in situ between vanadyl acetylacetonate and the Schiff base lig-
and. Using 1 mol% catalyst, 94% yield had been achieved after 16 hours.191 Although in
both cases a high enantiomeric excess has been reported, varying from 85% ee in the first
case237,238 to maximum 70% in Bolm’s system, a very long reaction time was required in
both cases for a high conversion of phenyl methyl sulfide. Bolm’s catalytic procedure,
based on hydrogen peroxide has the advantage of inexpensive and environmentally benign
oxidant. Therefore, this catalytic system has been adopted and optimized for different
substrates. For instance, Ellman et al. achieved 98% conversion with 91% e.e. in the
asymmetric oxidation of tert-butyl disulfide.239,240 Furthermore, the same catalytic con-
ditions were also applied to iron complexes.241 By comparison with vanadium system,
the iron complex was reported as less effective catalyst and required additives for an in-
crease of the reaction yield.242 Later reports of vanadium complexes able to catalyze the
sulfide oxidation reaction are known, but in majority of the cases the reaction time varies
from 16 to 24 hours.189,190,192 Therefore, the development of a catalyst, able to catalyze
the sulfoxidation reaction more efficiently is a final goal. Based on the fact that two
metal centers will be more effective than a single one, binuclear cis-dioxovanadium(v)
and cis-dioxomolybdenum(vi) complexes with bis-N-salicylidene hydrazide ligands have
been designed. The Schiff base ligands were obtained following the reported described
procedure,243 with small modification regarding the excess of hydrazine hydrate used
for hydrazinolysis of the diacid esters. In the first step of the reaction the di-aliphatic
esters were reacted with a slight excess (2.5 equivalents) of hydrazine hydrate solution
when the bis-carbonic acid hydrazides were obtained quantitatively as very pure com-
pounds. In the second step Schiff base reaction with salicylaldehyde yielded the desired
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bis-N-salicylidene hydrazides (H4Ln). The ligand system, H4Ln, may be considered as
two N-salicylidene hydrazides linked via a methylene chain of variable length. There are
potentially four ionizable protons, two from the phenol site and two from the amide moi-
eties, respectively. By analogy with previous described N-salicylidene hydrazides (H2L),
the H4Ln ligands can potentially act as hexadentate chelate system, binding two metal
ions, one in each tridentate cavity. Schematic representation of the ligand system and its
tautomeric form are represented in Figure 96.
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Figure 96: Schematic representation of bis-N-salicylidene hydrazide ligands and its tau-
tomeric forms.
The bis-N-salicylidene hydrazide ligands exhibit also diverse isomerization possibil-
ities. The first isomers, detected in NMR spectra, both in 1H and 13C NMR spectrum
are the E and Z isomers of the azomethine bond. A similar isomerism is caused by the
amide functionality which also permits the rotation around the partially double bound
NH=C-OH. A third possible set of isomers, not NMR detectable can appear in bis-N-
salicylidene hydrazides of succinic acid, where the methylene bridge makes possible syn
and anti orientation of the two Schiff base conjugated cavities. The synthesis of vanadium
and molybdenum complexes with these Schiff base ligand systems follows the previous
described procedures.
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6.1 Binuclear cis-dioxovanadium(v) complexes with
bis-N-salicylidene hydrazides
Reaction of the Schiff base ligands with ammonium and/or potassium metavanadate in
a 1:2 ratio, yields the anionic binuclear cis-dioxovanadium(v) complexes as ammonium
and/or potassium salts, respectively. bis N-salicylidene hydrazide derived from glutaric
and adipic acids were used as ligands to prepare the anionic vanadium complexes. A
binuclear cis-dioxovanadium(v) obtained with bis-N-salicylidene oxalic acid dihydrazide
has been crystallographically characterized.244 In this case the two cis-dioxovanadium(v)
moieties were reported to be in trans position to each other. Most likely the similar vana-
dium complexes obtained with bis-N-salicylidene hydrazide of adipic acid have a similar
orientation of the two metal centers due to the zigzag conformation of the methylene
chain. On the other hand, when bis-N-salicylidene hydrazide of glutaric acid has been
used as ligand system, the two cis-dioxovanadate centers are, most likely, in cis position
to each other. This is based on crystallographical characterization of a similar binuclear
cis-dioxomolybdenum complex containing the latter ligand (Chapter 6.2).
The herein described vanadium complexes have been spectroscopically character-
ized. Their spectroscopic data are in good agreement with the similar reported binuclear
anionic vanadium complex.244 Therefore, the bis-Schiff base ligands accommodate two
cis-VO+2 units, each in one cavity as depicted in Figures 97 and 98, respectively.
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Figure 97: Schematic representation of cis-dioxovanadium(v) complex with bis-N-
salicylidene hydrazide of glutaric acid.
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Figure 98: Schematic representation of cis-dioxovanadium(v) complex with bis-N-
salicylidene hydrazide of adipic acid.
The formation of the cis-dioxovanadium moieties was confirmed by 51V NMR
recorded in deuterated DMSO solution. The ammonium salts of the binuclear dioxo-
vanadium complexes exhibit a single resonance at -534 ppm, whereas the potassium salts
resonate at around -532 ppm. This resonances are similar with previous characterized
cis-dioxovanadium(v) complexes with N-salicylidene aliphatic acid hydrazides. No big
influence of the counter ions to the vanadium resonances has been observed. It is known
that the vanadium center resonates in general according with the donor atoms which
are directly involved in its coordination sphere.11 A different width at half height of the
51V resonances (>840 Hz) has been detected comparing to previous described mononu-
clear cis-dioxovanadium complexes. This is a consequence of the interaction between
the two vanadium nuclei which leads to a broadening of the signal. Therefore, a shorter
methylene bridge between the two vanadium centers caused an increase of the width at
half height with around 20-30 Hz. Comparison between 1H NMR patterns of the free
ligand and the 1H NMR spectra of the complexes supports the formation of binuclear
cis-dioxovanadium(v) complexes. In both, potassium and ammonium salts of the herein
described cis-dioxovanadium(v) complexes no specific NH and OH proton resonances
have been detected. This indicates that bonding of vanadium atoms occurs through the
phenolate and iminole groups. A downfield shift for the azomethine (–CH=N–) protons
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signal in 1H NMR spectra of the complexes relative to the corresponding free ligands
supports the coordination of the azomethine nitrogen atoms. The involvement of the
imine nitrogen atoms in the coordination of vanadium is also illustrated by existence of
a single isomer of these double bonds with the protons resonating as singlet at around
8.77 ppm. The enolization of the amide functionality on vanadium coordination is in
agreement with the upfield resonances of the methylene protons next to amide group.
The aromatic protons and other methylene protons appear in the expected regions in
1H NMR spectra of the complexes with insignificant differences in the chemical shifts
compared to their resonances in the 1H NMR of the free ligands. The most indicative
NMR measurement that proves the ligation of the Schiff base ligands is represented by
13C NMR recording. A comparison between 13C NMR spectra of the ligand and of the
corresponding anionic complexes is shown in Figure 99. Phenolate ligation is confirmed
by downfield 13C resonances on going from ligand to metal complexes. Similarly, the
azomethine (–CH=N–) carbon atoms have down field resonances of around 15 ppm as
a consequence of their involvement in coordination. Further on, the methylene carbons
adjacent to the iminole functionality have downfield resonances, although this effect is
less dramatic.
Bis-N-salicylidene hydrazide of adipic acid
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Figure 99: Comparison of 13C NMR spectrum of the bis-N-salicylidene adipic hydrazide
ligand and the corresponding binuclear anionic cis-dioxovanadium complexes.
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Further evidence for the coordination mode of the ligands was obtained by compar-
ing the IR patterns of the free ligands with the IR spectra of the isolated anionic binu-
clear complexes. The infrared spectra of the ligands exhibit bands in the regions 1668
and 3200 cm−1 due to ν(C=O) and ν(NH and OH) stretching vibrations, respectively.
On vanadium complexation, these two vibrations disappeared indicating coordination
through the phenolate oxygen atom as well as enolization of the amide functionality.
The existence of the iminole form of the ligand in vanadium complexes is in agreement
with the strong band observed at 1613 cm−1, assigned to the stretching vibration of the
conjugate –HC=N–N=C– group. This IR evidence has been registered earlier for the
similar class of ligands that behave as tridentate ligands upon enolization. A broad band
in the IR spectra of the ammonium salts of the binuclear cis-dioxovanadium complexes
at approximately 3430 cm−1 was assigned to the ammonium cations. Most important,
very intense bands in the regions 881-911 and 930-933 cm−1 in both the ammonium and
the potassium salts were assigned to the stretching vibrations of the cis-VO2 moiety. Se-
lected IR data for both the binuclear complexes and the Schiff base ligands are presented
in the Experimental Part. The IR results indicate that the Schiff base ligands exist as
a mixture of keto and iminole forms in the solid state, but that on metal binding the
deprotonated chelator has only iminole character.
6.1.1 Sulfoxidation catalytic reaction
Although a similar anionic binuclear cis-dioxovanadium(v) complex has been reported,
there is not so far any report of similar complexes employed as catalysts in the oxida-
tion of organic sulfides. Therefore, the herein described binuclear cis-dioxovanadium(v)
complexes based on bis-N-salicylidene hydrazides were tested regarding their capacity to
catalyze the oxidation of phenyl methyl sulfide. Hydrogen peroxide was used as oxidant,
always in excess (1.2 equiv.) with respect to the substrate. The catalytic reactions were
carried out at room temperature using a mixture of dichlormethane:methanol as reaction
solvent and 1 mol% catalyst. The monitoring of the reaction was accomplished quanti-
tatively by GC dosage of the substrate comparing to the formed sulfoxide, whereas the
qualitative monitoring was done by thin-layer chromatography technique. The outcomes
193
of the catalytic reaction are summarized in Table 16 for both the ammonium and potas-
sium salts of binuclear cis-dioxovanadium(v) complexes derived from bis-N-salicylidene
hydrazide of glutaric and adipic acid, respectively. Fast oxidative transformation of the
substrate was observed in the first 20 minutes of reaction times, when between 59 and
69% conversion was obtained. It should be mentioned that the H2O2 was added very
slowly at 0 ◦C over a period of around 5 minutes, whereas the time of GC measurements
were considered after the entire amount of oxidant was added. The stepwise addition of
hydrogen peroxide was compulsory in order to avoid the overoxidation reaction. TLC
monitoring of the reaction with H2O2 added at once showed large amounts of sulfone for-
mation at the beginning of reaction. After two hours of reaction time, the GC assay of the
reaction mixture showed around 78% conversion when binuclear cis-dioxovanadium(v)
complexes based on bis-N-salicylidene adipic acid were used as catalysts; whereas around
84% sulfoxide was obtained when complex 20 catalyzed the oxidation reaction. A plot
representing the sulfoxide conversion vs. time for the three catalysts is shown in Figure
100.
Table 16. Oxidation of methyl phenyl sulfide catalyzed by binuclear cis-
dioxovanadium(v) complexes within 2 hours.
Catalyst Conversion % (20 min.) Conversion % (120 min.) TONa
20 69.0 84.3 206
22 63.1 78.6 188
23 59.0 78.3 176
a TON: mmol substrate×(mol catalyst×h)−1, calculated for the conversion obtained
within 20 minutes.
As can be concluded from Table 16, a similar behavior of the complexes have been
observed when the same length of the methylene bridge was involved in the catalyst
structure, suggesting that, despite the differences in the counterparts, they exhibit the
same reactivity. A slight increase of efficiency was observed for complex 20 when a shorter
methylene bridge connects the two cis-dioxovanadium centers.
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Figure 100: Profile of the progress of the oxidation of methyl phenyl sulfide catalyzed by
binuclear anionic cis-dioxovanadium(v) complexes.
The short reaction time for 78-84% conversion of the sulfide in the corresponding
sulfoxide as the sole product, is an unprecedent result for vanadium catalysts for sul-
furoxidation reaction. The most efficient vanadium-based catalyst for the sulfide oxida-
tion reaction was reported as salan-type oxovanadium(iv) complex which accomplished
91% conversion after six hours when the reaction was performed in acetonitrile, but
still prolonged reaction time was reported when the catalytic reaction was performed
in halogen-containing solvents.189 The high efficient catalytic activity of the herein de-
scribed binuclear anionic dioxovanadates might be related to the existence of two metal
centers which accelerate the catalytic reaction. At this point the introduction of a chiral
center in the vanadium catalysts seems to be a final goal for designing highly efficient,
perhaps enatioselective catalysts.
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6.2 Binuclear cis-dioxomolybdenum(vi) complexes
based on bis-N-salicylidene hydrazide ligands
The bis-N-salicylidene hydrazide ligands were also reacted with molybdenum acetyl-
acetonate in a 1:2 ratio, in refluxing methanol, when binuclear cis-dioxomolybdenum
complexes have been isolated. As previous described, N-salicylidene hydrazide ligands
were also able to accommodate molybdenum atoms similarly to vanadium atoms. The
difference between molybdate and vanadate complexes consists in their different coordina-
tion numbers. While vanadium(v) prefers mainly five-coordination environment, molyb-
denum(vi) atom is commonly known as six-coordinated metal center. The hexaden-
tate chelate system coordinates via complete deprotonation of its donor atoms, whereas
the sixth coordination site on the molybdenum atoms is occupied by solvent molecules,
such as methanol which was used as reaction solvent. The existence of the methanol
molecules, as coordinated solvent at the molybdenum atoms, is proved by its charac-
teristic resonances detected in both the 1H and the 13C NMR of binuclear molybdenum
complexes. By comparison with precedented described binuclear cis-dioxovanadium(v)
complexes, a shorter methylene bridge of the bis-N-salicylidene hydrazide, namely the
derivative of the succinic acid, was also used as ligand system. Recrystallization of
the binuclear cis-dioxomolybdenum(vi) complex (25) obtained with bis-N-salicylidene
glutaric acid dihydrazide ligand, from a mixture acetonitrile:methanol afforded suitable
crystals for X-ray measurement. The molecular structure determination shows two cis-
dioxomolybdenum(vi) moieties (Figure 101). Each molybdenum atom is six-coordinated
in a distorted octahedral geometry. The Schiff base ligand acts as suggested, as tetraneg-
ative chelate system, coordinating one cis-dioxomolybdenum moiety in each dianionic
tridentate cavity. The basal plane of each polyhedra is formed by the donor atoms ONO
of the ligand system together with one of the double bonded oxygen atoms (O5 and O8).
The remained oxo groups (O6 and O9) of the molybdenum centers occupy the apical po-
sition. The coordination number of each molybdenum atom is completed by coordinated
methanol molecules, placed trans to apical oxo group. Both methanol molecules are per-
pendicular to the near-planar system containing the molybdenum atoms and adopt cis
orientation to each other. The ligand system forms six and five-membered chelate rings
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around each cis-MoO2 moiety. The angular distortion in the octahedral environment
around molybdenum atoms comes from the bites taken by the Schiff base ligand, e.g. the
angles N1–Mo1–O1 and N1–Mo1–O2 are 81 and 72◦ for Mo1 center and, N4–Mo2–O4 of
84◦ and 72◦ for N4–Mo2–O3, respectively, for Mo2 center. Also, indicative of the distor-
tion to an ideal octahedral geometry are the values of the trans axial angles (O6–Mo1–O7
and O9–Mo2–O10) which are significantly reduced from the ideal value of 180◦. Selected
bond lengths and angles in complex 25 are listed in Table 17. The Mo–O and Mo–N
bond distances of the two cis-MoO2 moieties are identical within the experimental error
and similar with reported corresponding bond lengths in cis-dioxomolybdenum(vi) com-
plexes.202,203,208 The Mo=O bond lengths of around 169±1 ppm are very similar with
corresponding bond distances reported for similar molybdenum complexes.245
Figure 101: Molecular structure and numbering scheme of the binuclear complex
[(MoO2)2(salhygu)·2CH3OH] (25); displacement ellipsoids are drawn at 50% probabil-
ity level.
The binuclear cis-dioxomolybdenum complex exhibits hydrogen bonding interac-
tions between the coordinated methanol molecules and the hydrazide nitrogen atom N2
and N3 of opposite enantiomeric molecules. The hydrogen bonding distances vary from
273.6 pm (N2· · ·O10C) to 274.5 pm (N3· · ·O7C), forming endless layers parallel to (010)
plane (Figure 102).
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Figure 102: Representation of the hydrogen bonding network observed in crystals of
[(MoO2)2(salhygu)·2CH3OH] (25) complex 25; view along the (010) axis (broken lines
represent hydrogen bonding interactions).
6.2.1 Spectroscopic characterization
The molybdenum complexes are soluble in DMF, DMSO and MeOH to give yellow solu-
tions. The characteristic ligand stretching bands attributed to C=O, OH and NH were
absent in the IR spectra of molybdenum complexes. As described for binuclear vanadium
complexes, the Schiff base ligands also coordinates via deprotonation of all donor atoms.
The molybdenum complex based on bis-N-salicylidene glutaric acid showed two promi-
nent bands at 938 and 916 cm−1 attributed to ν(MoO2+2 ) group; whereas the binuclear
molybdenum complexes formed with N-salicylidene hydrazide derived from adipic and
succinic acid, respectively, exhibit such strong vibrations at 930-941 and 887-889 cm−1.
The enolization of the amide functionality on molybdenum coordination, therefore the
tautomerization of the ligand during complexation is in agreement with the absence of
the NH vibration and the presence of the 1609-1613 cm−1 stretching vibration owing
to the conjugated -CH=N–N=C- group. A new broad band compared to IR spectra
of the free Schiff base ligands has been detected in the IR spectra of the binuclear cis-
dioxomolybdenum complexes in the range 3308–3321 cm−1, assigned to the vibration of
the hydroxyl functionality of the coordinated methanol molecules.
The 1H NMR spectra of the ligand displayed two resonances at 7.87 and 7.94 ppm
attributed to azomethine, CH=N protons. However, upon chelation to MoO2 moieties,
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Table 17. Selected bond lengths (pm) and angles (◦) for complex 25.
Mo1−O6 169.2(4) Mo2−O8 169.9(4)
Mo1−O5 170.3(4) Mo2−O9 169.5(4)
Mo1−O1 191.5(4) Mo1−O4 192.5(4
Mo1−O2 203.4(4) Mo2−O3 203.8(4)
Mo1−N1 224.7(4) Mo2−N4 224.3(4)
Mo1−O7 230.3(5) Mo2−O10 231.7(4)
O2−C8 130.7(6) O2−C12 130.4(6)
N2−C8 130.1(7) N3−C12 129.9(7)
O6−Mo1−O5 105.8(2) O9−Mo2−O9 105.36(19)
O6−Mo1−O1 100.55(19) O9−Mo2−O4 99.88(18)
O6−Mo1−O2 93.13(19) O9−Mo2−O3 94.65(17)
O6−Mo1−N1 94.0(2) O9−Mo2−N4 94.93(19)
O6−Mo1−O7 168.03(19) O9−Mo2−O10 170.94(18)
O5−Mo1−O1 102.77(19) O8−Mo2−O4 102.24(18)
O5−Mo1−O2 98.51(18) O8−Mo2−O3 98.57(17)
O5−Mo1−N1 158.54(19) O8−Mo2−N4 158.39(19)
O5−Mo1−O7 84.07(19) O8−Mo2−O10 82.61(17)
O1−Mo1−O2 150.38(17) O4−Mo2−O3 150.36(16)
O1−Mo1−N1 81.12(17) O4−Mo2−N4 81.09(16)
O1−Mo1−O7 83.49(17) O4−Mo2−O10 82.30(16)
O2−Mo1−N1 71.75(15) O3−Mo2−N4 71.98(15)
O2−Mo1−O7 78.44(17) O3−Mo2−O10 79.68(16)
N1−Mo1−O7 75.35(18) N4−Mo2−O10 76.65(16)
only one singlet, deshielded at 8.77 ppm was observed. Two sets of signals, observed at
11.22 and 11.93 ppm, in 1H NMR spectra for the ligand were attributed NH and OH
protons. These are distinctly absent in the spectra of the binuclear molybdenum com-
plexes. This observation ascertains the keto-imine tautomerism to have occurred during
molybdenum complexation and it confirms deprotonation and coordination of the phe-
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nolic oxygen atoms. The range of chemical shifts observed for aromatic and methylene
protons did not show any appreciable change upon molybdenum complexation. There-
fore, the H4Ln ligands coordinate the molybdenum atoms in the two tridentate binding
domains as similarly described for the binuclear dioxovanadate complexes. The existence
of the coordinated methanol molecules in binuclear molybdenum complexes is illustrated
by the characteristic doublet resonance observed at 3.15-3.16 ppm due to the methyl
protons and a quartet at 4.06-4.10 ppm owing to OH protons. Furthermore, comparison
between 13C NMR spectra of bis-N-salicylidene hydrazides and the corresponding binu-
clear cis-dioxomolybdenum complexes sustain the proposed coordination. The differences
of the 13C chemical shifts in 13C NMR of the Schiff base ligands and the 13C NMR of
the binuclear molybdenum complexes are similar with discussed differences found for the
binuclear cis-dioxovanadium complexes. 13C NMR spectra of all compounds described
in this chapter are presented in the Experimental Part.
6.2.2 Sulfoxidation reaction
High valent cis-dioxomolybdenum complexes have demonstrated the ability to catalyze
the oxidation of a variety of organic substrates.195 Although numerous molybdenum(vi)
complexes are reported, the molybdenum chemistry is dominated by catalytic reac-
tion involving epoxidation of alkenes196–199 and oxygen transfer reaction from DMSO to
PPh3.
202,203 At this moment very few examples of molybdenum-based catalysts for sulfox-
idation reaction are known.200 The herein described binuclear cis-dioxomolybdenum (vi)
complexes were also used as catalysts for the oxidation of phenyl methyl sulfide by hydro-
gen peroxide. Compared to binuclear cis-dioxovanadium(v), the molybdenum complexes
proved to be more efficient, with more than 95% conversion after 90 minutes. The results
for the catalytic reaction are tabulated in Table 18. A small difference in reactivity within
this series of complexes has been observed. Firstly, the binuclear cis-dioxomolybdenum
complexes formed with bis-N-salicylidene hydrazide of succinic acid seems to be a better
catalyst of the reaction, compared to glutaric and adipic acid derivatives. Nevertheless,
with all three binuclear cis-dioxomolybdenum(vi) complexes the catalytic reaction takes
place with a turnover rate higher than 200 mol sulfoxide×(mol catalyst×h)−1.
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Table 18. Oxidation of methyl phenyl sulfide catalyzed by binuclear cis-
dioxomolybdenum(vi) complexes within 90 minutes.
Catalyst Conversion % (20 min.) Conversion % (90 min.) TONa
24 75.2 99.2 225
25 68.0 95.4 204
26 73.1 98.9 218
a TON: mmol substrate×(mol catalyst×h)−1, calculated for the conversion obtained
within 20 minutes.
Due to the efficient catalytic activity of the binuclear molybdenum complexes, a
chiral center was introduced in the ligand system. Starting from (+) dimethyl R-methyl
succinate which is commercially available and following the described procedure, the bis-
N-salicilidene R-methyl succinic dihydrazide has been obtained. This ligand was reacted
with molybdenyl acetylacetonate in refluxing methanol, when the corresponding chiral
binuclear cis-dioxomolybdenum(vi) complex was formed (Figure 103).
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Figure 103: Schematic representation of the synthesis of chiral binuclear cis-
dioxomolybdenum(vi) complex (27).
Complex 27 was also tested for catalytic sulfoxidation, following the previous conditions.
The catalytic reaction took place with 96.8% conversion of phenyl methyl sulfide when the
reaction was performed in dichlormethane:methanol mixture, after 90 minutes time. Un-
fortunately no enantiomeric excess has been obtained, the ratio between the two isomers
of the sulfoxide being almost 50:50. Because the enantioselective sulfoxidation reaction
had been reported as being solvent dependent,189,240 the oxidation reaction catalyzed by
complex 27 was also performed in dichlormethane with no addition of methanol. The
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complex requires a longer period of time for dissolution, whereas the reaction takes place
with only 34.5% conversion after one hour. Further monitoring of the reaction showed
around 55% conversion within two hours and 63.6% sulfoxide formation after 150 minutes.
HPLC analyze of the dichlormethane solution showed also no representative enantiomeric
excess, the ratio between the two isomers of the phenyl methyl sulfoxide increasing only
to 52.0 to 48 percentage, with only 4% e.e. respectively. It seems, that the methanol
as cosolvent has an additive effect, contributing to the acceleration of catalytic reaction,
but is decreasing the enantioselectivity of the catalyst.
Particular attention in the reported vanadium-catalyst systems191 has been paid to
the di-tert-butyl substitution of the aromatic system. Bolm explained the high enan-
tioselective behave of the catalytic reaction as a dependence of the vanadium reactivity
directly connected with the substitution groups of the ligand system. Therefore, the ap-
parent requirement for the tert-butyl group at C-5 position of the aryl moiety might be a
sterically demanding substituent. Another advantage of Bolm’s catalytic system is also
represented by additionally tert-butyl substituted imine framework, which was explained
as capable to enable the enatioselectivity of the reaction. Schematic representation of
catalytic system developed by Bolm et al. is shown in Figure 104. Bolm also reported
that an withdrawing electron substituent on the aromatic system, has also a positive
effect on vanadium activation. Therefore, at this point, at least a tert-butyl substitution
on the aryl moiety in complex 27 might fulfill the required activation of molybdenum
center for an enatioselective oxidation of organic sulfides.
6.3 Conclusions
Binuclear cis-dioxovanadium(v) and cis-dioxomolybdenum(vi) complexes have been de-
signed as catalysts for sulfoxidation reaction. The vanadium complexes showed a lower
activity compared to corresponding molybdenum complexes, but still they are rare ex-
amples of efficient vanadium-based catalysts of the oxidative reaction. Whereas the binu-
clear vanadium-catalysts were synthesized only as prochiral complexes, a chiral binuclear
molybdenum complex was isolated. This complex showed an efficient activity towards
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Figure 104: Schematic representation of the most efficient chiral vanadium catalyst ac-
cording with reference [191].
catalytic oxidation of phenyl methyl sulfide in dichlormethane:methanol mixture, but a
more slower reaction in simple dichlormethane solvent. Unfortunately, in both cases a
racemic mixture of phenyl methyl sulfoxide has been obtained. An interesting features of
these catalysts might be represented by replacement of salicylaldehyde with di-tert-butyl
substituted aromatic aldehydes and focusing especially on vanadium-catalysts, due to
their known capacity to catalyze enantioselectively the sulfoxidation reaction.
6.4 Experimental Part
Abbreviations used throughout the text: H4salhysu = succinic acid (2-hydroxy ben-
zylidene) dihydrazide, H4salhygu = glutaric acid (2-hydroxy benzylidene) dihydrazide,
H4salhyad = adipic acid (2-hydroxy benzylidene) dihydrazide, salan ligand = reduced
salen Schiff base ligand, salen = bis-N-salicylidene R-diamine derivates, where R is an
alkyl rest.
6.4.1 Synthesis of bis-aliphatic acid hydrazides
Synthesis of glutaric acid dihydrazide
Dimethyl glutaric ester (18.4 mL, 125.0 mmol) was added stepwise under continuous
stirring to hydrazine hydrate 100 % (15.2 mL, 312.5 mmol). The resulting solution was
refluxed for 30 minutes when a colorless precipitate is formed. Ethanol (100 mL) was
added and refluxed for one additional hour. The precipitate was filtered and washed with
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ethanol. Yield: 18.7 g (117.0 mol; 93 %). 1H NMR (200 MHz, DMSO-d6): δ = 1.64-1.76
(m, 2H, CH2), 1.98 (t, 4H, CH2CO,
3J= 8.00 Hz), 4.12 (br, 4H, NH2), 8.33 (br, 2H, NH )
ppm. 13C NMR (50 MHz, DMSO-d6): δ = 21.9 (CH2), 33.3 (CH2CO), 171.6 (C=O)
ppm.
Synthesis of adipic acid dihydrazide
Diethyl adipic ester (14.0 mL, 100.0 mmol) was added stepwise under continuous stirring
to hydrazine hydrate 100 % (15.6 g, 15.2 mL, 312.0 mmol). The resulting solution was
refluxed for 30 minutes when a colorless precipitate is formed. Ethanol (100 mL) was
added and refluxed for one additional hour. The precipitate was filtered and washed with
ethanol. Yield: 18.7 g (117.0 mol; 93 %). 1H NMR (200 MHz, DMSO-d6): δ = 1.42-1.45
(m, 4H, CH2), 1.98 (t, 4H, CH2CO,
3J=7.80 Hz), 3.46 (br, 4H, NH2), 8.93 (br, 2H, NH )
ppm. 13C NMR (50 MHz, DMSO-d6): δ = 24.9 (CH2), 33.3 (CH2CO), 171.5 (C=O)
ppm.
Synthesis of succinic acid dihydrazide
This bis-hydrazide was prepared analogously to the previous similar hydrazide from di-
ethyl succinic ester (19.2 mL, 115.0 mmol) and hydrazine hydrate (14.0 mL, 287.5 mmol)
in refluxing ethanol. Yield: 15.2 g (104.0 mol; 90 %). 1H NMR (200 MHz, DMSO-d6):
δ = 2.19-2.23 (m, 4H, CH2CO), 4.13 (br, 4H, NH2), 8.98 (br, 2H, NH ) ppm.
13C NMR
(50 MHz, DMSO-d6): δ = 29.3 (CH2CO), 171.9 (C=O) ppm.
Synthesis of (+) dihydrazide R-methyl succinate
This dihydrazide was prepared analogously to the previous dihydrazides from (+) dimethyl
R-succinate ester (2.5 mL, 16.7 mmol) and hydrazine hydrate (2.1 mL, 41.7 mmol) in
refluxing methanol (10 mL). Yield: 2.45 g (15.30 mol; 91 %). Anal. for C5H12N4O2
(160.17): calcd. C 37.49, H 7.55, N 34.98; found C 37.51, H 7.24, N 35.42. 1H NMR (400
MHz, DMSO-d6): δ = 0.93-0.95 (d, 3H, CH3, J= 6.8 Hz), 2.00-2.06 and 2.20-2.25 (dd,
2H, CH2CO, J= 8.4 and 6.3 Hz), 2.55-2.56 (m, 1H, CH ), 4.10 and 4.12 (br, 4H, NH2),
8.94 and 8.97 (br, 2H, NH ) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 17.4 (CH3), 34.4
(CH), 37.1 (CH2CO), 169.9 and 174.2 (C=O) ppm.
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6.4.2 Synthesis of Schiff base ligands
Synthesis of bis-N-salicylidene glutaric acid hydrazide H4salhygu
To a suspension of glutaric acid dihydrazide (5.0 g, 31.2 mmol) in methanol (150 mL),
salicylaldehyde (6.6 mL, 62.5 mmol) was added dropwise at 0◦ C. The resulting yellow
solution was stirred at room temperature overnight. The formed precipitate was filtered
off and dried in vacuo. Yield: 11.2 g (30.3 mmol; 97 %). 1H NMR (200 MHz, DMSO-
d6): δ = 1.85-1.96 (m, 2H, CH2), 2.18-2.35 and 2.61-2.68 (m, total 4H, CH2CO, ratio
1.84:0.91), 6.76-7.0 (m, 4H, arom. CH ), 7.15-7.30 (m, 2H, arom. CH ), 7.45-7.61 (m, 2H,
arom. CH ), 8.24, 8.26 and 8.33 (s, 2H total, CH=N, ratio 0.46:0.96), 10.12, 11.20-11.22
and 11.63 (NH, OH, total 4H in ratio 0.35:1.29:0.86) ppm. 13C NMR (50 MHz, DMSO-
d6): δ = 19.9, 20.6 (CH2), 31.3, 31.4, 33.0 and 33.3 (all CH2CO), 116.1, 116.3, 118.6,
119.3, 119.4, 120.0, 126.7, 129.5, 130.8, 131.2 (all arom. CH and C ), 140.8, 146.5 (both
CH=N), 156.3, 157.3, 169.0, 168.2, (arom. C ), 173.4 and 173.6 (C=O) ppm. Selected
IR data (cm−1): ν= 3194 (NHass, OHass), 1668 (s; C=O), 1623 and 1609 (CH=N).
Synthesis of bis-N-salicylidene adipic acid hydrazide H4salhyad
To a suspension of adipic acid dihydrazide (4.0 g, 22.7 mmol) in methanol (150 mL),
salicylaldehyde (4.8 mL, 45.8 mmol) was added dropwise at 0◦ C. The resulting yellow
solution was stirred at room temperature overnight, when a colorless precipitate is formed.
The precipitate was filtered off and dried in vacuo. Yield: 8.6 g (22.5 mmol; 99 %).
1H NMR (400 MHz, DMSO-d6): δ = 1.53-1.62 (m, 4H, CH2), 2.25 and 2.58 (t, total
4H, CH2CO,
3J= 6.6 Hz, ratio 1.92:0.90), 6.82-6.89 (m, 4H, arom. CH ), 7.18-7.27 (m,
2H, arom. CH ), 7.45-7.61 (m, 2H, arom. CH ), 8.25, 8.33 (s, 2H total, CH=N, ratio
0.51:0.95), 10.12, 11.18 and 11.58 (NH, OH, total 4H in ratio 0.54:1.45:0.94) ppm. 13C
NMR (100 MHz, DMSO-d6): δ = 23.8, 23.9, 24.6, 24.7 (all CH2), 31.7, 33.7 (both
CH2CO), 116.1, 116.3, 118.6, 119.4, 120.0, 126.8, 129.5, 130.8, 131.1 (all arom. CH
and C ), 140.8, 146.5 (both CH=N), 156.3, 157.3, 168.3, (arom. C ), 173.7 (C=O) ppm.
Selected IR data (cm−1): ν= 3435, 3202 (NH, OH), 1667 (s; C=O), 1623 and 1611
(CH=N).
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Synthesis of bis-N-salicylidene succinic acid hydrazide H4salhysu
This Schiff base ligand was prepared by analogs procedure from succinic acid dihydrazide
(5.0 g, 34.2 mmol) and salicylaldehyde (7.2 mL, 68.50 mmol) in methanol at 0◦ C. Yield:
11.9 g (33.3 mmol; 97 %). 1H NMR (200 MHz, DMSO-d6): δ = 2.47-2.56 (m, CH2CO,
overlapped with the dmso-d6 signal) and 2.90-2.95 (t, CH2CO,
3J= 6.82 Hz), 6.84-6.99
(m, 4H, arom. CH ), 7.18-7.30 (m, 2H, arom. CH ), 7.40-7.70 (m, 2H, arom. CH ), 8.27,
8.33 (s, 2H total, CH=N, ratio 0.76:1.00), 10.14, 11.17, 11.28 and 11.70 (br, NH, OH,
total 4H in ratio 0.29:0.91:0.50:0.11) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 24.7,
26.5 28.2, 28.7 (all CH2CO), 116.1, 116.3, 118.6, 119.3, 119.5, 120.0, 126.8, 129.4, 130.9,
131.2 (all arom. CH and C ), 141.1, 146.3, 146.4 (all CH=N), 156.3, 157.3, 158.6, 167.6,
167.9 (arom. C ), 172.8 and 173.1 (both C=O) ppm. Selected IR data (cm−1): ν= 3200
(NH, OH), 1676 (s; C=O), 1622 and 1609 (CH=N). UV/Vis (CH3OH solution, λmax in
nm (ε in 103 M−1 cm−1)): 280 (37.9), 289 (35.7), 315 (20.4).
Synthesis of (+) bis-N-salicylidene R-methyl succinic acid hydrazide
To a suspension of R-methyl succinic acid dihydrazide (2.4 g, 15.0 mmol) in methanol
(60 mL) was added salicylaldehyde (3.1 mL, 30.0 mmol) under continuous stirring. The
resulting slurry solution was refluxed for about 15 minutes and additionally stirred at
room temperature overnight, when a colorless precipitate was formed. Yield: 1.7 g (4.6
mmol; 31 %). Anal. for C19H20N4O4·H2O (386.40): calc. C 59.06, H 5.74, N 14.50;
found C 59.54, H 5.58, N 16.65. 1H NMR (400 MHz, DMSO-d6): δ = 1.18-1.19 (d, 3H,
CH3), 2.33-2.47 and 2.68-2.73 (m, total 2H, CH2CO), 2.88-3.09 (m, 1H, CH ), 6.86-6.90
(m, 4H, arom. CH ), 7.18-7.29 (m, 2H, arom. CH ), 7.45-7.65 (m, 2H, arom. CH ), 8.26,
8.29, 8.33 and 8.37 (s, 2H total, CH=N), 10.12, 11.14, 11.24 and 11.68 (NH, OH, total
4H) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 16.9, 17.8 and 18.0 (CH3), 34.2, 34.8
and 35.7 (all CH), 36.8 and 37.3 (both CH2CO), 116.1, 116.3, 118.5, 119.2, 119.4, 120.0,
126.7, 129.4, 130.9, 131.1 (all arom. CH and C ), 140.9, 146.5 and 146.8 (all CH=N),
156.3, 157.2, 166.9 and 167.1 (arom. C -OH), 171.1, 171.5, 172.2 and 176.0 (C=O) ppm.
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6.4.3 Synthesis of cis-dioxovanadium(v) complexes
Synthesis of ammonium salts of binuclear cis-dioxovanadium(v)
complexes
General procedure: To a suspension of bis-N-salicylidene hydrazide (1.0 g) in methanol
(100 mL) was added an equimolar amount of ammonium metavanadate. The resulting
brown suspension was refluxed for around three hours while became a clear solution. The
hot solution was filtered and the volume reduced under reduced pressure to about half.
After standing at room temperature overnight a yellow precipitate was formed. This was
filtered off and washed with chloroform.
Synthesis of complex (NH4)2[(VO2)2(salhygu)] (20)
This complex was synthesized from bis-N-salicylidene glutaric acid hydrazide (1.00 g,
2.72 mmol) and NH4VO3 (0.64 g, 5.43 mmol) in methanol. Yield: 1.32 g (2.33 mmol;
86 %). Anal. for C19H24N6O8V2 (566.31): calcd. C 40.30, H 4.27; found C 39.83, H
4.01. 1H NMR (200 MHz, DMSO-d6): δ = 1.83-2.07 (m, 2H, CH2), 2.33 (t, 4H, CH2CO,
3J= 6.8 Hz), 6.74-6.76 (m, 4H, arom. CH ), 7.12 (br, 8H, NH+4 ), 7.26-7.30 (m, 2H, arom.
CH ), 7.45-7.49 (m, 2H, arom. CH ), 8.78 (s, 2H total, CH=N) ppm. 13C NMR (50
MHz, DMSO-d6): δ = 22.9 (CH2), 31.5 (CH2CO), 116.5, 119.2, 119.7, 132.3, 132.8 (all
arom. CH and C ), 154.2 (CH=N), 164.2 (arom. C –OV), 175.9 (aliphatic C –OV) ppm.
51V NMR (105 MHz, DMSO-d6): δ = -534.6 ppm (∆ν1/2 = 873 Hz). Selected IR data
(cm−1): ν= 3430 (br, NH+4 ), 1612 (s, -HC=N–N=C-), 911 and 891 (s, VO2). UV/Vis
(CH3OH solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (28.3), 290 (25.3), 312 (19.6),
389 (6.08).
Synthesis of complex (NH4)2[(VO2)2(salhyad)] (22)
This complex was synthesized from bis-N-salicylidene adipic acid hydrazide (1.00 g,
2.61 mmol) and NH4VO3 (0.61 g, 5.23 mmol) in methanol. Yield: 0.93 g (1.61 mmol;
62%). Anal. for C20H22N6O8V2 (576.31): calcd. C 41.68, H 3.84, N 14.58; found C
41.45, H 4.17, N 14.54. 1H NMR (400 MHz, DMSO-d6): δ = 1.62 (br, 4H, CH2), 2.27
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(t, 4H, CH2CO), 6.72-6.74 (m, 4H, arom. CH ), 7.11 (br, 8H, NH
+
4 ), 7.26-7.30 (m, 2H,
arom. CH ), 7.45-7.47 (m, 2H, arom. CH ), 8.77 (s, 2H total, CH=N) ppm. 13C NMR
(100 MHz, DMSO-d6): δ = 25.9 (CH2), 31.7 (CH2CO), 116.5, 119.3, 119.8, 132.3, 132.7
(all arom. CH and C ), 154.3 (CH=N), 164.3 (arom. C –OV), 176.1 (aliphatic C –OV)
ppm. 51V NMR (105 MHz, DMSO-d6): δ = -534.2 ppm (∆ν1/2 = 863 Hz). Selected
IR data (cm−1): ν= 3447 (br, NH4), 1610 (s, -HC=N–N=C-), 933 and 910 (s, VO2).
UV/Vis (CH3OH solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (25.51), 290 (22.16),
312 (17.8), 389 (5.60).
Synthesis of potassium salts of binuclear cis-dioxovanadium(v)
complexes
General procedure: To a suspension of bis-N-salicylidene hydrazide (1.00 g) in methanol
(100 mL) was added an equimolar amount of potassium metavanadate. The resulting
brown suspension was refluxed for around two days when a clear yellow solution was
formed. The hot solution was filtered and the volume reduced under reduced pressure
to about half. After standing at room temperature overnight a yellow precipitate was
formed.
Synthesis of complex K2[(VO2)2(salhygu)]·4H2O (21)
This complex was synthesized from bis-N-salicylidene glutaric acid hydrazide (1.00 g,
2.72 mmol) and KVO3 (0.75 g, 5.43 mmol) in methanol. Yield: 1.63 g (2.40 mmol; 88%).
Anal. for C19H16N4O8K2V2·4H2O (680.49): calcd. C 33.54, H 3.55, N 8.23; found C
33.80, H 3.43, N 8.03. Thermogravimetric measurement: 72.8-195◦C loss 11.9% (80.97
g) (4.5H2O).
1H NMR (200 MHz, DMSO-d6): δ = 1.87-1.93 (m, 2H, CH2), 2.29-2.33
(m, 4H, CH2CO), 3.31 (H2O), 6.71-6.75 (m, 4H, arom. CH ), 7.24-7.32 (m, 2H, arom.
CH ), 7.44-7.47 (m, 2H, arom. CH ), 8.78 (s, 2H total, CH=N) ppm. 13C NMR (50 MHz,
DMSO-d6): δ = 23.0 (CH2), 31.7 (CH2CO), 116.5, 119.4, 119.8, 132.3, 132.7 (all arom.
CH and C ), 154.4 (CH=N), 164.3 (arom. C –OV), 175.9 (aliphatic C –OV) ppm. 51V
NMR (105 MHz, DMSO-d6): δ = -531.4 ppm (∆ν1/2 = 842 Hz). Selected IR data (cm
−1):
ν= 3435 (br, H2O), 1616 (s, -HC=N-N=C-), 930 and 910 (s, VO2). UV/Vis (CH3OH
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solution, λmax in nm (ε in 10
3 M−1 cm−1)): 278 (28.12), 290 (26.25), 315 (18.87), 384
(5.90).
Synthesis of complex K2[(VO2)2(salhyad)] (23)
This complex was synthesized from bis-N-salicylidene adipic acid hydrazide (1.00 g,
2.61 mmol) and KVO3 (0.73 g, 5.23 mmol) in methanol. Yield: 1.28 g (1.94 mmol;
74%). Anal. for C20H18N4O8K2V2 (622.46): calcd. C 38.59, H 2.91, N 9.00; found C
38.94, H 3.06, N 9.11. 1H NMR (400 MHz, DMSO-d6): δ = 1.61 (t, 4H, CH2), 2.26 (t,
4H, CH2CO), 6.69-6.73 (m, 4H, arom. CH ), 7.25-7.29 (m, 2H, arom. CH ), 7.44-7.46
(m, 2H, arom. CH ), 8.76 (s, 2H total, CH=N) ppm. 13C NMR (50 MHz, DMSO-d6):
δ = 25.9 (CH2), 31.8 (CH2CO), 116.3, 119.3, 119.8, 132.3, 132.6 (all arom. CH and
C ), 154.2 (CH=N), 164.3 (arom. C –OV), 176.1 (aliphatic C –OV) ppm. 51V NMR (105
MHz, DMSO-d6): δ = -532.6 ppm (∆ν1/2 = 842 Hz). Selected IR data (cm
−1): ν= 1613
(s, -HC=N-N=C-), 930 and 909 (s, VO2).
6.4.4 Synthesis of binuclear cis-dioxomolybdenum(vi) complexes
General procedure: To a suspension of bis-N-salicylidene hydrazide (around 1.0 mmol)
in methanol (50 mL) was added an equimolar amount of molybdenyl acetylacetonate.
The resulting yellow suspension was refluxed under continuous stirring for two hours
and additionally stirred at room temperature for four hours. The resulting solution
was concentrated under reduce pressure to about third of the initial volume, when a
precipitate was formed. This was filtered off and washed with acetonitrile:methanol 1:1
mixture.
Synthesis of complex [(MoO2)2(salhysu)]·2CH3OH (24)
This complex was synthesized from bis-N-salicylidene succinic acid hydrazide (0.35 g,
1.00 mmol) and MoO2(acac)2 (0.65 g, 2.00 mmol) in methanol. Yield: 0.48 g (0.72 mmol;
72%). Anal. for C20H22N4O10Mo2 (670.29): calcd. C 35.84, H 3.31, N 8.36; found C
35.76, H 3.26, N 8.24. 1H NMR (200 MHz, DMSO-d6): δ = 2.71 (s, 4H, CH2), 3.14-3.16
(d, 6H, CH3OH, J=5.24 Hz), 4.08-4.12 (q, 2H, CH3OH, J=5.25 Hz), 6.88-7.07 (m, 4H,
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arom. CH ), 7.45-7.50 (m, 2H, arom. CH ), 7.65-7.70 (m, 2H, arom. CH ), 8.76 (s, 2H
total, CH=N) ppm. 13C NMR (50 MHz, DMSO-d6): δ = 27.5 (CH2), 48.6 (CH3OH),
118.5, 120.0, 121.4, 134.2, 134.8 (all arom. CH and C ), 155.4 (CH=N), 159.3 (arom.
C –OMo), 173.7 (aliphatic C –OMo) ppm. Selected IR data (cm−1): ν= 3321 (br, OH),
1613 (s, -HC=N-N=C-), 930 and 889 (s, MoO2), 820 (s) and 662 (s) and 590 (s) (Mo–O
and Mo–N linkage).
Synthesis of complex [(MoO2)2(salhygu)]·2CH3OH (25)
This complex was synthesized following the general procedure from bis-N-salicylidene
glutaric acid hydrazide (0.37 g, 1.00 mmol) and MoO2(acac)2 (0.65 g, 2.00 mmol) in
methanol. Yield: 0.59 g (0.86+mmol; 86 %). Anal. for C21H24N4O10Mo2 (684.31):
calcd. C 36.86, H 3.53, N 8.19; found C 37.04, H 3.30, N 8.26. 1H NMR (400 MHz,
DMSO-d6): δ = 1.89-1.96 (m, 2H, CH2), 2.42-2.48 (m, 4H, CH2CO), 3.15-3.16 (d, 6H,
CH3OH, J=5.20 Hz), 4.06-4.10 (q, 2H, CH3OH, J=5.21 Hz), 6.90-7.06 (m, 4H, arom.
CH ), 7.47-7.52 (m, 2H, arom. CH ), 7.65-7.68 (m, 2H, arom. CH ), 8.77 (s, 2H total,
CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 22.5 (CH2), 30.2 (CH2CO), 48.6
(CH3OH), 118.5, 120.1, 121.4, 134.2, 134.8 (all arom. CH and C ), 155.3 (CH=N), 159.3
(arom. C –OMo), 174.5 (aliphatic C –OMo) ppm. Selected IR data (cm−1): ν= 3310
(br, OH), 1609 (s, -HC=N-N=C-), 938 and 916 (s, MoO2), 821 (s) and 639 (s) and 575
(s) (Mo–O and Mo–N linkage) . UV/Vis (CH3OH solution, λmax in nm (ε in 10
3 M−1
cm−1)): 279 (27.8), 290 (26.5), 315 (15.8), 389 (1.62).
Synthesis of complex [(MoO2)2(salhyad)]·2CH3OH (26)
This complex was synthesized following the general procedure from bis-N-salicylidene
adipic acid hydrazide (0.36 g, 0.94 mmol) and MoO2(acac)2 (0.61 g, 1.88 mmol) in
methanol. Yield: 0.42 g (0.60 mmol; 64 %). Anal. for C22H26N4O10Mo2 (698.34):
calcd. C 37.85, H 3.75, N 8.02; found C 37.70, H 3.69, N 8.04. 1H NMR (400 MHz,
DMSO-d6): δ = 1.02-1.06 (m, 4H, CH2), 2.37-2.49 (m, 4H, CH2CO), 3.15-3.16 (d, 6H,
CH3OH, J=5.00 Hz), 4.06-4.10 (q, 2H, CH3OH, J=5.25 Hz), 6.89-7.05 (m, 4H, arom.
CH ), 7.47-7.50 (m, 2H, arom. CH ), 7.64-7.66 (m, 2H, arom. CH ), 8.74 (s, 2H total,
CH=N) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 25.3 (CH2), 30.7 (CH2CO), 48.6
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(CH3OH), 118.5, 120.1, 121.4, 134.2, 134.6 (all arom. CH and C ), 155.3 (CH=N), 159.2
(arom. C –OMo), 174.7 (aliphatic C –OMo) ppm. Selected IR data (cm−1): ν= 3308 (br,
OH solvent), 1613 (s, -HC=N-N=C-), 941 and 887 (s, MoO2), 818 (s) and 642 (s) and
580 (s) (Mo–O and Mo–N linkage). UV/Vis (CH3OH solution, λmax in nm (ε in 10
3 M−1
cm−1)): 279 (22.3), 290 (20.9), 315 (12.2), 389 (1.59).
Synthesis of chiral binuclear molybdenum complex (27)
Complex 27 was synthesized from (+) bis-N-salicylidene R-methyl succinic acid hydrazide
(0.37 g, 1.00 mmol) and MoO2(acac)2 (0.65 g, 2.00 mmol) in methanol (50 mL) with reflux
for one hour. Yield: 0.35 g (0.51 mmol; 51 %). Anal. for C21H24N4O10Mo2 (684.32):
calcd. C 36.55, H 3.53, N 8.19; found C 36.55, H 4.40, N 7.52. 1H NMR (400 MHz,
DMSO-d6): δ = 1.20-1.22 (d, 3H, CH3, J= 6.9 Hz), 2.78-2.83 (d, 2H, CH2CO, J= 8.6
Hz), 2.93-3.02 (m, 1H, CH ), 3.14-3.16 (d, CH3OH), 4.01 (CH3OH ), 6.89-6.92 (m, 2H,
arom. CH ), 7.02-7.05 (m, 2H, arom. CH ), 7.47-7.51 (m, 2H, arom. CH ), 7.66-7.68 (m,
2H, arom. CH ), 8.75 and 8.77 (s, 2H total, CH=N) ppm. 13C NMR (50 MHz, DMSO-
d6): δ = 17.6 (CH3), 33.8 (CH2), 35.3 (CH), 48.6 (CH3OH), 118.5, 120.0, 121.4, 134.2,
134.7 (all arom. CH and C ), 155.4 and 155.7 (both CH=N), 159.2 and 159.3 (both arom.
C –OMo), 173.0 and 176.8 (both aliphatic C –OMo) ppm. Selected IR data (cm−1): ν=
3198 (br, OH), 1616 (s, -HC=N-N=C-), 938 and 913 (s, MoO2).
Catalytic oxidation of methyl phenyl sulfide
Vanadium and molybdenum complexes (0.025 mmol) was dissolved at room temperature
in a mixture CH2Cl2/CH3OH 7:3 (25 mL) and phenyl methyl sulfide (0.29 ml, 2.5 mmol)
was added. The resulting solution was cooled down on an ice-bath and H2O2 26 % (1.2
equiv., 0.35 mL, 3 mmol) was added dropwise. The reaction solution was stirred at room
temperature in a capped flask and monitored by thin layer chromatography using as elu-
ent a mixture of ethyl acetate/chloroform/methanol-5:10:3 (v/v/v)). After 18 hours 1 µL
of the solution was assayed by gas-chromatography technique. Temperature programm:
55 ◦C hold for one minute, then the temperature increased to 200 ◦C with a heating rate
of 15 ◦C per minute, followed by five minutes holding of 200 ◦C temperature and heating
up to 240 ◦C with 15 ◦C per minute. When the chiral binuclear cis-dioxomolybdenum(vi)
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complex 27 was used as catalyst, the sulfide and the sulfoxide were separated by column
chromatography on silica gel, using pentane/diethyl ether 1:1 mixture for the unreacted
sulfide and ethyl acetate for the sulfoxide. The enantiomeric excess was determined
by HPLC determinations using chiral stationary phase (Pirkle Covalent S,S-WHELK-01
Regis) and hexane/i-propanol 9:1 as mobile phase with a flow rate of 2 mL min−1).
212
Chapter 7
Conclusions and Future Projects
Vanadium-containing haloperoxidases are enzymes capable to catalyze the oxidation of
halides by hydrogen peroxide, resulting in hypohalous acid formation. This oxidized
halide intermediate can halogenate various organic substrates59,71,72 and/or react with a
second equivalent of hydrogen peroxide to form singlet oxygen.73–75
X− + H2O2 + H
+ −→ HOX + H2O
HOX + RH −→ RX + H2O
HOX + H2O2 −→ H2O + 1O2 + X−
The crystal structure determination of V-BPO and V-CPO showed vanadate as the
prosthetic group solely covalently bonded to a histidine residue and fixed in the pro-
tein shell through a very strong hydrogen bonding network established by the positively
charged amino acid residues from its vicinity.38,70 The geometry of the vanadium atom
was proposed to be trigonal bipyramid, resembling the transition state of phosphate in
phosphatase enzymes.6,70 Moreover, vanadate was found to be vital for these class of
enzyme and its replacement with molybdate or tungstate yielded an inactive enzyme.62
Mutagenesis studies performed on V-CPO, by replacement of the amino acids involved in
the hydrogen binding site with alanine, proved their important role during the catalytic
turnover.63,150,180
Since the reaction mechanism of V-HPOs is still under debate and the number
of reported vanadium model complexes with relevant hydrogen bonding interaction is
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reduced,115,116 we decided to prepare vanadium complexes based on N-salicylidene hy-
drazide system which exhibit strong hydrogen bonding interactions. Starting from a non
substituted aliphatic side-chain, the functionalization of the aliphatic part of the ligand
made possible isolation of vanadium complexes which structurally mimic the hydrogen
bonding sphere of the prosthetic group in the natural system.
A monoprotonated vanadate moiety [VO3(OH)]
2− has been proposed as the active
site in the native enzyme by analogy with phosphate chemistry although, as it has been
mentioned the vanadate exists in the diprotonated form [VO2(OH)2]
− at physiological
pH. Therefore, N-salicylidene hydrazide is a versatile ligand system, being capable of
accommodating both the cis-dioxo- and monooxovanadium(v) complexes which are re-
garded as structural models for the enzymatic system. Additionally, the tridentate ligand
system makes possible variation of the protonation state in the obtained complexes. In
instance, the N-salicylidene carbonic acid hydrazide ligand system reacts with ammo-
nium metavanadate yielding anionic and/or neutral cis-dioxovanadium(v) complexes.
Further, the neutral cis-dioxovanadium(v) complexes react stoichiometrically with 8-
hydroxyquinoline to form mono-oxovanadium(v) complexes, thus proving the versatility
of the chosen chelate system. The anionic cis-dioxovanadium(v) complexes support a
protonation reaction at the basic hydrazide nitrogen atom yielding the corresponding
neutral complexes, which also can be deprotonated by back-reaction with base.
In Chapter 3, vanadium(v) complexes with an hydroxyl functionalized side chain
represent model systems for vanadium dependent haloperoxidases, namely regarding the
serin residue. Spectrophotometric titration with aqueous hydrochloric acid of the anionic
cis-dioxovanadium complexes in water solution, showed one protonation step which oc-
curred at the hydrazide nitrogen atom as more basic site compared to the oxo groups
of the vanadate center. Further on, the formation of the oxo-monoperoxovanadium(v)
complex by reaction of dioxovanadates with H2O2 was accomplished by spectrophoto-
metric titration in non-aqueous medium and confirmed by X-ray characterization of one
of such species. The oxo-monoperoxovanadium(v) complex functioned as intermediate
of the biomimetic reaction catalyzed by the corresponding cis-dioxovanadium(v) com-
plex but only when one equivalent of perchloric acid was used in stoichiometric amount.
Relevant hydrogen bonding interactions for the enzymatic system were observed in all
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vanadium(v) complexes. A rare example of an apical hydrogen bonded oxo group in
mono-oxovanadium(v) complex was also described.
In Chapter 4, the amino functionalized side chain afforded anionic cis-dioxovanadium
complexes in which the compensation of the negative charge of the vanadate center was
accomplished by the protonated amino functionality. This is a similar situation with one
found in the enzymatic system, especially because the protonated amino group of the syn-
thetic model is also in hydrogen bonding interaction with the oxo groups of the vanadate
center. Therefore, these complexes represent relevant functionalized model complexes
for V-HPOs regarding the lysine residue. This amino acid plays a very important role
for the catalytic activity and it is believed to increase the electrophilicity on the per-
oxo oxygen atom through hydrogen bonding interaction in the peroxide-form of V-CPO.
When a short aliphatic side chain of the Schiff base ligand was involved in vanadium
complex formation, the first example of a cis-dioxovanadium(v) complex with in situ
formed dihydro-pyrrole structure was obtained. The later vanadium compound was iso-
lated both as dimeric and monomeric structures, whereas the intramolecular cyclisation
reaction resulted in the formation of neutral cis-dioxovanadium complexes.
Further functionalization of the alkyl side chain was described in Chapter 5, where
the guanidine group has been introduced both in the starting aliphatic ester and by
direct guanilation reaction of a coordination compound. Therefore, the first example of
functionalization of a vanadium coordination compound was presented. The two cis-
dioxovanadium(v) complexes model the hydrogen bonding interaction of the prosthetic
group of the native enzymes with the arginine residues.6
The described cis-dioxovanadium(v) complexes functioned also as catalysts of the
biomimetic reaction, being capable to catalyze the oxidation of bromide by hydrogen
peroxide. The reaction was monitored by gas chromatography dosage of brominated
and non-brominated 1,3,5-trimethoxybenzene. Turnover rate of the catalytic reaction
range from 34 to 75 mol product×(mol catalyst×h)−1, with a slight increase when amino
and guanidine functionalities were parts of the vanadium complex structures. Also, a
shorter aliphatic side chain showed a higher catalytic activity, with the complex 18 as
the best catalyst of the series of cis-dioxovanadium(v) complexes based on N-salicylidene
hydrazides. The results of the catalytic reaction display fairly superior ability of these
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complexes, compared to inorganic ammonium metavanadate which was reported to cat-
alyze the same reaction with a turnover rate of 15 mol product×(mol catalyst×h)−1.117
Furthermore, the cis-dioxovanadium complexes shown here appeared to be slightly bet-
ter than reported functional mimics of the natural system,120,136 but still they catalyze
very slow the biomimetic reaction compared to vanadium bromoperoxidase. Therefore,
the design of a ligand system which provides a catalyst able to approach the enzyme in
reaction rate is still a difficult task. Obviously, the structural environment of vanadate
in the active-binding site plays a very important role during the catalytic cycles.
In recent years, numerous vanadium catalysts were designed for sulfide oxidation
reaction.189–192 Part of these vanadium complexes are also models of vanadium haloperox-
idase which also catalyze the oxidation of organic sulfides, varying from an enantioselec-
tive behavior when vanadium bromoperoxidase mediated the reaction to a non-selective
sulfide oxidation when vanadium chloroperoxidase was used as biocatalyst.87,89,90,175 The
herein described cis-dioxovanadium(v) complexes were also tested towards their capac-
ity to mediate the catalytic reaction of phenyl methyl sulfide by hydrogen peroxide. The
outcomes of the catalytic reaction results range from 82 to 89 % sulfide conversion within
18 hours, when cis-dioxovanadium(v) complexes with an intact Schiff base ligand were
used as catalysts, whereas a quantitative conversion of phenyl methyl sulfide was achieved
after 16 hours when the cis-dioxovanadium(v) complex with in situ formed dihydropyr-
role structure catalyzed the reaction. These results are similar with reported capacity of
vanadium complexes to catalyze the sulfide oxidation reaction.237–240 Nevertheless, in the
last chapter unprecedent examples of high efficient vanadium-catalysts for sulfuroxida-
tion reaction were described. The binuclear cis-dioxovanadium(v) complexes catalyzed
the oxidation of thioanisole with 78-84 % yields after two hours reaction time, whereas
the binuclear molybdenum complexes catalyze the same reaction almost quantitatively
within 90 minutes. The design of a chiral binuclear molybdenum complex showed instead
a non selective reaction, yielding a mixture of R and S isomers of phenyl methyl sulfoxide.
Future research in asymmetric sulfide oxidation reaction should therefore, be fo-
cused on the development of chiral vanadium complexes. An interesting future of the
chiral bis-N-salicylidene R-methyl succinic acid hydrazide is the substitution of the aro-
matic cycles, especially with steric hindrance electron donating groups. Another possible
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ligand system, which might also lead to vanadium-catalysts that approach a high ena-
tiomeric excess is also represented by replacement of the methyl group of the chiral center
with amino functionality.
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Figure 105: Schematic representation of possible chiral binuclear vanadium catalysts
based on bis-N-salicylidene L-glutamic dihydrazide ligand and its Boc-protected deriva-
tive.
In this case starting from commercially available L-glutamic acid dimethyl ester and
following the described procedure, the isolation of a chiral binuclear cis-dioxovanadium
complex will be also possible. The last system has the advantage of a possible Boc-
protection of the amino group which might increase the reactivity of the closer vanadate
moiety.
Another interesting future prospect is regarding the reactivity of the cis-dioxovana-
dium complexes towards a possible formation of an oxo-hxdroxy-vanadate moiety
[VvO(OH)]2+. In this case the spectrophotometric titration of the dioxovanadium com-
plexes with hydrochloric acid should also be performed in non-aqueous solution; for exam-
ple spectroscopically standard solution of HCl in ethanol, which is commercially available.
Another possible future of the vanadium model complexes is represented by the possibility
to increase the aliphatic chain length favoring therefore, the performance of the protona-
tion reaction in unpolar solvents. The 12-dodeca amino-fucntionalized alkylic side chain
might be a solution for designing a cis-dioxovanadium(v) complex with a moderate solu-
bility in acetonitrile. Here should be mentioned that, Pecoraro et al. showed spectropho-
tometrically the formation of [VvO(OH)]2+ unit when cis-dioxovanadium complexes were
reacted with HCl in acetonitrile solution.102
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Chapter 8
Characterization techniques and
crystallographical data
Carbon, hydrogen and nitrogen contents were determined at the ”Institut fu¨r Organ-
ische und Makromolekulare Chemie”, Friedrich-Schiller University, Jena using LECO
CHN/932 and VARIO EL III elemental analyzers.
1H, 13C, 51V NMR, 1H{1H} COSY and 1H{13C} heteronuclear correlation NMR spectra
were recorded on Bruker Avance 200 and 400 MHz spectrometers.
Mass spectroscopy analysis were conducted on a MAT95XL Finnigan instrument, using
electron spray ionization, negative and positive mode.
GC measurements were performed on a SRI 8610 gas chromatograph using MXT-1 Restek
coloumn.
Spectrophotometric titrations and UV-Vis spectra were recorded on a Varian Cary 5000
UV/Vis/NIR spectrophotometer using solvents of high purity. The spectrophotometer
was equipped with dual cell peltier accessory, which offered a continuous stirring and
temperature control.
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IR spectra were recorded on Bruker IFS55/Equinox spectrometer on samples prepared
as KBr pellets.
Potentiometric titration were performed on a Metller Toledo DL 50 titrator, using an
electrode.
HPLC measurements were carried out on Jasco-MD 1515 instrument equipped with UV-
diode array multiwavelength detector. The chiral sulfoxide were assayed using a REGIS
chiral column (PIRKLE COVALENT S,S-WHELK-01 10/100 FEC; 25 cm x 4.6 mm)
with a mixture hexane/i-propanol:90/10 (v/v) as mobile phase.
Cyclic voltametry measurements and square wave voltametric measurements have been
conducted in a three electrode technique using a home built computer controlled instru-
ment based on the PCI 6110-E data acquisition board (National Instruments). The exper-
iments were performed in acetonitrile solutions containing 0.25 M tetra-n-butylammonium-
hexafluorophosphate under a blanket of solvent saturated with argon. The ohmic resis-
tance that has to be compensated was determined by measuring the impedance of the
system at potentials where the faradaic current was negligible. Background corrections
was accomplished only for cyclic voltammograms by subtracting the current curves of the
blank electrolyte containing the same concentration of the supporting electrolyte from the
experimental cyclic voltammograms. Ag/AgCl was used as reference electrode in acetoni-
trile containing 0.25 M tetra-n-butylammonium chloride. The potential of this reference
system was calibrated by measuring the potential of the couple ferrocenium/ferrocene at
the end of each experiment and was found to be 0.812 ± 0.002 V throughout the measure-
ments. The working electrode was drop hanging mercury (mHg−drop= 4 mg) produced
by CGME instrument from Bioanalytical Systems Inc., West Lafayette, USA. Theoret-
ical square wave voltammograms were simulated using DigiElch package available from
www.DigiElch.de.
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Electronic paramagnetic resonance measurements were performed on a Bruker ESP 300E
using X-Band (9 GHz). Thermogravimetric analysis were carried out using NETZSCH
STA 409PC/PG instrument. The samples were placed in a heating block with a heating
rate of 5 K/minute under nitrogen atmosphere.
The crystallographic data were collected on a Nonius KappaCCD difractometer, using
graphite-monochromated Mo-Kα radiation of 71.073 pm. A summary of crystallographic
data and data collection for all complexes is given in the last part of the thesis. The struc-
tures were solved by direct methods (SHELXT) and subsequent least square refinement.
All non-hydrogen atoms were refined by using anisotropic displacement parameters, while
the hydrogen atoms were fixed and refined including their isotropic displacement param-
eters. For small sized crystals a BRUKER AXS difractometer with synchrotron radiation
was used for collecting the data.
General Remarks
N,N-Dimethylformamide (p.a.) have been purchased from Roth, stored over molecular
sieves and used as received.
Hydrogen peroxide, purchased from Merck, was standardized by titration with potassium
permanganate in presence of sulfuric acid.
Perchloric acid (aqueous solution) was standardized by potentiometric titration with
NaOH 1M solution.
All other agents were used as received, with no further purifications, except the situations
where was specified.
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Crystallographic data
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Summary of crystallographic data for complex 1 NH4[VO2(salhyp)]·2CH3OH.
Formula C13H22N3O5V
Formula weight 351.28
Crystal size (mm) 0.10 x 0.10 x 0.03
Crystal system triclinic
Space group P-1
Lattice parameters
a (pm) 751.52(4), α 67.902(3)
b(pm) 1428.99(6)), β 87.191(3)
c (pm) 1643.68(7), γ 79.543(3)
β(◦) 93.149(2)
Cell volume (106pm3) 1607.98(13)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.483
F(000) 736
µ(Mo Kα)(mm
−1) 0.643
Data collection range (◦) 2.41≤ Θ ≤27.49
Index range -7 ≤ h ≤ 9
-18 ≤ k≤ 17
-21 ≤ l ≤ 21
Reflection measured
total 7307
unique 5406 (Rint= 0.0354 )
Goodness-of-fit 1.057
R1 0.0523
wR2 0.1141
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Summary of crystallographic data for complex 2 [VO2(Hsalhyp)]
Formula C12H15N2O4V
Formula weight 302.20
Crystal size (mm) 0.10 x 0.10 x 0.04
Crystal system triclinic
Space group P-1
Lattice parameters
a (pm) 842.87(9) , α 66.802(6)
b(pm) 1156.46(15), β 81.107(8)
c (pm) 1439.71(16), γ 89.943(6)
Cell volume (106pm3) 1607.98(13)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.579
F(000) 624
µ(Mo Kα)(mm
−1) 0.792
Data collection range (◦) 2.68 ≤ Θ ≤ 27.45
Index range -10 ≤ h ≤ 10
-13 ≤ k≤ 14
-18 ≤ l ≤ 18
Reflection measured
total 5572
unique 3669 (Rint= 0.0418 )
Goodness-of-fit 1.035
R1 0.0730
wR2 0.1660
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Summary of crystallographic data for complex 3 [VO(salhyb)(Q)]
Formula C20H18N3O4V
Formula weight 415.31
Crystal size (mm) 0.03 x 0.03 x 0.03
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 981.38(3)
b(pm) 1034.14(3)
c (pm) 1835.78(6)
β(◦) 93.149(2)
Cell volume (106pm3) 1860.29(10)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.483
F(000) 856
µ(Mo Kα)(mm
−1) 0.566
Data collection range (◦) 2.26 ≤ Θ ≤ 27.43
Index range -12 ≤ h ≤ 12
-12 ≤ k≤ 13
-23 ≤ l ≤ 23
Reflection measured
total 4237
unique 3187(Rint= 0.0314)
Goodness-of-fit 1.016
R1 0.0463
wR2 0.1153
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Summary of crystallographic data for complex 4 [VO(salhyp)(Q)]
Formula C21H20N3O4V
Formula weight 429.34
Crystal size (mm) 0.03 x 0.03 x 0.02
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 1032.82(4)
b(pm) 1004.59(3)
c (pm) 1918.96(7)
β(◦) 94.962(2)
Cell volume (106pm3) 1983.58(12)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.438
F(000) 888
µ(Mo Kα)(mm
−1) 0.533
Data collection range (◦) 3.09≤ Θ ≤27.49
Index range -13 ≤ h ≤ 13
-13 ≤ k≤ 12
-24 ≤ l ≤ 24
Reflection measured
total 4529
unique 3079(Rint= 0.0385)
Goodness-of-fit 1.031(4)
R1 0.0458
wR2 0.0983
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Summary of crystallographic data for complex 5 [VO(salhyh)(Q)]
Formula C22H22N3O4V
Formula weight 443.37
Crystal size (mm) 0.04 x 0.03 x 0.03
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 1031.99(3)
b(pm) 1052.39(3)
c (pm) 1834.62(5)
β(◦) 93.9260(10)
Cell volume (106pm3) 1987.82(10)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.481
F(000) 920
µ(Mo Kα)(mm
−1) 0.534
Data collection range (◦) 2.23≤ Θ ≤ 27.45
Index range -13 ≤ h ≤ 13
-13 ≤ k≤ 12
-23 ≤ l ≤ 23
Reflection measured
total 4514
unique 3331(Rint= 0.0322)
Goodness-of-fit 1.025
R1 0.0394
wR2 0.0848
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Summary of crystallographic data for methoxy-bis-(8-quinolinato)-oxovanadium(v) com-
plex (6)
Formula C19H15N2O4V
Formula weight 386.27
Crystal size (mm) 0.03 x 0.03 x 0.02
Crystal system monoclinic
Space group C2/c
Lattice parameters
a (pm) 4888.07(13)
b(pm) 965.42(2)
c (pm) 1427.88(4)
β(◦) 100.2750(10)
Cell volume (106pm3) 6630.2(3)
Z 16
Temperature (K) 183(2)
∆calc(g cm
−3) 1.548
F(000) 3168
µ(Mo Kα)(mm
−1) 0.627
Data collection range (◦) 1.69 ≤ Θ ≤ 27.47
Index range -60 ≤ h ≤ 63
-12 ≤ k≤ 12
-16 ≤ l ≤ 18
Reflection measured
total 7590
unique 5537(Rint= 0.0492)
Goodness-of-fit 1.055
R1 0.0480
wR2 0.1042
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Summary of crystallographic data for complex 9 [VO(O2)(Hsalhyhb)H2O]·H2O.
Formula C11H17N2O8V
Formula weight 356.21
Crystal size (mm) 0.04 x 0.03 x 0.03
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 1034.3(2)
b(pm) 698.86(14)
c (pm) 2006.6(4)
β(◦) 100.74(3)
Cell volume (106pm3) 1425.0(5)
Z 4
Temperature (K) 293)
∆calc(g cm
−3) 1.660
F(000) 736
µ(Mo Kα)(mm
−1) 0.740
Data collection range (◦) 3.09≤ Θ ≤ 29.39
Index range -14 ≤ h ≤ 14
-8 ≤ k≤ 9
-27 ≤ l ≤ 25
Reflection measured
total 14918
unique 3887(Rint= 0.1472)
Goodness-of-fit 0.768
R1 0.0454
wR2 0.0807
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Summary of crystallographic data for complex 10 [VO(salhyhb)(Q)].
Formula C20H18N3O5V
Formula weight 431.31
Crystal size (mm) 0.03 x 0.03 x 0.02
Crystal system triclinic
Space group P-1
Lattice parameters
a (pm) 1010.08(2), α 88.9150(10)
b(pm) 1042.23(3), β 89.170(2)
c (pm) 1779.17(6) , γ 88.790(2)
Cell volume (106pm3) 1872.06(9)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.530
F(000) 888
µ(Mo Kα)(mm
−1) 0.569
Data collection range (◦) 2.78 ≤ Θ ≤ 27.49
Index range -11 ≤ h ≤ 13
-12 ≤ k≤ 13
-23 ≤ l ≤ 22
Reflection measured
total 8519
unique 6635(Rint= 0.0269 )
Goodness-of-fit 1.029
R1 0.0401
wR2 0.0896
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Summary of crystallographic data for complex 13 [VO2(Hsalhycab)]2.
Formula C22H24N6O6V2
Formula weight 570.35
Crystal size (mm) 0.03 x 0.03 x 0.02
Crystal system monoclinic
Space group P21/c
Lattice parameters
a (pm) 695.49(9), α 90.00
b(pm) 1406.14(18), β 105.190(5)
c (pm) 1245.55(17) , γ 90.00
Cell volume (106pm3) 1175.5(3)
Z 2
Temperature (K) 120(2)
∆calc(g cm
−3) 1.611
F(000) 584
µ(synchrotron radiation)(mm−1) 0.442
Data collection range (◦) 2.02 ≤ Θ ≤ 12.42
Index range -8 ≤ h ≤ 8
-17 ≤ k≤ 17
-15 ≤ l ≤ 15
Reflection measured
total 2237
unique 1829(Rint= 0.0664)
Goodness-of-fit 1.029
R1 0.0384
wR2 0.1020
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Summary of crystallographic data for complex 14 [VO2(Hsalhycab)].
Formula C11H12N3O3V
Formula weight 285.18
Crystal size (mm) 0.04 x 0.04 x 0.03
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 814.74(5), α 90.00
b(pm) 663.96(4), β 91.545(3)
c (pm) 2133.14(9) , γ 90.00
Cell volume (106pm3) 1153.51(11)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.642
F(000) 584
µ(Mo Kα)(mm
−1) 0.864
Data collection range (◦) 3.21 ≤ Θ ≤ 27.47
Index range -10 ≤ h ≤ 8
-8 ≤ k≤ 8
-27 ≤ l ≤ 26
Reflection measured
total 2645
unique 1796(Rint= 0.0612 )
Goodness-of-fit 1.029
R1 0.0425
wR2 0.0906
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Summary of crystallographic data for complex 15a [VO2(salhyah)].
Formula C13H18N3O4V
Formula weight 331.24
Crystal size (mm) 0.03 x 0.03 x 0.02
Crystal system monoclinic
Space group P21/n
Lattice parameters
a (pm) 762.300(10), α 90.00
b(pm) 2129.02(5), β 108.1470(10)
c (pm) 902.08(2) , γ 90.00
Cell volume (106pm3) 1391.21(5)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.581
F(000) 688
µ(Mo Kα)(mm
−1) 0.733
Data collection range (◦) 2.97 ≤ Θ ≤ 27.50
Index range -9 ≤ h ≤ 9
-25 ≤ k≤ 27
-9 ≤ l ≤ 11
Reflection measured
total 3180
unique 2893(Rint= 0.0214)
Goodness-of-fit 1.029
R1 0.0289
wR2 0.0754
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Summary of crystallographic data for complex 15b [VO2(salhyah)]·0.5H2O.
Formula C13H19N3O4.5V
Formula weight 340.25
Crystal size (mm) 0.04 x 0.04 x 0.03
Crystal system orthorhombic
Space group Pbcn
Lattice parameters
a (pm) 1964.56(7), α 90.00
b(pm) 923.93(3), β 90.00
c (pm) 1687.40(7) , γ 90.00
Cell volume (106pm3) 3062.83(19)
Z 8
Temperature (K) 183(2)
∆calc(g cm
−3) 1.476
F(000) 1416
µ(Mo Kα)(mm
−1) 0.670
Data collection range (◦) 2.07 ≤ Θ ≤ 27.46
Index range -25 ≤ h ≤ 25
-11 ≤ k≤ 11
-9 ≤ l ≤ 9
Reflection measured
total 3487
unique 2312(Rint= 0.0709)
Goodness-of-fit 1.029
R1 0.0392
wR2 0.0919
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Summary of crystallographic data for complex 16 [MoO2(salhycab)CH3OH].
Formula C12H15N3O4Mo
Formula weight 361.21
Crystal size (mm) 0.03 x 0.02 x 0.02
Crystal system monoclinic
Space group P21/c
Lattice parameters
a (pm) 1021.06(3) , α 90.00
b(pm) 1282.03(4), β 110.274(2)
c (pm) 1091.66(2) , γ 90.00
Cell volume (106pm3) 1340.48(6)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.790
F(000) 728
µ(Mo Kα)(mm
−1) 0.996
Data collection range (◦) 2.55 ≤ Θ ≤ 27.46
Index range -13 ≤ h ≤ 13
-16 ≤ k≤ 16
-14 ≤ l ≤ 14
Reflection measured
total 3054
unique 2761(Rint= 0.0235)
Goodness-of-fit 1.064
R1 0.0283
wR2 0.0588
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Summary of crystallographic data for complex 18 [VO2(salhyga)]·3H2O.
Formula C10H18N5O7V
Formula weight 371.23
Crystal size (mm) 0.03 x 0.03 x 0.03
Crystal system orthorhombic
Space group P212121
Lattice parameters
a (pm) 674.76(2) , α 90.00
b(pm) 1293.61(6), β 90.00
c (pm) 1725.39(9), γ 90.00
Cell volume (106pm3) 1506.05(11)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.637
F(000) 768
µ(Mo Kα)(mm
−1) 0.704
Data collection range (◦) 2.84 ≤ Θ ≤ 27.46
Index range -8 ≤ h ≤ 8
-16 ≤ k≤ 16
-21 ≤ l ≤ 22
Reflection measured
total 3435
unique 2777(Rint= 0.0573)
Goodness-of-fit 1.025
R1 0.0398
wR2 0.0807
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Summary of crystallographic data for complex 19 [VO2(salhygh)].
Formula C14H19N5O4V
Formula weight 372.28
Crystal size (mm) 0.04 x 0.04 x 0.03
Crystal system monoclinic
Space group I2/a
Lattice parameters
a (pm) 1658.94(7) , α 90.00
b(pm) 995.55(3), β 94.397(2)
c (pm) 2076.82(9), γ 90.00
Cell volume (106pm3) 3419.9(2)
Z 8
Temperature (K) 183(2)
∆calc(g cm
−3) 1.446
F(000) 1544
µ(Mo Kα)(mm
−1) 0.608
Data collection range (◦) 2.27 ≤ Θ ≤ 27.45
Index range -21 ≤ h ≤ 19
-12 ≤ k≤ 12
-23 ≤ l ≤ 26
Reflection measured
total 3884
unique 2611(Rint= 0.0577)
Goodness-of-fit 1.036
R1 0.0497
wR2 0.1072
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Summary of crystallographic data for complex 25 [(MoO2)2(salhygu)·2CH3OH].
Formula C21H24N4O10Mo2
Formula weight 684.32
Crystal size (mm) 0.043 x 0.03 x 0.02
Crystal system orthorombic
Space group P212121
Lattice parameters
a (pm) 746.59(2) , α 90.00
b(pm) 954.11(3), β 90.00
c (pm) 3499.51(11), γ 90.00
Cell volume (106pm3) 2492.80(13)
Z 4
Temperature (K) 183(2)
∆calc(g cm
−3) 1.823
F(000) 1368
µ(Mo Kα)(mm
−1) 1.069
Data collection range (◦) 1.16 ≤ Θ ≤ 27.47
Index range -9 ≤ h ≤ 9
-12 ≤ k≤ 12
-28 ≤ l ≤ 44
Reflection measured
total 5485
unique 4056(Rint= 0.0716)
Goodness-of-fit 1.010
R1 0.0486
wR2 0.0799
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